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Cultures of astrocytes prepared from the brains of newborn mice, G26-24 
oligodendroglioma cells and C1300 neuroblastoma cells were treated with 
Interferon (IFN) and the effect on major histocompatibility complex (MHC) 
antigen expression assessed by indirect immunofluorescence. IFN-a/3 
Increased class I, but not class II, MHC antigen expression on astrocytes, 
G26-24 cells and C1300 cells. IFN-/3^ , increased class I, but not class II, 
MHC antigen expression on astrocytes? IFN- 7 increased both class I and 
class II MHC antigen expression on astrocytes and G26-24 cells. IFN-7  
increased class I, but not class II, MHC antigen expression on C1300 cells. 
IFN-a/3 and IFN-/L were additive with IFN- 7 in the induction of class I MHC 
antigen expression on astrocytes, but inhibited the ability of IFN- 7  to 
induce class II MHC antigen expression. IFN-a0 and IFN- 7 increased the 
susceptibility of astrocytes, C26-24 cells and C1300 cells to lysis by 
alloreactlve cytotoxic T-lymphocytes (CTL) indicating that IFNs increased 
the ability of the cells to participate in class I MHC restricted T-cell 
immune reactions. Astrocytes treated with IFN-a/3 or IFN-7 , and G26-24 
cells and C1300 cells treated with IFN-7 , prior to infection with Semlikl 
Forest virus (SFV), showed a similar or increased susceptibility to SFV- 
speclflc CTL lysis, despite a reduction of SFV antigen display on the 
cells, as assessed by indirect immunofluorescence and susceptibility to 
lysis by anti-SFV antibody plus complement. It is concluded that even when 
SFV antigen expression is reduced by IFN treatment, in the context of 
enhanced class I MHC antigen expression cells remain susceptible to SFV- 
specific CTL lysis. IFN-a/i and IFN- 7  treatment of astrocytes, and IFN-7  
treatment of G26-24 cells, prior to treatment with a /3-propiolactone 
inactivated preparation of SFV, increased the ability of the cells to 
stimulate SFV-specific T-cell release of IFN-7 . This increased ability 
correlated with an increase in MHC antigen expression on the cells. IFN-7  
released by SFV-specific T-cells increased class I and class II MHC antigen 
expression on astrocytes and G26-24 cells indicating that a positive 
feedback mechanism could operate. SFV-infected newborn and adult mice 
possessed high levels of IFN-a0 in the brain. Brain extracts prepared from 
SFV-infected newborn and adult mice increased class I, but not class II,
MHC antigen expression on astrocytes in vitro. Class I and class II MHC 
antigen expression was slightly elevated in the brains of SFV-infected 
newborn mice. To study the role of endogenous IFN-7 , R4-6A2 anti-IFN- 7 
monoclonal antibody was administered to adult mice, prior to infection with 
SFV, and the effect on the clinical course of SFV-disease monitored. R4- 
6A2 antibody had no effect and preliminary experiments indicated that the 
antibody may not neutralise all IFN- 7 activity in vivo under the conditions 
used.
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Introduction
Interferon (IFN) was discovered In 1957 by Isaacs and Lindenmann who 
observed that fluids harvested froa cultures of chick chorio-allantoic 
membranes which had been treated with a heat*inactivated preparation of 
influenza virus contained a factor which could be recognised by its ability 
to render fresh cultures of the membranes resistant to Infection by live 
influenza virus (Issacs and Lindenmann, 1957) . Since this time IFNs have 
been the subject of an immense number of studies, and it is now apparent 
that they have a wide range of activities including immunomodulatory 
effects which may, under certain circumstances, be of more importance than 
the classical antiviral effect.
The purpose of this Introduction is not to give an exhaustive review of the 
IFN system, but rather to discuss those areas of IFN biology most relevant 
to this project and the possible physiological role of IFNs in viral 
disease. Since this project made use of the inbred mouse as a convenient 
model system on which the effects of IFN could be studied, much of what 
follows will be largely concerned with the murine system. However, since 
the long term hope of these studies is to facilitate the understanding of 
the role of human interferons in resistance to viral disease, comparisons 
with the human system will be made whenever differences between the systems 
are known to exist or as appropriate.
I D __Introduction to the Interferon system
IFNs are defined as proteins which exert a virus non-specific antiviral
1
activity at least in homologous cells through cellular metabolic processes 
involving the synthesis of both ribonucleic acid (RNA) and protein 
(Comittee on Interferon nomenclature, 1980). To date three main classes 
of murine and human IFN have been identified; a, fi and 7 , which were 
classified on the basis of antigenicity using polyclonal antisera 
(Committee on Interferon nomenclature, 1980). IFNs a and fi, also known as 
type I or viral IFNs, are produced by most cell types when infected with 
virus (De Maeyer, 1984). In contrast IFN-7 , also known as type II or 
immune IFN, is produced exclusively by T-lymphocytes following stimulation 
by specific antigen or mitogen (Klein Al-, 1982). Prior to the official 
nomenclature designations in 1980, IFN-o and IFN-0 were termed leukocyte 
and fibroblast IFN respectively, since the predominant form of IFN produced 
by each of these cell types found to be antigenlcally distinct (Havell *£ 
al. . 1975; Edy al. , 1976). These terms were however misleading and were 
abondoned since leukocytes and fibroblasts are able to produce both 
antigenic species of IFN (Dalton and Paucker, 1979; Pang &£ al. , 1980). 
Throughout this thesis IFN-o and IFN-/9 will be referred to as IFN-a/3 
whenever the exact type has not been specified or where a mixture of the 
two types exists.
DNA sequence analysis of molecularly cloned IFN-a has revealed that the 
antigenlcally distinct IFN-a species actually consist of a family of 
closely related proteins (designated IFN-o^, IFN-a^, etc ...) which are 
between 161 and 167 amino-acids long in the murine system, and between 165 
and 172 amino-acids long in man (Kawade, 1987). The IFN-o proteins have 
around 80% homology in amino-acid sequence (Knight, 1984) and are coded for 
by a multi gene family comprised of at least 10 genes in the murine system, 
and at least 13 genes in man (Goeddel et al. . 1981; Shaw £_£ al. , 1983; 
Kawade, 1987). In contrast, there is only one gene for IFN-0 in both the
2
murine and human system, which codes for a protein 161 and 166 amino-acids 
long, respectively (Derynck g_£ Ai -. 1980; Higashi a£ Ai-» 1983). A second, 
putative IFN- ^ 2 gene has been cloned in both the murine and human system 
although it is at present unclear whether the protein coded has an 
antiviral activity (Marx, 1988). Both murine and human IFN-a and fi genes 
do not contain lntrons (Nagata at Ai -. 1980; Degrave a£ Ai -. 1981; Higashi 
et al. , 1983; Shaw at ai ■ . 1983; Gray and Goeddel, 1983) and are located on 
chromosome U in the mouse (Kelley at Ai- . 1983) and on chromosome 9 in man 
(Shows at ai-. 1982). DNA sequence analysis has revealed regions of 
extensive homology within the upstream flanking regions of the IFN-a and 
IFN-/9 genes, which are not found associated with the IFN-f gene (Degrave at 
al.. 1981; Gray and Goeddel, 1982). These regions may contain the 
consensus sequences regulating the expression of the IFN-a and IFN-/9 genes, 
and may explain why these IFNs are often produced simultaneously (Riordan 
and Pltha-Rowe, 1985). Fujita and coworkers have recently Isolated a 
virus-inducible gene encoding a transcription factor IRF-1 (Interferon 
regulatory factor-1) which mediates the transcription of IFN-a and IFN-0 
genes (Miyamoto ££ Ai-• 1988; FUjlta At Ai-• 1989). IRF-1 has been shown 
to bind to the upstream regulatory region of the IFN-0 gene (Fujita fit Ai-• 
1988) but it is not yet known whether IRF-1 also binds to the homologous 
upstream region of the IFN-a genes. IFN-a and IFN-0 are related proteins 
which share 20t homology at the amino-acid level in the mouse (Dljkmans and 
Billiau, 1985) and 29% homology in man (Taniguchi At al. . 1980). Both 
share a common receptor on the surface of cells which are sensitive to 
their effects (Aguet and Blanchard, 1981; Branca and Baglioni, 1981) and 
are generally stable at pH2 and 56°C, although an acid labile IFN-a has 
been reported (Preble £t Ai- . 1982; Balkwlll, 1983). IFN-7 , which was 
first described in 1965 as being produced in lymphocyte cultures stimulated 
by the T-cell mitogen phytohaemagglutinin (Wheelock, 1965), differs from
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IFN-a and IFV-fi not only by Its node of Induction but also by Its 
physicochemical properties and genetic organisation. Thus, to date one 
IFN-y gene has been Identified in both the isurlne and human system, and in 
contrast to the genes for IFN-a and IFN-0, contains three introns (Gray and 
Goeddel, 1982, 1983) and is located on chromosome 12 in the mouse (Naylor 
et al. . 1984) and on chromosome 10 in man (Trent *1-, 1982). DNA 
sequence analysis of molecularly cloned IFN-y has also revealed the IFN-y 
molecule, which is 136 amino-acids long in the murine system (Gray and
Goeddel, 1983) and 146 amino-acids long in man (Gray and Goeddel, 1982) to
be shorter than both IFN-a and IFN-fi. Furthermore, the primary amino-acid 
sequence of IFN-y is unrelated to that of IFN-a and IFN-0 (Dijkmans and 
Billiau, 1985). IFN-y is labile at pH 2 and 56°C, and binds to a receptor 
on the surface of cells which appears to be distinct from that used by IFN- 
a and IFN-0 (Branca and Baglioni, 1981; Aguet and Blanchard, 1981). It is 
now clear that IFN-0 and IFN-y are glycosylated in both the murine and
human system (Bocci, 1983; Kawade, 1987). The subtypes of murine IFN-a are
also glycosylated (Fljisawa g_£ al. . 1978; Kawade, 1987) but in contrast the 
majority of human IFN-a subtypes are non-glycosylated with only 3 
glycosylated subtypes recognised to date (Zoon ££ al.. 1987).
Glycosylation of IFN does not however appear to be important for biological 
activity since recombinant IFNs produced in bacteria (hence which are non- 
glycosylated) have activities comparable, at least in vitro, to those 
displayed by natural IFN (McCullagh et al-• 1983). The possibility that 
glycosylation may influence the stability and tissue specificity of IFNs in 
vivo has been suggested as a result of the observations that human IFN-0 
and IFN-y when administered intramuscularly were found to remain at this 
site, whereas IFN-a when administered Intramuscularly rapidly diffused into 
the plasma (Bocci, 1983).
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Although IFNs were originally identified and are currently defined by 
virtue of their antiviral activity, it ia now clear that they also exert a 
series of effects on immune cells, on myelomonocytlc cells, and on a 
variety of other cell types (Trlnchlerl and Perussla, 1985; Vilcek and De 
Haayer, 1984). Some of these effects are mediated by all three IFN types 
whilst others are mediated exclusively by IFN-7 . In the cases where the 
effects are mediated by all three IFN types, IFN-y has been shown to be 
effective at significantly lower concentrations (relative to antiviral 
activity units) than IFN-a or IFN-0. For example, Varesio and coworkers 
demonstrated that both natural IFN-/? and recombinant IFN-7 activated murine 
macrophages for tumour cell killing in vitro. and showed that IFN- 7 was 100 
to 1000 times more potent than IFN-0 in Inducing this activity (Varesio 
al. . 1984). Similar observations were also made by Pace ££ al. . (1985) who 
found that recombinant IFN-7 was 500 to 1000 times more active than both 
natural IFN-a and natural IFN-0 in inducing murine macrophage tumourlcldal 
activity in vitro. Recombinant IFN-a, natural IFN-/? and recombinant IFN-7  
have also been shown to increase murine macrophage Fc receptor mediated 
phagocytic activity in vitro. and again IFN-y was found to be 10 to 1000 
times more potent in this respect (Fertsch and Vogel, 1984). Rubin and 
Gupta (1980) compared the antiproliferative effect of human natural IFN-a0 
and natural IFN- 7 in vitro, and found that IFN- 7 was more than 160 times 
more active in inhibiting human fibroblast proliferation. Human 
recombinant IFN- 7 has also been shown to be 50 times more active than human 
natural IFN-a and IFN-/? in enhancing the natural killer activity of human 
lymphocytes in vitro (Welgent ¿1., 1983). Studies by Uallach and 
coworkers also demonstrated that human natural IFN-y Increased class I 
major histocompatibility complex (MHC) HIA-A.-B.-C, antigen expression on 
human lymphoblastoid cells at concentrations 100 times lower than needed to 
Induce an antiviral state. This difference was not found with human
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natural IFN-a or IFN-/9 which Increased class I MHC antigen expression and 
Induced an antiviral state over the same range of concentrations (tfallach 
et al. . 1982). Taken together the results of these studies clearly 
indicate that IFN- 7  is a potent lmmunomodulator and suggest that the 
antiviral activity may not be its most important function.
When protein extracts of human fibroblasts induced with human natural IFN- 
a, IFN-ft or IFN- 7  are analysed by two-dimensional gel electrophoresis, it 
is clear that all three IFN types induce the synthesis of a common group of 
polypeptides (Well fetal-, 1983). These probably include those responsible 
for mediating the shared activities of IFNs. The synthesis of two proteins 
(molecular weights 56 and 67 kilodaltons) induced by both natural IFN-a and 
IFN- 7  has also been found to be regulated differently in human fibroblasts. 
Thus, synthesis of these proteins was regulated both at the transcriptional 
level and at the translational level in cells treated with IFN-a, whereas 
the translational regulation was inoperative in IFN- 7  treated cells (Sen 
and Rubin, 1984). Clearly, even in the shared activities of the two IFN 
types, the molecular mechanisms involved are not identical. IFN- 7 has also 
been shown to induce a unique set of twelve distinct polypeptides in 
addition to the common group of polypeptides induced by all three IFN types 
(Veil fet al.. 1983). This additional set of polypeptides may mediate the 
activities which appear to be exclusive to IFN-7 , an example of which is 
the ability to increase (or induce) class II MHC antigen expression on a 
number of cell types (Trinchieri and Perussia, 1985).
As mentioned previously, it is now clear that the IFN-a species actually 
consist of a family of closely related proteins. The biological 
significance of this diversity may lie with the observations that a number 
of IFN-a subtypes differ in biological activity. For example, Evinger and
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coworkers purified eight subtypes of human natural IFN-a and showed that 
the ratio of antiproliferative to antiviral activity was not constant for 
each of the subtypes but varied upto thirty fold. Furthermore, the ratio 
of antiviral activity on human cells to that on bovine cells differed 
between the IFN-a subtypes (Evinger *1-, 1981). Similar observations 
were also made by Streull al- (1980) who compared the antiviral 
activities of recombinant human IFN-al and IFN-a2 (bacterial products were 
used) on human and bovine cells, and showed that IFN-al was 10-20 fold more 
active on bovine cells than on human cells while IFN-a2 was twice as active 
on human cells as on bovine cells. Recombinant human IFN-aD has also been 
shown to be slightly more active than recombinant human IFN-aA in inducing 
the natural killer cell activity of human lymphocytes (both IFN-aA and IFN- 
aD were bacterial products, IFN-aA — IFN-a2 and IFN-aD — IFN-al : Taylor- 
Papidlmitriou, 1985) (Targon and Stabbing, 1982).
(2) Mechanisms of the antiviral effect of IFN on cells
IFN has no direct effect on viral particles. Instead, all antiviral 
effects of IFN are the results of biochemical modifications of treated 
cells whereby the cells are rendered unable to proceed through the various 
steps required for the synthesis and assembly of virions.
As mentioned previously, IFN-y binds to a receptor on the surface of cells 
which appears to be distinct from that used by IFN-a and IFN-0 (Branca and 
Baglioni, 1981; Aguet and Blanchard, 1981). The presence of a specific 
receptor at the cell-surface is the first requirement for IFN action : 
cells which do not express receptors are resistant to the action of IFN 
(Aguet, 1980; Marti a£ al-. 1981). Cells respond to IFN treatment by 
initiating a series of biochemical changes which eventually result in the
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development of an antiviral state. Not only Is the activation of these 
biochemical changes different In different cell-types but viruses show a 
differential susceptibility to their action. For example, whilst 
encephalomyocardltls virus and vesicular stomatitis virus are very 
sensitive to the antiviral activity of IFNs, the replication of these two 
viruses Is Inhibited by different IFN-Induced biochemical changes in a 
given cell-type (Taylor-PapIdimitrlou, 1985). In this section I shall 
briefly outline the mechanisms whereby IFNs may exert their antiviral 
effect. For a comprehensive review of this area the reader Is referred to 
Friedman (1984).
The antiviral effect of IFN Is considered to depend, at least In part, on 
the expression of two enzymic pathways : the 2',5*-oligoadenylate 
synthetase-nuclease pathway, and the elongation Initiation factor-2 (eIF-2) 
protein kinase pathway. Both enzyme systems are induced by IFNs-a, -f) and - 
1 , but remain in a latent state until they are activated by double-stranded 
ribonucleic acid (ds RNA) (Content, 1984). Experiments performed in vitro 
have shown that the 2*,5*-oligoadenylate synthetase Is activated when bound 
to ds RNA containing more than 30 base-pairs. ds RNA of this size is 
thought to be only found In virus-Infected cells (Baglioni, 1987).
Activated 2'-5' ollgoadenylate synthetase has been shown to synthesise 2'- 
5' linked oligoadenylates [pppA(2'p5'A)n] (known as 2-5A) from adenosine 
triphosphate (Minks Al-, 1979). 2-5A activates endogenous rlbonuclease
L by binding to the enzyme. Activated ribonuclease L degrades viral 
messenger RNA and Is thus thought to inhibit viral replication (Baglioni, 
1987). A number of studies have Indicated that the 2-5A system Is 
operative in intact cells. Thus, Nilsen ££ fil., (1982a) showed that 2-5A 
was synthesised In reovirus-infected IFN-0 treated human HeLa cells and 
that viral messenger RNA was degraded. Similarly, in encephalomyocarditis
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virus - infected IFN-a£ created murine L cells che 2-5A synthetase la 
activated, 2-5A is present (Knight At al.. 1980), and the ribonucleaae is 
activated (Vreschner At Al-. 1981). Chebath At Al- (1987) transfected 
Chinese hamster ovary cells with cDNA encoding the 2-5A synthetase enzyme. 
They obtained transfectants which expressed high constitutive levels of 2- 
5A synthetase and showed that the elevated enzyme activity correlated with 
resistance to infection by Mengovirus, but did not make the cells resistant 
to vesicular stomatitis virus. These observations clearly indicate that 2- 
5A synthetase is sufficient to protect chínese hamster ovary cells against 
infection by Mengovirus, but not by vesicular stomatitis virus. A 67-73 
kilodalton ds RNA-dependant protein kinase has been detected in cellular 
extracts of IFN-afi-treated cells by several groups (Sen At Al- . 1978; 
Baglionl and Maroney, 1980). Purified ds RNA-dependant protein kinase has 
been shown to phosphorylate the smallest subunit (a) of eIF-2 (Berry At 
al.. 1985). Phosphorylation of eIF-2 impairs its ability to participate in 
the formation of the AOS initiation complex, and thus leads to an 
inhibition of protein synthesis initiation (Jagus a£ a 1-• 1980). A number 
of studies have Indicated that the protein kinase system is operative in 
Intact cells. Thus, Gupta and Holmes (1982) detected kinase activation 
(i.e. 67 kd protein phosphorylation) in IFN-afl treated and reovlrus- 
infected murine L929 cells. Nllsen At Al- (1982b) showed that reovirus- 
infectlon of IFN-0 treated HeLa cells resulted in the elevation of kinase 
activity and the concomitant phosphorylation of eIF-2. Two HeLa lines 
which showed different sensitivities to IFN induced inhibition of reovirus 
growth had comparable levels of 2-5A synthetase activity, but the more 
sensitive line demonstrated 3-4 times more protein kinase activity and an 
Increased phosphorylation of eIF-2 (Nilsen At al.. 1982b). A lack of 
correlation between the induction of protein kinase activity and inhibition 
of vesicular stomatitis virus replication in several murine cells has also
9
The antiviral effects of IFNs cannot be accounted for soley by the 2-5A and 
protein kinase pathways. For example, Lewis (1988) showed that IFN-/9 
Induced an antiviral state which prevented replication of vesicular 
stomatitis virus, Mengovlrus and reovlrus In murine Ltk cells In the 
absence of elevated levels of 2-5A synthetase and eIF-2 kinase. Several 
studies have shown that IFNs may also have a number of effects on the final 
maturation of virus. For example, In IFN treated Ocomavlrus-Infected 
cells there Is no detectable Inhibition of viral RNA or protein synthesis 
but an accumulation at the cell-surface of non-Infectious defective vlrus- 
partlcles (Friedman a£ al. . 1975; Pltha £_£ al- . 1976; Bllllau at al- .
1976). The mechanlsm(s) whereby these IFN-lnduced abnormalities in 
assembly, maturation and release occur are not known. Maheshwar si al. 
(1980) showed that whilst low amounts of IFN-ar/) reduced the yield of 
vesicular stomatitis virus particles from murine L cells 10-fold, the 
Infectivlty of progeny particles was reduced 1000-fold. Subsequently, the 
reduction In Infectivlty was shorn to result from the specific inhibition 
of Incorporation of the G and M proteins Into suturing virions in IFN- 
treated cells (Jay si al-. 1983).
Alleles of a mouse gene, Mx, have been shown to selectively influence the 
ability of IFN-a/9 (but not IFN-y) to protect cells against influenza virus 
infection. Thus, cells derived from mice carrying the Mx gene are 
protected against Influenza virus infection by much lower concentrations of 
IFN-al than cells from non-Mx bearing strains (Taylor-Papidlmltriou, 1985). 
The kinetics of protection against influenza in Mx-bearing peritoneal
been reported (Sen and Herz, 1983). Clearly, as for the 2-5A system, the
relative Importance of protein kinase In mediating the antiviral effect of
IFN Is dependant on the virus-cell system being used.
macrophages has been shown Co be markedly different from Che anCivlral 
state induced againsC vesicular scomatis virus in these cells, indicating 
Chat Che two antiviral mechanisms are unrelated (Arnheiter and Haller,
1983) . A 72 kilodalton protein which is specific to Mx-bearing cells has 
been described, and rn mRNA specific to IFN-a0 treated Mx-carrying cells 
has been isolated which codes for a similar protein (Horlsberger g_£ ai., 
1983; Staehell at al. , 1983; Taylor-Papidlmitrlou, 1985). This protein is 
not induced by IFN-y (Taylor-Papidimitriou, 1985). The role of this 
protein in mediating the antiviral effect of IFN-<*0 in Mx-bearing cells is 
not known but there is a marked inhibition of translation of influenza mRNA 
in these cells with other steps remaining unaltered (Meyer and Horlsberger,
1984) .
(3) importance of malor histocompatibility complex antigens in the immune 
system
(a) Introduction to the malor histocompatibility complex antigens
The major histocompatibility complex (MHC) is a highly polymorphic region 
of the genome whose products play a major role in the immune response. It 
is known as the MHC for historical reasons since the molecules of this 
complex were first recognised as classical transplantation antigens on the 
cell-surface. The antigens were initially characterised in the murine 
system using alloantibodles, produced in one inbred strain of mice 
immunised with cells of other strains differing only at the MHC. 
Subsequently, with the use of specific antibodies to molecules encoded by 
small regions of the MHC and using techniques of protein chemistry and 
molecular biology, the characteristics of MHC genes and their products have 
been analysed in great detail.
The MHC In aan, known as the human leukocyte antigen (HLA) system, is coded 
for by a genetic region located on the short arm of chromosome 6 . In the 
murine system the MHC has been mapped to a genetic region (termed H-2) on 
chromosome 17 (McConnell a£ al. , 1984). Three classes of molecules, 
denoted I, II and III, have been identified in the MHC of both mouse and 
man. At least three separate class I loci (termed H-2K, -D and -L in the 
mouse and HLA-A, -B and -C in man) encoding classical transplantation 
antigens have been demonstrated. Other class I genes in the mouse map at 
the right of the MHC in regions known as Qa-2,3 and Tla (Male at ¿1 - ,
1987). The class I MHC genes are highly polymorphic. Thus, more than 50 
different alleles have been demonstrated at both the H-2K and H-2D class I 
loci of mice. In contrast, the Qa-2,3 and Tla region class I genes exhibit 
little polymorphism (Male at al.. 1987). The class I MHC antigens are 
comprised of a glycosylated polypeptide chain of 45 kilodaltons (Kd) (heavy 
chain) in close non-covalent association with ^2*n c^ro8^0 >^u^^n * a 12 Kd 
polypeptide (Lew at al.. 1986). £2*nlcroSl°bulln Is encoded outside the 
MHC on human chromosome 15 (Goodfellow et al. . 1975) and on mouse 
chromosome 2, and appears to stabilise the class I MHC molecule (Male at 
al.. 1987). Amino-acid sequence analyses of human and murine class I 
molecules have demonstrated that the heavy chain is divided into five 
distinct regions : three extracellular domains of about 90 amino-acids 
designated a^t a 2 and a^, a transmembrane region of about 25 hydrophobic 
amino-acids, and a cytoplasmic domain which consists of about 25 
hydrophobic amino-acids. Interchain disulphide bonds in the and
microglobulin domains stabilise the structure of the molecule (see figure 
1.1a). Very recently, Bjorkman at al- (1987a, 1987b) determined the three- 
dimensional structure of the human class I MHC HLA-A2 antigen by X-ray 
crystallography, and confirmed the presence of the o^, a^, and 
microglobulin domains (see figure 1.1b). Class I MHC antigens can be
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Figure 1.1a
Structure of the murine class I  M H C  H -2K^ ontiqen
°*1
Figure M b
Three-dim emionol structure of humon cIq m  I  M H C  HLA~A2 gntiflgn
7 0  X
-:o fte r Bjorkman fit g j. (1987)
detected by indirect immunoperoxidase staining on the surface membrane of 
virtually all nucleated cells (exceptions being hepatocytes and cells of 
the central nervous system, exocrine pancreas and cornea-endothelium : Male 
££ Al- • 1987) and are intimately Involved in the presentation of antigen to 
cytotoxic T-cells (see section c below). The products of the Qa-2,3 and 
Tla loci are 44 Kd proteins which are both found associated with 0^’ 
microglobulin (McConnell g£ al. . 1984). Qa-2,3 and Tla proteins have been
found on thymocytes, and Qa-2 protein on some peripheral T-cells (McConnell 
et al.. 1984). Whether these proteins are normally expressed on other 
cell-types and whether they are involved in the presentation of antigen to 
cytotoxic T-cells is still unknown (Male al-• 1987). It has been 
suggested that the Qa-2,3 and Tla region genes provide a pool of genetic 
information which is used in the generation of polymorphism of class I 
molecules (Male fit fil- , 1987).
The highly polymorphic class II genes, encoded in the H-2I region of the 
mouse MHC and the HLA-D region of man, are identical to the immune response 
(Ir) genes known to control murine responses to different antigens (e.g. to 
thyroglobulin, for review see McConnell £t al. , 1984). The products of 
class II genes (I-A and I-E in the mouse, DP, DQ and DR in man) are 
heterodimers comprising heavy (a) and light (,0) glycoprotein chains. The a 
chains have molecular weights of 30 to 34 Kd and the 0 chains range from 
26-29 Kd, depending on the alleles involved (Male at al. . 1987). On the 
basis of amino-acid sequence, each chain has been shown to consist of four 
domains; two extracellular domains of about 90 amino-acids designated 
and c*2 or 0^ and 0^, a transmembrane region of about 30 amino-acids, and a 
short cytoplasmic domain of between 10 and 15 hydrophobic amino-acids (Male 
et al. . 1987). The a^, 0^ and 0^ domains contain disulphide bonds which 
stabilise the molecule (see figure 1.2). The cellular distribution of
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Figura 1.2
Slrmtur. of c lg ii H MHC online.
■  ; disulphide bond 
N H 2  : amino terminus 
C O O H  : carboxyl terminus 
9 ; glycosylation
02™ ; P2micro9*°^u*'n
- after Mal* et ai.(1967)
class II MHC antigens (also known as immune-associated [la] antigens) is 
not as wide as for class I MHC antigens. Only a few cell types 
constitutively express class II MHC antigens (for example, B-cells and 
dendritic cells; Knight si &1-. 1987; Male al., 1987) although a number 
of other cell-types express class II MHC antigens when induced by treatment 
with IFN- 7 (for example, macrophages, astrocytes and fibroblasts - see 
section b below).
The class III genes encode the Cj, C^ and factor B components of the 
complement system (McConnell si &1-. 1984). There is no evidence for 
functional or structural similarities between these products and the class 
I and class II antigens, hence these genes may be better considered as 
being closely linked to the MHC rather than part of it (Male ££ *1. , 1987).
(b) Interferon modulation of MHC antigen expression
In 1973 Lindahl and coworkers demonstrated that natural IFN-a0 treated 
mouse lymphoma L1210 cells (H-2d) displayed an enhanced antibody absorbing 
capacity for serum from C57 BL/ 6 mice (H-2*>) Immunised with Balb/c (H-2*1) 
splenic lymphocytes (Lindahl al. . 1973). Although the antiserum was 
crude, these observations suggested that IFN-a/3 increased MHC antigen 
display on the surface of L1210 cells. Subsquently, using monospecific 
antisera against determinants controlled by subregions of the H-2 complex, 
it was shorn that natural murine IFN-a£ enhanced class I MHC H-2D and H-2K 
antigen expression, but not class II MHC antigen expression, on mouse 
spl enic lymphocytes in vitro (Lonai and Stelnman, 1977; Vignaux and 
Crasser, 1977), on mouse embryo fibroblasts 1b  vitro (Vignaux and Crasser, 
1978), and on mouse splenic lymphocytes in vivo (Vignaux and Crasser,
1977). Several years later Sonnenfeld and coworkers demonstrated that
crude preparations of natural IFN- 7 (prepared by pulsing spleen cells of 
Swiss/Uebster mice sensitised to Bacillus Calswtte-Guerin with tuberculin 
in vitro) increased both class I and class II MHC antigen expression on 
murine thymocytes in vitro (Sonnenfeld g£ gl. , 1981).
Since this time IFNs have been shown to modulate MHC antigen expression on 
a wide variety of cell types in vitro in both the murine and human system. 
With few exceptions, IFNs-a/9 have been shown to induce only class I MHC 
antigen expression whilst IFN- 7 induces both class I and class II (on 
certain cell types only) MHC antigen expression. For example, IFNs-a0 have 
been shown to induce class I, but not class II, MHC antigen expression on 
human lymphoblastoid cells (Fellous e_£ ¿1-, 1979), human melanoma cells 
(Imai £_£ al. . 1981), human keratinocytes (Nlederwieser g_£ gl. , 1988), 
murine fibroblasts (Dr A Morris, University of Warwick, unpublished 
observations), and murine astrocytes (Wong g£ al.. 1985). In contrast, 
IFN- 7 has been shown to induce both class I and class II MHC antigen 
expression on murine B cells, macrophages and mast cells (Wong g£ gl. , 
1984c; Koch g£ al.. 1984), murine fibroblasts (Maudsley and Morris, 1988), 
human keratinocytes (Nlederwleser e_t al. . 1988), murine astrocytes (Wong g£ 
al.. 1985), and human melanoma cells (Rosa g£ al. . 1983b). IFN- 7 has also 
been shorn to induce class II MHC antigen expression on human monocytes 
(Virelizier g£ gl. , 1984), human endothelial cells (Manyak g£ gl. , 1988), 
human glioma cells (Takiguchi g£ al.. 1985), rat Schwann cells (Wekerle g£ 
al.. 1986a), and murine microglial cells (Suzumura g£ gl-, 1987), but does 
not Induce class II MHC antigen expression on human T-cell lines (Garrard 
et al.. 1988), human neuroblastoma cells (Lampson and Fischer, 1984), and 
murine oligodendrocytes (Suzumura g_£ gl., 1986). In exception to the 
general trend, IFN-a^ (but not IFN-aj) has been shorn to induce class II 
MHC antigen expression on human monocytes (Rhodes g£ gl., 1986).
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Similarly, IFN-a and IFN-/Î have been shown to Induce class II MHC antigen 
expression on human melanoma cells (Dolei £_t ai. , 1983). In many of the 
above studies preparations of recombinant IFNs were used, thereby 
confirming that MHC antigen expression was Indeed modulated by IFN rather 
by contaminants which may be present in natural IFN preparations. IFNs 
have also been shown to induce MHC antigen expression on a variety of cell 
types in vivo. Thus, Momburg £_£ al- (1986a) demonstrated that intravenous 
administration of recombinant IFN-7 to B10.BR mice Induced or enhanced 
class I MHC antigen expression in almost every organ, and also reported 
that the effect was particularly conspicuous on renal tubular cells, 
hepatocytes, bronehlolar epithelial cells, gastric mucous cells, thymic 
cortical lymphocytes and capillary endothelial cells in the heart and 
kidney. Intravenous and intraperitoneal administration of recombinant IFN- 
7 to B10.BR mice has also been shown to increase class II MHC antigen 
expression throughout the body, with marked increases observed in the 
heart, kidney, pancreas, lung, liver, adrenal, and small intestine 
(Skoskiewicz at al-. 1985; Momburg at ai. , 1986b). Intravenous 
administration of recombinant IFN-7 to B10.BR mice did not induce class I 
or class II MHC antigen expression on neurons or glial cells within the 
brain (Momburg at al. . 1986a, 1986b). In contrast, intracerebral 
administration of recombinant IFN- 7 to CBA mice has been shown to induce 
class I MHC antigen expression on neurons and glial cells, and class II MHC 
antigen expression on astrocytes (a glial cell) (Wong at Al- . 1984). Taken 
together, these observations indicate that IFN- 7  does not normally traverse 
the blood-brain barrier of a healthy mouse. Intraperitoneal administration 
of recombinant IFN- 7 to C3H/HeN mice has also been shown to induce class II 
MHC antigen expression on kératinocytes (Caspar! and Katz, 1988). 
Furthermore, intravenous administration of natural IFN-0 to Balb/c mice has 
been shown to induce class I MHC antigen expression on bone marrow cells
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(Bukowski and Welsh, 1986).
Wong gi al• . (1984) showed Chat actinomycin D (an inhibitor of RNA 
synthesis) and cyclohexlmide (an inhibitor of protein synthesis) blocked 
the induction of class I MHC antigens on murine brain cells in vitro, 
indicating that the induction required new RNA and protein synthesis. 
Similarly, Rosa g£ gl. (1983b) reported that the enhancement of class I MHC 
antigen expression on human lymphoid cells In vitro was preceded by an 
Increase in class I MHC protein synthesis. Northern blot analysis of uRNA 
encoding class I and class II MHC antigens has shown that IFS-afi increases 
the steady state level of class I MHC mRNA in human fibroblasts and 
lymphoblastoid cells (Fellous g£ gl. , 1982). Likewise, IFN- 7 has been 
shown to increase the steady state level of class I MHC and 
microglobulin mRNA in human lymphoblastoid cells (Wallach gl gl. , 1982), 
and class II mRNA in human glioma and macrophage cell lines (Takiguchi £_£ 
al. . 1986; Nakamura g£ gl. , 1984). The steady state level of mRNA in a 
cell is the result of several processes : transcription of the gene, 
processing of the primary nuclear transcript, and mRNA degradation within 
the cell (Rosa gl gl. , 1986). The increased level of mRNA encoding class I 
and class II MHC antigens in IFN treated cells may thereby reflect 
modifications of transcription, processing or degradation of the mRNA. To 
determine whether IFN-/) and IFN- 7 increased transcription of class I, class 
II MHC and /^-nicroglobulin genes, Rosa gi gl. (1986) followed the 
transcription of the genes in isolated nuclei using the "nuclear run-off" 
technique. The nuclear run-off technique is based on the fact that RNA 
polymerases in Isolated nuclei are able to carry out elongation of the 
nascent RNA chain, but cannot promote the initiation of new mRNA molecules. 
Thus, incorporation of radiolabelled nucleotides into RNA, which is able to 
hybridize to probes for the genes of interest, allows one to quantify the
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race of transcription of the genes. Using this technique, Rosa gl gl. 
(1986) showed that IFN-0 and IFN- 7 Induced an Increase in the transcription 
of class I MHC and 0 2*BlcroSl°bull-n genes in hunan melanoma cells, and that 
IFN- 7  (but not IFN-0) induced transcription of class II MHC genes in human 
fibroblasts.
Friedman and Stark (1985) compared the DNA sequences of four human genes 
which are sensitive to IFN regulation : two class I MHC genes, a class II 
MHC gene, and a metallothioneln gene. They defined a consensus sequence 30 
nucleotides long in the promoter region of each gene which was postulated 
to be Involved in regulating transcription. The promoters of several 
murine class I MHC genes have also been shown to contain a similar sequence 
(Israel gl gl. , 1986). Israel gl gl. (1986) showed that the murine class I 
MHC H-2K*> gene promoter could be induced by IFNs -o, -0 and -7 , and that 
the consensus sequence was necessary for induction to occur. Another 
consensus sequence has recently been found in the promoter region of 
several IFN-7 -inducible human and murine class I and class II MHC genes, 
although its efficacy has not yet been shown (Baste gl gl-. 1987). It has 
been speculated that there may be separate and distinct regulatory regions 
for the different classes of IFN (Baste et gl. , 1987).
Tumour necrosis factor (TNF-a) and lymphotoxln (now known as tumour 
necrosis factor-0 {TNF-01) have also been shown to increase class I, but 
not class II, MHC antigen expression on human endothelial cells In vitro 
(Leeuwenberg gl gl., 1987; Laplerre gl gl., 1988; Wedgewood gl gl., 1988), 
and, for the case of TNF-a, class I MHC antigen expression on human 
fibroblasts in vitro (May gl gl. , 1986; Leewenberg gl gl. , 1987), and both 
class I and class II MHC antigen expression on the murine WEHI-3 macrophage 
cell-line (Chang and Lee, 1986). The observations that TNF-a induced FS4
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fibroblasts to produce IFN-02 mRNA (but not IFN-^j mRNA) (Kohase at *1. , 
1986; May at al-. 1986), and that cross-reacting polyclonal antlserun to 
IFN-0 Inhibited the ability of TNF-o to Induce class I MHC antigen 
expression on FS4 fibroblasts (May at al., 1986), suggest that the affect 
of TNF-q  on class I MHC antigen expression «ay actually be mediated by IFN- 
However, Leewenberg at al. (1987) reported that the ability of TNF-o 
to induce class I MHC antigen on primary cultures of fibroblasts and 
endothelial cells was inhibited by antibodies which specifically 
neutralised IFN-^j (but not IFN-^). This apparent contradiction of 
results may be due to an ability of TNF-o to induce different cells to 
release different types of? IFN-/J, or may be due to the fact that Kohase at 
al. (1986) and May at al- (1986) did not look specifically for IFN-^ 
protein. Nevertheless, it is clear from these studies that IFN-/? is an 
intermediate in the TNF-o-induced increase in class I MHC antigen 
expression.
TNF-o and -0 have also been shown to interact with IFN-y in the induction 
of MHC antigen expression on cells In vitro. Thus, Pujol-Borrell at al- 
(1987) showed that human pancreatic islet cells did not express class II 
MHC antigens when induced with TNF-o, TNF-0 or IFN-y alone, but expressed 
high levels when induced with IFN-y in combination with either TNF-o or 
TNF-0. Ueetman and Rees (1988) showed that IFN-y induced class II MHC 
antigen expression on rat thyroid cells (whereas TNF-o did not), and that 
TNF-o increased the ability of IFN-y to increase class II MHC antigen 
expression. Similarly, Wedgewood at al- (1988) showed that TNF-o slightly 
increased the ability of IFN-y to induce class II MHC H1A-DQ antigen 
expression on human endothelial cells, but slightly inhibited the ability 
of IFN-y to induce class II MHC HLA-DR antigen expression. In contrast, 
Lapierre at ¿1- (1988) reported that TNF-o and TNF-/? did not affect the
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ability of IFN- 7 to Induce cless II MHC HLA-DR antigen expression on human 
endothelial cells. Wedgewood gl. (1988) and Lapierre £1 gl. (1988) both
showed that TNF-a in combination with IFN- 7 induced class I MHC antigen 
expression on human endothelial cells to a level higher than was observed 
with either mediator alone. Taken together, the results of these studies 
suggest that TNF can modulate or act in synergy with IFN-y in the Induction 
of class I and class II MHC antigen expression on a number of cell types, 
although details remain to be fully clarified.
The different IFN classes have also been shown to Interact in the induction 
of MHC antigen expression. Thus, IFN-a and IFN-0 have an additive effect 
with IFN- 7 in the induction of class I MHC antigen expression on human 
endothelial cells (Lapierre gfc gl- , 1988). In contrast, IFN-a and IFN-0 
have been shown to inhibit the ability of IFN- 7 to Induce class II MHC 
antigen expression on murine macrophages (Ling g£ gl., 1985; Inaba g£ gl.. 
1986; Fertsch g£ gl., 1987; Kltaura gl., 1988), and on human endothelial 
cells (Lapierre g£ gl., 1988; Manyak g£ gl., 1988). Similarly, 
prostaglandin E has been shown to Inhibit the ability of IFN- 7 Co induce 
class II MHC antigen expression on murine macrophages, but not on human 
macrophages (Snyder g£ gl. , 1982; Kunkel g£ gl., 1986). Corticosteroids, 
transforming growth factor-/3^, transforming growth factor-^ • and 
Interleukin-3 have also been shown to inhibit the ability of IFN- 7  to 
induce class II MHC antigen expression on murine macrophages, human 
melanoma cells, human glioma cells, and murine mast cells, respectively 
(Snyder and Unanue, 1982; Czamiecki g£ gl. , 1988; Zuber g£ gl., 1988; Wong 
g£ gl. , 1984b).
It is now clear that viruses may also modulate host cell MHC antigen 
expression in vitro, and by a mechanism which does not involve the
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intervention of IFNs. For example, measles virus, JHM coronavirus, and 
simian immunodeficiency virus have been shorn to induce class II MHC 
antigen expression on their host cell, and in the case of measles virus 
also class I MHC antigen expression (Massa g_£ al- , 1987a; Massa ££ *1. , 
1986; Kannagi at al.. 1987). In contrast, adenovirus-12, herpes simplex 
virus types I and II, hepatitis B virus, and Moloney and Kirsten murine 
sarcoma viruses have been shown to reduce class I MHC antigen expression on 
their host cell (Schrier a£ al. , 1983; Jennings at al- . 1985; Onji at Al-. 
1987; Flyer at al- . 1985; Maudsley and Morris, 1988). Hepatitis B virus 
and Kirsten murine sarcoma virus have also been shown to inhibit the 
ability of IFN- 7  to Induce class I MHC antigen expression on their host 
cell, and for the case of Kirsten murine sarcoma virus also class II MHC 
antigen expression (Onji at al-. 1987; Maudsley and Morris, 1988). Since 
class I and class II MHC antigens are intimately Involved in T-cell 
recognition of antigen (see sections c and d below) , it has been proposed 
that virus inhibition of host cell MHC antigen expression may help the 
virus evade T-cell mediated immune surveillance. Virus induction of host 
cell class II MHC antigen expression has also been proposed to play a role 
in the generation of autoimmune disease. Thus, induction of class II MHC 
antigens may result in the generation of an inappropriate immune response 
to an antigen not normally seen by the immune system, for example, to 
myelin basic protein which results in allergic encephalomyelitis in rats 
(Massa al. , 1987a, 1987b). For a comprehensive review of virus 
modulation of host cell MHC antigen display see Maudsley a£ al- (1989).
In summary, it is clear that IFNs are able to influence MHC antigen 
expression on a variety of cell types both In vitro and in vivo. and that 
other factors modulate the ability of IFNs to induce MHC antigen 
expression, at least in vitro. Although many effects observed in vitro
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■till remain Co be extended Co Che in vivo situation, it does ac lease seem 
likely Chat Che induction of MHC antigen expression in vivo during 
infectious or autoimmune disease may be mediated by a number of different 
factors which inhibit or act in synergy with IFN.
(c) Importance of class I MHC antigens for cytotoxic T-lymphocyte
recognition <?£ target sella
The fundamental importance of the MHC in T-cell mediated immune responses 
was first fully appreciated in 1974 with Che studies of Zinkernagel and 
Doherty. Zinkemagel and Doherty (1974) showed that cytotoxic T-cells from 
mice infected with lymphocytic choriomeningitis virus (LCMV) could kill 
LCMV-Infected target cells only if the targets possessed the same set of 
genetic determinants located at the H-2 complex (i.e. were of the same 
haplotype). This phenomenon was termed MHC restriction. Subsequently, the 
requirements for MHC matching were mapped to the K and D regions of the H-2 
by the use of H-2 recombinant mice (Zinkernagel and Doherty, 1975; Gardner 
et al. . 1975; Blanden Al-. 1975; Doherty ££ al- , 1976; for review see 
Zinkemagel and Doherty, 1979). McMichael (1978) extended these 
observations to the human system and showed that influenza-specific CTL 
only killed infected target cells that shared identical HLA-A and HLA-B 
locus antigens.
That the expression of class I MHC antigens is essential for CTL 
recognition of antigen was initially demonstrated using cell lines which do 
not express these antigens, an example being the murine F9 teratoma cell 
line. Zinkemagel and Oldstone (1976) showed that F9 cells do not express 
class I MHC antigens detectable by either serological or alloreactive CTL 
assays. When infected with either LCMV or vaccinia virus F9 cells were
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found Co express viral antigens on che cell surface and released Infectious 
virus in amounts equivalent to class I antigen bearing call lines. Despite 
these cells expressing sufficient viral antigen adequate for lysis by 
antiviral antibody plus complement or antibody-dependant cell-mediated 
cytotoxicity, these cells were not susceptible to lysis by virus-specific 
T-cells.
Similarly, Forman and Vltetta (1975) demonstrated that haptenated 
(trinitrophenyl-modified (TNP)) F9 cells were not susceptible to lysis by 
TNP-speclflc CTL unlike TNP modified class I MHC antigen expressing targets 
from the same strain of mouse from which the F9 cell line originated. The 
conclusion made from each of these experiments was the same, that the F9 
cells lack MHC antigens which are required for CTL recognition. Studies 
have also related levels of MHC antigen expression on target cells with 
recognition by CTL. Thus, Kuppers ££ ¿1. (1981) treated murine target 
cells with papain, prior to TNP modification, and then examined the 
susceptibility of the cells to lysis by both allogeneic and syngeneic CTL. 
Papain treatment removes MHC antigens from the surface of target cells, 
thereby allowing comparison between levels of MHC antigen on the target 
cell and lysis by CTL. It was found that papain treatment reduced the 
susceptibility of the target cells to lysis by TNP-specific CTL. 
Furthermore, the decrease in susceptibility followed the same dose and time 
kinetics as the reduction of MHC antigen expressed on the cell surface as 
assessed by serological assay and susceptibility to lysis by alloreactlve 
CTL. These authors also used a panel of murine cell lines, known to 
display different levels of class I MHC antigen in order to study further 
the relationship between levels of MHC antigen expressed on the target 
cells and susceptibility to CTL lysis. As before, cells were TNP-modifled 
and the susceptibility to lysis by alloreactive and TNP-specific CTL
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measured. The resulcs of Cheee studies again showed that there was a 
direct correlation between the level of MHC antigen expressed on each cell 
type, as assessed by serological assay and susceptibility to alloreactive 
CTL lysis, and its susceptibility to TNP-speciflc CTL lysis.
In view of the ability of IFNs -o, -fi and - 7  to augment the expression of 
class I MHC antigens, and the correlation between levels of class I MHC 
antigen expressed on the surface of target cells and susceptibility to CTL 
lysis, it is not unreasonable to propose that the enhancement of class I 
MHC antigens by IFN should make cells more susceptible to CTL lysis. This 
does seem to be the case since IFNs (a, 0, 7 ) have been shown to increase 
the susceptibility of the following cell types to alloreactive CTL lysis; 
murine C3H10TH fibroblast and RDM4 lymphoblastold cells (Blackman and 
Morris, 1985), murine bone marrow cells and fibroblasts derived from heart, 
brain, liver, and skin (Bukowskl and Welsh, 1986), and rat mammary 
carcinoma cells (Yeoman and Robbins, 1988). As mentioned previously, 
transformation of murine cells by adenovirus-1 2 reduces the level of class 
I MHC antigen on the cell-surface. Transformation by adenovirus-12 also 
reduces the susceptibility of cells to both alloreactive and influenza- 
specific CTL lysis (Eager ££ al. . 1985; Yewdell £_£ al- , 1988a). Likewise, 
Moloney murine sarcoma virus inhibits the ability of Moloney murine 
leukemia virus to induce class I MHC antigen expression on murine 
fibroblasts, and inhibits the ability of Moloney murine leukemia virus to 
augment the susceptibility of infected cells to alloreactive CTL lysis 
(Flyer al al-. 1985). IFN- 7 has been shown to increase class I MHC antigen 
expression on cells infected with Moloney murine sarcoma virus, and on 
cells transformed by adenovirus-12, and increases the susceptibility of the 
calls to alloreactive CTL lysis (Eager al al. , 1985; Flyer al al-> 1985). 
Probably the strongest evidence to date which suggests that the level of
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class I MHC antigen expression of target cells is Important for T-cell 
recognition in vivo comes from the experiments of Bernards ££ *1. (1983). 
These studies demonstrated that whereas both adenovirus-5 transformed cells 
(Ad-S; which express class I MHC antigens) and adenovirus-12 transformed 
cells (Adl2; which do not express class I MHC antigens) were oncogenic In 
T-call deficient nude mice, only the class I MHC deficient Ad-12 
transformed cells metastasised in normal mice. These results indicate that 
T-cells can play a role in the regulation of tumour growth, but only if the 
transformed cells express the class I MHC antigens necessary for T-cell 
recognition to occur. Likewise, the restoration of class I MHC antigen 
expression by gene transfection into MHC antigen-negative tumour cell 
clones has been found to reduce tumourigeniclty and abolish metastasis in 
mice (Wallich al.. 1985). Furthermore, Hayashi ££ *1- (1985) showed 
that Ad-12 transformed cells which were treated with IFN- 7 , and hence 
expressed class I MHC antigen, were less tumourigenic in mice than non- 
treated cells. Similarly, tumour1genicity of murine B16 melanoma cells on 
which class I MHC antigen expression had been induced by IFN- 7 was reduced 
compared with non-IFN treated cells (Hammerling si al.. 1987). Although 
these data suggest that the reduced tumourigeniclty of the cells may be due 
to increased expression of MHC antigens, it cannot be concluded that this 
is the only reason, since IFN- 7 also has effects on adhesion molecule 
expression and cell growth (Dustin ££ al., 1988; Balkwill, 1985).
Several studies have also investigated the effects of IFN-enhanced class I 
MHC antigen expression on virus-infected cells upon their susceptibility to 
virus-specific CTL lysis. This situation is more complex because whilst 
IFN enhances class I MHC antigen expression, it will generally inhibit 
virus replication and thus depress viral antigen expression, the other 
component essential for virus-specific CTL recognition. However, it has
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been shown thet even where viral antigen expression is markedly reduced by 
IFN treatment the level of virus-specific CTL lysis may only be slightly 
depressed or even augmented. For example, Blackman and Morris (1985) 
showed that treatment of murine RDM4 lymphoblastoid cells and C3H10TH 
fibroblasts with IFN-a£ or -7 , prior to infection with the neurotropic 
Semllki Forest virus (SFV), markedly increased the expression of class I 
MHC antigens on the cells but reduced the expression of viral antigen as 
assessed by antiviral antibody plus complement lysis. Despite the 
reduction of viral antigen expression cells remained susceptible to SFV- 
speciflc CTL lysis, presumably reflecting the enhancement of class I MHC 
antigen expression. Similar observations have also been made in other 
virus systems and these are discussed in detail in chapter 5.
The T-cell antigen receptor is a complex of the Ti molecule and T3 
molecular complex. Ti is a highly polymorphic glycoprotein which consists 
of a disulphide-linked heterodimer formed of two peptides, known as the a 
and fi chains, which have molecular weights of 44 Kd and 37 Kd, 
respectively. The a and 0 chains both consist of variable and constant 
domains (stabilised by intrachain disulphide bonds), a transmembrane 
region, and a cytoplasmic region (Samelson ££ fl_L- , 1985; Male ££ Al-.
1987). The T3 complex consists of four non-covalently associated peptides, 
known as 7 , S, < and f chains, which have molecular weights of 25 Kd, 21 
Kd, 26 Kd and 16 Kd, respectively. The 7 and 6 chains are glycosylated 
whereas the e and f chains are not. The c chain possesses an Intrachain 
disulphide bond and f exists as a disulphide-linked homodimer. All four 
peptides are thought to traverse the cell membrane and possess a 
cytoplasmic region (Samelson ££ Al-, 1985).
It is now clear that CTL use the a and 0 chains of their T-cell receptor to
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recognise specific ancigen in association with class I MHC antigen on the 
target cell. The lack of direct involvement of other molecules (for 
example, those of the T3 molecular complex) in the specific recognition of 
antigen has been shown by transfection experiments. Thus, Demblc &£ al. 
(1986) transfected the a and 0 chain genes of a fluoroscein (FL)-specific 
H-2Dd-restricted CTL clone into a cytotoxic T-cell hybrldoma specific for 
the hapten SP (3-(p-sulphophenyldiazo)-4-hydroxy-phenylacetic acid) in 
association with H- 2Kk. and obtained transfectants which could lyse FL- 
coupled H-2Dd targets, as well as SP-coupled H-2Kk cells. The activation 
of T-cells for both initiation of cytolytic activity and proliferation is 
dependant on an Influx of C a ^  ions. It has been proposed that the T3 
molecular complex may act as an ion channel to effect the passage of Ca** 
across the membrane (Hale ££ fll- . 1987).
Townsend and coworkers studied antigen recognition by murine class I MHC 
restricted CTL clones specific for the nucleoprotein (NP) of Influenza 
virus. They showed that the CTL were able to recognise and lyse L cells 
cotransfected with the NP gene and the appropriate class 1 gene. 
Furthermore, through the use of deletion mutants and synthetic peptides, 
short peptide regions of NP were identified as being recognised by the CTL 
(Townsend &£ al. . 1985; 1986). These observations suggest that target 
cells may have the potential to degrade viral proteins into peptide 
fragments, which are then presented in association with class I MHC 
antigens on the cell-surface and recognised by CTL. X-ray crystallographic 
studies by BJorkman £_£ al. (1987a, 1987b) revealed a deep groove on the top 
of the human class I MHC H1A-A2 antigen. The groove was reported to run 
between two long a-helices derived from the al and a2 domains of the 
molecule, and the floor of the grove was formed by 0 -strands also derived 
from both al and a2 domains. Since the size of the groove was large enough
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Co accomodate peptides of 8 to 20 amino-acids in length (which is of the 
same order ss the peptides used by Townsend) it was proposed that this nay 
be the site for the foreign antigen that is recognised together with HLA 
antigen by the T-cell receptor. Very recently, Chen and Parham (1989) 
demonstrated that a 14 amino-acid fragment of influenza matrix protein did 
indeed directly bind to the human class I MHC HLA-A2 antigen. It has been 
suggested that the Insertion of foreign peptide antigen into the genome of 
class I MHC antigens may take place within the cell and possibly as the 
class I molecules fold and associate with -microglobulin (Townsend and 
McMichael, 1987).
Several groups have reported the isolation of class II MHC restricted CTL 
clones (Morrison g£ gl., 1986; Jones g£ gl. , 1987). Class II MHC 
restricted CTL however make up only a minor proportion of the total CTL 
population, the majority being class I MHC restricted (Braakman g£ gl-, 
1987). Class II MHC restricted CTL are also thought to utilise the a and (l 
chains of their T-cell receptor to recognise specific antigen in 
association with the appropriate class II MHC antigen on the target cell 
(Male at gl-. 1987). Morrison at al- (1986) studied antigen recognition by 
murine class II restricted CTL clones specific for haemagglutinin of 
influenza virus. They showed that Isolated influenza virus haemagglutinin 
(HA) polypeptide could sensitise target cells for recognition by class II 
restricted HA-specific CTL. Treatment of target cells with the 
lysosomotropic agent chloroquine was shown to abolish recognition of 
haemagglutinin treated cells by class II MHC restricted HA-specific CTL. 
Since chloroquine is known to inhibit antigen processing, these results 
indicate that class II MHC restricted CTL only recognise processed antigen 
which has bound to class II MHC antigens. That peptide fragments may 
indeed bind to class II MHC antigens was shown by Babbitt g£ al. (1986) who
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demonstrated that a ten amino-acid fragment of hen egg lysozyme bound 
directly to the murine class II MHC H-2IAk antigen. The structure of class 
II MHC antigens has not yet been studied by X-ray crystallography.
However, models based on the amino-acid sequence of class II molecules have 
indicated that the two amino-terminal domains of the class II a and 0 
chains (l.e. the al and 01 domains) may form an intermolecular dimer with a 
structure similar to the al and a2 region of HLA-A2, thereby creating a 
binding site for the antigens similar to that in HLA-A2 (Bjorkman a£ al. , 
1987a).
Although the minimal requirement for antigen-specific CTL recognition of 
target cells appears to be the recognition by a and 0 chains of the T-cell 
receptor of antigen in association with the appropriate MHC molecule, it is 
now clear that a number of other cell-adhesion molecules stabilise the 
Interaction with the target cell. To date, two receptor-ligand pairs of 
adhesion molecule have been defined. Thus, the CD2 and lymphocyte function 
associated antigen-1 (LFA-1) receptors (which are expressed on the surface 
of T-cells) interact with the ligands LFA-3 and intercellular adhesion 
molecule-1 (ICAM-1) (which are expressed on a variety of cell types), 
respectively (Dustin a£ al■ , 1986; Springer a£ 41-, 1987). IFN-y has been 
shown to increase ICAM-1 expression on a variety of cell types (Dustin ££ 
al.. 1988). It is possible that the augmentation by IFN-y of ICAM-1 
expression on target cells may Increase the avidity of CTL-target cell 
Interactions. In man, class I MHC restricted CTL express the cell-surface 
molecule CD8 (Lyt 2 is the equivalent molecule in the mouse), while class 
II MHC restricted CTL and T-helper cells express the CD4 molecule (L3T4 in 
the mouse) (Male ££ al. 1987). CD8 and CD4 have been shown to Interact 
directly with class I and class II MHC antigens, respectively (Bushkin at 
al. . 1988; Doyle and Strominger, 1987). The interaction of CD4 and CD8
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with MHC antigens may also increase the avidity of effector-target cell 
interactions.
Once a virus specific CTL has undergone recognition of viral antigen on a 
target cell it is activated to undergo the lytic process. The mechanisms 
»^hereby a virus-specific CTL may lyse its target cell are discussed in 
detail in section 4 of this introduction. Following antigenic stimulation, 
virus-specific CTL are induced to express receptors for lnterleukln-2 (IL-2 
: T-cell growth factor), and proliferate in response to IL-2 (Kaplan ££ 
al. . 1984). CTL also release IL-2 and IFN- 7 on appropriate recognition of 
antigen on a target cell (Morris Ai-, 1982; Andrus *j£ al. , 1984; 
Cunningham fet al.. 1985; Taylor ££ al., 1985). IL-2 released by virus- 
specific CTL may bind to receptors for IL-2 on virus-specific CTL and 
thereby induce proliferation. The fact that virus-specific CTL only 
express IL-2 receptors and respond to IL-2 on specific recognition of viral 
antigen may ensure the specificity of the T-cell response. IFN- 7 released 
by virus-specific CTL would exert a wide range of immunomodulatory effects, 
as well as inhibit further replication of virus.
A number of studies have shown that virus-specific CTL play a protective 
role In vivo- For example, Askonas and coworkers showed that 
administration of influenza-specific CTL clones to Balb/c mice, immediately 
after challenge with a lethal dose of the A/X-31 strain of Influenza virus, 
protected mice against lethal infection and reduced the titre of virus 
present in the lungs (Lin and Askonas, 1981; Taylor and Askonas, 1986).
(d) Importance of class II MHC antigens for helper T-lymphocyte function
An essential step in the Induction of an immune response to a protein
30
antigen is the activation of antigen-specific T-helper cells. This 
activation cannot be induced by free antigen but only by antigen presented 
by an accessory cell which displays the class II antigens of the MHC. 
Furthermore, T-helper cells are only activated by accessory cells which 
possess the same set of class II MHC genes (Schwartz il- , 1985).
The relationship between expression of class II antigens and ability to 
present antigen has been most studied using the macrophage. These cells do 
not constltutlvely express class II MHC antigens, but can be induced to 
express class II MHC antigens by IFN- 7 (Unanue, 1981; Keller, 1984). That 
expression of class II MHC antigen on macrophages correlates with the 
functional ability of these cells to present antigen was demonstrated by 
Beller and Ho (1982). In this study it was shorn that macrophages isolated 
from the peritoneal cavity of C57 BL6J mice were both class II MHC antigen 
positive and able to present Listeria monocytogenes to listeria-specific T- 
cells. However, when cultured, macrophages no longer expressed class II 
antigen, and this correlated with an inability to act as antigen presenting 
cells. The addition of a lymphokine supernatant derived from activated T- 
cells (and which we now known to contain IFN-7 ) to the class II MHC 
negative cells resulted in the re-aquisition of class II MHC antigen 
expression and restored the ability to present Listeria antigen to T-cells. 
In a subsequent study Beller (1984) treated cultured macrophages with 
various concentrations of the T-cell lymphokine supernatant, in order to 
study further the relationship between the level of class II MHC antigen 
induced and ability to present antigen. The results showed that over a 
concentration range of the lymphokine supernatant, the induction of class 
II MHC antigen on macrophages was linear, and the ability to present 
Listeria antigen to T-cells directly correlated with the amount of class II 
MHC antigen induced. Beller (1984) also showed that recombinant IFN- 7
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Induced class II MHC antigen expression on cultured macrophages and 
restored the ability of the cells to present antigen. Further studies on 
the induction of class II MHC antigen expression and its role in the 
antigen presenting ability of the murine P338 D1 macrophage cell line were 
performed by Zlotnik ££ . (1983). In these studies the ability of T-cell
lymphokine and recombinant IFN-y induced macrophages to present tuberculin- 
purified protein derivative (PPD) antigen to PPD-specific T-cell hybrldomas 
was assessed by measuring production of IL-2. Both the T-cell lymphokine 
supernatant and recombinant IFN-y (but not IFN-o or IFN-/J) Induced class II 
MHC antigen expression on the cells in a dose-dependant manner, and this 
was directly related to the ability of the cells to present PPD antigen to 
T-cells.
That IFN- 7 can increase class II MHC antigen expression and hence the 
ability of cells to present antigen to T-cells has also been demonstrated 
in other systems. Thus, recombinant IFN- 7 has been shown to increase class 
II MHC antigen expression on cultured human foreskin capillary endothelial 
cells, cultured human dermal fibroblasts, and human U-373 MG glioma cells, 
and also Increases the ability of the cells to stimulate the proliferation 
of allogeneic T-cells (Pober £_£ fl_l-, 1983; Takiguchi £_£ fii- , 1985). IFN-7  
has also been shown to increase class II MHC antigen expression on human 
monocytes and also the ability of these cells to stimulate T-cell 
proliferation in response to tetanus toxoid and to allogeneic monocytes 
(Becker si al. . 1985). That the level of allogeneic and antigen driven 
proliferation was related to the level of class II MHC antigen expressed at 
the time of stimulation was demonstrated by incubation of the monocytes 
with antibody to the class II MHC antigens which inhibited the ability of 
the cells to stimulate both allogeneic and tetanus toxoid driven 
proliferation. Interestingly, Becker (1985) also showed that the Increased
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ability of IFN- 7 treated monocytes to stimulate T-cell proliferation in 
response to tetanus toxoid was partly due to a shift in the time course of 
proliferation. Thus, the response to tetanus toxoid peaked 1 to 2 days 
earlier when IFN- 7  treated cells acted as the accessory cells than when 
untreated monocytes presented the antigen. Treatment of murine vascular 
endothelial cells with concanavalin-A-conditioned medium (which contains 
IFN-7 ) has also been shown to induce the ability of these cells to present 
guinea pig basic protein to specifically sensitised lymph node lymphocytes 
(depleted of macrophages and monocytes). Again the aquisltion of antigen 
presenting ability correlated with an Increase in class II MHC antigen 
expression from otherwise undetectable levels. Furthermore, the Importance 
of class II MHC antigens for antigen presentation was shown by the blocking 
of proliferation by addition of antiserum to class II MHC antigens 
(McCarron fi£ al., 1985) . IFN- 7 treatment has also been shown to induce the 
ability of Schwann cells isolated from rat sciatic nerve (Wekerle fi£ fil- , 
1986a) and murine microglial cells (Frei fit fl_L■ , 1987) to present 
endogenous myelin autoantigen to myelin-specific T-cells and ovalbumin to 
ovalbumin-specific T-cells, respectively. Yet again, IFN- 7  treatment 
induced the expression of class II MHC antigens and only class II positive 
cells could present antigen to T-cells. In addition, Todd fit fil- (1985) 
demonstrated that IFN-7 induced class II MHC antigen expression on cultured 
thyroid epithelial cells, whilst Londai £t fii- (1984) showed that thyroid 
epithelial cells aberrantly expressing class II MHC antigens were able to 
present virus peptide antigens to influenza specific T-helper cell clones. 
This may have implications not only for immune responses to viruses but 
also for the generation of autoimmune disease.
Matis and coworkers examined the relationship between class II MHC antigen 
expression on murine splenic cells and the concentration of pigeon
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cytochrome c required for the cells to activate cytochrome c specific T- 
cell clones for proliferation. Through the study of cytochrome c 
concentration - response curves for T-cells stimulated with splenic cells 
known to display different amounts of class II MHC antigen, it was shown 
that the magnitude of the T-cell proliferative response was a function of 
cytochrome c concentration and the level of class II MHC antigen display 
(Matls i**l.. 1982, 1983).
The data discussed above suggest that the aquisltlon of antigen presenting 
ability is a consequence of class II MHC antigen expression, and the 
magnitude of T-cell responses is dependant on both the level of class II 
MHC antigen displayed and the concentration of foreign antigen present. It 
is however important to note that there may be other requirements for the 
induction of a cells antigen presenting ability. This point has been aptly 
Illustrated by Geppart and Lipsky (1987) who investigated the capacity of 
IFN- 7 treated HLA-DR expressing human dermal fibroblasts to present 
streptokinase streptodornase (SKSD) antigen to T-cells. The IFN-y treated 
fibroblasts were able to take up SKSD antigen, internally process the 
antigen, and express class II MHC-SKSD antigen complexes on the cell 
surface but they failed to present antigen to T-cells. Possible reasons 
for the failure to present antigen were investigated and it was shown that 
although the class II MHC antlgen-SKSD antigen complex was a functionally 
recognizable element, the fibroblasts were unable to provide an additional 
accessory signal which was necessary for the antigen induced activation of 
resting T-cells.
Shimonkevitz ££ *1. (1983) studied antigen recognition by murine class II 
MHC restricted T-cell hybridomas specific for ovalbumin (OVA). These cells 
were found to recognise OVA presented by untreated antigen presenting B-
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lymphoma cells (APBCs) (as assessed by Che release of IL-2), but failed Co 
respond when che APBCs were rendered metabolically inert by fixaCion with 
glutaraldehyde. When OVA peptides (prepared by digesCion with the enzyme 
trypsin or by cleavage at methionine residues with cyanogen bromide) were 
used as the stimulating antigen, the T-cell hybridomas could respond 
whether the APBCs were fixed or not. These results were the first to 
suggest that class II MHC restricted T-cells require antigen to be 
fragmented before it can be recognised. The mechanism whereby class II MHC 
restricted T-helper cells and CTL recognise processed foreign antigen 
peptide fragments is believed to be identical and has been discussed 
previously in section c.
T-helper cells constitutively express receptors for interleukin-1 (IL-1) 
(Lowenthal and MacDonald, 1987). IL-1 is produced by a variety of cell 
types including macrophages, monocytes, endothelial cells, dendritic cells, 
and epithelial cells (Male £_£ al.. 1987). T-helper cells bind IL-1 on 
recognition of foreign antigen on an antigen presenting cell and are thus 
induced to express receptors for IL-2 and to release IL-2, and IFN-y (Male 
et al.. 1987). IL-2 stimulates the proliferation of CTL and T-helper cells 
which have undergone recognition of antigen (and hence express IL-2 
receptors) (Male fil., 1987). The importance of T-helper cells and IL-2 
in the generation of virus-specific CTL activity was shown by Braakman et 
al. (1986). In this study, stimulation of human peripheral blood 
lymphocytes with influenza A virus in vitro was found to result in the 
generation of virus-specific CTL activity. Depletion of T-helper cells 
from the PBL completely abrogated the generation of virus-specific CTL 
activity, and activity was restored by the addition of exogenous IL-2. T- 
helper cells were originally defined in functional assays as being able to 
induce B lymphocytes to secrete antibody. By using this criterion.
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T-helper cell* were also shown Co interact with B- lymphocytes in a class II 
MHC-restricted manner (Killer sti al- . 1987). The binding of T-helper cells 
to B cells causes the B cells to synthesise receptors for a B-cell growth 
factor called interleukin-4 (IL-4) (Harlow and Lane, 1988). IL-4 is 
synthesised by activated T-helper cells (Killer at &1-. 1987). After 
binding IL-4, B cells start to proliferate and synthesise cell-surface 
receptors for a B-cell differentiation factor known as interleukin-5 (IL- 
5). IL-5 is also produced by activated T-helper cells. The binding of IL- 
5 to proliferating B cells induces the cells to differentiate into plasma 
cells (which secret* antibody) and memory cells (Harlow and Lane, 1988). 
Evidence that class II MHC restricted L3T4+ T-helper are involved in 
antibody generation in vivo was obtained by Lightman and coworkers. Thus, 
depletion of L3T4+ cells from Balb/c spleen cells prior to adoptive 
transfer to irradiated mice greatly reduced the ability of mice to produce 
IgG antibody in response to influenza A virus infection (Lightman ££ al-, 
1987).
LM_Mechanism of cytotoxic I-lymphocyte killing pf target csllfl
With the advent of techniques for cloning T-cell populations, rapid 
advances have been made in the understanding of the mechanisms of target 
cell killing by CTL. It is now clear that the killing process can be 
separated into three distinctly recognisable phases. The first is the 
Interaction between CTL and the target cell, the second is the preparation 
by the CTL for delivery of its 'lethal hit', and the third is the CTL- 
dependant destruction of the target cell (Hale £_£ ¿X. , 1987) .
As mentioned above, CTL use the a and P chains of their T-cell receptor to 
recognise specific antigen in association with the appropriate class I MHC
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antigen on the target cell. Other membrane molecules such as Lyt-2/CD8, 
L3T4/CD4, CD2 and LFA-1 stabilise the interaction with the target cell.
The effective adhesion of CTL to target cells is an active process, since 
it is inhibited by metabolic inhibitors such as azide (Male &£ al-. 1987). 
It also has a requirement for divalent cations, with Mg++ being more 
effective than Ca++. Although effector to target interactions occur in the 
absence of Ca**, no lysis occurs because later events are Ca**-dependant 
(Male &£ al. . 1987). Once CTL recognition of antigen and adhesion to the 
target cell has taken place the concentration of Intracellular Ca** in the 
CTL Increases, and the CTL is activated to undergo the lytic process 
(Ostergaard and Clark, 1987). The CTL begins to reorganise its cytoplasmic 
constituents such that the Golgi apparatus and cytoplasmic organelles lie 
between the nucleus and the area of contact with the target cell. The 
cytoskeletal proteins tubulin and actin also become polarised within the 
CTL in order to face the target (Male a£ *1. , 1987). A broadening of the 
region of membrane contact with the target cell has been observed and this 
Involves interdlgltations of the two membranes (Sanderson and Glauert,
1979). This may provide a greatly increased area of contact with the 
target cell and thereby improve the efficiency of lysis. Yanelli g_£ al. 
(1986) also reported that CTL formed a uropod which extended the region of 
interaction. Furthermore, cytoplasmic granules were found to reorientate 
into the region of contact, and fusions of granules with the cell membrane 
were observed (Yanelli ££ al. . 1986). Since it had been shown that a 
marked correlation existed between the presence of cytoplasmic granules and 
the ability of cloned CTL to lyse target cells (Gross! a£ al. , 1983), and 
granules Isolated from CTL lysed targets in a non-specific Ca++ dependant 
manner (Podack and Koningsberg, 1984), the observations that granules 
reorientated and fused with the cell membrane indicated that the secretion 
of granule contents was involved in the cytolytic mechanism. The major
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protein« in CTL granule« are a family of serine proteases designated 
granzyaes A to H (Masson and Tschopp, 1987), and a pore-forming protein 
called perforin (also known as cytolysln) (Masson and Tschopp, 1985). The 
fact that proteases were detected in the supernatants of CTL-target 
conjugates also supports the hypothesis that secretion of granule contents 
is involved in the cytolytic mechanism (Tschopp and Jongeneel, 1988). 
Perforin is a hydrophillic single chain protein with a molecular mass of 66 
Co 75 Kd (Tschopp and Jongeneel, 1988). When secreted from CTL granules, 
perforin binds to phosphorylcholine on the target-cell membrane (Tschopp ££ 
al.. 1989), and in the presence of C a ^  polymerises within the cell 
membrane into an amphiphilic polymeric form (Young and Cohn, 1988). 
Polymerised perforin (polyperforin) forms tubules in the target cell 
membrane which have an inner diameter of 16 nanometres (nm), a height of 16 
nn, and are composed of 10 to 20 perforin monomers (Tschopp and Jongeneel, 
1988; Young and Liu, 1988). These tubules perforate the target membrane 
and form non-selective transmembrane channels which ultimately lead to cell 
death (Tschopp and Jongeneel, 1988). Thus, there results an equilibrium of 
ions across the membrane, and cytoplasmic macromolecules exert an 
unbalanced osmotic pressure such that water is taken up and the nuclear 
membrane invaginates. Convolution of the plasma membrane leads to the cell 
separating into small membrane bound segments called apoptotic bodies. 
Accompanying the nuclear changes, the chromatin is rapidly degraded into 
discrete fragments which have multiples of about 200 base pairs of DNA 
(Male al.. 1987). Pore formation has been shown to be similar in many 
respects to the channel formation induced by the ninth component of 
complement (C9) (for review see Tschopp and Jongeneel, 1988), although C9 
and perforin clearly differ in their mode of target cell recognition.
Thus, C9 insertion is directly dependant on a receptor moiety assembled 
from the complement components C5b, C6 , C7 and C8 on the target cell
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membrane, whereas perforin binds to phosphorylchollne on the target cell 
membrane (Tschopp ££ al. . 1989). After a CTL has damaged its target cell. 
It can recycle to lyse new targets, hence clearly spares Itself from lysis 
(Young and Liu, 1988). Classic experiments performed some time ago 
indicate that under certain conditions CTL are effectively lysed by other 
CTL, implying that CTL must themselves be sensitive to the mechanism they 
use to kill target cells (Golstein, 1974). However, more recent 
experiments have suggested that CTL show an unusually high resistance to 
lysis by effector CTL. Resistance appears to vary in proportion to the 
lytic potency of the CTL - the more aggressive the CTL, the more resistant 
it is to other attacking CTL (Kranz and Eisen, 1987; Blakely £_£ gl., 1987; 
Skinner and Marbrook, 1987). Cloned CTL are not only resistant to other 
effector CTL, but also to lysis by purified perforin, which normally lyses 
target cells in the presence of Ca++ (Young and Cohn, 1988). It has been 
speculated that the resistance of CTL to their own perforin may be mediated 
by a theoretical surface protein known as protectin which rapidly combines 
with any perforin monomers that get into the cell membrane, and thereby 
prevents the polymerisation that leads to pore formation (Young and Cohn, 
1988).
Although perforin is abundantly present in murine and human CTL lines 
maintained in vitro. detectable levels have not been found in lymphocytes 
Isolated from human blood, in murine peritoneal exudate lymphocytes, or in 
any tissues so far examined. However, when isolated lymphocytes are 
stimulated with interleukin- 2 in vitro they proliferate and begin to 
synthesise perforin (Young and Cohn, 1988; Young and Liu, 1988). It is 
possible that perforin may only be present in CTL in vivo during disease 
states which show an increase in Interleukin- 2 levels.
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As mentioned above, CTL granules have been shown to contain a family of 
proteases designated granzymes A to H. The function of the granzymes is 
poorly understood. Unlike purified perforin, purified granzymes alone have 
no cytolytic activity, and there is no evidence to suggest that granzymes 
act in a proteolytic cascade which leads to the activation of perforin (as 
is the case in the complement system) (Tschopp and Jongeneel, 1988). The 
fact that protease inhibitors were found to suppress the lytic activity of 
CTL does however suggest that proteases may be involved in CTL-mediated 
killing (Hudig ££ al. . 1984). It has been suggested that granzymes may 
need to pass through polyperforin tubules in order to have their effect 
(Male al. . 1987). Furthermore, it has been suggested that granzymes may 
facilitate the detachment of CTL from the target cell after delivery of the 
lethal hit has taken place (Tschopp and Jongeneel, 1988).
The ability of some cloned CTL to lyse targets cannot be accounted for 
solely by the effect of perforin. Thus, Young ££ al. (1987) showed that 
only four out of eight CTL lines tested contained perforin, whereas all 
eight were potent killers. Furthermore, subcellular fractions (granules 
and cytosolic material) of all eight CTL lines were found to be cytotoxic 
to tumour targets even in the absence of calcium (Young si al. . 1987).
Trenn Al. (1987) also showed that CTL killed target cells even when 
secretion of granule contents did not take place. These findings clearly 
indicate that a calcium and perforin independent pathway of killing also 
exists.
Lymphotoxin was originally described as a cytotoxic activity secreted by 
activated T-cells (Granger and Williams, 1968). Its role in the cytolytic 
process has remained controversial. Lymphotoxin has been shown to have a 
high level of amino-acid sequence homology with the macrophage cytotoxic
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factor, tumour necrosis factor (TNF), and to have biological activities 
Indistinguishable from those of TNF, probably because the two proteins 
share the same receptor (Aggarwal §_£ al. . 1985). Therefore, they are now 
called TNF-a (formerly TNF) and TNF-/? (formerly lymphotoxin). The proposed 
role of TNF-/3 in CTL-medlated cytolysis is based on the fact that many CTL 
lines secrete TNF-/? when Incubated with target cells, and that TNF-0- 
containing cell supernatants induce DNA degradation in some tumour cell 
lines (Tschopp and Jongeneel, 1988). However, several lines of evidence 
argue against a direct role for TNF-/? in target cell killing by CTL.
First, it is known that many cell lines that can be killed by CTL are 
refractory to the toxic effects of TNF-/?. Second, the appearance of TNF 
mRNA after antigenic stimulation and secretion of the protein takes several 
hours, and CTL kill their targets within minutes of contact. Third, 
several CTL lines have been found to kill their targets without producing 
detectable quantities of TNF-/? mRNA or protein (Tschopp and Jongeneal, 
1988).
As mentioned previously, adhesion of CTL to its target cell ultimately 
results in a degradation of the target cell genome into DNA fragments which 
consist of multiples of 200 base pairs. The observations made by Wyllie 
(1980) that treatment of cortisone-sensitive thymocytes with glucocorticoid 
hormone resulted in a similar pattern of DNA fragmentation led Ucker (1987) 
to postulate that the CTL and glucocorticoid mediated cytolytic pathways 
may share a common mechanism. Ucker reasoned that if the CTL and 
glucocorticoid mediated cytolytic pathways do indeed share a common 
mechanism, then genetic defects which abolish cytolysis by glucocorticoids 
must also confer resistance to killing by CTL. The susceptibilities of a 
glucocorticoid-sensitive thyoma cell line (S49), and a glucocorticoid- 
resistant mutant derived from this cell line, to lysis by alloreactlve CTL
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were thereby examined. The results obtained clearly showed that whilst 
both cell-types were effectively recognised by the CTL (as determined by 
conjugate formation), only the glucocorticoid sensitive cells were killed 
by the CTL. A single step spontaneous reversion event was also found to 
restore sensitivity of the glucocorticoid-resistant cells to both 
glucocorticoid and CTL lysis. These observations led Ucker (1987) to 
conclude that a single genetic lesion was responsible for the resistant 
phenotype, and that the normal gene activity of this locus in a target cell 
must be required for the target cell to respond (by dying) to the cytolytic 
signal provided by CTL or glucocorticoids. Hence, target cells play an 
active role in their own death, and CTL act by inducing the autolytlc 
process.
In summary, it is clear that killing by CTL is complex, and probably 
Involves multiple mechanisms as well as multiple mediators. It is possible 
that these may act either independently or synerglstically in the cytolytic 
process.
ID__Role qf IFPg in vlv9
It is now widely accepted that IFNs constitute an integral part in host 
defence against viral Infection. However, much of the evidence has been 
indirect; based on temporal associations between the presence of virus and 
IFN in different tissues, and the fact that administration of exogenous IFN 
can confer a marked protection in virus-infected animals and man (for 
review see Flnter and Oldham, 1985). While such studies indicate the 
possible importance of IFNs in vivo they do not allow firm conclusions to 
be made as to the actual role of IFNs produced endogenously during the 
course of infection. More direct evidence for the role of endogenous IFN
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In resistance to disease has been obtained in comparatively few studies by 
monitoring the effect of neutralising anti-IFN antibody on the course of 
disease. Fauconnier (1970, 1971) was the first to show that intravenous 
administration of anti-IFN-a/3 serum resulted in an earlier and increased 
incidence of mortality in mice infected intramuscularly with small amounts 
of Semliki Forest virus (SFV). Thus, mice infected with 0.2 U >50 of SFV 
survived, whereas over 50% of infected mice died when treated with anti* 
IFN-a/9 serum. Titres of virus in the brains of SFV*infected mice treated 
with anti-IFN-a^ serum were also found to be about ten times higher than in 
control mice. Fauconnier concluded that the anti-IFN-o/3 serum neutralised 
IFN-q/9 produced in response to SFV* infection and thus permitted extensive 
viral multiplication to take place. Subsequently, administration of antl- 
IFN-q0 serum was also shown to exacerbate disease in mice infected with 
encephalomyocardltis virus (Gresser et al.. 1976a; Guillon and Gresser, 
1978), polyoma virus (Grosser ££ ai. , 1979), mouse hepatitis virus type 3 
(Vlrelizier and Gresser, 1978), rabies virus (Marcovistz el al., 1986), 
Moloney sarcoma virus, vesicular stomatitis virus, and Newcastle disease 
virus (Gresser at al-. 1976b). These observations indicate that IFN-a/9 has 
an important role in the response of the mouse to a number of viruses which 
exhibit different pathogeneses. Gresser at al• (1976b) showed that 
intranasal and intravenous administration of anti-IFN-a/J serum had no 
effect on the course of Influenza (strain PR8) virus infection of mice. 
Although these observations suggest that IFN-a£ has no role in the immune 
response to influenza virus infection, it is possible that the absence of 
affect may have been related to an inability of the globulin to diffuse to 
the tracheobronchial epithelium and thus to neutralise IFN-a£ at the site 
of viral replication (Gresser el al.. 1976b). Berlardelli el al. (1984) 
obtained evidence that small amounts of IFN-a/9 may be present in healthy 
mice. Thus, vesicular stomatitis virus and encephalomyocarditis virus were
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found to multiply in only a small percentage of peritoneal macrophages 
freshly explanted from healthy adult mice. However, when mice were 
intraperitoneally treated with anti-IFN-<*0 serum several days prior to 
harvesting peritoneal macrophages the viruses multiplied to high tltres and 
most cells were infected. These results indicate that there may be low 
levels of endogenous IFN-a/J that contribute to host defense by maintaining 
some cells in an antiviral state. Bocci (1988) speculated that these low 
levels of IFN-a£ in healthy mice may be stimulated, at least in part, by 
lipopolysaccharlde derived from bacteria which colonise the gut. IFN-a£ 
cannot however nonsally be detected in peritoneal washings, splenic 
extracts or serum from healthy mice (Gresser g_£ &1. , 1983). IFN-a£ also 
appears to play a role in the Immune response against tumours since 
administration of anti-IFN-a/) serum has been shown to enhance the 
transplantability of a number of different murine tumours, as determined by 
an Increase in the number of tumour bearing mice and a decrease in survival 
time (Gresser &£ ¿1-, 1983).
Although IFN-O0 has a beneficial role in the immune response of the mouse 
to a number of virus-infections, there are also instances in which IFN-a/3 
does not protect the mouse but is actually responsible for the lethal 
outcome of virus-infection. Thus, Riviere £J£ al- (1977) showed that 
although administration of anti-IFN-a^ serum enhanced lymphocytic 
choriomeningitis virus (LCMV) multiplication 100-fold, it neutralised 
circulating IFN-afi and inhibited the decreased growth, liver necrosis and 
death normally observed in LCMV-infected newborn mice. Similarly, Pfau at 
al. (1983) showed that administration of anti-IFN-a^ serum enhanced tltres 
of the 'aggressive' strain of LCMV in adult mice but the mice survived the 
lethal outcome observed in control mice.
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Until very recently there were no preparations of antibody available which 
specifically neutralised IFN-y. Consequently, only a small number of 
studies have used anti-IFN-y antibody to examine the role of IFN-y produced 
endogenously during the course of disease in mice. Buchmeler and Schrelber 
(1985) were the first to show that endogenous IFN-y has a beneficial role 
in the immune response of the mouse. Thus, administration of anti - IFN-y 
monoclonal antibodies to mice Infected intraperitoneally with sublethal 
doses of Listeria monocytogenes was shown to completely Inhibit the 
generation of activated macrophages in the peritoneal cavity, abrogate the 
clearance of bacteria from the spleen and peritoneal cavity, and lead to 
the death of at least some mice. Subsequently, administration of anti-IFN- 
7 monoclonal antibodies was also shown to abrogate both protective immunity 
against malaria sporozoite challenge (Schofield &£ a1 . , 1987) and tumour 
immunity against Rous sarcoma virus-induced murine sarcomas (Prat Al-, 
1987). The use of anti-IFN-y monoclonal antibodies has revealed a role for 
IFN-y in both Inflammatory responses and the pathogenesis of autoimmune 
disease. Thus, administration of antl-IFN-y monoclonal antibodies has been 
shown to alleviate systemic lupus erythematosus disease (Jacob ££ a1-. 
1987), and inhibit the general Shwartzman reaction (endotoxic shock 
syndrome) in mice treated with two separate injections of
lipopolysaccharide (Bllliau ££ gl-> 1988). Skoglund a£ a1- (1988) studied 
the effects of anti-IFN-y monoclonal antibodies on the delayed type of 
hypersensitivity (DTH) reaction induced by administration of 2 ,4-dinitro-l- 
fluorobenzene onto the ears of sensitised Lewis rats. Anti-IFN-y 
monoclonal antibodies were found to inhibit the Induction of class II MHC 
antigen expression on kératinocytes during the DTH reaction but in contrast 
increased the swelling of ears. These observations suggest that endogenous 
IFN-y induced class II MHC antigen expression on kératinocytes during the 
DTH reaction, and that IFN-y had a suppressive role in the local immune
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response. Jephthah-Ochola al ai. (1988) showed that anti-IFN-7  monoclonal 
antibodies inhibited the ability of lipopolysaccharide to induce class I 
and class II MHC antigen expression in the kidney of nice. These 
observations indicate that lipopolysaccharide may stimulate endogenous IFN- 
7 production which Induces MHC antigen expression in the kidney. To date, 
there have been no reports in which anti-IFN-7  antibodies have been used to 
study the role of IFN-7  produced endogenously during viral disease. 
Hopefully this situation will soon be remedied now that anti-IFN-7  
antibodies are more widely available.
__Seallk1 Forest virus
(a) History, classification, structure and replication
Semllki Forest virus (SFV) was originally isolated from a pool of 130 
female mosquitos caught in Bwamba, Uganda in 1942 (Smithburn and Haddow, 
1944). Semllkl means * I do not know' - the reply given by natives when 
asked the name of the forest (Rowson et al., 1981).
SFV is a species in the genus alphavirus of the family Togaviridae 
(Porterfield at al. . 1978). It is also described as an arbovirus 
(arthropod borne virus) since it is transmitted by a mosquito vector and 
Infects vertebrates (Rowson £_£ al. , 1981). The natural vector-host cycle 
of the virus is not known although antibodies have been found in man and 
wild primates in Uganda, Mosambique, Cameroon, Central African republic, 
Kenya, Nigeria, Borneo and Malaya (Rowson al al-. 1981). SFV is not 
associated with any disease, and is generally considered to be non- 
pathogenic for man although a fatal case of encephalitis in a laboratory 
worker with purulent bronchitis has been associated with the virus (Willems
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al al.. 1979).
SFV 1« an enveloped virus with a diameter of 50-60 ran. The virus consists 
of an Icosahedral nucleocapsld surrounded by a lipid bllayer (Murphy,
1980). The nucleocapsld Is a complex of capsid (C) proteins and the genome 
(Garoff fet al-. 1980). SFV contains as Its genome a single strand of RNA 
of positive polarity and Is thus classified as a group IV virus using the 
Baltimore classification of viruses (Sawlcki and Sawlckl, 1980; Primrose 
and Dlmmock, 1980). The SFV genome has a sedimentation coefficient of 42S, 
and has been mostly sequenced (Levin and Friedman, 1971; Simons aJL-.
1982). The lipid bllayer has external glycoprotein spikes each consisting 
of three different polypeptides : El, E2 and E3, which exist as a trlmer 
(Garoff ££ al.. 1974; Zlemleckl and Garoff, 1978). E2 spans the lipid 
bilayer such that the hydrophobic carbcxyterminus interacts with thm 
nucleocapsid (Garoff and Simons, 1974; Ziemieckl and Garoff, 1978). El is 
anchored to the lipid bilayer by its hydrophobic carboxytermlnus (Zimmieckl 
and Caroff, 1978).
SFV attaches to cells by its glycoprotein spikes (Osterrieth and Calberg- 
Bacq, 1966). Helenius a£ al. (1978) provided evidence that SFV binds to 
class I MHC antigens on the surface of human and murine cells. However, 
Oldstone at al. (1980) showed that SFV replicated equally well In smrlne 
cells that both expressed, and did not express, class I MHC antigens. 
Indicating that class I MHC antigens may not be the only cell-surface 
receptor for SFV. SFV is thought Co enter cells by receptor mediated 
endocytosis. Thus, Helenius al- (1980) showed that SFV was incorporated 
into coated pits on the surface of baby hamster kidney-21 (BHK-21) cells, 
which invaglnated to form coated vesicles inside the cell. Vesicles 
bearing endocytosed virions subsequently fused with lysosomes. The lipid
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bilayer of Che virus was found Co fuse wlch lysosomal membranes when Che pH 
was 6 or lower, and 1c was proposed chac chis fusion may resulc In Che 
release of Che nucleocapsid In Che cycoplasm. RepllcaCion of SFV Cakes 
place In Che cycoplasm (Grlmley £_£ ai-, 1968). The nucleocapsid is 
uncoaced and Che released genomic RNA translated by hose cell ribosomes Co 
produce a precursor polypepclde which is subsequenCly cleaved Co yield non- 
structural polypeptides which form a viral coded RNA polymerase (Kaariainen 
and Soderlund, 1978). The virus polymerase Chen synChesises complementary 
sCrands of Che genome (42S negative sense RNA) which are used as a template 
for Che synchesis of two specios of positive sense RNA : new 42S RNA 
genomes and a subgenomic 26S RNA which codes for Che structural El, E2, E3 
and C polypeptides of the virus (Sawlcki and Sawlckl, 1980). The newly 
syncheslsed capsid procein is located in Che cell cyCosol, where it binds 
Co 42S RNA Co form new nucleocapslds. In contrast, Che envelope proceins 
are inserted into the membrane of Che endoplasmic reciculum, where they 
become glycosylaCed (Alberts ££ al.. 1983). Remaining membrane-bound at 
all times, Che envelope proceins are transported flrsC to Che Golgi 
apparatus (where they are further glycosylaCed) and then Co Che plasma 
membrane. As a resulc of specific interaction with Che envelope proceins, 
Che nucleocapsid becomes wrapped in a portion of Che plasma membrane that 
is highly enriched with virus envelope proteins, and subsequenCly buds out 
of Che cell in such a way as Co acquire a complete envelope (AlberCs et 
Al.. 1983).
.ÜÜ__SFV Infection ?£ the lafrgraiory mpvse
SFV was discovered by the abiliCy of mosquito extracts Co cause a lethal 
encephalieis in mice when inoculated intracerebrally. Initially, mice died 
at around day 6 post-InfecCion, but after 40 passages mice inoculated with
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a high dose of virus died ac around day 2 pose-infection (Smlthburn and 
Haddow, 1944; Atkins £_£ fll- , 1985). Seamer al- (1967) studied the 
course of SFV Infection in Porton nice infected with a thirteenth mouse 
brain passage of the original Isolate. Following footpad inoculation high 
titres of virus were found in the blood, spleen, brain, liver and popliteal 
lynph nodes, but only the brain and spinal cord showed histological 
lesions. Titres of virus were higher in the spleen and brain than in 
blood-observations which led Seamer and coworkers to conclude that the 
brain and spleen were sites of virus multiplication. Although the spleen 
was a site of virus multiplication its Importance in this respect was 
overshadowed by the brain where considerably higher titres of virus were 
found later in the course of infection. SFV is thus described as being 
neurotropic.
Bradish ai. (1971) studied the virulence of Smlthbum and Haddow's 
original strain and three other isolates (isolated by other workers from 
pools of mosquitos in Nigeria and Mosamblque, and from human blood in 
Surinam) which had been passaged in mice, and in some cases also in chick 
embryo fibroblasts in vitro, to different extents. Although these strains 
could not be distinguished serologically, they were found to differ 
markedly in their virulence for mice, guinea-pigs and rabbits when 
administered by the Intraperitoneal, intracerebral or respiratory routes. 
For Porton mice, neonatal animals were susceptible to all strains, but 
adult mice infected intraperitoneally were susceptible only to virulent 
strains. There was also found to be a sharp transition to resistance to 
the avirulent A7 strain at 16 to 17 days of age. Infection with avirulent 
strains then led to benign replication of the virus and protection of the 
host against challenge with a virulent strain (Bradish Al-, 1972; 
reviewed by Atkins gl. , 1985). Several studies have utilised strains of
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defined virulence In an attempt to relate virulence to properties of the 
virus. Pusztai gl. (1971) compared the multiplication of a virulent 
strain (V13) to that of an avirulent strain (A7) in weanling mice. They 
showed that, following intraperitoneal infection, the two strains 
multiplied similarly in the early stages of Infection. A viraemla of 
similar tltre occurred, which was followed by Invasion of the brain. 
However, V13 appeared in the brain 12 hours before A7 and increased in 
tltre until the death of the mice, whereas A7 reached a peak in the brain 
and then declined. Subsequent studies also showed that the initial 
patterns of Infection in brain and blood following avirulent or virulent 
infection were indistinguishable (Bradish and Allner, 1972; reviewed by 
Atkins tt al.. 1985). Pathak al- (1976) carried out electron- 
microscopic studies of the brains of SFV-infected mice. Development of SFV 
in the brain was found to be similar in weanling and adult mice infected 
with the virulent L10 strain, and in weanling mice infected with the 
avirulent A7(74) strain. Mature virus could not however be seen in the 
brains of adult mice infected with the avirulent A7(74) strain. For the 
case of weanling mice infected with the virulent L10 strain, replicating 
virus was found to be associated predominantly with neurons. Subsequently, 
replicating virus was also found in oligodendrocytes within the brains of 
both adult mice infected with the virulent L10 strain (Pathak and tfebb,
1983) and weanling mice infected with the avirulent M9 mutant of SFV 
(generated by mutation of the virulent L10 strain with N-nitro-N-methyl-N'- 
nitrosoguanidine : Barrett £_£ ¿1., 1980) (Sheahan et al. . 1983). 
Replicating virus was not found associated with neurons in weanling mice 
Infected with the avirulent A7 strain or M9 mutant (Sheahan g£ gl. , 1983; 
Gates g£ fi_l. 1985). Atkins and Sheahan (1982) studied the
cytopathogenicity of the virulent L10 strain and four avirulent mutant 
strains (M4, M9, M103, M136: Barrett g£ gl. . 1980) for G26-24
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oligodendroglioma cells and C1300 neuroblastoma cells in vitro. They 
showed that the virulent L10 strain and four avlrulent mutants produced a 
rapid cytopathlc effect in C26-24 cells. In contrast, C1300 cells infected 
with the avlrulent mutants were found to survive infection, and only the 
virulent L10 strain produced a cytopathlc effect. Subsequent studies also 
showed that the cytopathogenicity of the avlrulent A7 strain was reduced 
compared to the virulent L10 strain in C1300 cells, but not in G26-24 cells 
(Atkins, 1983). Similarly, Gates at gl-,(1985) showed that the virulent 
L10 strain multiplied better in cultures of neurons, prepared from newborn 
mice, than did the avlrulent A7 strain or M9 mutant. Furthermore, Bruce g£ 
al. (1984) showed that mixed primary brain cell cultures, derived from 
newborn rats, became depleted of oligodendrocytes following infection with 
the avirulent A7 strain. Administration of myocrisln (sodium 
aurothlomalate) to adult mice has been shown to potentiate infection by the 
avirulent A7 strain, and to thus convert a normally avirulent infection 
into a virulent one (as determined by increased mortality, mean survival 
and neuronal destruction) (Allner gl-, 1974; Bradlsh g£ gl., 1975b). 
Myocrisin treatment did not depress the antibody response and it was 
suggested that macrophage phagocytic activity may have been inhibited 
(Allner g£ gl-. 1974; Bradish g£ gl- , 1975b). Myocrisin has been shown to 
stimulate membrane proliferation on brain cells and to inhibit lymphocyte 
proliferation. However, it is not yet clear which effects of myocrisin 
were actually involved in the change of pathogenesis (for review see Atkins 
et al.. 1985). In summary, it does appear that the lethal event in 
virulent SFV-infection is the destruction of neurons. Limited damage to 
oligodendrocytes during avirulent SFV-Infection is probably tolerated by 
the mouse and arrested by immune intervention before a lethal threshold of 
damage can be exceeded.
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Infection of adult »ice with «virulent SFV results in the formation of 
demyelinating lesions in the brain (Jagelman £_£ gi., 1978; Suckling gt gi., 
1978; Chew-Li» g£ gi- , 1978; Uebb g£ gi. . 1979; Sheahan g£ gi- , 1981; Kelly 
et al.. 1982; Pathak g£ al.. 1983). The pathogenesis of demyelinatlon in 
SFV Infection has been subject to a number of studies and some of the data 
presented is contradictory. Chev-Lim e_£ al. (1977) reported that 
irradiation of mice, prior to Infection with the A7(74) strain of SFV, 
resulted in an Increased severity of demyelination and increased titres of 
virus in the brain. Similar observations were made when the same strain of 
virus was used in athymic (T-cell deficient) nude mice (Chew-Lim, 1979). 
These workers concluded that demyelination in A7(74) SFV-infection resulted 
from direct viral activity rather than from an autoimmune reaction. In 
contrast, Jagelman g£ gl. (1978) and Fazakerley g£ al. (1983, 1987) found 
no evidence of demyelination in nude mice infected with the A7(74) strain 
of SFV, while demyelination was observed in similarly infected heterozygous 
Immune-competent litter mates. It was concluded from these studies that a 
T-cell mediated immunological response was involved in the development of 
demyelination in immunocompetent mice. Berger (1980) reported that 
although demyelination occurred in nude mice infected with the A7 strain of 
SFV, it was reduced in severity as compared to immune-competent mice. 
Demyelination induced by the A7(74) strain and M9 and M136 mutants of SFV 
has been shown to be accompanied by an infiltration of leukocytes into the 
brain (Sheahan g£ gi., 1981, 1983; Kelly g£ gi., 1982; Pathak g£ gi.,
1983). Reconstitution of T-cells and/or B cells to lmmunosupressed mice, 
and of T-cells to nude mice, prior to infection with the A7 and A7(74) 
strains of SFV has also been shown to induce the formation of demyelinating 
lesions (Berger, 1980; Fazakerley g£ gi., 1983, 1987). These observations 
indicate that T and B cells play a role in demyelination.
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The role of the immune system in recovery from SFV Infection has elso been 
subject to a number of studies. It is now clear that infection of mice 
with SFV results in the endogenous production of IFN-o/J. Bradlsh and co­
workers found that in Porton mice Infected intraperitoneally with the 
virulent V10, virulent V12, avirulent A7, and avirulent A7(74) strains of 
SFV, the amount of IFV-afi in serum rose from an undetectable level, peaked 
at around 36 hours post-infection, and then declined back to an 
undetectable level by day 5 post-infection (Bradish and Allner, 1972; 
Bradish a 1-. 1975a). Similarly, Fleming (1977) detected IFN-afi in the 
serum of Porton mice infected intraperitoneally with the virulent L10, 
virulent V14 and avirulent A7(74) strains of SFV, and found that maximal 
levels were present at around 24 hours post-infection. In this study 
Fleming also found that at 24 hours post-Infection the level of IFN-a0 in 
the spleen was nine times higher than in serum, an observation which led to 
the conclusion that the spleen may be a site of IFN-a/3 secretion. Bradish 
and Allner (1972) and Fleming (1977) monitored the amount of IFN-a£ in the 
brains of Porton mice infected intraperitoneally with the virulent L10, 
virulent V14, avirulent A7 and avirulent A7(74) strains of SFV, and found 
that little IFN-a/9 was present early in infection. At 24 hours post- 
infection with the avirulent A7(74) strain of SFV, the levels of IFV-afi in 
the brain were only one twentieth of those in serum. Oaten ££ al- (1976) 
found large amounts of IFU-afi in the brains of Swiss AgG mice 24 hours 
after intracerebral Infection with the avirulent A7(74) strain of SFV, and 
showed that the amount of IFN-a/3 present declined to an undetectable level 
after day 3 post-infection. As mentioned previously, IFN-a£ produced 
endogenously during SFV-infection of mice appears to have a protective role 
since intravenous administration of anti-IFN-a£ serum to Swiss mice 
immediately following intramuscular infection with low doses of SFV (strain 
not specified) resulted in earlier and higher mortality (Fauconnier, 1970,
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1971). Finter (1966) demonstrated that intramuscular administration of 
exogenous natural IFS-afi protected Alderley Park strain I mice against 
lethal doses of the MB strain of SFV Injected into the peritoneum. 
Intraperitoneal administration of exogenous natural IFN-a0 and double- 
stranded RNA (an Inducer of IFN-a/9) to Swiss AjG mice and Balb/c mice has 
also been shorn to reduce the efficiency of intraperitoneal infection with 
the virulent L10 and avirulent A7(74) strains of SFV (Bradish and Tltmuss,
1981). To date, no studies have monitored levels of IFN-y present in SFV- 
infected mice, or have administered anti-IFN-y antibody to determine the 
role of endogenously produced IFN-y. The generation of SFV-speclfic T- 
cells and antibody in SFV-Infected mice, and the possible importance in 
recovery are discussed in detail in chapter 8 .
(7) Alms of project and introduction to the experimental system
It is now well established that CTL and T-helper cells only recognise 
foreign antigens presented in association with antigens of the MHC. Cells 
within the brain differ from most other cells in the body in that they do 
not usually express detectable amounts of MHC antigen. However, like other 
organs of the body the brain can suffer from infection with viruses and 
other microorganisms and thus requires protection by the immune system. It 
is not yet known whether virus-infected brain cells are able to participate 
in T-cell mediated immune reactions. IFNs have been shown to increase MHC 
antigen expression on a variety of cell types. Several studies have also 
demonstrated that IFNs increase the ability of cells to participate in 
antigen specific T-cell mediated immune reactions, and that this increased 
ability correlates with an augmentation of MHC antigen display on the 
cells. IFNs-a and -0 are released by most cell types when infected with 
virus, and IFN-y is released by T-cells on specific recognition of viral
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antigen on cells. It is possible that IFNs-o. •$, and -7  within a virus 
infected brain may modulate the ability of brain cells to participate in 
virus-specific T-cell mediated immune reactions.
The major aims of this thesis are:
(i) To investigate whether virus-Infected brain cells participate in 
class I and class II MHC restricted virus-specific T-cell mediated 
Immune reactions in vitro.
(ii) To investigate the effect of IFNs on class I and class II MHC antigen 
expression by brain cells in vitro.
(ill) To investigate the ways in which IFNs may modulate the susceptibility 
of brain cells to infection by virus in vitro.
(iv) To investigate the ways in which IFNs may modulate the ability of 
virus-infected brain cells to participate in virus-specific T-cell 
mediated Immune reactions in vitro.
SFV was chosen for use in these studies since it is neurotropic and the 
pathogenesis of disease in mice is reasonably well understood. Studies on 
the Interactions between SFV-infected brain cells and SFV-speclfic T-cells 
may also provide an insight into the mechanism by which SFV-infection 
triggers an apparently T-cell mediated autoimmune reaction which results in 
demyelination. This may assist in the understanding of multiple sclerosis 
in man, which is speculated to have a viral aetiology.
The brain cells chosen for use in these studies were primary cultures of 
astrocytes, G26-24 oligodendroglioma cells, and C1300 neuroblastoma cells. 
Astrocytes were chosen since nearly pure primary cultures of these cells 
can be prepared from the brains of newborn mice with little difficulty - a
55
factor which facilitates routine use (McCarthy and Vellis, 1980; Fontana g£ 
al.. 1982: Gates g£ al.. 1985). In contrast, cultures of oligodendrocytes 
and neurons are such more difficult to prepare as pure and stable 
populations, and require laborious techniques (McCarthy and Vellis, 1980; 
Suzusura g£ gl., 1984; Snyder g£ ai-, 1980; Gates g£ al- , 1985). This 
makes the routine use of oligodendrocytes and neurons more difficult. The 
G26-24 oligodendroglioma and C1300 neuroblastoma tumour cell lines were 
thereby chosen as representative cell types. The G26-24 oligodendroglioma 
cell line was cloned in 1975 by Sundarraj and coworkers (Sundarraj g£ gl., 
1975) from a glial cell tumour (G26) of central nervous system origin 
induced by methylcholanthrene treatment of the C57 BL/6 mouse (Zimmerman, 
1955). G26-24 cells are referred to as oligodendroglioma cells since they
exhibit some (but not all) of the properties associated with Immature 
oligodendrogllal cells (Dawson, 1979) . The C1300 neuroblastoma cell line 
was cloned from a spontaneous tumour which appeared around the spinal cord 
of an A/J mouse (Schubert g£ gi. , 1969). C1300 cells have been shown to
possess some properties of a mature neuron (Schubert g£ al., 1969). It is 
important to note that whilst C26-24 and C1300 cells provide a convenient 
model system, they clearly will not possess characteristics Identical to 
normal oligodendrocytes and neurons.
Neurons receive, conduct, and transmit signals within the nervous system.
In the brain, astrocytes and oligodendrocytes support the activity of 
neurons. Astrocytes provide both mechanical and metabolic support for the 
complex neuronal circuits; they synthesise and degrade neuronally important 
compounds and help to control the ionic composition of fluids surrounding 
neurons. Oligodendrocytes form insulating myelin sheaths around neurons 
and thereby Increase the speed and efficiency of signal transmission 
(Alberts g£ gl., 1983).
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The experimental alms mentioned above will yield information about the ways 
in which SFV-infected brain cells may participate in SFV-specific T-cell 
mediated Immune reactions in vitro. However, these studies may have no 
relevance to the situation in vivo during SFV-infection of mice. Studies 
will therefore be extended to the in vivo system to determine whether IFN- 
afi and IFN-y are actually present within the brains of SFV-infected mice. 
Class I and class II MHC antigen expression by cells within the brains of 
SFV-Infected mice will also be monitored. Furthermore, to determine 
whether IFN-y produced endogenously during SFV-infection of mice has any 
role, R4-6A2 rat-anti-murine IFN-y neutralising monoclonal antibody will be 
administered to mice, prior to infection, and the effect on the clinical 
course of SFV disease studied. The R4-6A2 monoclonal antibody was chosen 
since it was the only neutralising monoclonal antibody to IFN-y available 
(Spitalny and Havell, 1984), and a polyclonal antiserum to recombinant IFN- 
y (recombinant to exclude the possibility of contamination with other 
lymphokines which may be present in preparations of natural IFN-y) was not 
available.
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Chapter 2
Material» and Method»
(A) Madly
Dulbecco's modification of Eagles minimum essential medium (DMEM), the 
Glasgow modification of Eagles minimum essential medium (GMEM), Roswell 
Park Memorial Institute (RPMI) 1640, and 2 x 199 were all obtained from 
Glbco Ltd and prepared by Mrs B Wood (University of Warwick) . Foetal calf 
serum (FCS) was obtained from both Glbco Ltd and Northumbria Blologlcals 
Ltd and was heat-inactivated for 45 minutes at 56°C in order to inactivate 
complement, prior to use. Newborn calf serum (NBCS) was obtained from 
Glbco Ltd. All media were buffered with bicarbonate to pH 7.0, and were 
supplemented with glutamine (2 mM) (Flow Laboratories Ltd) Penicillin (60 
tig/ml) and streptomycin (100 pg/ml) from Glaxo Laboratories Ltd. GMEM was 
also supplemented with non-essential amino-acids (NEAA) obtained from 
Sigma. For GMEM BHK, GMEM was supplemented with tryptose phosphate broth 
(2.9 mg/ml) obtained from Dlfco Ltd. For RPMI 1640 complete, fi~ 
mercaptoethanol (BDH Chemicals Ltd) was added to RPMI 1640 medium to a 
final concentration of 10*^ M.
ill fiaU llnaa
All cell Unas used were stored long term in liquid nitrogen (see methods). 
When required cells were thawed and maintained in continuous culture for at 
least 14 days before use.
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1. Baby hamster kidney calls (BHK-21) were obtained from Flow Laboratories
2 2Ltd. BHK-21 cells were routinely grown in either 75 ca or 150 ca 
tissue culture flasks (obtained froa Costar Ltd) containing 15 als and 
40 als respectively of GMEM BHK suppleaented with 10% PCS. Cells were 
subculturad when a confluent aonolayer had formed. For subculture of 
cells in 150 cm^ flasks, medium was aspirated and the monolayer washed 
with 10 mis warn PBS (see materials section I) containing 0.02% 
diaainoethanetetra-acetic-acid (EDTA, obtained from Flsons pic) 
followed by 5 minutes incubation with 10 als of the same solution 
containing 1 mg/al trypsin (obtained froa Flow Laboratories Ltd) .
Cells were harvested by pipetting into 10 als medium, pelleted by 
centrifugation at approximately 3,000 rpm for 5 minutes in an MSE minor 
bench centrifuge, and resuspended in 10 mis fresh medium. Fresh tissue 
culture flasks were then seeded with 1 ml of cell suspension (hence, 
subcultured 1:10). Cells were Incubated at 37°C in a Wedco Incubator 
with an humidified atmosphere of 5% carbon dioxide in air. Cells 
2growing in 75 cm flasks were subcultured in an identical manner, with 
the exception that the volumes of EDTA/PBS and EDTA/PBS/trypsin 
solutions were halved. 2
2. Murine neuroblastoma cells (C1300) derived froa the A/J mouse (Augusti- 
Tocco and Sato, 1969) were brought to this department by Dr D J 
Mauds ley (University of Warwick) . C1300 cells were routinely grown in
DMEM supplemented with 10% FCS. Incubation and subculture conditions 
as for BHK-21 cells.
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3. Murine oligodendroglioma cells (G26-2A) derived from Che C57 BL/6 mouse
(Sundarraj a1- , 1973) were brought Co this department by Dr D J 
Maudaley (University of Warwick). G26-24 cells were grown in DMEM
supplemented with 10% FCS. Incubation conditions and subculture (1:6) 
as for BHK-21 cells.
4. Murine L929 fibroblasts derived from the C3H mouse were brought to this 
department by Prof D C Burke (currently at University of East Anglia). 
L929 cells were grown in GMEM NEAA supplemented with either 10« FCS or 
NBCS. Incubation and subculture as for BHK-21 cells, into 1 litre 
glass bottles (obtained from Flow Laboretories).
3. Murine ELA lymphoblastold cells derived from the C37 BL/6 mouse, were 
obtained from the American Tissue Culture Collection (ATCC), clone
TIB 39. ELA cells were grown in 23 cm^ tissue culture flasks (obtained 
from Costar Ltd) containing 10 mis RPMI 1640 supplemented with 10% FCS. 
Cells grew in suspension end were subcultured at a 1:10 dilution. 
Incubation conditions as for BHK-21 cells.
6 . Murine mastocytoma cells (P81S) derived from the DBA/2 mouse, were 
obtained from the ATCC, clone TIB64. Media, incubation conditions and 
subculture as for ELA cells.
7. Murine RDM4 lymphoblastoid cells were obtained from Mr M J Blackman 
(currently at National Institute for Medical Research, London). Media, 
incubation conditions and subculture as for ELA cells.
8 . Murine myelomonocyte cells (WEHI 3b) derived from the Balb/c mouse, 
were brought to this department by Dr D J Mauds ley and were originally
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obtained from Dr P Kaye (London School Hygiene and Tropical Medicine, 
London). Media, Incubation conditions and subculture as for ELA cells.
9. Murine Yac-1 lymphoblastoid cells derived fro* the A/Sn souse, were 
obtained fro* Mr M J Blacknan (currently at National Institute for 
Medical Research, London). Media, Incubation conditions and subculture 
as for ELA cells.
(C) Vlrm
The virulent L10 strain of Semllki Forest Virus (SFV) (Bradish fit al. ,
1971) was originally obtained fro* Dr R Fltzgeorge and Dr C Bradish (Porton 
Down, Wiltshire, UK). Stocks used In the experiments presented In this 
thesis were prepared by nyself fro* a seed stock of souse brain SFV as 
described In nethods section A. The avlrulent A7(74) strain of SFV 
(Bradish fit al., 1971) was obtained fro* Dr A Barrett (currently at the 
Department of Biological Sciences, University of Surrey) and all stocks 
used were prepared by Mr M J Blackman (currently at National Institute for 
Medical Research, London).
Male and female 5 to 6 week-old A/J (H2a) and C57 BL/ 6 (H2b) mice were 
obtained from Bantin and Kingman. Male and female 5 to 6 week-old Balb/c 
(H2d), DBA/2 (H2d), B10.A.(5R) (H215) and MFI nu+/«u+ nude mice were all 
obtained from Olac Ltd. Male and female C3H/He (H2k ) mice were obtained 
from a breeding colony present within this department, and which was 
originally established using breeding pairs supplied by Bantin and Kingman.
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(E) Intsrfcrgna
Murine natural IFN-a0, specific activity 4.0 x 103 *6 unlts/mg protein was 
purchased from Lee Biomolecular. Murine reconblnant IFN /3 and 7 were 
prepared in this laboratory from Chinese hamster ovary cells transfected 
with the mammalian expression vector pKSV^g containing a cDNA copy of the 
IFN-0,, or 7 mRNA (Morris and Ward, 1987). The IFN present in supernatants 
harvested from the transfected cells was then partially purified by 
affinity chromatography on cibricron blue sepharose (obtained from Sigma) 
by Mr P D Shaw (University of Warwick). The resultant activities of the 
preparations were as follows: IFN-/3, 6.3 x 106 units/mg protein, IFN-7  3.2 
x 10^ units/mg protein. Murine IFN-a0 international standard G002-904-511 
was obtained from National Institute for Health, Bethseda, Maryland, USA.
(F) AnUbodlas
1. Murine monoclonal anti-H2Kk (IgC2a) provided by Dr D J Maudsley 
(Univeslty of Warwick) in both supernatant and ascites form derived 
from hybridoma clone 11-4-1 (ATCC TIB95). These preparations were used 
neat and at a 1 :1 0 0 dilution, respectively.
2. Murine monoclonal anti-H2Dk (IgG2a) was provided as purified antibody 
derived from hybridoma clone 15-5-55 (ATCC HB24) by E Culbert (ICI, 
Macclesfield, UK) and was used at a 1:40 dilution.
3. Murine monoclonal antl-H2Ak (IgG2a) was provided as purified antibody
by Mr M J Blackman (currently at National Institute for Medical
Research, London) and in supernatant form from Dr D J Maudsley
(University of Warwick). Both preparations were produced from
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hybridoma clone 10.3.6 (ATCC TIB92) and were used aC a 1:80 and 2:3 
dilution. respectively.
4. Murine monoclonal antl-H2DkKk , cross-reactivity H2Kb (IgC2a) w** 
obtained from Unisclence Ltd as ascites fluid produced from hybrldoma 
clone 3-83P and was used at a 1:20 dilution.
5. Murine monoclonal anti-H2Ab (IgM) was obtained from Unisclence Ltd as 
ascites fluid produced from hybrldoma clone 28-16-8, and was used at a 
1:40 dilution.
6 . Murine monoclonal antl-H2Dd, cross reactivity H2Db (IgM) was produced 
by myself in supernatant form from hybrldoma clone 28-11-5S (ATCC HB19) 
as described in methods section I, and was used neat.
7. Murine monoclonal antl-H2Kd (IgM) was obtained from Unisclence Ltd as 
an ascites fluid derived from hybridoma clone 31-3-4S, and was used at 
a 1:50 dilution.
8 . A polyclonal rabbit antiserum to cow glial fibrillary acidic protein 
(GFAP) was obtained from Dako Ltd, and was used at a 1:100 dilution.
9. A polyclonal goat antiserum to rat flbronectln was obtained from 
Cambridge Bloscience Ltd, and was used at a 1:100 dilution.
10. A polyclonal rabbit antiserum against SFV was prepared in this 
laboratory by C Sutton (University of Warwick). The SFV used to 
immunise rabbits was grown in BHK cells (see methods section A) and was 
purified by sucrose gradient centrifugation. Rabbits were immunised at
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regular intervals by conventional techniques using Freunds complete and 
Incomplete adjuvants. For indirect immunofluorescence staining of 
cell-surface SFV antigens the antiserum was diluted 1:20 and 
preabsorbed for 1 hour at 4°C with approximately 1 x 106 cells of the 
appropriate type, to reduce non-specific binding prior to use.
11. A polyclonal rabbit antiserum to murine natural IFN-a£ was produced in 
this laboratory by C Sutton (University of Warwick) . The IFN-a0 used 
to immunise rabbits was produced by Infection of L929 cells with 
Newcastle Disease Virus. Cell supernatants were harvested at 24 hours 
post-infection, extensively dialysed against pH 2 glycine buffer to 
Inactivate live virus and the IFN-a0 partially purified by affinity 
chromatography on phenyl-borate-agarose-30 matrex gel. Rabbits were 
Immunised at 14 day intervals by conventional techniques using Freunds 
complete and incomplete adjuvants. Rabbits were bled from the ear and 
the blood allowed to clot overnight at 4°C, after which the serum was 
clarified by centrifugation and heat-inactivated at 56°C for 30 minutes 
to remove complement, prior to storage at -20°C.
12. Rat monoclonal anti-murine IFN-y (IgG^) was produced by myself in 
ascites form (see methods section I) from hybridoma clone R4-6A2 which 
was generously provided by E Havell (Trudeau Institute, New York, USA).
13. Fluorescein isothiocyanate (FITC) conjugated goat-anti-mouse 
Immunoglobulins (anti-IgA, IgM, IgG, heavy and light chains specific) 
IgG fraction was obtained from Cappel and used at a 1:80 dilution.
14. FITC conjugated sheep-anti-rabbit (anti-IgC, IgM, IgA) was obtained 
from Wellcome diagnostics and used at a 1:100 dilution.
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15. FITC conjugated rabblt-anti-goat (antl-IgG) IgG fraction, was obtained 
from Nordic Immunological reagents and used at a 1:100 dilution.
(C) Radigchcaicalg
All radiochemlcals used were obtained froa A^ersham radlochealcals pic.
1. 51Cr-sodlum chroaate (250-500 aCl/ag Cr).
2. Methyl-3H-thymidine (25 Cl/mmol).
3. 5-3H-urldine (25-30 Ci/mmol).
(HI Other materials
Actlnoaycln D (obtained from Sigma).
Aluminium foil (obtained from Alcan Ltd).
Ammonium chloride (obtained from Flsons pic).
Calcium chloride (obtained from Flsons pic).
Callbrlte beads (obtained from Becton-Dlcklnson Ltd).
Concanavalln A (obtained from Mlles-Yeda Ltd).
DEAE dextran (obtained from Sigma).
Deoxyribonuclease I (obtained froa Sigma).
Dialysis tubing 8/32", 16/32" (obtained from Fisons pic).
Diethyl-ether (obtained from May and Baker Ltd).
Dimethyl sulphoxlde (obtained from Fison pic).
Disodium hydrogen phosphate (obtained from BDH).
Eppendorf tubes 0.75 and 1.5 ml (obtained from Sarstedt Ltd).
Ethanol (obtained from James Burroughs Ltd).
Filter paper 12.5 cm analytical grade (obtained from Whatman Ltd).
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Flow pore 0.45 pm filter sterilizing units (obtained from Flow Laboratories 
Ltd).
Freezing ampoules 2 ml (obtained from Flow Laboratories Ltd).
Gelatin (obtained from Difco Ltd).
Glass filter paper (obtained from Uhatman Ltd).
Glycerol (obtained from Flsons pic).
Glycine (obtained from Fisons pic).
Hydrochloric acid (obtained from Fisons pic).
Hypodermic syringes 21, 25 and 26H gauge (obtained from Sabre 
International).
Indomethacin (obtained from Sigma).
Lymphoprep (obtained from Nyegaard UK) .
Lympholyte M (obtained from Sera-lab).
Kodak ektachrome 160 tungsten film (obtained from Kodak).
Magnesium chloride (obtained from Fisons pic).
Mitomycin C (obtained from Sigma).
Micropipette tips, 200 pi and 1 ml (obtained from L.I.P. Equipment and 
Services).
Microtitre 96 well trays flat-bottomed (obtained from Costar Ltd). 
Microtltre 96 well trays round-bottomed (obtained from Flow Laboratories). 
Microtitre 96 well tray adhesive sealers (obtained from Flow Laboratories). 
Multipipette tips, 200 pi (obtained from Alpha Laboratories).
Neutral red (obtained from Difco Ltd).
Nescofilm (obtained from Nippon Shoji Ltd).
Noble agar (obtained from Difco Ltd) .
Paraffin wax (obtained from BDH Ltd) .
Paraformaldehyde (obtained from BDH Ltd).
Potassium chloride (obtained from Fisons pic).
Potassium dihydrogen phosphate (obtained from BDH Ltd).
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4 cm Plastic taat-tubea (obtained froa Stacilin).
Plastic bijous and universals (obtained from Sterilin) .
/î-Propiolactone, grade II (obtained from Sigma).
Rabbit complement, Pelfreez (obtained from Northeast Biomedical). 
Recombinant Interleukin-2, glycosylated (obtained from Genzyme). 
Scintillation fluid, ready value and E.P. (obtained from Beckman Ltd). 
Scintillation tubes, 6 ml (obtained froa LKB Pharmacia Ltd).
Sodium chloride (obtained from May and Baker Ltd).
Sodium hydroxide (obtained froa BDH Ltd).
Silica (obtained froa Sigma).
Syringes 1,2,5,10 and 20 mis (obtained from Sterilin).
2,6,10,14-Tetramethylpentadecane, 'Prlstane* (obtained from Sigma). 
Tissue culture petri-dlshes 6 cm (obtained from Becton Dickinson).
24 Well-tissue culture plates (obtained from Costar Ltd). 
Trichloroacetic acid (obtained froa May and Baker Ltd) . 
Trishydroxyaethylaainomethane, 'TRIS' (obtained from BDH Ltd).
Triton X-100 (obtained froa BDH Ltd).
I D Buffers and g<?lutl<?ns
1. Phosphate buffered saline (PBS) pH 7.4:
137 mM Sodium chloride 
2.7 mM Potassium chloride
8 mM Disodlum hydrogen phosphate 
1.5 mM Potassium dihydrogen phosphate
2. Glycine buffer pH 2.0
100 mM Glycine
Concentrated hydrochloric acid added to pH 2.0
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50 mM Tris-HCl pH 7.253.
50 mM Tri shydroxyme thylaminóme chañe (TRIS)
Concentrated hydrochloric acid added to pH 7.25
4. 3% Paraformaldehyde solution in PBS
3 g paraformaldehyde was dissolved in 100 mis PBS by stirring at 
80°C (in fume cupboard). While constantly stirring 10 pi 1M 
calcium chloride and 10 pi magnesium chloride was added, after 
which the solution was cooled to room temperature, the pH checked 
to be 7.4 and filter sterilized through a 0.45 pm pore. The 
solution was divided into aliquots and stored at -20°C.
5. Ammonium chloride red blood cell lysis solution
155 mM Ammonium chloride
1 M NaOH added to pH 7.0 and solution sterilized by autoclave 
(J) Name and address of suppliers
Alcan Ltd: 90 Ashbridge Road, Chesham, Bucks, HP5 2QE, UK.
Alpha Laboratories Ltd: 40 Parham Drive, Eastleigh, Hampshire, UK. 
Amersham International pic: Lincoln Place, Aylesbury, Buckinghamshire, UK. 
ATCC: 12301 Parklawn Drive, Rockville, Maryland, USA.
Bantin and Kingman: The Field Station, Grimston, Aldbrough, UK.
BDH Chemicals Ltd: Fourways, Atherstone, Warwickshire, UK.
Beckman-RIIC Ltd: Progress Road, High Wycombe, Buckinghamshire, UK. 
Becton-Dlckinson Ltd: Between Towns Road, Cowley, Oxford, UK.
Cambridge Bloscience: 42 Devonshire Road, Cambridge, UK.
Cappel: West Chester, PA, 19380, USA.
Costar Ltd: PO Box 94, 1170 Afi Badhoevedorp, Netherlands.
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Dako Led: 22 Tha Arcade, High Vycoabe, Buckinghamshire, UK.
Difco Led: PO Box 148, Ease Molesey, Surrey, UK.
Fisona pic: Bakewell Road, Loughborough, UK.
Flow Laboracories Led: Woodcock Hill, Rickaansworch, Hertfordshire, UK. 
Cenzyae Corporation: 75 Kneeland Street, Boston, Massachusetts, USA.
Glbco Led: Tridenc House, PO Box 35, Paisley, UK.
Glaxo Laboratories Led: Greenford Road, Creenford, Essex, UK.
Jaaes Burroughs F.A.O. Led: 70 Eastways Industrial Estate, Vlthaa, Essex, 
UK.
Kodak Photographic Ltd: PO Box 33, Swallowdale, Heael Hempstead, 
Hertfordahlre, UK.
Lee Bloaolecular: 11211 Sorrento Valley Road, San Diego, California, USA. 
L.I.P. Equipment and Services: 111 Dockfield Road, Shipley, Yorkshire, UK. 
LKB Pharmacia Ltd: Midsummer Boulevard, Milton Keynes, Buckinghamshire, UK. 
May and Baker Ltd: Liverpool Road, Eccles, Manchester, UK.
Mlles-Yeda Ltd: Box 37, Stoke Poges, Slough, Berkshire, UK.
Nippon Shajl Kaisha Ltd: Osaka, Japan.
Nordic Immunological Reagents: PO Box 544, Maidenhead, Berkshire, UK. 
North-East Biomedical: PO Box 45, Uxbridge, UK.
Northumbria Biologlcals Ltd: South Nelson Industrial Estate, Cramlington, 
Northumberland, UK.
Nyegaard Ltd: 11 Wagon Lane, Sheldon, Birmingham, UK.
Olac Ltd: Shavs Farm, Bicester, Oxon, UK.
Sabre International: Manor Farm Road, Reading, UK.
Sarstedt Ltd: 68 Boston Road, Beaumont Leys, Leicester, UK.
Sera-lab: Crawley Down, Sussex, UK.
Sigma London Chemical Co. Ltd: Fancy Road, Poole, Dorset, UK.
Sterllin Ltd: 43 Broard Street, Teddlngton, Middlesex, UK.
Unlscience Ltd: 12 St Annas Crescent, London, UK.
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(A) frodwctlgn and assay <?f SFY
All of Che SFV used during the course of chis projecC for Che In vitro 
infección of cells, was of Che virulent L10 serein. Laboracory stocks of 
virus were prepared by a single passage of seed sCock mouse brain SFV 
(produced by passage of virus in newborn mouse brains by Mr M J Blackman, 
currencly at Nacional InsCituCe for Medical Research, London) in BHK-21 
cells. More specifically, BHK-21 cells were grown Co confluency in 
UlnchesCer roller boceles containing 100 mis GMEM BHK supplemented with 10% 
FCS. The medium was then replaced with 40 mis GMEM BHK supplemented with 
2% FCS and 20 pi seed mouse brain SFV added. The cells were Chen lncubaced 
for 1 hour aC 37°C Co allow virus Co adsorb. The medium was Chen replaced 
with 100 mis of GMEM BHK supplemented with 2% FCS, and Che roller boceles 
gassed with 5% carbon dioxide in air before incubation at 37°C for 30 Co 36 
hours, after which a cycopathic effect was observed. Cell supernatants 
were Chen harvested, cell debris pelleted by centrifugation for 10 minutes 
at approximately 4,000 rpm in an MSE minor bench centrifuge, and the pH of 
supernatants containing SFV adjusted to pH 7.0 with bicarbonate prior to 
storage in aliquots at -70°C. Infectlvity of the stock SFV was assessed by 
incorporation of [3H]-uridine into viral RNA in infected cells (see methods 
section P) and by plaque assay. For plaque assay, ten-fold dilutions of 
virus were made in ice-cold PBS (containing 0.5% FCS) and 200 pi aliquots 
innoculated in duplicate onto monolayers of chick embryo fibroblasts in 6 
cm petrl-dlshes (obtained from Prof N Dimmock, University of Warwick).
After allowing the virus to adsorb for 1 hour at 33°C in a Wedco incubator 
with an atmosphere of 5% C02 in air, monolayers were overlaid with 4 mis 
199 medium containing 2% FCS, 0.9% noble agar and 0.04% DEAE dextran. The
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petri-dishes were then incubated for 2 days at 33°C as before. Plaques 
were visualised by staining the aonolayer with 3 ala 0.01« neutral red in 
PBS for 3 hours at 33°C, and counted. The tltre of stock virus was usually 
around 109 plaque foralng units per al (pfu/al).
(B) Preparation of fl-propiolactone inactivated SFV (BPLSFV)
In order to produce a preparation of SFV which was antigenlcally Intact yet 
unable to replicate in cells, stocks of virus were treated with 0- 
proplolactone essentially by the aethod of Barrett ££ al. (1984). Stock 
virus was dialysed overnight against SO aM Trls buffer pH 7.2S at 4°C, then 
incubated with 0.1% 0-proplolactone for 5 hours at 4°C, followed by 
overnight dialysis against the saae Tris buffer to reaove residual 0- 
proplolactone and its breakdown products, prior to two overnight dialyses 
back into CKEM. This procedure was found to reduce the infectivlty of the 
SFV stock froa 109 pfu/al to less than 10 pfu/al, rendered the virus unable 
to undergo replication - as assessed by the Incorporation of ^H-urldine 
into viral RNA in Infected cells, and abolished the ability of the virus to 
produce a cytopathlc effect when added to prlaary brain cell cultures 
(prepared as described in aethods section F). Since defective-interfering 
(DI) viruses have been shown to inhibit the ability of standard virus to 
synthesise virus-specific RNA in Infected cells or produce plaques on an 
Infected aonolayer (Barrett al., 1981; Johnston at Al- . 1975) the 
possibility existed that live virus was still present in the 0~ 
propiolactone-inactivated SFV (BPLSFV) preparation, but that 01 virus also 
present was inhibiting the ability to detect the live virus in the assay 
systeas used. To Investigate this possibility and deteralne whether any DI 
virus was present in the BPLSFV preparation, a plaque assay was set up in 
which a dilution series of live standard virus was assayed in the presence
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or absence of the BPLSFV preparation. If DI virus wars Indaad present In 
the BPLSFV preparation then the ability of the live standard virus to 
produce plaques In the presence of this preparation should be Inhibited as 
compared with the parallel assay In which the virus was titrated in the 
absence of the BPLSFV preparation. In fact no difference was observed 
between the number of plaques or size of the plaques obtained (data not 
shown) Indicating that neither detectable DI virus nor live virus were 
present In the BPLSFV preparation.
(C) Inoculation of mice with virus
(!) Intranasal
Mice were placed under light ether anaesthesia. A 20 pi aliquot of the A7 
(74) strain of SFV, diluted In GMEM supplemented with 2% FCS, was then 
placed on the tip of the nose and was subsequently Inhaled by the nice.
For Immunisation of 5 to 6 week-old male or female C3H/He, C57BL/6, A/J and 
BIO.A.S(R) mice 6.4 x 10^ pfu of virus were administered. For immunisation 
of 5 to 6 week-old male or female Balb/c and DBA/2 mice 1.6 x 10* pfu of 
virus were administered. For experiments In which 6 week-old male or 
female C3H/He mice were challenged with IOLD^q of the A7(74) strain of SFV, 
6.4 x  10* pfu of virus were administered.
(11) Intraoerltoneal
For the lntraperltoneal infection of newborn C3H/He nice the abdominal wall 
was first washed with ethanol and then 8 x 10^ pfu of the A7(74) strain of 
SFV In 50 pi of GMEM mediumwere administered lntraperitoneally using a 1 ml 
Starllln syringe with a 26W gauge needle. For experiments In which 6 week-
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old mala or female C3H/He mica warm infected with Cha L10 strain of SFV, 
mica vara placad under light athar anaesthesia, tha abdominal walls wara 
than washed with ethanol and IOLD^q (1.3 x 108 pfu) of tha L10 strain of 
SFV in 200 pi PBS administered intraperitoneally using a 1 ml Sterilin 
syringe with a 21 gauge needle.
(D) Administration of Interferon gamma and antibodies to Interferon ganm
Interferon gamma was first diluted to the appropriate concentration in PBS 
(sea results legend for details) and placad on lea. The abdominal walls of 
the mice were chan washed with ethanol and either 200 /«I or 500 pi aliquots 
of interferon gamma administered Intraperitoneally vising a 1 ml Sterilin 
syringe and 21 gauge needle. For experiments in which an ascites fluid 
containing neutralising monoclonal antibodies to Interferon gamma were 
used, exactly the same was performed except that the ascites fluid 
(neutralising titre 105: see methods section I) was always used neat and 
200 pi aliquots administered.
(E) Harvesting of mouse tissues
The following procedures were used to isolate serum and produce a 
suspension of mouse brain from which the presence of interferon, virus or 
antibodies to interferon gamma were Investigated for experiments presented 
in this thesis.
(1) S tn a
To obtain blood from newborn mice, the mice were first swabbed with ethanol
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and Chan killed by decapitation. Blood was then collected froa the severed 
neck into a 1.5 ml eppendorf tube on ice. Adult alee were killed by 
cervical dislocation, blood harvested asceptically froa the heart and then 
placed into a 1.5 nl eppendorf tube on ice using a pasteur pipette. Both 
newborn and adult blood was allowed to clot overnight at 4°C and the next 
day serua isolated by centrifugation for two ainutes at 10,000 g in an 
eppendorf alcrofuge. Serua was stored at -70°C prior to use.
(11) Brtln
Newborn and adult alee were killed as described above and the brains 
asceptically harvested then placed into plastic bijoux containing 0.75 al 
or 3.5 mis of ice-cold PBS supplemented with 0.5* FCS, respectively. A 
suspension was produced by dispersing the brain into the PBS solution using 
a 1 ml Sterilin syringe. Aliquots were then stored at -70°C. When 
required, the brain suspensions were thawed in a waterbath at 37°C and the 
cell debris pelleted by centrifugation at 10,000 g for two minutes in an 
eppendorf raicrofuge. The supernatant was then harvested and assayed.
(F) Preparation of primary brain cell cultures _from newborn C3H/He mice
Primary brain cell cultures were prepared froa newborn to 2-day-old C3H/He 
alee. Ten to fifteen mice were killed by decapitation with sterile 
dissecting scissors. The heads were then washed with ethanol, the skin 
over the skull removed and the brain revealed by cutting the skull open 
from the base of the skull over towards the nose. The brains were then 
removed and placed in a sterile plastic universal containing 5 mis sterile 
PBS. The brains were then carefully rolled on dry filter paper (sterilized 
by 20 minutes irradiation under UV light) to remove the meninges, and the
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tissue obtained placed In a 6 ca petrl-dlsh containing S mis PBS and a 
stainless steel mesh, through which the tissue was subsequently gently 
disaggregated using a glass rod. The homogenate was then rinsed off the 
mesh, placed In a plastic universal, and the mesh washed a further 3 times 
with S mis of PBS to remove any remaining tissue which was also placed In 
the universal. The homogenate was then placed in a 20 ml Sterilin syringe 
and passed through a 21 gauge needle to further disaggregate the tissue, 
which was pelleted by centrifugation for 5 minutes at approximately 3,000 
rpm In an MSE minor bench centrifuge, and reduced to a single cell 
suspension by trypslnlsatlon with 10 mis trypsin at 1 mg/ml In PBS also 
containing 40 >ig/ml DNase-1 (to reduce viscosity due to released DNA) and 
0.2 mM magnesium chloride, for 30 minutes at 37°C. 10 mis of DMEM
supplemented with 10% FCS were then added and the brain cells pelleted by 
centrifugation as before. After aspiration of the supernatant the brain 
cells were resuspended In DMEM supplemented with 10% FCS, and the number of 
cells counted using a Neubauer counting chamber. Around 2 x 10* cells were 
obtained per brain. 1 -2 x 10* cells were then seeded onto 6 cm tissue 
culture petrl-dishes In 5 mis DMEM supplemented with 10% FCS. The cells 
were then incubated at 37°C in a Wedco incubator with a humidified 
atmosphere of 5% carbon dioxide in air. Fresh medium was added at 2, 4 and 
7 days after seeding and the cells were usually confluent between day 8 and
10. This method of preparation of brain cells 1m essentially that of Gates 
Mi Ml. (1983).
(C) Procedure for .Indirect Imunofluoregcsnca sta in in g  gf Intracellular 
g lia l f ib r il la r y  acid protein and flbronectln  let observation by VY
microscopy
Primary brain cell cultures were produced as described in the previous
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section and grown until nearly confluent In 6 cm plastic tissue culture 
petri-dishes. 2 cm discs were then quickly cut out of the dishes using a
hot cork-borer, washed twice with PBS and the cells fixed with 3% 
paraformaldehyde solution (see materials, section 1) for 20 minutes at room 
temperature. The cells were then washed twice with PBS, quenched for 10 
minutes with 50 mM ammonium chloride in PBS, and washed a further twice in 
PBS before submerging in 0.2% triton X-100 in PBS for 4 minutes to 
permeabilise the cells. 50 m 1 aliquots of antibody to both glial 
fibrillary acid protein and fibronectln (each diluted 1 :1 0 0 with 0 .2% 
gelatin in PBS [gelatin/PBS]) were then placed onto a strip of parafilm 
lying flat on wet filter paper in a plastic box. Separate discs were 
placed cell side down onto each of the antibody solutions and Incubated for 
20 minutes at room temperature, after which the cells were washed three 
times in gelatin/PBS and then incubated with 50 >¿1 of the relevant FITC- 
conjugated antibody (diluted 1:100 in gelatin/PBS) as before. The cells 
were then washed a further three times in gelatin/PBS, twice in PBS and 
coversllps mounted onto the disc using a small drop of glycerol. The 
plastic side of the disc was then carefully washed with water to remove any 
remaining PBS and the cells observed under a Zeiss UV microscope. 
Photographs were taken using Kodak ektachrome 160 tungsten film, exposed 
for 160 seconds.
(H) Indirect immunofluorescence staining of cell surface antigens and 
Quantification bv flow cvtometrv
The expression of SFV and MHC antigens on the surface of cells was measured 
by Indirect immunofluorescence staining with quantification by flow 
cytometry.
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(1) Interferon treatment of cells and staining of cell-surface antigen« bv 
indirect Immunofluorescence
The cells were grown until nearly confluent In 6 ca tissue-culture petrl- 
dishes in the appropriate aediua supplemented with 10% FCS (see materials 
section B) in a Uedco incubator at 37°C with an humidified atmosphere of 5% 
carbon-dioxide In air. The medium was then aspirated and replaced with 3 
mis of the same medium containing the appropriate concentration of 
interferon (see results legend). 3 mis of medium alone were added to
control cultures. The cells were then incubated for a further 48 hours at 
37°C (48 hour treatment with IFN has been shown to induce maximal levels of 
H-2 antigen on brain cells: Uong ££ al.. 1984) after which the medium was 
aspirated, the monolayer washed with 2 mis of 0.02% EDTA in PBS and 2 mis 
of the same solution also containing trypsin (1 mg/ml) added. The cells 
were then incubated for 5 minutes at 37°C (as before) to detach the cells 
from the monolayer. For experiments in which SFV antigens were to be 
stained the cells were detached by 15 minutes incubation at 37°C (as 
before) with 3 mis of 0.02% EDTA in PBS alone. Trypslnlsatlon has no 
effect upon MHC antigen display by cells (Uong ai., 1984). The cells 
were then transferred into a plastic universal containing 5 mis medium (as 
before) and were pelleted by centrifugation for 5 minutes at approximately 
3,000 rpm in an HSE minor bench centrifuge. The supernatant was then 
aspirated and the cells resuspended in PBS supplemented with 0.1% sodium 
azide (PBS/azide) and placed on ice. Treatment of the cells with azide and 
holding on ice prevents the antibody capping at a later stage.
Approximately 5 x 105 cells in 200 pi PBS were then transferred into the 
wells of a 96-well round-bottom mlcrotitre plate. The cells were pelleted 
at 1,000 rpm in an MSE mark II centrifuge and the supernatants carefully 
discarded. The cells were then resuspended in 200 pi of the appropriate
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antibody specific for tha antigen of interest. A proportion of the cells 
harvested fron the plates for each treatment were also stained with an 
irrelevant antibody (whenever possible irrelevant antibody of the same 
class and subclass was used) in order to monitor background levels of 
fluorescence by the cells. Any staining above such background levels could 
then be attributed to the specific staining of cell surface antigens. All 
antibodies used were previously titrated and used in saturating 
concentrations (see section [ill] below). After resuspending the calls in 
antibody, the mlcrotltre plates were covered with an adhesive plate sealer 
and placed on a microtltre plate shaker for 30 minutes at 4°C. The cells 
were then pelleted as before, washed twice with 200 pi PBS/azide (covering 
the plates as before prior to each centrifugation step) and resuspended in 
200 pi of the appropriate fluorescein-isothiocyanate (FITC) conjugated 
antibody specific for the species of origin of the first antibody used.
The cells were then shaken for a further 30 minutes at 4°C, then washed 
twice with 200 pi PBS/azide. resuspended in 200 pi of PBS/azlde and stored 
at 4°C prior to analysis of fluorescence by flow cytometry. Typically 
cells were analysed within 24 hours, however if the samples were to be left 
for longer periods of time the cells were fixed with 200 pi of 3% 
paraformaldehyde solution (see materials section I) and washed once in 
PBS/azlde prior to resuspension as before and storage at 4°C. For some 
experiments (see results legend) propidlum iodide was used to stain non- 
vlable cells, and in such cases the cells were resuspended in PBS 
containing propidlum iodide at 1 pg/ml immediately prior to analysis. For 
most experiments presented in this thesis the flow cytometer analysis of 
cells was performed by myself, using the Becton-Dicklnson FACStar flow 
cytometer. The flow cytometer was set-up and the laser aligned with the 
sample stream using callbrite beads, as described in the users manual. All 
fluorescence data were collected in list mode using logrlthmlc
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amplification and analysed subsequently (see section (11] below). For some 
experiments (see results legend) the Becton-Dickinson FACS440 at the 
University of Birmingham was used, and in such cases the machine was 
operated by Miss A Milner or Mr R Byrd with fluorescence data again being 
collected In list mode, but using linear amplification. For both the 
FACS440 and FACStar, forward scatter and side scatter signals were 
amplified by linear amplification. Between 5,000 and 20,000 cells were 
analysed for each sample.
(11) Analysis of data
Data were analysed using the Becton-Dickinson Consort-30 computor program. 
Typically histograms of number of cells per channel against fluorescence 
intensity channel were plotted. Statistical data giving the mean 
fluorescence, peak channel (l.e. fluorescence channel with the largest 
number of cells collected in it) and coefficient of variation were also 
printed. To determine the proportion of cells showing specific 
fluorescence (hence displaying the antigen under investigation) a marker 
was set on the fluorescence histogram for a control sample (stained with an 
irrelevant antibody) at a point where only 5% of the cells processed were 
of higher fluorescence. For each sample thereafter the same marker was 
used and the proportion of cells above the marker determined. If the 
percentage of cells above the marker exceeded the 5% background value then 
this was attributed to specific staining, hence expression of the antigen 
of interest. Similarly, to determine the percentage of cells induced to 
express a particular antigen by interferon treatment, a marker was set on 
the fluorescence histogram of the non-interferon treated cells (stained 
with the antibody to the antigen of interest) in a similar manner, and the 
same marker used for all the interferon treated samples with the proportion
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of cells above the Marker determined as before. With very few exceptions, 
control samples stained with an Irrelevant antibody always showed an 
Identical level of fluorescence. Consequently, differences In fluorescence 
seen between samples stained with specific antibody were taken as being 
significant whenever they were observed. A package for statistical 
analysis of fluorescence data is available within the Consort-30 computor 
program. Preliminary studies indicated that differences in fluorescence 
were statistically significant (p <0.05) whenever they were observed. The 
statistical package was not used for routine analysis of data.
8 0 a
(ill) Tltracion of antibody preparations
Preparations of antibody were titrated In order to determine the highest 
dilution of antibody which, when used in the above protocol for indirect 
immunofluorescence staining, gave maximal staining of the antigen under 
investigation. For tltracion of antibody, Che appropriate cell type was 
prepared, treated with interferon, harvested and then stained with a 
dilution series of the antibody In exactly the same way as described in 
section (i). The cells were then stained with a saturating amount of the 
appropriate FITC-conjugated antibody (titrated in a previous experiment) 
and analysed by flow-cytometry (as before). To determine the highest 
dilution of antibody which gave maximal staining of the antigen (and above 
which the fluorescence of cells became dependant upon the dilution of 
antibody) histograms were plotted of fluorescence intensity channel against 
number of cells per channel, and correlated with the dilution of antibody 
used.
(I) Production of monoclonal antibody supernatant and ascites fluld^
A supernatant containing monoclonal antibodies specific for H2Dd (cross- 
reactivity H20^) was prepared from the hybridoma clone HB19 (see materials 
section B). The hybridoma cells were cultivated in DMEM medium 
supplemented with 10% FCS and 1 mM sodium pyruvate, in 175 cm^ tissue 
culture flasks incubated at 37°C in a Wedco Incubator with a humidified 
atswsphere of 5% carbon dioxide in air. The cells grew in suspension and 
were subcultured several times to fresh medium at a dilution of 1 in 1 0, 
prior to growing until a heavy suspension of cells had formed and the medium
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exhausted, after which the calls were pelleted by centrifugation in a 
plastic universal at approximately 3,000 rpn in a USE minor bench 
centrifuge, and the supernatants harvested and stored at -20°C, prior to 
titration and use.
To produce a preparation of ascites fluid containing monoclonal antibodies 
specific for murine interferon gamma, 200 pi of the ascites Inducing 
substance 2, 6 , 10, 14-tetramethylpentadecane ('Pristane') were first 
administered intraperitoneally to 10 week old male or female MF1 nu+/nu+ 
nude mice, using a 1 ml Sterllln syringe and 21 gauge needle. 14 to 21 
days later 5 x 106 R4-6A2 hybrldoma cells, cultivated as described above, 
were administered intraperitoneally to the mice in 500 pi PBS (as before). 
After a further 14 to 21 days the mice became enlarged and were then killed 
by cervical dislocation and the ascites fluid asceptlcally removed taking 
care not to puncture the stomach or intestines, using a 10 ml syringe and 
21 gauge needle. Cellular sutterlal was then pelleted by centrifugation at 
approximately 5,000 rpm in an MSE minor bench centrifuge and the ascites 
fluid stored at -70°C, prior to use. Around 30% of the mice to which the 
hybrldoma clone was administered developed solid tumours without ascites 
fluid, and were discarded.
The neutralisation tltre of an anti-interferon gamma ascites preparation 
was defined as being the reciprical of the highest final dilution of 
antibody which neutralised 50% of the antiviral activity of a laboratory 
recombinant Interferon gamma preparation (titre 1 ,0 0 0 unlts/ml) when 
titrated in a standard interferon neutralisation assay (see methods section 
P). Since a linear relationship was known to exist between the amount of 
R4-6A2 antibody present and neutralisation of Interferon-gamma antiviral 
activity (Havell, 1985), the neutralisation tltre of the ascites fluid was
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obtained by plotting a graph of dilution of ascites fluid against percent 
neutralisation of Interferon gamma standard antiviral activity, and 
determining the dilution at which the line Intersect with the 50% 
neutralisation of antiviral activity value. The neutralisation tltre of 
the ascites preparations was always found to be within the range of 10^ to
(J) Preparation of SFV-speclflc effector T-cella
Mice were Immunised lntranasally with the A7(74) avlrulent strain of SFV as 
described In methods section C. At day 7 post-Infection apparently healthy 
mice were killed by cervical dislocation and the spleens aseptlcally 
removed. Up to 4 spleens were then placed onto a stainless steel mesh In a 
6 cm petri-dlsh containing 5 mis PBS, and converted into a single-cell 
suspension by gently teasing with a glass rod. The cell-suspension was 
then placed in a plastic universal and the mesh washed with a further 5 mis 
of PBS to remove remaining cells. 10 mis of ammonium chloride solution 
(see materials section I) was then added for 2 minutes at room temperature 
to remove red blood cells by osmotic lysis. The cell suspension was 
pelleted for 5 minutes at approximately 3,000 rpm In an MSE minor bench 
centrifuge, and gently resuspended In 10 mis of RPMI 1640 complete media 
supplemented with 10« FCS (see materials section A). Cells were counted 
using a Neubauer counting chamber and resuspended at 5 x 10^/ml in the same 
medium containing a 1:30 dilution of 0-proplolactone-Inactivated SFV (see 
methods section B) . Cells were then placed in a Costar 24 well plate at 
1.3 ml/well, and Incubated at 37°C In a Wedco Incubator with an humidified 
atmosphere of 5% carbon-dioxide In air. Cells were harvested at day 5 
post-culture for cytotoxicity assays and day 7 post-culture for 
proliferation and IFN-7  release studies. Harvested cells were passed over
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Lymphoprep or Lympholyte M to remove non-viable cell* and debris, prior to
usa.
HO Preparation of alloreactive effector T-celli
To generate Balb/c-anti-C3H/He (H2d-anti-H2^) alloreactive effector cells, 
three Balb/c nice were primed intraperitoneally with 1 x 108 live C3H/He 
splenocytes in 500 pi PBS (spleen cell suspensions were prepared as 
described in methods section J). Ten to fourteen days later single cell- 
suspensions were prepared from the spleens of these primed mice and also 
from three C3H/He mice. The C3H/He (stimulator) splenocytes were then 
treated with mitomycin C at 25 pg/ml in PBS for 45 minutes in the dark at 
37°C, followed by four washes in RPMI complete medium supplemented with 10% 
FCS (see materials section A) . Treatment with mitomycin C results in the 
cross-linking of DNA and thereby inhibits cellular division, protein 
synthesis by the cells is not affected (Swain, 1980). 25 x 106 C3H/He
spleen cells were then mixed with 25 x 106 primed Balb/c cells in 25 mis 
2RPMI medium (as before) in a 25 cm tissue culture flask, which was 
Incubated standing upright at 37°C in a tfedco incubator with a humidified 
atmosphere of 5% carbon-dioxide in air. On day 5 post-culture 5 mis of 
medium was removed and replaced with the same volume of fresh medium, to 
prevent the medium becoming too acidic. For cytotoxicity assays and 
proliferation assays cells were harvested on day 5 and day 7 post-culture 
respectively, and passed over Lymphoprep or Lympholyte M to remove non- 
viable cells and debris, prior to use. Balb/c-anti-C57 BL/6 (H2d-anti-H2b) 
and C3H/He-anti-Balb/c (H2^-antl-H2d) alloreactive effector cells were 
prepared in exactly the same way but using the different stains of mice as 
appropriate.
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(L) Harvesting of lvmphocvtca for assay of non-specific cytotoxicity
Hie* were treated with IFN-7 , antibodies to IFN- 7  and PBS as described in 
methods section D. The spleens were then removed and a single-cell 
suspension prepared as described in methods section J, with the exception 
that the cells were not subjected to ammonium chloride treatment. 
Approximately S x 107 splenocytes in 4 mis of RPMI 1640 complete medium 
supplemented with 10% FCS (see materials section A) were then carefully 
layered onto 8 mis of Lympholyte K in a plastic universal and centrifugated 
at approximately 3,000 rpm for IS minutes in an USE minor bench centrifuge. 
All medium, Lympholyte M and centrifugation were at room temperature to 
facilitate the separation of lymphocytes. The viable lymphocytes were then 
removed from the Interface using a pasteur pipette, pelleted by 
centrifugation for S minutes (as before) and washed once in medium (as 
before) prior to use. The cytotoxicity of the lymphocytes was then 
determined against Yac-1 cells in essentially the same way as described in 
methods section M.
(M) Cvtotoxlcltv_ assays
For SFV-speciflc cytotoxicity assays, cultures of primary brain cells,
C1300 cells or G26-24 cells were grown until nearly confluent in 6 cm 
tissue-culture petri-dlshes containing 5 mis DMEM medium supplemented with 
10% FCS, and incubated at 37°C in a Vedco Incubator with an humidified 
atmosphere of 5% carbon-dioxide in air. The cells were then treated with 3 
mis of the same medium containing IFN-a0 or IFN-7  at the appropriate 
concentration (see results legend) and Incubated as before for 48 hours 
prior to cytotoxicity assay. Control cultures were untreated and 3 mis 
medium alone added. 16 hours prior to cytotoxicity assay 50 pCl 51Cr
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(sodium chromate, see materials section G) were added to each culture to 
allow the cells to take up 51Cr overnight. The next morning cells were 
either infected with SFV (multiplicity of infection approximately 1000) 
treated with an equivalent amount of BPLSFV (see methods section B) or mock 
Infected with medium alone. At 2 hours post-infection the cells were 
washed three times with 2 mis medium, once with 2 mis 0.02% EDTA in PBS and 
the cells detached from the monolayer by Incubation with 2 mis of the same 
EDTA solution for 15 minutes at 37°C. The cells were then harvested using 
a pasteur-pipette, placed into 5 mis medium in a plastic universal, 
pelleted by centrifugation for 5 minutes at approximately 3,000 rpm in an 
MSE minor bench centrifuge, resuspended in fresh medium and counted using a 
Neubauer counting chamber. The cell concentrations were adjusted to 1 x 
105/ml and 100 pi aliquots added to the wells of 96 well round bottomed 
mlcrotltre plates. 100 pi aliquots of SFV-speclflc effector T-cells (see 
materials section J) were then added to the wells at between 3** to 5 hours 
post-Infection (see results legend) to give effector:target ratios (E:T) 
within the range 1:1 to 50:1. In addition, 100 pi aliquots of 1 M 
hydrochloric acid or medium were added to control wells of each target cell 
type in order to assess total release and spontaneous release of 51Cr from 
the cells. 4 to 5 hours later (see results legend) the microtltre plate 
was sealed with an adhesive plate sealer and subjected to centrifugation at 
1 ,00 0 rpm for 1 minute to pellet cells and facilitate dissolution of 5^Cr 
from lysed cells, after which 100 pi of each supernatant was removed and 
placed in a 4 mm plastic test-tube which was sealed with paraffin wax. 
^Cr-released was determined using an LKB gamma counter and specific 
release calculated using the formula:
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(release In presence effectors - spontaneous release)
« lysis - -----------------------------------------------------  xKX)
(total release - spontaneous release)
In each experiment cytotoxicity of the effector T-cells against SFV- 
infected lymphoblastoid or fibroblast cells was assessed in order to 
monitor the specificity and restriction of killing. Cytotoxicity against 
Yac-1 cells (a cell line higly susceptible to natural killer cell lysis: 
Chervenak and Wolcott, 1988) was also assessed to monitor levels of natural 
killer cell activity in the effector population.
The susceptibility of the target cells to lysis by antl-SFV in the presence 
of complement was also assessed in parallel for each assay, in order to 
monitor levels of viral antigen display. Here, 35 minutes before 
harvesting the virus-specific T-cell assay, either 50 m 1 aliquots of a 1:30 
dilution of antl-SFV antibody in PBS or PBS alone were added to a duplicate 
mlcrotltre plate (containing 100 /¿I aliquots of each cell type) which was 
then Incubated for 30 minutes at 4°C. 50 pi aliquots of a 1:10 dilution of
rabbit complement in PBS were then added to the wells, prior to incubation 
for a further 30 minutes at 37°C, after which supernatants were harvested 
and 51Cr-released assessed as before. In addition, control wells to assess 
total release and spontaneous release values were set up for this assay as 
before.
Alloreactive cytotoxicity assay were carried out in essentially the same 
way as for virus-specific cytotoxic T-cell assays except that the SFV 
infection was omitted, cells were harvested using 0.02% EDTA in PBS 
containing 1 mg/ml trypsin (trypsinlsation has no effect upon MHC antigen 
expression by cells; Wong ai-, 1984) and alloreacti' * effector T-cells 
were used (see methods section K).
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Natural cytotoxicity assays wars again carrlad out in essentially the same 
way as for virua-specific assays, except that the SFV Infection was 
omitted and Yac-1 cells were used as target cells. Effector lymphocytes 
were prepared as described in methods section L.
(N) Assay to study the ability of SFV-treated astrocytes to stimulate 
SFV-speclflc T-cells to proliferate and release IFN-t
In order to determine whether interferon pretreatment of astrocytes, prior 
to treatment with a 0-propiolactone inactivated preparation of SFV 
(BPLSFV) , modulates the ability of the cells to stimulate SFV-specific T- 
cells to proliferate, an assay was set up in essentially the same way as 
for SFV-specific cytotoxic T-cell assays with the exception that; 
astrocytes vara not laballad with 51Cr:astrocytes wera traatad with 
mitomycin C at 25 pg/ml in PBS for 1 hour at 37°C in tha dark followed by 
flva washes with RPM1 1640 complete medium supplemented with 10% FCS, the 
SFV-specific effector T-cells used (prepared as described in methods 
section J) ware depleted of accessory cells by incubation with 200 pg/ml 
silica in RPMI 1640 medium (as before) for 24 hours prior to harvesting 
over Lymphoprep and addition to the assay, and BPLSFV at a final dilution 
of 1:4 was added to each well. The co-cultures of astrocytes with SFV- 
specific T-cells were then Incubated for 48 hours at 37°C in a Wedco 
incubator with a humidified atmosphere of 5% carbon-dioxide in air, after 
which 20 pi of medium (as before) containing 1 pCl tritlated thymidine were 
added to each well. The cells were then incubated a further 24 hours at 
37°C (as before) and harvested onto glass filter paper using a HASH II cell 
harvester. The filter paper was then allowed to dry at room temperature 
and discs containing the harvested cells cut out and placed into plastic
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scintillation viola. 3 ails of acintillation fluid added and the amount
of tritiatad thymidine incorporated asaeased uaing a Rackbeta scintillation 
counter.
In order to monitor the production of IFN-7  by SFV-effector T-cella 
stimulated with BPLSFV treated astrocytes, an assay was set up in which 
astrocytes were cultured in the presence and absence of SFV-effector T- 
cells again in essentially the sane way as for SFV-speclfic cytotoxic T- 
call assays except that; astrocytes were not labelled with 51Cr, only an 
effector to target ratio of 10 to 1 was used, and cells were only treated 
with either BPLSFV or media (since live virus would Interfere with the 
subsequent interferon assay) . The supernatants were harvested from the 
cocultures of astrocytes with or without SFV-effector T-cells at 6 hours 
coculture, and were subjected to centrifugation for 2 minutes at 
approximately 1 0 ,0 0 0 g in an eppendorf nicrofuge to pellet any cells 
collected, after which the supernatants were harvested and Interferon 
activity assayed and characterised by both Interferon assay and Interferon 
neutralisation assay (see methods section P). Six replicate titrations 
were performed for each sample, from which the mean tltra and standard 
daviation were calculated. For experiments Investigating the effect of 
these supernatants upon class I and class II MHC expression by astrocytes, 
the supernatants were diluted in DM EM supplemented with 10% FCS and added 
to cultures of the appropriate brain cell type in a 6 cm tissue culture 
petri-dish which were then incubated for 48 hours at 37°C, as before. MHC 
antigens were stained by indirect Immunofluorescence and fluorescence 
quantitated by flow cytometry as described in methods section H.
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(O) Alloprollferatlon assays
For alloprollferatlon experiments an assay was sat up essentially the same 
way as for alloreactive cytotoxicity assays (see methods section M) except 
that the brain cells when harvested were washed once with 5 mis of PBS and 
then treated with 5 mis of mitomycin C at 25 /ig/ml in PBS for 45 minutes at 
37°C in the dark. The cells were then washed four times with RPMI 1640 
complete medium supplmented with 10% FCS to remove mitomycin C, prior to 
the addition of alloreactive responders (prepared as described in methods 
section K) at ratios of 3 and 10:1. The cells were then Incubated for 30 
hours at 37°C in a Vedco incubator with an humidified atmosphere of 5% 
carbon dioxide in air, after which 20 /¿I of medium (as before) containing 1 
/iCi trltlated thymidine were added to each well. After a further 24 hours 
incubation at 37°C (as before) the cells were harvested onto glass filter 
paper using a MASH II cell harvester and the amount of tritiated thymidine 
Incorporated assessed as described in methods section N.
(P) Interferon assay
IFN was assayed by a modified version of the 50% Inhibition of nucleic acid 
synthesis method of Atkins *£ £l> (1974) using SFV to challenge mouse L929 
cells. L929 cells were grown and a single-cell suspension prepared by 
trypsinsation (in the same way as for subculture) as described in materials 
section B. The cells were then counted using a Neubauer cotinting chamber 
and the concentration adjusted to 2 x 10^/ml, using GMEM supplemented with 
10% FCS. 200 m 1 aliquots were then seeded into the wells of a 96 well 
flat-bottomed microtitre plate (giving 40,000 cells/well) and the plates 
Incubated overnight at 37°C in a Vedco Incubator with an humidified
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atmosphere of 5% carbon dioxide in air, after which the calls had formed 
confluent monolayers at the base of each well. The medium was then 
aspirated from the wells and replaced with 180 pi of GMEM medium containing 
2% FCS (maintenance medium). 20 pi aliquots of IFN sample were then placed
in replicate wells (see results legend for number of replicate wells used) 
and were thoroughly mixed with the medium prior to transferring 20 pi 
aliquots to the next well across the plate. This procedure was repeated 
giving a serial ten-fold dilution of the IFN sample across the plate. The 
cells were then incubated for 16 to 18 hours at 37°C (as before) to allow 
the IFN to induce en antiviral state in the cells. The medium was then 
aspirated from each of the wells and the cells challenged with 100 pi of 
SFV (multiplicity of infection approximately 300) in maintenance medium 
also containing 3 pg/ml actinomycin D (AMD, to inhibit cellular DNA 
dependant RNA synthesis but allow viral RNA-dependent RNA synthesis to 
continue). The cells were then incubated for 3 hours at 37°C (as before) 
after which 100 pi aliquots of trltated uridine (^H-uridine at 10 pCi/ml in 
maintenance medium containing 3 pg/ml AMD) were added. After a further 3 
hours incubation at 37°C (as before) the medium was aspirated and the plate 
flooded twice with ice-cold 5% trichloroacetic acid and once with distilled 
water. The plates were dried in an oven at 65°C and 50 pi of 1 M sodium 
hydroxide added to each well. The plates were then sealed with Nescofilm 
and incubated overnight at 37°C in a warm room to dissolve the monolayer. 
The next day 50 pi aliquots of 1 M hydrochloric acid were added to each 
well and the entire contents of each well transferred to plastic 
scintillation vials. 3 mis scintillation fluid were then added and the 
incorporation of trltlated uridine assessed by counting samples in an LKB 
Rackbeta scintillation counter for a period of 1 minute per vial. 
Uninfected and infected control cultures without added IFN ("cell control" 
and "virus control", respectively) were included in each assay to determine
9)
che background level of criclated uridine Incorporation by AMD treated 
cella and the level of maximal trltated uridine incorporation into viral 
RNA in Infected cells. Furthermore, a laboratory IFN standard was included 
in order to monitor the sensitivity of each assay. The laboratory IFN-a/9 
standard was a hundred fold dilution of the natural IFN-a0 stock purchased 
from Lee Blomolecular and the laboratory IFN-7  standard was a preparation 
of recosfolnant IFN-7  (see materials section E for details of these 
preparations) . The tltre of both preparations was calibrated against 
National Institutes of Health murine IFN-a£ standard G002-904-511, there is 
at present no international standard for murine IFN-7 .
For IFN neutralisation experiments the assay was set up in essentially the 
same way as for a typical IFN assay except that prior to titration of the 
IFN samples 160 pi of maintenance medium were added to each well, and also 
20 pi of anti-IFN-<*0 or antl-IFNy antibody (at 1:10 and 1:50 dilution of 
polyclonal serum and ascites fluid, respectively). The samples were then 
titrated as usual In the presence of the antibodies. Furthermore, control 
cultures of titrations of IFN-a/9 standard preparations against each antl- 
IFN antibody solution were included, as well as titrations of each standard 
preparation alone, in order to monitor the specificity of neutralisation.
In this assay system 1 unit/ml of IFN is defined as the concentration of 
IFN which Induces 50% inhibition of incorporation of trltlated uridine into 
virus-specific RNA in treated cells. The tltre of an IFN sample can 
thereby be obtained by taking the reclprlcol of the dilution of the IFN- 
sample which gave a 50% inhibition of incorporation of trltlaCed uridine 
into virus-specific RNA, hence a concentration of 1 unit/ml. To determine 
the 50% inhibition of incorporation value the mean counts per minute (CFM) 
values for the cell control and virus control wells were substituted into
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eh* following fornula:
50% Inhibición value '
virus concrol CPM - cali concrol CPM
+• cali concrol
The ratio of virus concrol value co cell concrol value were cypically 
wichin Che range 8:1 Co 25:1.
A graph of naan CPM againsc log1Q dilution facCor of Cha sample was Chen 
plocced for each sample cieraced. The IFN cicre was obcained by caking Che 
reclprlcol of Che dilution factor where che resulting titration curve 
intersected Che 50% inhibition of incorporation value.
In order co determine che reproducibility and variability of an IFN Cltre 
obcained from this assay a preparation of IFN- 7 was derated in eleven 
separate assays and che geometric mean and standard deviation of the tltre 
were calculated. The mean Cltre was found to be 3.05 with a standard 
deviation of 0.12. Since the distribution of titres follows a normal 
distribution the 95% confidence limits for the assay can be obtained using 
the formula:
ft ± 1.96 a - 3.05+0.24
Where ft is che mean and a che standard deviation of the titres (Parker, 
1979). The 95% confidence limits, that is the limits between which the 
tltre of a sample may fall in 95% of all assays in which it is titrated, 
are ±0.24 log^Q units. This means that as a general rule of thumb 
differences in log^Q IFN tltre of greater than 0.48 units, or a three fold 
difference in arlthmetric units, represent a statistically significant
difference In elcres. Furthermore, should Che IFN standard In any assay 
fall outside the limits ±0.24 log1Q units of the mean Cltre, the assay was 
considered to be less sensitive than usual and was repeated. It should 
also be noted Chat these confidence limits assume a constant standard 
deviation in Cltre obtained froa the assay and are thereby really of use 
only when comparing citres obtained from titrations done In duplicate, 
hence from which no reliable estimate for the standard deviation can be 
obtained. For some experiments where comparison between tltres was of 
particular importance each sample was titrated in six replicate titrations 
and the mean and standard deviation of the titre calculated. In such cases 
the significance of differences between titres obtained were determined 
using the Students c-test (Parker, 1979).
(O) Determination of relative sensitivity of brain cells to interferon
To determine the relative sensitivity to IFN-ad end IFN-7  of SFV 
replication in each of the brain cell types used during this project, the 
cells were distributed (in the appropriate media, see materials section B) 
into the wells of a 96 well flat-bottom microtltre plate, in the same 
manner as for a typical Interferon assay. The fibroblast cell line L929, 
known to be highly sensitive to both IFN-ad and IFN-7  was then distributed 
in parallel wells to allow comparison of sensitivity to IFN. The next day 
a preparation of IFN-ad or IFN-7  (whose titre had been previously 
determined) was added to the first wells across the plate and a ten-fold 
dilution series of IFN prepared across the plate as usual. Thereafter, all 
procedures used were as for a typical IFN essay.
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(R) Storage of cell» In liquid nitrogen
Stock« of call line« used during the course of this project were stored 
frozen In liquid nitrogen until required. For storage, cells were 
harvested In exacly the sane way as for subculture (see materials section 
B) and resuspended to approximately 1 x 106/ml In medium containing 10% PCS 
and 10% dimethyl sulphoxlde (medlumsolutlon was filter sterilized using a 
flowpore filter unit). 1 ml aliquots of cell suspension were then placed 
Into freezing ampoules, which were wrapped In several layers of tissue 
paper and aluminium foil (to ensure a slow decrease In temperature) and 
placed at -20°C for 2 hours, -70°C overnight and then stored In liquid 
nitrogen. When required, cells were thawed quickly at 37°C In a waterbath, 
added to 10 mis medium In a plastic universal, pelleted by centrifugation 
for 5 minutes at 3,000 rpm In an MSB minor bench centrifuge and resuspended 
In fresh medlumprlor to seeding to fresh tissue culture flasks as usual. 
Cells were maintained In continuous culture for at least 14 days before 
use.
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ghaptcr 3
RwllcAtlgn at SfV in t o t e  ce ll«
Introduction
The ability of tha L10 strain of SFV to undargo replication in brain calls 
has bean subject to a number of studies both la vivo and la vitro. Thus, 
electron microscopic studies have revealed the destruction of neurons 
within the brains of SFV-lnfected mice (Pathak £_£ Al-. 1976) and the 
presence of replicating virus within both neurons (Pathak fil &1-, 1976; 
Barrett ££ al.. 1980) and oligodendrocytes (Pathak and Vebb, 1983). 
Similarly, la vitro studies have demonstrated the ability of SFV to undergo 
replication in both G26-24 oligodendroglioma cells and C1300 neuroblastoma 
cells (Atkins and Sheahan, 1982; Atkins, 1983) as well as in primary 
cultures of neurons and primary cultures of brain cells which were 
predominantly astrocyte in composition (Gates ££ al. 1985).
One of the major alms of this thesis is to investigate the ways in which 
IFN treatment of brain cells modulates both the susceptibility of brain 
cells to infection by SFV, and ability to participate in SFV-specific T- 
cell mediated immune reactions. In this chapter the production and partial 
characterisation of primary brain cell cultures is described, and the 
ability of SFV to undergo replication in brain cell cultures, G26-24 
oligodendroglioma and C1300 neuroblastoma cells investigated. Since the 
ability of SFV to undergo replication in each of these cell types has 
previously bean subject to a small number of studies, comparisons of 
results obtained will also be made as appropriate.
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Results
Production and partial characterization of primary brain cell culture« 
prepared from the brains of newborn C3H/He mice.
Primary brain call cultures were prepared from newborn C3H/He mice as 
described in methods section F. Photograph 3.1 shows a typical culture of 
brain calls when viewed by phase contrast microscopy on day 8 post-culture, 
at which time the cells were usually confluent, or wera approaching 
confluency. It can be seen that the majority of cells present were 
morphologically similar and resemble the cultures of astrocytes as prepared 
by Tedeschl and coworkers (Tedeschl tt &1-. 1986). To determine the actual 
proportion of astrocytes present, cells were permeabillsed and glial 
fibrillary acidic protein (GFAP; an intracellular cytoskeletal protein 
marker of astrocytes; Bignami Al-. 1972) stained by indirect 
immunofluorescence. Photograph 3.2a shows a culture of brain cells when 
stained for GFAP and viewed under ultra-violet light. It should be noted 
that photographs 3.1 and 3.2 were taken of cultures of brain cells prepared 
in an identical manner, but in separate experiments. It can be seen 
(Photograph 3.2a) that a large number of GFAP+ astrocytes are present in 
these cultures and that the fluorescence is associated with an 
intracellular filamentous network. This pattern of staining resembles that 
observed previously by other workers whom stained GFAP within astrocyte 
cultures by indirect immunofluorescence (Fontana , 1972; Giulian and
Lachman, 1985; Tedeschi ££ al■- 1986). Observation of the pattern of GFAP 
staining also revealed the predominant astrocyte type present to be the 
type 1 protoplasmic astrocyte, an example of which is shown in photograph 
3.2b. Type 2 astrocytes as determined by their smaller cell body and 
extended processes (see Photograph 3.2c) were rarely detected. In a series
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Primary brain cell cultures prepared from the brains of newborn mica C3H/He
als*
Photograph 3.1.
(1) 8 day-old primary brain call culture, phase contrast, magnification
1600 X.
(ID Photograph taken and printed by Mr R Ling (University of Warvick) .
Primary brain cell culture stained with antiserum to glial fibrillary 
acidic protein by Indirect Immunofluorescence
Photograph 3.2.
Kas
(a) 8 -day old primary brain cell culture stained with rabbit-antl-GFAP 
serum and FITC-conjugated goat-anti-rabbit serum, as described in 
methods section C. Viewed under ultra-violet light, magnification 
1600 X.
(b) A type 1 astrocyte, stained and viewed as for (a).
(c) A type 2 astrocyte, stained and viewed as for (b).
- Photographs taken with assistance from Mr R Ling (University of Warwick) .
of three experiments by myself end one experiment by Mr M J Bleckman 
(University of Warwick) the proportion of GFAP+ cells present in the brain 
cell cultures was found to be between 90% and 100% of the total. In each 
experiment the permeabilised cells were also stained by indirect 
immunofluorescence for fibronectin, a marker protein of fibroblasts.
However fibroblasts, as determined by their reaction with the antl- 
fibronectin sera, were rarely found (data not shown). Since GFAP+ 
astrocytes were by far the most predominant cell type present in these 
brain cell cultures, the cultures will hereafter be referred to as 
astrocyte cultures. It is however Important to note that for each 
experiment within this thesis in which astrocytes are used, a small 
population (up to 10%) of other uncharacterised cells may also have been 
present.
Replication of SFV in astrocytes. C26-24 and C1300 cells
In order to determine whether SFV was able to undergo replication in 
astrocytes, G26-24 and C1300 cells, the synthesis of SFV-RNA in Infected 
cells was monitered via the incorporation of trltlated uridine, and the 
display of viral antigen on the cell surface measured by indirect 
immunofluorescence staining with quantitation by flow cytometry.
The data in table 3.1 show the incorporation of [^HJuridlne into astrocytes 
as compared with L929 cells, a fibroblast line derived from the C3H/He 
mouse known to be sensitive to infection by SFV (Meager, 1987). It can be 
seen that viral RNA synthesis took place in both astrocytes and L929 cells, 
since the amount of [^H]uridine incorporated into each of these cell types 
when Infected with SFV, was far higher than the background level of 
incorporation of [^HJurldine into cellular RNA in uninfected cells.
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RNA synthesis bv SFV ln astrocytes and L929 cell»
libia 3.1
Cell typt
Astrocyte Infected
Uninfected
L929 Infected
Uninfected
Tstal RHA arathcala isca)
37,037 ± 3,298 
587 ± 139
91,429 ± 8,971 
3,071 ± 611
(1) RNA synthests measured by lncorporatlon of (^H)urldlne between 3 and 
6 hours post-infection, in the presence of 3 ¿ig/ml actinomycin D 
(AMD) to inhlbit cellular RNA synthesls, as descrlbed in methods 
sectlon P.
(11) Uninfected cells give a measure of residual Incorporation of 
[3H]uridine Into cellular RNA.
(ill) Data expressed as mean counts per minute (cpm) Incorporated ± 
standard deviation for six replicate wells.
Similarly, Che amount of (^HJuridine incorporated into both SFV-infected 
G26-24 and C1300 celle was far higher than the background level of 
incorporation into uninfected cells (Table 3.2a and b) Indicating that 
viral RNA synthesis had taken place in the cells. Over a time course in 
which Incorporation of [^H]uridlne was followed, SFV Infected G26-24 cells 
were found to Incorporate far lower amounts of [3H]urldine than SFV 
Infected L929 cells (Table 3.2a). Similarly, SFV Infected astrocytes also 
incorporated slightly lower amounts of [^H]uridine than SFV Infected L929 
cells (Table 3.1) but in contrast, SFV infected C1300 cells Incorporated 
slightly higher amounts of [^H]urldine than SFV Infected L929 cells (Table 
3.2b).
Uninfected and SFV-Infected astrocytes, G26-24 and C1300 cells were also 
stained with anti-SFV serum by indirect Immunofluorescence and analysed by 
flow cytometry. As shown in figure 3.1, the fluorescence of SFV-infected 
astrocytes was markedly higher than for uninfected astrocytes, indicating 
that SFV-infected astrocytes display SFV antigen on the cell surface. 
Statistical analysis of the fluorescence data also revealed a shift in mean 
fluorescence from 7 for uninfected cells to 110 for SFV Infected cells. 
Furthermore, the proportion of cells collected above fluorescence channel 9 
was found to increase from 10% for the uninfected astrocytes, to 96% for 
the SFV Infected astrocytes. Thus, at least 86% of the SFV infected 
astrocytes display SFV antigen on the cell surface. The fluorescence of 
both SFV infected G26-24 and C1300 cells was also found to be markedly 
higher than for uninfected cells (Figure 3.2a and b) Indicating that the 
SFV-infected cells display SFV antigen on the cell surface. Statistical 
analysis of the fluorescence data for uninfected as compared with SFV- 
infected G26-24 cells, revealed a shift in mean fluorescence from 23 to 
141, and an increase in the proportion of cells collected above
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RNA synthesis bv SFV In C26-24 and L929 cells
Tibi« 3.2a
Cell tvne Totil RflA avnthcala Iswl
G26-24 Infected 20,143 ± 2,350
Uninfected 1,149 ± 189
L929 Infected 145,192 ± 11,961
Uninfected 5,590 ± 1,236
(1) Legend as for Table 3.1.
Tibi« 3.2b
BMA JXtthttll to-in In S13QQ a«LLt21 cilia 
Cell, type Totil RFA gyntheala (cpnl
C1300 Infected 122,377 ± 5,490
Uninfected 1.991 ± 2,020
L929 Infected 82,611 1 5,377
Uninfected 5,108 ± 635
(1) Legend as for Table 3.1.
Figure 3.1
SFY antigen exprcggjgn fry injected ggtrpcYtfig
Kax
(A) Astrocytes, uninfected.
(B) Astrocytes, infected with SFV.
(1) Astrocytes were Infected with SFV, harvested and SFV antigens
stained by indirect lnmunofluorescence at 7 hours post*infection as 
described in methods section H.
(ii) SFV antigen expression was quantified using the FACS440 flow
cytometer at the University of Birmingham, operated by Miss A Milner.
(ill) 9728 cells were analysed in each case.
Flout 1*1
i n  antlm ilon bv invested Q26-2*> and C13QQ sell»
(A) G26-24 cells solid line : 
dashed 1ine :
Uninfected 
 Infected with SFV
<B> C1300 cells solid line 
dashed line
: Uninfected 
: Infected with SFV
FLI : Fluorescence Intensity channel
(I) G26-24 cells were infacted with SFV, harvested and SFV antigens 
stained by indirect immunofluorescence at 8 hours post-Infection as 
described in methods section H. An identical protocol was followed 
for C1300 cells except that cells were stained at 9 hours post- 
infection. (I)
(II) SFV antigen expression was quantified using the FACStar flow 
cytometer and 10 ,00 0 cells were analysed in each case.
fluorescence channel 37 from 5« Co 71ft, indicating that at lease 66ft of 
SFV-Infacted C26-24 cells display SFV antigen on tha cell surface.
Likewise, analysis of the fluorescence data for uninfected as compared with 
SFV-Infected C1300 cells, revealed a shift in mean fluorescence froa 33 to 
239, and an increase in the proportion of cells above fluorescence channel 
63 froa 5% to 66ft, indicating that at least 61ft of SFV-Infected C1300 cells 
display SFV antigen on the cell surface. The Increased fluorescence 
observed for SFV-infected astrocytes, G26-24 and C1300 cells, was specific 
for staining with anti-SFV serua, since the fluorescence of SFV infected 
cells stained with an irrelevant antibody was Identiflcal to that of 
uninfected cells stained with the same antibody (data not shown).
SFV-Infected C26-24 cells were also found to exhibit a clear cytopathlc 
effect (CPE) at 8 hours post-Infection, at which tiae SFV-Infected 
astrocytes and C1300 cells appeared normal. By 24 hours post-infection an 
extensive CPE was observed for all cell types, with many cells 
disintegrated.
Discussion
In Chis chapear che parcial characCarlsaClon of primary brain call 
culCures, prepared frota che brains of newborn C3H/He alee, has been 
described. IndlrecC Immunofluorescence sCaining showed ChaC che culCures 
were ac lease 90% GFAP+ ascrocyce In composición, wlch 10% or less 
uncharaccerised cells also presenc. Based upon Che paccern of GFAP 
scalnlng as llluscraCed by McCance (McCance, 1984) che majorlcy of 
ascrocyces were IdenClfled as type 1 proCoplasmlc astrocytes, wlch few Cype 
2 fibrous ascrocyces presenc. Fibronectln+ fibroblasts were rarely 
dececced in Chase culcures. Although Che ldanClfy of (ac most) 10% of Che 
cells was noc defined, 1C does ac lease seem possible ChaC Chey represent a 
mixture of neurons , oligodendrocytes and microglial cells, since Chase 
call Cypes have been characcerised previously in primary brain cell 
cul Curas prepared from che brains of newborn mice and raCa (Bruce gl- , 
1984; GaCas g£ al. . 1985). The resulcs presented in Chis chapear also 
clearly show that che LIO scrain of SFV was able Co undergo RNA synthesis 
in Che brain cell culCures, and ChaC ac lease 86% of Che infacCed cells 
displayed SFV ancigen on Che cell surface. Since aC lease 90% of Che cells 
presenc in chese culCures are ascrocyces, ic follows ChaC Che majority of 
ascrocyces presenc muse have displayed SFV ancigen on cha call surface. Ic 
is chereby noC unreasonable Co propose ChaC ac lease some of Che SFV-RNA 
synthesis detected in Chese culCures may have taken place in astrocytes.
The ability of Che L10 strain of SFV Co undergo RNA and protein synthesis 
in primary brain cell cultures, predominantly astrocyte in composition and 
prepared from newborn Balb/c mice, has also been previously reported (Gates 
et al. . 1985). It is noc possible from Che data presented in this chapter 
Co determine whecher SFV-RNA synthesis had taken place in Che 
uncharaccerised cells presenc in chese cultures, or whecher any of Chese
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cells display SFV antigen on the cell surface. However, if the 
uncharacterised cells present were neurones or oligodendrocytes, it would 
be a strong possibility since Gates and coworkers have demonstrated RNA 
synthesis by the L10 strain of SFV in primary cultures of neurons which 
were 100» pure (Gates ££ al. , 1985) and Pathak and Uebb demonstrated that 
oligodendrocytes can be Infected with the L10 strain of SFV in vivo (Pathak 
and Uebb, 1983). Whether SFV is able to replicate in microglial cells 
which may be present in these cultures is unknown.
In agreement with previous reports by Atkins (Atkins and Sheehan, 1982; 
Atkins, 1983) the L10 strain of SFV was also found to undergo RNA synthesis 
in G26-24 and C1300 cells, as assessed by the incorporation of [^H]urldlne 
into Infected cells. When compared to the amount of SFV-RNA synthesised in 
L929 cells, the amount of SFV-RNA synthesised in C26-24 cells was found to 
be far lower than the amount of SFV-RNA synthesised in C1300 cells. SFV 
infected C26*24 cells were also found to exhibit a CPE at 8 hours post* 
infection, at which time SFV*Infected C1300 cells appeared normal. These 
observations are consistent with the report by Atkins and Sheehan (Atkins 
and Sheehan, 1982) which concluded that G26-24 calls are sensitive to small 
amounts of SFV-RNA synthesis, whereas C1300 cells are able to tolerate 
extensive SFV-RNA synthesis without showing a CPE. The ability of the L10 
strain of SFV to undergo protein synthesis within G26*24 and C1300 calls 
has also been reported by Atkins and Sheehan (Atkins and Sheehan, 1982) .
In the present study SFV antigen on the surface of Infected G26-24 and 
C1300 cells was monitored, and it was found that at least 66% of SFV- 
infected G26-24 cells, and at least 61« of SFV Infected C1300 cells display 
SFV antigen on the cell surface.
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Chapter 4
Effect of IFN on SFV replication and MHC antigen display bv brain cells
It Is now well established that IFNs are able to Induce the expression of 
MHC antigen on a variety of cell types In both the murine and human system 
(for review see chapter 1). In this chapter the effect of natural IFN-a0 
and recombinant IFN- 7 on class I and class II MHC antigen expression by 
astrocytes, G26-24 cells and C1300 cells is Investigated. Furthermore, 
since both IFN-<*0 and IFN-y may be present within a virus-infected brain, 
the way in which natural IFN-a£ and recombinant IFN-0 interact with 
recombinant IFN-y in the Induction of class I and class II MHC antigen 
expression on astrocytes is also investigated.
In the previous chapter the ability of SFV to undergo replication in brain 
cells was Investigated. IFNs by definition have an antiviral activity and 
in this chapter the relative sensitivities of astrocytes, G26-24 cells and 
C1300 cells to the antiviral effect of natural IFN-a/? and recombinant IFN-7  
are assessed, via the inhibition of the incorporation of [^H]uridine into 
SFV-RNA in Infected cells. The effect of natural IFN-a£ and recombinant 
IFN-y on SFV antigen expression by infected astrocytes, G26-24 cells and 
C1300 cells is also studied.
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Relative sensitivity of brain cells to IFN-od and IFN-v
In order to assess the relative sensitivity of astrocytes to IFN-a^ and 
IFN-7 , the incorporation of [3H]uridine into IFN-treated SFV-Infected 
astrocytes and L929 cells was determined. L929 cells are a fibroblast cell 
line derived from the C3H/He mouse known to be highly sensitive to both 
IFS-afi and IFN- 7 (Meager, 1987). Figures 4.1 and 4.2 show the 
incorporation of [3H]uridine into IFN-a0 and IFN- 7  treated SFV-infected 
astrocytes respectively, as compared with L929 cells. The data show that 
both cell types had about equal sensitivity to IFN-a0 and IFN-7 , with about 
50% inhibition of incorporation of [3H]urldlne into viral RNA at 1 u/ml for 
both IFN-a/9 and IFN-7 , and essentially no Incorporation of [3H]uridlne 
above background levels (hence no detectable viral RNA synthesis) at 1000 
u/ml IFN-a/? and 100 u/ml IFN-7 . The relative sensitivities of G26-24 cells 
and C1300 cells were also determined in the same manner. Figures 4.3 and 
4.4 show the incorporation of [3H]uridine into IFN-a/3 and IFN- 7  treated 
SFV-infected G26-24 cells respectively, as compared with L929 cells. The 
data show that both G26-24 cells and L929 cells had about equal sensitivity 
to IFN-a/) and IFN-7 , with about 50% inhibition of incorporation of 
(3H]uridine into viral RNA at around 1 u/ml for both IFN-a/J and IFN-7 , and 
no incorporation of [3H]uridine above background levels (hence no 
detectable viral RNA synthesis) at 300 u/ml IFN-q^ and 500 u/ml IFN-7 . 
Figure 4.5 shows the Incorporation of [3H]uridine into IFN-a0 treated C1300 
cells, as compared with L929 cells. The data show that C1300 cells were 
slightly less sensitive to IFN-a0 than L929 cells, with only 23% inhibition 
of incorporation of [3H]uridine at 1 u/ml IFN-a0 for C1300 cells, as 
compared with 58% inhibition of incorporation in this experiment at 1 u/ml
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SFV Infoctad calla In cha abaanca of ItV-afi, wlth thè background of 
raaldual cellular incorporation (by uninfoctad calla; 3% or laaa that 
of infoctad calla) aubtractad.
(il) Aaaay protocol aa daacribad in aathoda aection Q.
Figura 4 . 2
Effect g f  IFW-i gn incorporation o f  i3H]uridino into SFV-RHA bv astrocytes
«nd L929 celi»
Astrocytes 
L929 cells (I)
(I) Incorporation of (3H]urldine is expressed as a percentage of chat by 
SFV infected cells in the absence of IFN-y, with the background of 
residual cellular incorporation (by uninfected cells: 3% or less that 
of infected cells) substracted.
(II) Assay protocol as described in methods section Q.
Flgmi 4.3
Effect of IFN-afl on incorporation of f3H1urldlne into SFV-RNA bv G26-24 and
L92? Cllil
Kax
(•--•) G26-24 cells
(▲— ▲) L929 cells 1
(1) Incorporation of [3H]uridine is expressed as a percentage of that by 
SFV infected cells in the absence of IFN-afl, with the background of 
residual cellular incorporation (by uninfected cells; 4% or less that 
of infected cells) subtracted.
(ii) Assay protocol as described in methods section Q.
Figura 4.^
Effect of IFN-tt on incorporation of f3H1uridlne Into SFV-RNA bv G26-24 and
19Z2 galli
tax
(•--•) G26-24 cells
(▲— ▲) L929 cells (I)
(I) Incorporation of [3H]urldlne is expressed as a percentage of that by 
SFV Infected cells in the absence of IFN-y, with the background of 
residual cellular incorporation (by uninfected cells; 32% or less 
that of Infected cells) subtracted.
(II) Assay protocol as described in methods section Q.
Figur« i J
Effect of IFN-afl on Incorporation of f3H1urldlne Into SFV-RNA bv C1300 and 
L92? Ciill
läX
(A A.) C1300 cells
(#— •) L929 cells 1
(1) Incorporation of [3H] uridine is expressed as a percentage of that by 
SFV infected cells in the absence of IFN-aß, with the background of 
residual cellular incorporation (by uninfected cells; 8t or less that 
of Infected cells) subtracted.
(il) Assay protocol as described in methods section Q.
IFN-al for L929 cells. No Incorporation of (3H)uridine above background 
levels (hence no detectable viral RNA synthesis) was observed In this 
experiment at 10 u/ml IFN-afl for L929 cells, a concentration at which 
Incorporation of [3H]urldlne Into C1300 cells was only Inhibited by 80%.
No Incorporation of [3H)urldlne above background levels (hence no 
detectable viral RNA synthesis) was observed at 100 u/ml IFN-a/) for C1300 
cells. Figure 4.6 shows the Incorporation of [3H)urldlne Into IFN- 7  
treated SFV-Infected C1300 cells, as compared with L929 cells. The data 
show that C1300 cells were far less sensitive to IFN- 7  than L929 cells, 
with about 20% Inhibition of Incorporation of [3H]urldine at 1 u/ml IFN-7  
for C1300 cells, as compared with around 50% Inhibition of incorporation In 
this experiment at 1 u/ml IFN- 7 for L929 cells. Essentially no 
Incorporation of [3H]urldlne above background levels (hence no detectable 
viral RNA synthesis) was observed for L929 cells at 2000 u/ml IFN-7 , 
whereas C1300 cells still Incorporated 35% of [ 3H]uridine at this 
concentration of IFN-7 . Thus, viral RNA synthesis was still taking place 
in at least In some IFN- 7 treated SFV-Infected C1300 cells at 2000 u/ml 
IFN-7 . At the time at which these experiments were performed 2000 u/ml of 
IFN- 7 was the highest concentration of IFN- 7 which was available for use in 
these experiments. Whether concentrations of IFN- 7  greater than 2000 u/ml 
inhibit the incorporation of [3H]uridine Into viral RNA in C1300 cells 
further, remains to be determined.
Effect of IFN-afl and IFN-tt treatment on SFV antigen expression by 
SFV-Infected brain cells
In chapter 3, data were presented which showed that SFV-Infected 
astrocytes, G26-24 cells and C1300 cells display SFV antigen on the cell 
surface. In this section the effect of IFN-a0 and IFN- 7 treatment on SFV
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Effect of IFN--r on Incorporación of í3H1uridine into SFV-RHA bv C13QQ and
L929 calla
Kax
(A— A) C1300 calis 
(•— •) L929 calis 1
(1) Incorporación of [3H]uridlna is expressad as a percentage of that by 
SFV infaccad calis in che absence of IFN-7 , wich Che background of 
residual callular incorporación (by uninfecced calis; 6% or less Chat 
of infaccad calis) subcracced.
(il) Assay prococol as described in aechods sección Q.
antigen expression by the brain cells Is Investigated. The expression of 
SFV antigen was measured by indirect iossunofluorescence staining with 
quantitation by flow cytometry.
Figure 4.7 shows the effect of IFN-a/J on SFV antigen expression by 
astrocytes. It can be seen that SFV-Infected astrocytes display high 
levels of SFV antigen on the cell surface, since the fluorescence of SFV- 
infected astrocytes was markedly higher than for uninfected astrocytes (fig 
4.7a and b). Statistical analysis of the fluorescence data revealed a 
shift in mean fluorescence from 30 for uninfected astrocytes to 160 for 
SFV-infected astrocytes, and an Increase in the percentage of cells 
collected in the maximum fluorescence intensity channel (channel 255) from 
0% for uninfected astrocytes to 26% for SFV infected astrocytes. As shown 
in figure 4.7b and 4.7c, pretreatment of astrocytes with IFN-O0, prior to 
infection with SFV, markedly reduced the fluorescence of the astrocytes 
hence the display of SFV antigen on these cells. Statistical analysis of 
the fluorescence data revealed a shift in mean fluorescence from 160 for 
non-IFN treated SFV-infected astrocytes, to 66 for IFN-ap treated SFV- 
infected astrocytes. Pretreatment of astrocytes with IFN-a/S did not 
totally abolish SFV antigen expression, since the mean fluorescence of IFN- 
a$ treated SFV-infected astrocytes at 66 was still clearly elevated above 
that of uninfected cells at 30. Furthermore, statistical analysis of the 
fluorescence data showed that 4% of IFN-a/J treated SFV-infected cells were 
still highly fluorescent and were collected in the maximum fluorescence 
intensity channel. Figure 4.8 shows the effect of IFN-y on SFV antigen 
expression by astrocytes. Again it can be seen that SFV-infected 
astrocytes display high levels of SFV antigen on the cell surface, since 
the fluorescence of SFV-infected astrocytes was markedly higher than for 
uninfected astrocytes (fig. 4.8a and b). Statistical analysis of the
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Effect of IFN-od on expression of SFV antigen bv SFV-Infected astrocyte*
Fltura 4.7
Fluorescence intensity channel (0 »o 2 5 5 )
lax
(A) non-IFN treated, uninfected
(B) non-IFN treated, infected with SFV
(C) treated with IFN-a0, infected with SFV
(I) Astrocytes were treated with 1000 u/ml IFN-a¿3, or medium alone for 48 
hours prior to infection with SFV, as described in methods section M. 
SFV antigens were stained by indirect immunofluorescence at 9 hours 
post-infection, as described in methods section H. (I)
(II) SFV antigen expression was quantified using the FACS440 flow 
cytometer at the University of Birmingham, operated by Hiss A Milner.
(ill) 9728 cells analysed in each case.
(iv) Data obtained by Mr M J Blackman (University of Warwick).
Effect of IFN-t on exoresaion of SFV antigen bv SFV-infected «strocvtaa
Figura. ¿Ji
Fluorescence intensity channel (0  to 255)
(A) non-IFN treated, uninfected
(B) non-IFN treated, infected with SFV
(C) treated with IFN-7 , infected with SFV
(D) non-IFN treated, treated with BPLSFV
(i) Astrocytes were treated for 48 hours with 100 u/el IFN- 7  or medium 
alone, prior to treatment with BPLSFV or infection with SFV, as 
described in methods section M. SFV antigens were then stained by 
indirect immunofluorescence at 7 hours post-Infection, as described 
in methods section H.
(il) SFV antigen expression was quantified using the FACS440 flow
cytometer at the University of Birmingham, operated by Miss A Milner.
(ill) 9728 cells analysed in each case.
(iv) BPLSFV; fi-prop io lac tone inactivated preparation of SFV, see methods 
section B.
fluorescence data revealed a shift In mean fluorescence from 7 for 
uninfected astrocytes to 110 for SFV-Infected astrocytes, and an Increase 
In the percentage of cells collected above fluorescence Intensity channel 
13 from 10% for uninfected astrocytes to 96% for SFV-infected astrocytes.
As shown In figure 4.8b and 4.8c, pretreatment of astrocytes with IFN-y, 
prior to Infection with SFV, markedly reduced the fluorescence of the 
astrocytes hence the display of SFV antigen on these cells. Statistical 
analysis of the fluorescence data revealed a decrease In mean fluorescence 
from 110 for non-IFN treated SFV-Infected astrocytes to 10 for IFN-y 
treated SFV-infected astrocytes, and a decrease In the percentage of cells 
collected above fluorescence Intensity channel 13 from 96% for SFV-infected 
astrocytes to 14% for IFN-y treated SFV-lnfected astrocytes. The data 
obtained also suggest that pretreatment of astrocytes with IFN-y did not 
totally abolish SFV antigen expression, since the mean fluorescence of 10 
for IFN-y treated SFV-lnfected astrocytes was slightly above that of 7 for 
uninfected astrocytes, and the percentage of cells collected above 
fluorescence intensity channel 13 at 14% for IFN-y treated SFV-lnfected 
astrocytes was slightly higher than 10% for uninfected cells. Thus, 
approximately 4% of IFN-y treated SFV-infected astrocytes may display very 
low levels of SFV antigen on the cell surface. To determine whether the 
Input SFV antigen with which the cells were challenged could be detected on 
the surface of astrocytes, the cells were treated with an equivalent amount 
of a 0-proplolactone inactivated preparation of SFV (BPLSFV) . It can be 
seen that the fluorescence of BPLSFV treated astrocytes was essentially 
Identical to that of uninfected cells (fig 4.8d). However, statistical 
analysis of the fluorescence data revealed that the mean fluorescence of 13 
for BPLSFV-treated astrocytes was very slightly above that of 7 for 
uninfected astrocytes, and the percentage of cells collected above 
fluorescence intensity channel 13 at 20% for BPLSFV treated astrocytes was
higher chan that of 10% for untreated astrocytes. Thus, the data suggest 
that at least 10% of BPLSFV-treated astrocytes may display very low levels 
of the Input SFV antigen on the cell surface. The Increased fluorescence 
of SFV-Infected and BPLSFV-treated astrocytes, was specific for staining 
with anti-SFV serum, since the fluorescence of these cells stained with an 
Irrelevant antibody was Identical to that of uncreated astrocytes stained 
with the same antibody (data not shown).
Figure 4.9 shows the effect of IFN- 7  on expression of SFV antigen by SFV- 
Infected G26-24 cells. It can be seen that SFV-Infected G26-24 cells 
display high levels of SFV antigen on the cell surface, since the 
fluorescence of SFV-lnfected G26-24 cells was markedly higher than for 
uninfected G26-24 cells (fig 4.9a). Statistical analysis of the 
fluorescence data revealed a shift In mean fluorescence from 23 for 
uninfected G26-24 cells to 141 for SFV-infected G26-24 cells, and an 
increase In the percentage of cells collected above fluorescence intensity 
channel 38 from 5% for uninfected G26-24 cells to 71% for SFV-lnfected G26- 
24 cells. As shown In fig 4.9a, pretreatment of G26-24 cells with IFN-7 , 
prior to Infection with SFV, markedly reduced the fluorescence of SFV- 
infected G26-24 cells hence the display of SFV antigen on the surface of 
these cells. Statistical analysis of the fluorescence data revealed a 
decrease In mean fluorescence from 141 for non-IFN treated SFV-lnfected 
G26-24 cells to 55 for IFN-7 treated SFV-infected G26-24 cells, and a 
decrease in the percentage of cells collected above fluorescence intensity 
channel 38 from 71% for SFV-lnfected G26-24 cells to 16% for IFN- 7  treated 
SFV-lnfected G26-24 cells. Pretreatment of G26-24 cells with IFN- 7  did not 
totally abolish SFV antigen expression, since the mean fluorescence of 55 
for IFN- 7  treated SFV-infected G26-24 cells was still clearly elevated 
above that of 27 for IFN- 7  treated uninfected G26-24 cells, and the
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Effect of IFN- 7  on expression of SFV antigen bv BPLSFV-treated and
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FLI; Fluorescence intensity channel
*; BPLSFV: 0 -proplolactone inactivated SFV (see methods section B) 1
(1) G26-24 cells were treated with either 500 u/ml IFN- 7  or medium alone
for 48 hours, prior to treatment with BPLSFV or infection with SFV, 
as described in methods section M. SFV antigens were then stained by 
indirect Immunofluorescence at 8 hours post-infection, as described 
in methods section H.
(ID 10 000 cells analysed In each case.
percentage of cells collected above fluorescence channel 38 at 16% for IFN- 
7 treated SFV-Infected G26-24 cells was above that of 6% for IFN- 7 treated 
uninfected G26-24 cells. Thus, at least 10% of IFN- 7  treated SFV-Infected 
C26-24 cells display low levels of SFV antigen on the cell surface. To 
determine whether the Input SFV antigen with which cells were challenged 
could be detected on the surface of G26-24 cells, the cells were treated 
with an equivalent amount of BPLSFV. It can be seen that the fluorescence 
of BPLSFV-treated G26-24 cells was slightly higher than that of uninfected 
G26-24 cells (fig 4.9b). Statistical analysis also revealed the mean 
fluorescence of 30 for BPLSFV-treated G26-24 cells to be slightly higher 
than of 23 for untreated G26-24 cells, Indicating that at least some G26-24 
cells may display low levels of the Input SFV antigen on the cell surface. 
IFN- 7  treatment of G26-24 cells, prior to treatment with BPLSFV, slightly 
increased the fluorescence of the cells (fig 4.9b). However, this Increase 
does not appear to be specific since IFN-y treatment also slightly 
Increased the fluorescence of G26-24 cells stained with an Irrelevant 
antibody (data not shown) . The Increased fluorescence of SFV-Infected and 
BPLSFV-treated G26-24 cells, was specific for staining with anti-SFV serum, 
since the fluorescence of these cells stained with an Irrelevant antibody 
was identical to that of untreated G26-24 cells stained with the same 
antibody (data not shown) .
Figure 4.10 shows the effect of IFN-a0 and IFN-y on expression of SFV 
antigen by infected C1300 cells. It can be seen that SFV-infected C1300 
cells display high levels of SFV antigen on the cell surface, since the 
fluorescence of SFV-Infected C1300 cells was markedly higher than for 
uninfected C1300 cells (fig 4.10a). Statistical analysis of the 
fluorescence data revealed a shift In mean fluorescence from 33 for 
uninfected C1300 cells to 237 for SFV-Infected C1300 cells, and an increase
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(1) C1300 cells were treated with either 1000 u/al IFN-al, 1000 u/al
IFN- 7 or aedlua alone for 48 hours, prior to treataent with BPLSFV or 
infection with SFV, as described In aethods section M. SFV antigens 
were then stained by Indirect laaunofluorescence at 9 hours post- 
infection, as described In aethods section H.
(ID 10 000 cells analysed In each case.
In Che percentage of cells collected above fluorescence channel 63 from 3% 
for uninfected C1300 cells to 66% for SFV-Infected C1300 cells. As shown 
in figure 4.10a, pretreatnent of C1300 cells with IfV-afi, prior to 
Infection with SFV, markedly reduced the fluorescence of SFV*Infected C1300 
cells hence the display of SFV antigen on the surface of these cells. 
Statistical analysis revealed a decrease In mean fluorescence from 239 for 
non-IFN treated SFV-Infected C1300 cells to 64 for IFS-afi treated SFV- 
infected C1300 cells, and a decrease In the percentage of cells collected 
above fluorescence Intensity channel 63 from 66% for SFV-Infected C1300 
cells to 9% for IFN-a/9 treated SFV-Infected C1300 cells. Pretreatment of 
C1300 cells with IFN-a0 did not totally abolish SFV antigen expression, 
since the mean fluorescence of 64 for IFN-O0 treated SFV-Infected C1300 
cells was slightly higher than that of 33 for untreated C1300 cells, and 
the percentage of cells collected above fluorescence Intensity channel 64 
at 8% for IFN-a/9 treated SFV-Infected C1300 cells was slightly above that 
of 5% for uninfected C1300 cells. Thus, at least 3% of IFN-O0 treated SFV- 
Infected C1300 cells display low levels of SFV antigen on the cell surface. 
As shown In figure 4.10a, pretreatment of C1300 cells with IFN-y, prior to 
Infection with SFV, markedly reduced the fluorescence of a proportion of 
SFV-Infected C1300 cells hence the display of SFV antigen on the surface of 
at least some of the cells. Statistical analysis of the fluorescence data 
revealed a decrease In mean fluorescence from 239 for non-IFN treated SFV- 
Infected C1300 cells to 128 for IFN-y treated SFV-Infected cells, and a 
decrease In the percentage of cells collected above fluorescence Intensity 
channel 64 from 66% for SFV-Infected C1300 cells to 34% for IFN-y treated 
SFV-Infected C1300 cells. Pretreatment of C1300 cells with 1000 u/ml IFN-y 
quite clearly did not reduce SFV antigen display on all of the cells 
present, since the mean fluorescence of 128 for IFN-y treated SFV-Infected 
C1300 cells was clearly elevated above that of 33 for untreated C1300
no
cell«, and the percentage of cells collected above fluorescence channel 64 
at 34% for IFW- 7  treated SFV-Infected C1300 cells was substantially higher 
than that of 5% for untreated C1300 cells. Thus, at least 29% of IFN-7  
treatad SFV-Infected C1300 cells display SFV antigen on the cell surface, 
and observation of the fluorescence hlstograsi shows that some of these 
cells display SFV antigen at a very high level (fig 4.10a). To determine 
whether the input SFV antigen with which cells were challenged could be 
detected on the surface of C1300 cells, the cells were treated with an 
equivalent amount of BPLSFV. It can be seen that the fluorescence of 
BPLSFV-treated C1300 cells was slightly higher than that of untreated C1300 
cells (fig 4.10b). Statlsticsl analysis of the data revealed the mean 
fluorescence of 45 for BPLSFV-treated C1300 cells to be slightly higher 
than that of 33 for untreated cells, and the percentage of BPLSFV-treated 
C1300 cells collected fluorescence channel 64 at 8% was higher than that of 
5% for untreated C1300 cells. Thus, the data suggest that at least 3% of 
C1300 cells may display low levels of the input SFV antigen on the cell 
surface. As shown in figure 4.10b, treatment of C1300 cells with IFN- afi 
or IFN-7 , prior to treatment with BPLSFV, slightly reduced the already low 
level of input SFV antigen displayed on the surface of these cells. The 
increased fluorescence of SFV-infected and BPLSFV-treated C1300 cells was 
specific for staining with antl-SFV serum, since the fluorescence of these 
cells stained with an irrelevant antibody was essentially identical to that 
of untreated C1300 cells stained with the same antibody (data not shown).
Effect v f  IfH -al and l¥V-i treatment vn expreselvn c f  clese I end class II
MHC antigen bv brain cells
In this section the affect of natural IFN-a/J and recombinant IFN- 7  
treatment on expression of class I and class II MHC antigen by astrocytes,
G26-24 cells and C1300 cells is investigated. The expression of both major 
class I MHC determinants, H-2D and H-2K, and the class II MHC determinant 
H-2A, was assessed by Indirect immunofluorescence staining with 
quant1tat ion by flow cytometry. An indirect measure of functional class I 
MHC antigen expression was also obtained by measuring the susceptibility of 
the cells to lysis by alloreactlve cytotoxic-T-lymphocytes (CTL) since 
these recognise class I MHC determinants alone (Kuppers ££ Al-, 1981). In 
some cases a measure of functional class II MHC expression was obtained by 
assaying the ability of cells to stimulate an allogeneic mixed lymphocyte 
reaction (Takiguchi a£ &1-. 1986).
Figures 4.11 and 4.12 show the effect of IFN-a0 and IFN-y on expression of 
class I MHC H-2D^ antigen by astrocytes. As shown in figure 4.lie and 
4.12a, at least some untreated astrocytes expressed very low levels of H- 
2Dk antigen since the fluorescence of anti-H-2Dk stained cells was slightly 
higher than for the same cells stained with an Irrelevant antibody anti-H- 
2Dd (background fluorescence). Statistical analysis of the fluorescence 
data showed that at least 18 of untreated astrocytes displayed H-2Dk 
antigen on the cell surface. IFN-a0 treatment markedly increased H-2D*C 
antigen expression on the astrocytes (fig 4.11a and b). The augmentation 
of H-2D^ antigen was first observed at a concentration of 10 u/ml IFN-a/3 on 
at least 19% of the astrocytes, and Increased thereafter in a dose- 
dependant manner. Statistical analysis showed that at least 91« of 
astrocytes expressed H-2D*6 antigen when treated with 1000 u/ml IFN-a£.
IFN-y treatment also markedly Increased H-2D^ antigen expression on the 
astrocytes (fig 4.12a and b). The augmentation of H-2Dk antigen by IFN-y 
was first observed at a concentration of 0.1 u/ml on at least 57% of the 
astrocytes, and Increased thereafter in a dose-dependant manner.
Statistical analysis showed that at least 94% of astrocytes expressed H-2D^
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FLI; Fluorescence Intensity channel
(1) Astrocytes were created for 48 hours with Che appropriate
concentration of IFN-ad prior to staining H-2Dk antigens by Indirect 
Immunofluorescence and quantitation by flow cytometry as described in 
methods section H.
(ii) 10 000 cells analysed in each case.
Figura 4.12
Effect of IFN- t on ix n r m l o n  of cl*«. I MHC H-2Dk antigen bv utroCYt»!
(A) solid line background fluorescence
spaced dots untreated
close dots 0.01 u/ml IFÌI- 7
dashed line 0.1 u/ml IFN- 7
(B) dashed line 0.1 u/ml IFN- 7
solid line 1 u/ml IFN- 7
spaced dots 10 u/ml IFN- 7
close dots 100 u/ml IFN- 7
FLI; Fluorescence Intensity channel
(I) Astrocytes were treated for 48 hours with the appropriate 
concentration of IFN- 7  prior to staining H-2Dk antigens by indirect 
immunofluorescence and quantitation by flow cytometry as described in 
methods section H.
(I I ) 10 000 cells analysed In each case.
antigen when treated with 100 u/ml IFN-7 . Figures 4.13 and 4.14 show the 
effect of IFN-a/9 and IFN- 7 on expression of class I MHC H-2Kk antigen by 
astrocytes. As shown in figure 4.13a and 4.14a, sone untreated astrocytes 
displayed moderate levels of H-2K^ antigen on the cell surface, since the 
fluorescence of anti-H-2K^ stained cells was clearly elevated above that of 
the same cells stained with an irrelevant antibody anti-H-2D** (background 
fluorescence). Statistical analysis of the fluorescence data showed that
Itat least 66% of untreated astrocytes displayed H-2K antigen in the
experiment shown in figure 4.13a, and at least 26% in the experiment shown
vin figure 4.14a. IFN-afi treatment markedly increased H-2K antigen 
expression on the astrocytes (fig 4.13a and b). The augmentation of H-2Kk 
antigen was first observed at a concentration of 10 u/ml IFN-a/3 on at least 
7% of the astrocytes, and increased thereafter in a dose-dependant manner. 
Statistical analysis showed that at least 92% of astrocytes expressed H-2Kk 
antigen when treated with 1000 u/ml IFN-a0. IFN- 7  treatment also markedly
Increased H-2K antigen expression on the astrocytes (fig 4.14a and b). 
vThe augmentation of H-2K antigen by IFN- 7  was first observed at a 
concentration of 0 . 0 1 u/ml on at least 11% of the astrocytes, and increased 
thereafter in a dose-dependant manner upto 10 u/ml. The fluorescence of 
astrocytes treated with 100 u/ml IFN- 7 was essentially identical to that 
for astrocytes treated with 10 u/ml IFN-7 , suggesting that the cells were 
expressing maximum levels of H-2K*6 antigen. Statistical analysis showed 
that at least 92% of astrocytes expressed H-2Kk antigen when treated with 
100 u/ml IFN-7 . The increased fluorescence of IFN-a/J and IFN- 7 treated 
astrocytes shown in figures 4.11, 4.12, 4.13 and 4.14 was specific for 
staining 11-20^ and H-2K^ antigen, since the fluorescence of IFN-treated 
astrocytes stained with an irrelevant antibody was identical to that of 
non-IFN treated astrocytes stained with the same antibody (data not shown). 
Similarly, the increased fluorescence of IFN-a0 and IFN- 7 treated cells
113
Figuri ‘t+u
Effect of IFN-ad on expression of class I MHC H-2Kk antigen bv «itrocvt«»
Kfi*
(A) solid line background fluoreacance
spaced dots untreated
close dots 0 . 1 u/ml IFN-afi
dashed line 1 u/al IFN-a/3
(B) dashed line 1 u/ml IFN-ad
solid line 10 u/al IFN-a/3
spaced dots 100 u/ml IFN-a/3
close dots : 1000 u/ml IFN-a/3
FLI; Fluorescence Intensity channel
(1) Astrocytes were treated for 48 hours with the appropriate
concentration of IFN-ad prior to staining H-2Kk antigens by indirect 
loonmofluorescence as described in methods section H.
(ii) 10 000 cells analysed in each case.
figura 'i.ih.
Efface of IFN-1> on expression of eia«« I MHC H-2Kk antigen bv astrocyte«
350
A
350
B
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A  ' A:4\  \ j l \
IQ Q id1 io2 id2
F L 1
0
10 ° io* io2 io3 
FLI
Kaa
(A) solid line background fluorescence
spaced dots untreated
close dots 0.01 u/ml IFH- 7
dashed line : 0.1 u/ml 1FW-7
<B) dashed line : 0.1 u/ml IFN-7
solid line 1 u/ml IFM-7
spaced dots 10 u/ml IFN- 7
close dots 100 u/ml IFN- 7
FLI; Fluorescence intensity channel
(I) Astrocytes were treated for 48 hours with the appropriate 
concentration of IFN prior to staining H-2Kk antigens by indirect 
immunofluorescence as described in methods section H.
(I I ) 10 000 cells analysed In each case.
shown in the subsequent figures 4.16 to 4.33 wes specific for stelnlng the 
antigen under Investigation, since unless stated otherwise the fluorescence 
of IFN-treated cells stained with an Irrelevant antibody was always 
Identical to that of non-IFN treated cells stained with the same antibody 
(data not shown) .
Figure 4.15 shows the effect of IFN-a£ and IFN- 7 treatment on the 
susceptibility of astrocytes to lysis by alloreactive CTL. It can be seen 
that untreated astrocytes were slightly more susceptible to alloreactive 
CTL lysis than untreated control cells of the wrong haplotype (P815). 
Although it is possible that astrocytes and P815 cells differ in the 
background level of susceptibility to alloreactive CTL lysis, this 
observation does at least indicate that some astrocytes may express a 
sufficient level of functional class I MHC antigen for T-cell recognition 
to occur. IFN-a/9 and IFN-7 treatment of the astrocytes markedly increased 
the susceptibility to alloreactive CTL lysis, indicating that both IFN 
types increased the ability of astrocytes to participate in class I MHC 
resrlcted T-cell mediated immune reactions. This increased ability may be 
due to an increased level of functional class I MHC antigen and/or adhesion 
molecule display on the cells. The killing by alloreactive CTL was H-2 
specific since RDM4 cells (H-2k) were lysed whereas P815 cells (H-2d) were 
not.
Figures 4.16 and 4.17 show the effect of IFV-afi and IFN- 7 on expression of 
class II MHC H-2Ak antigen by astrocytes. As shown in figure 4.16a and 
4.17a, untreated astrocytes displayed no dectable H-2Ak antigen since the 
fluorescence of anti-H-2Ak stained cells was identical to that of the same 
cells stained with an irrelevant antibody anti-H-2Dd (background 
fluorescence). Statistical analysis of the fluorescence data revealed that
rituii <t.u
Effect of IFN-afl and IFN--r treatment on susceptibility of aatrocvtfea. 
lvals bv alloreactlve CTL
E:T ratio
( O — O) 
(A— A)
Astrocytee (H-2k), untreated
Astrocytes (H-2**) , treated with 100 unlts/ml IFN-y 
Astrocytes (H-2k), treated with 1000 unlts/ml IFN-a0 
P815 cells (H-2d), untreated 
RDM4 cells (H-2^), untreated (I)
(I) Calls were treated with IFN-a/J, IFN-y or medium alone for 48 hours. 
The cells were then harvasted and susceptibility to alloreactlva CTL 
lysis measured In a 5 hour chromium release assay, as described In 
methods section M.
(II) Effector alloreactlve CTL were Balb/c-anti-C3H/He (H-2d-antl-H-2'c) 
alioline.
(III) E:T ratio; Effector to Target ratio.
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Figure ^.16
Effect of IFN-t on expression of class II MHC H-2A__antigen bY aatroCYtBl
(A) solid line 
spaced dote
close docs 
dashed line
(B) dashed lina
solid lina 
spaced docs 
close docs
background fluorescence
untreated
0 .0 1 u/el IFN-7
0.1 u/al IFN- 7
0.1 u/al IFN- 7
1 u/al IFN- 7
10 u/al 1FH-7
100 u/al IFN- 7
FLI; Fluorescence intensity channel
(i) Astrocytes were treated for 48 hours with the appropriate
concentration of IFN - 7  , prior to staining H-2A^ antigens by
indirect iaaunofluorescence as described in aethods section H.
(ii) 10 000 cells analysed in each case.
Flpirs 4,17
E lite t  of IFN-afl on m r t i i l f l n  ai e l m  I I  MHC H2Ak a n tlw a  by a itrg c v tti
(A) solid line background fluorescence
spaced dots untreated
close dots 10 u/ml IFN-q/9
dashed line 100 u/ml IFN-afi
<»> dashed line 100 u/ml IFN-a/3
spaced dots 1000 u/ml IFV-afi
solid line 10 u/ml IFN - 7
FLI; Fluorescence Intensity channel
(I) Astrocytes were treated for 48 hours with the appropriate 
concentration of lFS~afi or IFN-y, prior to staining H-2A^ antigens by 
indirect issunofluorescence as described in methods section H.
(I I ) 10 000 cells analysed in each case.
at least 1* of untreated astrocytes display low levels of H-2A^ antigen In 
the experiment shown in figure 4.16a, and 0% in the experiment shown in 
figure 4.17a. IFN- 7 treatment markedly increased H- 2A^ antigen expression 
on the astrocytes (fig 4.16a and b) . The augmentation of H-2Ak antigen was 
first clearly observed at a concentration of 1 u/ml IFN- 7  on at least 34% 
of the astrocytes, and increased thereafter in a dose-dependant manner. 
Statistical analysis showed that at least 86% of astrocytes expressed H-2Ak 
antigen when treated with 100 u/ml IFN-7 . In contrast to IFN-7 , 
concentrations of IFV-afi between 1 and 1000 u/ml had no effect upon H-2A^ 
antigen expression on the astrocytes, since the fluorescence of IFN-o/9 
treated anti-H-2A^ stained cells was identical to that of untreated cells 
stained with the same antibody (fig 4.17). In a separate experiment 10 000 
u/ml IFN-a/J was also found to have no effect on H-2A^ antigen expression 
(data not shown).
A measure of functional class II MHC antigen expression on astrocytes was 
also obtained by assaying the ability of the cells to stimulate an 
allogeneic mixed lymphocyte reaction (MLR). As shown in table 4.1 
treatment of astrocytes with 1000 u/ml IFN-a0 did not increase the ability 
to stimulate an allogeneic MLR, since levels of [ ] thymidine incorporated 
by the responder lymphocytes stimulated by untreated and IFN-a0 treated 
astrocytes were essentially identical. In contrast, astrocytes treated 
with 100 u/ml IFN- 7 clearly stimulated an allogeneic MLR with levels of 
[^H]thymidine incorporated by the responders rising from 8920 to 29971 
c.p.m. (table 4.1). It is not possible to determine whether untreated 
astrocytes display any functional class II MHC antigen from the data 
obtained.
Figures 4.18 and 4.19 show the effect of IFN-ct0 and IFN- 7 on expression of
Tifali 4 .1
ablllty ai aitrafivts
Reapondar:SClmulaCor Rado SClaulacor
Stlaulator aacrocyce 1 0 :1 3:1 Alone
Untreated 8920 ± 1295 7925 ± 1211 4094 ± 1675
IFN-a0 treated 8815 ± 1388 8959 ± 1933 2912 ± 1373
IFN*7 treated 29971 ± 2074 26992 ± 2858 2674 ± 300
(1) Aetrocytea we re createci ffor 48 houra with elcher 100 u/al IFN-y, 1000 
u/al IFN-a£ or medium alone. The calla vere Chan harvested and Che 
ablllty Co atlaulaCe an allogeneic nixed lymphocyte reaction aaaeaaed 
aa deacrlbed in aechoda aecClon 0 .
(il) Reapondera vere Balb/c-antl-C3H/He (H-2d-anci-H-2^) allollne.
(ili) Reaulca vere Che mean of quadruplicate culCurea and are expreaaed as 
Mean CPM ± S.D. of [ ^H] thymidine IncorporaCed.
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Figur« 4.18
Effmet of IFN-ad en expression pf clan I MHC H-2Db «nClean bY G26-24 C«li«
(A) solid line background fluorescei
spaced dots untreated
close dots 0 . 1 u/al ITV-aß
dashed line 1 u/al IFN-O0
(») dashed line 1 u/al IFN-ad
spaced dots 10 u/al ITV-aß
close dots 100 u/al IFN-O0
solid line 1000 u/al ITV-aß
FLI; Fluorescence Intensity channel
(I) G26-24 cells were treated for 48 hours with the appropriate 
concentration of IFN-a£ prior to staining H-2Db antigens by indirect 
laaunofluorescence as described in methods section H.
(II) 5000 cells analysed in each case.
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Effect of IFN-t on expression of class I MHC H-2D__antigen bv C26-24 tells
(A) solid line 
spaced dots
close docs 
deshed line
(B) deshed line 
speced dots
close dots 
solid line
background fluorescence
untreated
0.05 u/ml IFN-t
0.5 u/ml IFN-t
0.5 u/ml IFN-t
5 u/ml IFN-t
50 u/ml IFN-t
500 u/ml IFN-t
FLI; Fluorescence intensity channel
(i) G26-24 cells were treated for 48 hours with the appropriate
concentration of IFN-t prior to staining H-2D** antigens by Indirect 
itmeunofluorescence as described in methods section H.
(li) 10 000 cells analysed in each case.
class I MHC H-2Db antigen by G26-24 calls. As shown in figure 4.18a and 
4.19a, some untreated G26-24 cells displayed moderate levels of H-2Db 
antigen on the cell surface, since the fluorescence of antl-H-2Db stained 
cells was clearly elevated above that of the same cells stained with an 
irrelevant antibody anti-H-2Kd (background fluorescence). Statistical 
analysis of the fluorescence data showed that at least 84% of untreated 
G26-24 cells displayed H-2Db antigen in the experiment shown in figure 
4.18a, and at least 12% in the experiment shown in figure 4.19a. IFV-afi 
treatment markedly increased H-2Db antigen expression on G26-24 cells (fig 
4.18a and b) . The augmentation of H-2Db antigen expression was first 
observed at a concentration of 1 u/ml IFS-a0 on at least 10% of G26-24 
cells, and increased thereafter in a dose-dependant manner. Statistical 
analysis showed that at least 92% of G26-24 cells expressed H-2Db antigen 
when treated with 1000 u/ml IFN-a/3. IFN- 7 treatment also markedly 
Increased H-2Db antigen expression on G26-24 cells (fig 4.19a and b). The 
augmentation of H-2Db antigen by IFN-7 was first observed at a 
concentration of 0.05 u/ml IFN- 7  on at least 28% of G26-24 cells, and 
Increased thereafter in a dose-dependant manner upto 50 u/ml. The 
fluorescence of G26-24 cells treated with 500 u/ml IFN- 7 was essentially 
Identical to that of G26-24 cells treated with 50 u/ml IFN-7 , suggesting 
that the cells were expressing maximum levels of H-2Db antigen.
Statistical analysis showed that at least 87% of G26-24 cells expressed H- 
2Db antigen when treated with 500 u/ml IFN-7 . Figures 4.20 and 4.21 show 
the effect of IFN-afi and IFN- 7 on expression of class I MHC H-2Kb antigen 
by G26-24 cells. As shown in figure 4.20a and 4.21a, some untreated G26-24 
cells displayed moderate levels of H-2Kb antigen on the cell surface, since 
the fluorescence of anti-H-2Kb stained cells was clearly elevated above 
that of the same cells stained with an irrelevant antibody anti-H-2K^ 
(background fluorescence). Statistical analysis of the fluorescence data
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Effect of lFH-ai? gn cxbe i of clA ii I aac H-2Kb i l bY 02ki2k Milt
background fluorescence
uncreated
0 . 1  u/«l IFVt-afi
1 u/ml IFN-O0
1 u/«l IFN-a/9
10 u/*l IFN-a0
100 u/ml IFN-a0
1000 u/ml IFN-a/3
FLI; Fluorescence lnCensity channel
(1) G26-24 cells were created for 48 hours with Che appropriate
concentration of IFN-a0 prior to staining H-2Kb antigens by indirect 
inmunofluorescence as described in methods section A.
(ii) 3600 to 4500 cells analysed in each case.
Figure 4.21
Effect of IFN-t on expression of class I MHC H2-Kb antigen bv G26-24 cella
Kax
(A) solid line 
spaced dots
close dots 
dashed line
(B) dashed line 
spaced dots
close dots 
solid line
background fluorescence
uncreated
0.05 u/«l IFN-f
0.5 u/al IFN- 7
0.5 u/al IFN-7
5 u/al IFN-7
50 u/al IFN-7
500 u/al IFN- 7
FLI; Fluorescence intensity distribution
(i) G26-24 cells were treated for 48 hours with the appropriate
concentration of IFN- 7  prior to staining H2-Kb antigens by indirect 
lanunofluorescence es described in aethods section H.
(li) 10 000 cells analysed in each case.
showed that at least 15% of untreated G26-24 cells displayed H-2Kb antigen 
In the experiment shown In figure 4.20a, and at least 42% In the experiment 
shown In figure 4.21a. IFN-a£ treatment markedly Increased H-2Kb antigen 
expression on the G26-24 cells (fig 4.20a and b). The augmentation of H- 
2Kb antigen was first observed at a concentration of 1 u/ml IFN-a0 on at 
least 3% of the G26-24 cells, and Increased thereafter In a dose-dependant 
manner. Statistical analysis showed that at least 65% of G26-24 cells 
expressed H-2Kb antigen when treated with 1000 u/ml IFN-a0. IFN-7  
treatment also Increased H-2Kb antigen expression on the G26-24 cells (fig 
4.21a and b) . The augmentation of H-2Kb antigen by IFN- 7 was first 
observed at a concentration of 0.05 u/ml on at least 15% of the G26-24 
cells, and increased thereafter In a dose-dependant manner. Statistical 
analysis showed that 92% of G26-24 cells expressed H-2Kb antigen when 
treated with 500 u/ml IFN-7 .
Figure 4.22 shows the effect of IFN-a^ and IFN- 7  treatment on the 
susceptibility of G26-24 cells to lysis by alloreactive CTL. It can be 
seen that untreated G26-24 cells were clearly more susceptible to 
alloreactive CTL lysis than untreated control cells of the wrong haplotype 
(L929). Although the possibility exists that G26-24 cells and L929 cells 
differ in the background level of susceptibility to alloreactive CTL lysis, 
this observation does at least indicate that some G26-24 cells may express 
a sufficient level of functional class I MHC antigen for T-cell recognition 
to occur. IFN-a£ and IFN- 7  treatment of G26-24 cells markedly increased 
the susceptibility to alloreactive CTL lysis, indicating that both IFN 
types increased the ability of G26-24 cells to participate in class I MHC 
restricted T-cell mediated immune reactions. This increased ability may be 
due to an increased level of functional class I MHC antigen and/or adhesion 
molecule display on the cells. The killing by alloreactive CTL was H-2b
FUuil 4.22
Effect of IFN-a/9 and IFN--Y treatment on susceptibility of G26-24_cells to
lYila by aUorcactiYfi CTL
tax
3 10 30
E^T ratio
(A— A) G26-24 cells (H-2b) , uncreated
(A  - A ) G26-24 cells (H-2b) . treated with 500 unlts/ml IFN-7  
(+ ♦) G26-24 cells (H-2b) , treated with 1000 unlts/ml IFN-a/9 
(■— ■) EL4 cells (H-2b), untreated 
(# #) L929 cells (H-2b), uncreated
(O—-O) Yac-1 cells (H-2m), uncreated (I)
(I) Cells were treated with IFN-a/9, IFN-y or medium alone for 48 hours. 
The cells were then harvested and susceptibility to alloreactlve CTL 
lysis measured In a 4.5 hr chromium release assay, as described In 
methods section M.
(II) Effector alloreactlve CTL were Balb/c-antl-C57 BL/6 (H-2d-anti-H-2b) 
alioline.
(III) E:T; Effector to Target ratio.
specific since EUU cells (H-2°) were lysed whereas L929 cells (H-2*) were
noc. Yac-1 cells were noC lysed, showing ChaC there was no significant 
natural killer cell activity in the effector population.
Figures 4.23 and 4.24 show the effect of IFN-a0 and IFN-y on expression of 
class II MHC H-2Ab antigen by G26-24 cells. As shown in figure 4.23a and 
4.24a, untreated G26-24 cells displayed no detectable H-2Ab antigen since 
the fluorescence of anti-H-2Ab stained cells was identical to that of the 
same cells stained with an irrelevant antibody anti-H-2Kd (background 
fluorescence). Statistical analysis also showed that 0% of untreated G26- 
24 cells displayed H-2Ab antigen on the cell surface. IFN- 7  treatment 
markedly increased H-2Ab antigen expression on G26-24 cells (fig 4.23a and 
b). The augmentation of H-2Ab antigen was first observed at a 
concentration of 0.5 u/ml IFN-y on at least 41% of G26-24 cells, and 
increased thereafter in a dose-dependant manner upto 50 u/ml IFN-7 . The 
fluorescence of G26-24 cells treated with 500 u/ml IFN- 7  was identical to 
that of G26-24 cells treated with 50 u/ml IFN-7 , suggesting that the cells 
were expressing maximum levels of H-2Ab antigen. Statistical analysis 
showed that at least 87% of G26-24 cells expressed H-2Ab antigen when 
treated with 500 u/ml IFN-7 . In contrast to IFN-7 , concentrations of IFN- 
afi between 1 and 100 u/ml had no effect upon H-2Ab antigen expression on 
G26-24 cells, since the fluorescence of IFN-a0 treated anti-H-2Ab stained 
cells was identical to that of untreated cells stained with the same 
antibody (fig 4.24a and b). As shown in figure 4.24b, the fluorescence of 
anti-H-2Ab stained G26-24 cells treated with 1000 u/ml IFN-a/3 was slightly 
higher than for untreated G26-24 cells. This increase in fluorescence was 
not specific for staining H-2Ab antigen since this concentration of IFN-a0 
also slightly increased the fluorescence of G26-24 cells stained with an 
irrelevant antibody (data not shown).
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Flmra . 24
Efface of IFN-afl on expression of class II H-2Ab antigen bv G26-24 cells
(A) solid line background fluorescence
spaced dots untreated
close dots 1 u/al IFN-ad
dashed line 10 u/al IFN-a/9
<B> dashed line 10 u/al IFN-O0
solid line 100 u/nl IFN-O0
spaced dots : 1000 u/al IFN-O0
close dots 500 u/al IFN-7
FLI; Fluorescence intensity channel
(I) G26-24 cells were Created for 48 hours with che appropriate 
concentration of IFN prior to staining H-2A** antigens by Indirect 
laaunofluorescence as described in aethods section H.
(II) 5000 cells analysed in each case.
Figures 4.25 end 4.26 show the efface of IFN-a/J end IFN- 7  on expression of 
cless I MHC H-2Dd enCigen by C1300 cells. As shown in figure 4.25s end 
4.26s, e smell proportion of untreeted C1300 cells expressed low levels of 
H-2Dd antigen since the fluorescence of anti-H-2Dd stained cells was 
slightly higher than for the same cells stained with FITC conjugated 
antibody alone (background fluoresence) . Statistical analysis of the 
fluorescence data showed that at least 5% of untreated C1300 cells 
displayed H-2Dd antigen on the cell surface. IFH-a/J treatment markedly 
increased H-2Dd antigen expression on C1300 cells (fig 4.25a and b) . The 
augmentation of H-2Dd antigen was first observed at a concentration of 0.1 
u/ml IFN-a/3 on at least 5* of C1300 cells, and increased thereafter in a 
dose-dependant manner (with the exception of 1 u/ml IFN-afi which increased 
H-2Dd antigen expression to the same level as 0.1 u/ml IFN-a/9).
Statistical analysis showed that at least 92% of C1300 cells expressed H- 
2Dd antigen when treated with 1000 u/ml IFN-afi, and that this concentration 
of IFN-a0 increased H-2Dd antigen on at l«mst 88% of cells. IFN-y 
treatment also markedly increased H-2Dd antigen expression on C1300 cells 
(fig 4.26a and b) . The augmentation of H-2Dd antigen by IFN- 7  was first 
observed at a concentration of 0.01 u/ml on at least 12% of C1300 cells, 
and Increased thereafter in a dose-dependant manner upto 100 u/ml (with the 
exception of 0.1 u/ml IFN- 7  which increased H-2Dd antigen expression to the 
same level as 0.01 u/ml IFN-7 ). The fluorescence of C1300 cells treated 
with 1000 u/ml IFN-y was identical to that for C1300 cells treated with 100 
u/ml IFN-7 , suggesting that the cells were expressing maximum levels of H- 
2Dd antigen (data not shown) . Statistical analysis showed that at least 
84% of C1300 cells expressed H-2Dd antigen when treated with 100 u/ml IFN- 
7 , and that this concentration of IFN- 7 increased H-2Dd antigen on at least 
83% of the cells. Figures 4.27 and 4.28 show the effect of IFN-a/9 and 
IFN- 7  on expression of class I MHC H-2K^ antigen by C1300 cells. As shown
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fitur. 4.25
M m  at Ü L a l  m  m i n i i l t n  t l  i l l I IMS H-2B i by C130Q u l l i
(A) apacad dots background fluorescenca
solid lina untreated
cloaa dots 0.1 u/al IFN-ad
dashed lino 1 u/al IFN-ad
<B> dashed lina 1 u/al IFN-ad
spaced dots 10 u/al IFN-ad
dosa dots 100 u/al IFN-ad
solid lina 1000 u/al IFN-ad
FLI; Fluorescence intensity channel
(1) C1300 call« vara treated for 48 houra with the approprlata
concentration of IFN-ad prior Co staining H-2Dd antigen by indirect
laaunofluorascence aa daacribad in Methods section H.
(ii) 5000 calla analysed in each caaa.
jaquinu ||a^
Flturi 4.26
Etfafit at IFH-t  on txprtulgn of c la n  I fflC H-2Dd antUin by C130Q call*
lax
(A) solid line background fluorescence
spaced dots untreated
close dots 0.01 u/ml IFN-y
dashed line 0.1 u/ml IFN-y
(B) dashed line 0.1 u/ml IFW-y
spaced dots 1 u/ml IFN-y
close dots 10 u/ml IFN-y
solid line 100 u/ml IFN-y
FLI; Fluor« scenes in tans ley channel
(1) Cl300 cells were Created for 48 hours with the appropriate
concentration of IFN-y prior to staining H-2Dd antigen by Indirect 
immunofluorescence.
(ii) 5000 cells analysed in each case.
In figure 4.27a and 4.28a, a proportion of untreated C1300 cells expressed
k kmoderate levels of H-2K antigen since the fluorescence of antl-H-2K
stained cells was clearly higher than for the same cells stained with FITC
conjugated antibody alone (background fluorescence). Statistical analysis
showed that at least 47% of untreated C1300 cells displayed H-2K^ antigen
on the cell surface. IFV-a0 treatment markedly increased H-2Kk antigen
jcexpression on C1300 cells (fig 4.27a and b) . The augmentation of H-2K 
antigen expression on IFN-a0 was first observed at 0.1 u/ml IFN-a0 on at 
least 20% of C1300 cells. 1 u/al and 10 u/ml IFN-a/9 increased H-2K^ 
antigen expression to the sane level as for 0.1 u/ml IFN-a£.
Concentrations of IFN-a0 above 10 u/ml increased H-2Kk antigen expression 
on C1300 cells In a dose-dependant manner. Statistical analysis showed 
that at least 94% of C1300 cells expressed H-2K^ antigen when treated with 
IFN-al, and that this concentration of IFN-a0 increased H-2K antigen on at
least 66% of cells. IFN-y also markedly Increased H-2K^ antigen expression
von C1300 cells (fig 4.28a and b). The augmentation of H-2K antigen by 
IFN- 7 was first observed at a concentration of 0.01 u/ml on at least 38% of 
C1300 cells, and Increased thereafter in a dose-dependant manner upto 10 
u/ml IFN-y (with the exception of 0.1 u/ml IFN - 7  which Increased H-2K*C 
antigen expression to the same level as 0.01 u/ml IFN-7). The fluorescence 
of C1300 cells treated with 1000 u/ml IFN- 7  was identical to that for C1300 
cells treated with 10 u/ml and 100 u/ml IFN-7 , suggesting that these cells 
were expressing maximum levels of H-2K^ antigen (data not shown). 
Statistical analysis showed that at least 83% of C1300 cells expressed H- 
2Kk antigen when treated with 1000 u/al IFN-7 , and that this concentration 
of IFN- 7 increased H-2K*1 antigen on at least 77% of cells.
C1300 cells are derived from the recombinant A/J mouse (H-2*) which encodes 
the class I MHC determinants H-2D** and H-2K^. By using alloreactlve CTL
120
C
e
l 
nu
m
be
r
ritUEB ^.27
Effect of IFN-aS < ; C l*« i I MHC H-2K___i n d u n  by C13QQ f i i l i i
(A) dashed 11ns 
solid line 
spaced dots 
close dots 
close dots 
spaced dots 
solid line 
dashed line
(B)
background fluorescence
untreated
0.1 u/nl IFN-q/3
1 u/ml IFN-a/9
1 u/nl IFN-a/9
10 u/nl IFN-O0
100 u/nl IFN-al
1000 u/nl IFN-a/9
FLI; Fluorescence intensity channel
(i) C1300 cells were treated for 48 hours with the appropriate
concentration of l¥V-a0 prior to staining H-2K*6 antigens by indirect
imunofluorescence as described in methods section H.
(11) 5000 cells analysed in each case.
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Effect gf im-TT on expression of class I MHC H-2Kk antigen bv C1300 cells
(A) solid 11ns 
spaced dots
close docs 
dsshsd line
(B) deshed line
solid line 
close dots 
spaced dots
background fluorescence
uncreated
0.01 u/nl IFN-7
0.1 u/nl IFN-7
0.1 u/al IFN- 7
1 u/al IFN- 7
10 u/al IFN-7
100 u/al IFN- 7
FLI; Fluorescence intensity channel
(1) C1300 cells were treated for 48 hours with the appropriate
concentration of IFN-7 prior to staining H-2Kk antigen by indirect
inntunofluorescence as described in aethods section H.
(li) 5000 cells analysed in each case.
specific for H-2d and H-2k antigens it was possible to study independently 
the level of functional H-2Dd and H-2K^ antigen expressed on C1300 cells, 
and the effect of IFN-a/J and IFN- 7  treatment on expression of these 
antigens. Figure 4.29a shows the effect of IFN-a£ and IFN- 7 treatment on 
the susceptibility of C1300 cells to lysis by H-2*-anti-H-2k alloreactive 
CTL. It can be seen that untreated C1300 cells were clearly more 
susceptible to alloreactive CTL lysis than untreated control cells of the 
wrong haplotype (P815 cells, H-2d). Although it is possible that C1300 
cells and P815 cells differ in the background level of susceptibility to 
alloreactive CTL lysis, this observation does at least indicate that some 
C1300 cells may express a sufficient level of functional class I MHC H-2K 
antigen for T-cell recognition to occur. IFN-a0 and IFN- 7 treatment of 
C1300 cells Increased the susceptibility to alloreactive CTL lysis, 
indicating that both IFN types increased the ability of C1300 cells to 
participate in H-2K region associated T-cell mediated immune reactions.
This increased ability may be due to an increased level of functional H-2K^ 
antigen and/or adhesion molecule display on the cells. The killing by the 
alloreactive CTL was H-2K^ specific since L929 cells (H-2^) were lysed 
whereas P815 cells (H-2d) were not. Figure 4.29b shows the effect of IFN- 
a(J and IFN- 7 treatment on the susceptibility of C1300 cells to lysis by H- 
2^-anti-H-2d alloreactive CTL. It can be seen that untreated C1300 cells 
were clearly more susceptible to alloreactive CTL lysis than untreated 
control cells of the wrong haplotype (L929 cells, H-2k). Again, although 
the possibility exists that C1300 cells and L929 cells differ in the 
background level of susceptibility to alloreactive CTL lysis, this 
observation does at least indicate that some untreated C1300 cells express 
a sufficent level of functional class I MHC H-2Dd antigen for T-cell 
recognition to occur. IFN-o/9 and IFN - 7  treatment of C1300 cells increased 
the susceptibility t- alloreactive CTL lysis, Indicating that both IFN
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Efface af IFM-tt and IFN-ad treatment on susceptibility of C130Q cell« to 
lvala bv alloreactive CTL
(A— A) C1300 calls (H-2*; Kk untreated
(•— •) C1300 calls (H-2*; Kk D"). traatad with 1000 unlts/nl 1F1I*7
< ■ - ■ ) C1300 calls (H-2*; Kk Dd). traatad with 1000 units/al IFV-afl
(A— A) P815 calls (H-24 ; K* » V untrsatad
(O— O) L929 calls (H-2k ; Kk Dk). untreated
(D-Q) EL4 calls <H-2b ; Kb »b>. untrsatad
(1) Call* vara treated with IFN-O0, IFN- 7 or aadiua alone for 48 hours.
The calls wars than harvascad and susceptibility to (a) Hfid-anti-Hik , 
(b) H2 - anti -H4d and <c) Hfid-anti-H2b alloreactlva CTL lysis aMasured 
in a 4.5 hr chroaiua relaasa assay, as dascribad in aethods saction 
M.
<ii) 'Effactor' slloraactiva CTL wars: Balb/c anti C3H/Ha (H2d-anti-H2k)
(iii) E:T; Effactor to Targat ratio.
C3H/He anti Balb/c (H2 -anti-H«d) 
Balb/c anti C57 BL/6 (Hed-anti-H«b)
(a ) H-2d anti H-2^
(b ) H-2k ontiH-2d
( c  ) tin ti H3b
E sT ratio
types increased the ability of C1300 cells to participate in H-2D region 
associated T-cell mediated immune reactions. This increased ability may be 
due to an increased level of functional H-2Dd antigen and/or adhesion 
molecule display on the cells. The killing by the alloreactive CTL was H- 
2Dd specific since P815 cells (H-2d) were lysed whereas L929 cells (H-2^) 
were not. Figure 4.29c shows the effect of IFN-y on the susceptibility of 
C1300 cells to lysis by H-2d-anti-H-2b alloreactive CTL. It can be seen 
that untreated and IFN- 7  treated C1300 cells were not susceptible to H-2d- 
anti-H-2b alloreactive CTL lysis, since the amounts of chromium released 
only corresponded to the background lysis observed for untreated control 
cells of the wrong haplotype (P815 cells, H-2d). The susceptibility of 
IFN-a0 treated C1300 cells to lysis by H-2d-anti-H-2b alloreactive CTL was 
not determined. In contrast to untreated and IFN- 7 treated C1300 cells,
ELA cells (H-2b) were lysed by the alloreactive CTL indicating that the 
killing was H-2b specific.
Figure 4.30 shows the effect of IFN-O0 and IFN-y on expression of class II 
MHC H-2A^ antigen by C1300 cells. As shown in figure 4.30a, untreated 
C1300 cells displayed no detectable H-2A^ antigen since the fluorescence of 
anti-H-2A^ stained cells was identical to that of the same cells stained 
with FITC-conjugated antibody alone (background fluorescence). Statistical 
analysis of the fluorescence data also showed that 0% of untreated C1300 
cells displayed H-2A^ antigen on the cell surface. Neither IFN-ct/3 nor 
IFN- 7  treatment had any effect upon H-2A^ antigen expression since the 
fluorescence of IFN-treated C1300 cells was identical to that for untreated 
C1300 cells. In a parallel control experiment IFN- 7  augmented the 
expression of H-2A** antigen on astrocytes (data not shown).
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Effgfit g£ IFN-afl and IFN-7 on expression of class II MHC H-2Ak antigen bvC13QQ c a l l i
Kax
(A) solid lino 
spocod docs
doso does 
doshed lino
(B) solid lino 
spocod docs
doso docs 
doshsd lino
bockground fluorosconco
untreated
100 u/al IFN-O0
1000 u/al IFN-O0
bockground fluorosconco
uncreaCed
100 u/al IFN-7
1000 u/al IFN- 7
FLI; Fluorosconco inConsiey channel
(i) C1300 cells were treated for 48 hours with che appropriaco
concentration of IFN-a£ or IFN- 7  prior to staining H-2A*6 antigen by 
indiracc immunofluorescence as described in aathods section H.
(ii) 5000 colls analysed in each cose.
Interaction of IFNs a. B and i In the induction of MHC antleei
astrocytes
In the previous section the effects of natural IFN-a/J and recombinant IFN-7  
on class I and class II MHC antigen expression on astrocytes were 
described. In this section the way in which natural IFN-a/9, recombinant 
IFN-0 and recombinant IFN- 7  interact in the induction of class I (H-2K^) 
and class II (H-2A^) MHC antigen on astrocytes is investigated. Again, the 
expression of MHC antigen on astrocytes was assessed by indirect 
immunofluorescence staining with quantification by flow cytometry. Table 
4.2 shows the way in which IFN-a/? and IFN- 7  Interact in the induction of 
class I MHC H-2K^ antigen on astrocytes. It can be seen that the mean 
fluorescence for astrocytes treated with concentrations of IFN-a0 together 
with IFN- 7  were greater than for astrocytes treated with the same 
concentration of either IFN alone, indicating an additive effect of IFN-a/9 
and IFN- 7 on induction of H-2K antigen on astrocytes. The data presented 
in table 4.2 also clearly show that IFN- 7 was far more potent (in terms of 
antiviral activity units) in augmenting H-2K^ antigen expression on 
astrocytes than IFN-a/9, since the mean fluorescence for astrocytes treated 
with 1 u/ml IFN- 7  at 462 was clearly higher than for astrocytes treated 
with 1000 u/ml IFN-a0 at 326. Similarly, table 4.3 shows the way in which
lr
IFN-0 and IFN- 7  Interact in the induction of class I H-2K antigen on 
astrocytes. It can be seen that the mean fluorescence for astrocytes 
treated with concentrations of IFN-0 together with IFN- 7  was greater than 
for astrocytes treated with the same concentration of either IFN alone, 
indicating an additive effect of IFN-0 and IFN- 7  on induction of H-2K*C 
antigen on astrocytes. The data presented in table 4.3 also show that IFN- 
7 was more potent (in terms of antiviral activity units) in Increasing H- 
2Kk antigen expression on astrocytes than IFN-0, since the mean
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Liuct gi lia-a 
gn astrocyte«
UHT* 10 »ic 100 afi
antigen
1000 afi
UNTb II4 30 109 326
1 7C 462 341 607 751
10 7 «62 •70 981 1142
lax
(a) UNT, untreated with IFN-q^
(b) UNT, untraatad with IFN-7
(c) rafar to units/ml IFN-q^ and IFN- 7 present
(d) refer to the mean fluorescence of cells, stained with anti-H- 
2Kk (I)
(I) Astrocytes were treated with either IFN-a0 alone, IFN- 7  alone or a 
combination of IFH-afl and IFN- 7 for 48 hours prior to staining H-2K^ 
antigen by indirect immunofluorescence as described in methods 
section H.
(I I ) 10 000 cells analysed in each case.
(iv) All fluorescence histograms obtained followed a normal distribution.
Tabi«
E»«gt g£ ira-
astrocytes
UNT* 10 0C
gi —  1 1  — a 
100 fi 1000 fi
UNTb 1*4 74 271 629
1 TC 398 429 363 812
10 7 681 688 896 1041
Kax
(a) UNT, untreated with IFN-0
(b) UNT, untreated with IFN- 7
(c) refer to unlts/al IFN-0 and IFN- 7  present
(d) refer to the mean fluorescence of the cells, stained with 
antl-H-2Kk (I)
(I) Astrocytes were treated with either IFN-fi alone, IFN- 7  alone or a 
combination of IFN-fi and IFN- 7 for 48 hours prior to staining H-2Kk 
antigen by Indirect Inusunofluorescence as described In methods 
section H.
(I I ) 10 00 0 cells ware analysed In each case.
(III) All fluorescence histograms obtained followed a normal distribution.
fluorescence for astrocytes treated with 10 u/nl IFN- 7  at 681 was higher 
than for astrocytes treated with 1000 u/ml IFN-0 at 629. The histograms 
which generated the mean fluorescence values shown in tables 4. 2 and 4.3 
all followed a normal distribution.
Figure 4.31 shows the way in which lFN-a£ and IFN- 7  interact in the 
induction of class II MHC H-2Ak antigen on astrocytes. In contrast to 
induction of class I MHC H-2K^ antigen in which IFN-a0 and IFN- 7 were found
to have an additive effect, IFN-a/3 was found to slightly inhibit the
kability of IFN- 7 to augment class II H-2A antigen expression on at least 
some astrocytes, since the fluorescence of astrocytes treated with both 
IFN-a0 and IFN- 7 was slightly lower than for astrocytes treated with the 
same concentration of IFN- 7  alone (fig 4.31a and b). Statistical analysis 
of the fluorescence data showed that 1 u/ml IFN- 7 increased H-2a 'C antigen 
expression on at least 27% of astrocytes, and that this concentration of 
IFN- 7  only increased H-2A^ antigen expression on 19% of astrocytes in the 
presence of 1000 u/ml IFN-a/J and on 17% of astrocytes in the presence of 
10 000 u/ml IFN-a/l. Similarly, statistical analysis showed that 10 u/ml 
IFN- 7  increased H-2A antigen expression on at least 85% of astrocytes, and 
that this concentration of IFN- 7  only increased H-2Ak antigen expression on 
77% of astrocytes in the presence of 1000 u/ml IFN-a/J and on 67% of 
astrocytes in the presence of 10 000 u/ml IFN-a0. Thus, 1000 u/ml IFN-a/9 
and 10 000 u/ml IFN-O0 inhibited the ability of 10 u/ml IFN- 7  to augment H- 
2Ak antigen on at least 8% and 18% of astrocytes, respectively. To 
determine whether a longer treatment with IFN-q^ would have a greater 
effect on the augmentation by IFN- 7  of class II H-2A antigen on 
astrocytes, the cells were pretreated with IFN-a/? for 2 days prior to the 
addition of IFN- 7  and incubation for a further 2 days. As shown in figure 
4.32, the effect of IFN-a0 was essentially no greater. Statistical
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Effect of IFN-afl on the augmentation bv IFN--y of class II MHC H-2Ak antigen
o n  a scrg C Y tca
Fl. I FL l
(A) solid line untreated
dashed line 1 u/ml IFN- 7  alone
close dots 1 u/ml IFN- 7  + 1000 u/ml IFN-a0
spaced dots 1 u/ml IFH- 7  ♦ 10000 u/ml IFN-c.0
<»> solid line untreated
dashed line 10 u/ml IFN- 7  alone
spaced dots 10 u/ml IFN- 7  + 1000 u/ml IFN-a/9
close dots 10 u/ml IFN- 7  + 10000 u/ml IFN-a0
FLI; Fluorescence intensity channel
(I) Astrocytes were treated with IFN- 7  in the presence or absence of 
IFN-O0 for 48 hours prior to staining H-2a'c antigen by indirect 
immunofluorescence as described in methods section H.
(I I ) 10 000 cells analysed in each case.
Flyura 4.32
Elfact a£ 2 day protraataang vith IBLafl an tha au— ntatifln by IFH-7 ai 
clan II MBC H-2Ak antUen an aagrocvtaa
Kax
■olid line untreeced 
spaced docs : 10 u/ml IFN- 7  alone
close docs 1000 u/ml IFN-O0 + 10 u/al IFN- 7
FLI; Fluorescence InCenslCy channel
(1) Ascrocyces were treated wich 1000 u/ml IFN-O0 or medium alone for 48 
hours prior Co cha addicion of 10 u/ml IFN- 7 and incubaCion for a 
furCher 48 hours. H-2A^ antigens were Chan sCainad by indirecC 
immunofluorescence as described in mechods sacCion H.
(ii) 10 000 cells analysed in each case.
analysis of the fluorescence data showed that 10 u/ml IFN- 7  increased H-2Ak 
antigen expression on at least 80% of astrocytes, and that this 
concentration of IFN- 7 only increased H-2Ak antigen expression on 69% of 
astrocytes when pretreated with 1000 u/ml IFN-a/3. Thus, pretreatment of
astrocytes with 1000 u/ml IFN-a0 inhibited the ability of 10 u/al IFN- 7  to 
vaugment H-2A antigen expression on 11% of astrocytes, a figure directly 
comparable to that stated above for 1000 u/ml l¥V-afi excluding the 48 hour 
pretreatment prior to IFN- 7  treatment.
Figure 4.33 shows the way in which IFN-0 and IFN- 7  interact in the 
induction of class II MHC H-2Ak antigen on astrocytes. Again, in contrast 
to the Induction of class I MHC H-2Kk antigen in which IFN-0 and IFN- 7 were 
found to have an additive effect, IFN-0 was found slightly to inhibit the 
ability of IFN- 7 to augment class II MHC H-2Ak antigen on at least some 
astrocytes, since the fluorescence of astrocytes treated with both IFN-0 
and IFN- 7 was slightly lower than for astrocytes treated with the same 
concentration of IFN- 7  alone (fig 4.33a and b) . Statistical analysis 
showed that 1 u/ml IFN- 7  Increased H-2A*C antigen expression on at least 34% 
of astrocytes, and that this concentration of IFN- 7 only increased H-2A 
antigen expression on 24% of astrocytes in the presence of 100 u/ml IFN-/)
and on 29% of astrocytes in the presence of 1000 u/ml IFN-/3. Similarly,
Itstatistical analysis showed that 10 u/ml IFN- 7  Increased H-2A antigen 
expression on at least 83% of astrocytes, and that this concentration of 
IFN- 7  only increased H-2Ak antigen expression on 79% of astrocytes in the 
presence of 100 u/ml IFN-0 and on 78% of astrocytes in the presence of 1000 
u/ml IFN-0. Thus. 100 u/al IFN-/9 and 1000 units/ml IFN-0 inhibited the 
ability of 10 u/ml IFN- 7  to augment H-2A antigen expression on at least 4% 
and 5% of astrocytes, respectively. IFN-0 treatment alone had no effect 
upon H-2Ak antigen expression on astrocytes (data not shown).
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E ffrct o£ IFB-fl an tht aucMniAtlgn by IFM-t gf e l m  I I  MHC H-2Ak anfilMP
gn u a n ttii
solid line untreated
dashed line 1 u/al IFN -7 alone
close dots 1 u/al IFM - 7 ♦ 100 u/al IFN-0
spaced dots 1 u/al IFN - 7 «• 1000 u/al IFH-fi
solid line untreated
dashed line 10 u/al IFN- 7 alone
close dots 10 u/al i m - 7 ♦ 100 u/al IFV-fi
spaced dots 10 u/al IFN-7 ♦ 1000 u/al IFN-0
FLI; Fluorescence lnCenslCy channel
(1) Astrocytes were treated with IFN - 7  in the presence or absence of 
IFN-0 for 48 hours prior to staining H-2Ak antigen by direct 
iaaunofluorescence as described in aethods section H.
(ii) 10 000 cells analysed in each case.
Discussion
In this chapter the relative sensitivities of astrocytes, G26-24 
oligodendroglioma cells and C1300 neuroblastoma cells to the antiviral 
effect of natural IFN-a/) and recombinant IFN- 7 are assessed, via the 
incorporation of [^HJuridine into SFV-RNA in IFN-treated SFV-Infected 
cells. It was found that astrocytes and C26-24 cells were highly sensitive 
to both IFN-a0 and IFN-7 , with total inhibition of SFV-RNA synthesis at 
1000 u/ml IFN-a/) and 100 u/ml IFN- 7 for astrocytes, and at 300 u/ml IFN-a0 
and 500 u/ml IFN- 7  for G26-24 cells. Pretreatment of astrocytes with 1000 
u/ml IFN-a/) or 100 u/ml IFN-7 , and of G26-24 cells with 500 u/ml IFN-7 , 
prior to infection with SFV, also markedly reduced the amount of SFV 
antigen displayed on the surface of infected cells. C1300 cells were also 
found to be highly sensitive to IFN-a£, with total inhibition of SFV-RNA 
synthesis at 1000 u/ml IFN-a/). Pretreatment of C1300 cells with 1000 u/ml 
IFN-a£, prior to infection with SFV, markedly reduced the amount of SFV- 
antigen displayed on the surface of infected cells. In contrast, C1300 
cells were found to be relatively insensitive to the antiviral effect of 
IFN-7 , with 2000 u/ml IFN- 7 inhibiting SFV-RNA synthesis in C1300 cells by 
only 65%. Similarly, treatment of C1300 cells with 2000 u/ml IFN-7 , prior 
to infection with SFV, reduced SFV antigen display on only a proportion of 
the cells, with 29% of IFN- 7 treated SFV-infected C1300 cells still 
displaying levels of SFV antigen comparable to non-IFN treated SFV-infected 
cells.
The effects of natural IFN-a/9 and recombinant IFN- 7  on class I and class II 
MHC antigen expression by astrocytes, G26-24 cells and C1300 cells were 
also determined. The data show that 26-66% (range in separate experiments)
1cof untreated astrocytes displayed moderate levels of H-2K antigen, but in
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contrast displayed no detectable H-2D^ antigen. Experiments in which 
untreated astrocytes were found to be susceptible to alloreactive CTL lysis 
also suggest that at least some astrocytes display sufficient levels of
functional class I MHC antigen for T-cell recognition to occur. The
yobservation that at least some cultured astrocytes express H-2K antigen is 
consistent with the results of Fontana and coworkers who demonstrated that 
cultured astrocytes derived from C57 BL/6 mice display H-2K** antigen on the 
cell surface (Fontana g£ gl., 1986). These results do not however reflect 
the situation in vivo, since less than 1% of astrocytes Isolated from the 
brains of newborn CBA mice were found to display H-2K*C antigen (Wong g£ 
al. . 1984). The expression of H-2Kk antigen on cultured astrocytes may be 
due to the presence of stimulatory components in the culture medium (e.g. 
from foetal calf serum). That cultured astrocytes do not express 
detectable levels of H-2Dk antigen may reflect the fact that the expression 
of H-2D and H-2K antigens is independently regulated, as has been
demonstrated for mouse embryo fibroblasts (King g£ gl. , 1985) or may be due
k kto the inability of the anti-H-2D antibody to stain low levels of H-2D
antigen to a sufficient level for detection by flow cytometry. Very
recently Sklas and coworkers also demonstrated that untreated cultured
astrocytes derived from DBA/2 mice were susceptible to alloreactive CTL
lysis (Skies g£ gl-, 1987). The data presented in this chapter also show
that IFH-afi and IFN- 7  treatment markedly increased H^D^ and H-2K^ antigen
expression on astrocytes, in a dose-dependant manner. Observation of the
data obtained also revealed that IFN- 7  was more potent in inducing class I
MHC class I MHC antigen expression than IFN-a/J, on the basis of antiviral
Icactivity units. Thus, it was found that 10 u/ml IFN-a0 Increased H-2D and
H-2K^ antigen expression on 19% and 7% of astrocytes respectively, whereas 
k k0.1 unit/ml IFN- 7  increased H-2D and H-2K antigen expression on 57% and 
62% of astrocytes, respectively. Since the astrocyte cultures are at least
90% GFAP+ astrocyte In composition (see chapter 3) and greater than 90% of 
calls displayed H-2Dk and H-2Kk antigen whan treated with 1000 u/ml IFN-a£ 
or 100 u/ml IFN-y, it follows that at least the majority of IFN-a£ and IFN- 
7 treated astrocytas must have displayed H-2Dk and H- 2Kk antigen on the 
cell surface. It is not possible from the data obtained to determine
k kwhether IFN-a£ and IFN-y treatment also increased H-2D and H-2K antigen 
expression on the (at rest) 10% uncharacterised cells present in these 
cultures. It does however seem to be a strong possibility, since IFN-afi 
has been shown to Increase class I MHC antigen expression on fibroblasts 
(Dr A Morris, University of Varvlck, unpublished observations) and IFN-y 
has been shown to Increase class I MHC antigen expression on fibroblasts, 
neurons , microglial cells and oligodendrocytes (Vong £_£ al- , 1984;
Suzumura &£ al. . 1987; Maudsley and Morris, 1988). IFN-a0 and IFN-y 
treatment also increased the susceptibility of astrocytes to alloreactlve 
CTL lysis, indicating that both IFNs Increased the ability of astrocytes to 
participate in class I MHC restricted T-cell mediated immune reactions.
The ability of IFN-a£ and IFN-y to Increase class I MHC H-2Kk antigen 
expression on cultured astrocytes, derived from CBA mice, has been reported 
previously by Wong and coworkers, who also extended their studies in vivo, 
and found that Intracerebral injection of IFN-y Increased H-2Kk antigen 
expression on astrocytes within the brain (Wong a£ al. . 1984). In contrast 
to the results presented In this chapter, Sklas and coworkers recently 
reported that IFN-y treatment did not Increase the susceptibility of DBA/2 
astrocytes to lysis by an alloreactlve antl-H-2Ld CTL clone (Sklas al al., 
1987). The reason for this discrepancy In results Is not clear since IFN-y 
treatment Increased H-2Ld antigen expression on DBA/2 astrocytes, as 
assessed by Indirect immunofluorescence staining with analysis by UV 
microscopy. However, Skias and coworkers also reported that the increase 
In H-2Ld antigen expression could not be detected by flow cytometry. This
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suggests that treatment with IFN-7 may have only very slightly increased H- 
2Ld antigen expression on the DBA/2 astrocytes, and perhaps by a level 
which could not be detected in the alloreactive CTL assay. Alternatively, 
IFN- 7  treatment may not increase the level of functional H-2Ld antigen 
expression on DBA/2 astrocytes.
The data presented in this chapter also show that untreated astrocytes
lrdisplayed undetectable levels of class II MHC H-2A antigen on the cell 
surface. IFN- 7  treatment Induced H-2a 'C antigen expression on astrocytes, 
but in contrast IFV-afi treatment did not. Similarly, IFN- 7 treatment 
Increased the ability of astrocytes to stimulate an allogeneic mixed 
lymphocyte reaction (MLR) indicating an increased level of functional class 
II MHC antigen on the cells. IFN-a0 treatment had no effect on the ability 
of astrocytes to stimulate an allogeneic MLR. These observations are 
consistent with previous reports by Hirsch g£ gl. (1983) and Wong gj£ gl. 
(1984) which demonstrated that untreated cultured astrocytes (derived from 
outbred Swiss mice and CBA mice, respectively) displayed undetectable 
amounts of class II MHC antigen, as assessed by indirect Immunofluorescence 
staining. Furthermore, these groups also reported that IFN- 7 treatment 
Induced class II MHC antigen on cultured astrocytes, whereas IFN-a0 
treatment did not. That IFN- 7  has the potential to induce class II MHC 
antigen display on astrocytes jjj vivo has been shown by Wong and coworkers, 
who directly injected IFN- 7  into the brains of CBA mice (Wong g£ gl. ,
1984). Since the present studies were undertaken, Fontana and coworkers 
have also demonstrated that IFN- 7 treatment increases the ability of 
astrocytes (derived from C57 BL/6 mice) to stimulate an allogeneic MLR 
(Fontana g£ gl. 1986).
kIn the present study IFN- 7  treatment was found to Induce H-2A antigen
expression on at lease 86% of Che calls present In Che astrocyte cultures. 
Since the cultures are at least 90% GFAP+ astrocyte in composition it 
follows that at least the majority of IFN- 7  created astrocytes must have 
displayed H-2Ak antigen on the cell surface. It cannot be deduced from the 
data obtained whether IFN- 7  treatment also Induced H-2Ak antigen expression 
on Che (at most) 10% uncharacterised cells present in these cultures. 
However, it does at least seem possible since IFN- 7  treatment has been 
shown to augment class II MHC antigen expression on fibroblasts and 
microglial cells (Maudsley and Morris, 1988; Suzumura £_£ al.. 1987). A 
possible experimental approach to determine the identity of all cells which 
express (and do not express) H-2A^ antigen (as well as H-2D^ and H-2K^ 
antigen) could be to use a fluorescence activated cell sorter to sort H-2A^ 
expressing cells (and non-H-2A^ expressing cells) and then use a range of 
antibodies to stain markers specific for the possible cell types present. 
For example, antiserum to neurofilaments and the monoclonal antibody A2B5 
may be used to characterise neurons , antiserum to galactocerebroside to 
characterise oligodendrocytes and antiserum to fibronectin to characterise 
fibroblasts (Mirsky, 1982). Ependymal cells can be recognised by their 
beating cilia , and microglial cells by non-specific esterase activity, Fc 
receptor expression and the ability to endocytose latex beads (Mirsky,
1982; Suzumura *£ gl-. 1987).
The effect of IFN-<*0 and IFN- 7  on class I and class II MHC antigen 
expression by G26-24 oligodendroglioma cells were also determined. The 
data show that 12-84% and 15-42% (range in separate experiments) of 
untreated G26-24 cells displayed moderate levels of H-2D** and H-2K** 
antigen, respectively. Experiments in which untreated G26-24 cells were 
found to be susceptible to alloreactive CTL lysis also suggest that at 
least some G26-24 cells display sufficient levels of functional class I MHC
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antigen for T-cell recognition Co occur. These observations do noc however 
reflect Che situation with normal oligodendrocytes in vivo, since less than 
1% of oligodendrocytes isolated from the brains of newborn CBA mice were 
found to display class I MHC antigen (Uong at ai. , 1984) . The expression 
of H-2Db and H-2Kb antigen on at least some G26-24 cells may be due to the 
presence of stimulatory components in the culture medium (as was proposed 
for cultured astrocytes) or may be a feature of the transformed cells. 
IFN-O0 and IFN-y treatment markedly increased H-2Db and H-2Kb antigen 
expression on G26-24 cells, in a dose-dependent manner. Observation of the 
data obtained also revealed that IFN-y was more potent in inducing class I 
MHC antigen expression than IFN-a^, on the basis of antiviral activity 
units. Thus, it was found that 1 u/ml IFN-q^ increased H-2Db and H-2Kb 
antigen expression on 10% and 3% of G26-24 cells respectively, whereas 0.05 
u/ml IFN-y increased H-2Db and H-2Kb antigen expression on 28% and 15% of 
G26-24 cells, respectively. Greater than 65% of G26-24 cells expressed H- 
2Db and H-2Kb antigen when treated with 1000 u/ml IFN-a0, and greater than 
87% when treated with 500 u/ml IFN-y. IFN-a£ and IFN-y treatment was also 
found to increase the susceptibility of C26-24 cells to alloreactlve CTL 
lysis, indicating that both IFN types increased the ability of G26-24 cells 
to participate in class I MHC restricted T-cell mediated immune reactions. 
The ability of IFN-y to Increase class I MHC H-2Kk antigen expression on 
normal oligodendrocytes present in 2 day-old mixed brain cell cultures 
(prepared from CBA mice) has been reported previously by Uong at ai.
(1984). Uong and co-workers also extended their studies in vivo and 
demonstrated that Intracerebral administration of IFN-y increased H-2Kb 
antigen expression on oligodendrocytes within the brains of CBA mice (Uong 
at Ai-. 1984).
The data presented in this chapter also show that untreated G26-24 cells
displayed no detectable class II H-2Ab antigen on the cell surface, as has 
been shown for normal untreated rat and mouse oligodendrocytes In culture 
(Llsak et al.. 1983; Wong &£ al. . 1984). Whether untreated cultured normal 
human oligodendrocytes display detectable amounts of class II MHC antigen 
Is still controversial. Thus, Llsak and coworkers (Lisak £_£ al. , 1983) 
reported that untreated cultured human oligodendrocytes (obtained at 
autopsy from two subjects with no known neurological disease) displayed no 
detectable class II MHC antigen, whereas Kim and coworkers (Kim a£ al- .
1985) detected class II MHC antigen on the surface of some oligodendrocytes 
within cultures prepared from six subjects out of a total of twelve studied 
(all twelve subjects had no known neurological disease at autopsy). That 
Lisak and coworkers were unable to detect class II MHC antigen on cultured 
human oligodendrocytes may have been related to the limited number of 
samples obtained, in that cultures were prepared from only two subjects.
In the present study, IFN-y treatment induced H-2Ab antigen expression on 
G26-24 cells, but in contrast IFN-a£ treatment did not. The ability of 
IFN-y to induce class II MHC antigen expression on G26-24 oligodendroglioma 
cells does not reflect the situation with normal oligodendrocytes, at least 
in the murine system. Thus, it has been shown that IFN-y treatment does 
not increase class II MHC antigen expression on mouse oligodendrocytes in 
culture (Wong &£ al. . 1984; Suzumura £_£ ¿1-, 1986). Similarly, Wong and 
coworkers also reported that intracerebral administration of IFN-y did not 
increase class II MHC antigen expression on oligodendrocytes within the 
brains of CBA mice (Wong £_£ al. . 1984). Whether IFN-y augments class II 
MHC antigen expression on normal human oligodendrocytes remains to be 
determined.
The effects of IFN-a/9 and IFN-y on class I and class II MHC antigen 
expression by C1300 neuroblastoma cells were also determined. The data
show that 5% and 47% of uncreated C1300 cells displayed moderate levels of 
H-2Dd and H-2K^ antigen, respectively. Experiments In which uncreated 
C1300 cells were found to be susceptible to both H-2d and H-2^ specific 
alloreactlve CTL lysis also suggest that at least some C1300 cells display 
sufficient levels of functional class I MHC H-2Dd and H-2K^ antigen for T- 
cell recognition to occur. These observations do not reflect the situation 
with human neuroblastoma cells which have been shown to express 
exceptionally low levels of class I MHC antigen (Lampson £_£ Al-, 1983; 
Lampson and Fisher, 1984) and are not susceptible to alloreactlve CTL lysis 
(Main at Al-. 1985). These observations also do not reflect the situation 
with normal murine neurons in vivo, since less than 1% of neurons 
Isolated from the brains of newborn CBA mice were found to display class I 
MHC H-2k'C antigen (Vong g£ gl-, 1984). The expression of H-2Dd and H-2K^ 
antigen on at least some untreated C1300 cells may thereby be a feature 
unique to the murine C1300 neuroblastoma cell line. IFN-a0 and IFN-y 
treatment was also found to markedly Increase H-2Dd and H-2K^ antigen 
expression on C1300 cells. In an essentially dose-dependant manner. 
Observation of the data obtained also again revealed that IFN-y was more 
potent In Inducing class I MHC antigen expression than IFN-a0, on the basis 
of antiviral activity units. Thus, It was found that 100 u/ml IFN-a/) 
Increased H-2Dd and H-2K*1 antigen expression on 45% and 35% of C1300 cells 
respectively, whereas 1 u/ml IFN-y Increased H-2Dd and H-2K antigen 
expression on 42% and 37% of cells, respectively. These observations 
contrast with studies on the sensitivity of C1300 cells to the antiviral 
effect of IFN-a0 and IFN-y, in which C1300 cells were shown to be sensitive 
to IFN-a/}, but relatively insensitive to IFN-y. Thus, IFN-y induces class 
I MHC antigen expression on C1300 cells at concentrations far lower than 
needed to induce an antiviral state. Similar observations have also been 
made previously by Wallach and coworkers who demonstrated that IFN-y
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induced class I MHC antigen expression on human fibroblast and 
lymphoblastoid cells at concentrations far lower than needed to induce (2 '- 
5') oligo (A) synthetase and the antiviral state (Uallach si Al-. 1982).
In the present study IFN-a£ and IFN-y treatment was also found slightly to 
increase the susceptibility of C1300 cells to H-2** and H-2k specific 
alloreactlve CTL lysis, indicating that both IFN types increased the 
ability of C1300 cells to participate in H-2D and H-2K region associated T- 
cell mediated immune reactions. The ability of IFN-y to augment class I 
MHC antigen expression on human neuroblastoma cells has also been reported 
previously by Lampson and Fisher (1984). Similarly, IFN-y has been shown 
to Increase class I MHC antigen expression on at least some normal neurons 
in mixed brain cell cultures, derived from newborn CBA mice, as well as on 
neurons within the brains of CBA mice (Vong ££ al. , 1984).
The data presented in this chapter also show that untreated C1300 cells 
displayed no detectable class II MHC H-2Ak antigen on the cell surface. 
Neither IFN-a£ nor IFN-y treatment of C1300 cells was found to induce H-2A*t 
antigen expression. Similarly, Lampson and Fisher (1984) reported that 
both untreated and IFN-y treated human neuroblastoma cells displayed no 
detectable class II MHC antigen on the cell surface, and Wong and coworkers 
demonstrated that Intracerebral administration of IFN-y did not induce 
class II MHC antigen expression on normal neurons within the brains of CBA 
mice (Wong si dl-. 1984).
In this chapter the way in which natural IFN-a/9, recombinant IFN-/J and 
recombinant IFN-y interact in the induction of class I and class II MHC 
antigen expression was also investigated. The data obtained clearly show 
that IFS-afi and IFN-0 were additive with IFN-y for the enhancement of class 
I MHC H-2Klc antigen on astrocytes. Similar observations have also been
made by Lapierre and coworkers who demonstrated that recombinant IFN-a and 
recombinant IFN-/9 were additive with IFN- 7  for the enhancement of class 1 
MHC HLA-A.B antigen on human endothelial cells (Lapierre &£ ¿1., 1988) and 
by Dr A Morris (University of Warwick) who demonstrated that natural IFN-a0 
and recombinant IFN-/J were additive with IFN- 7 for the enhancement of class 
I MHC H-2D** antigen on G26-24 cells, and H-2Kk antigen on C3H10Th 
fibroblast cells (unpublished observations). In contrast to the 
augmentation of class I MHC antigen expreslon, IFV-afi and IFN-/) were found 
to inhibit the ability of IFN- 7  to augment class II MHC H-2Ak antigen 
expression on a proportion of cells present In the astrocyte cultures. The
kability of IFN-a/> to inhibit the augmentation of H-2A antigen expression 
by IFN- 7  was dose-dependant, although even very high concentrations of IFN - 
afi only inhibited H-2Ak antigen expression on a small proportion of cells. 
Thus, it was found that 10 000 u/ml IFN-a/) inhibited the ability of 10 u/ml 
IFN- 7  to augment H-2Ak antigen expression on at least 18% of the cells 
present in the astrocyte cultures. Since the cultures were at least 90% 
GFAP+ astrocyte in composition, it follows that 10 000 u/ml IFN-a/) must 
have inhibited the ability of IFN- 7  to augment H-2Ak antigen expression on 
at least some astrocytes. It cannot be deduced from the data obtained 
whether IFN-a0 also inhibited the ability of IFN- 7  to augment H-2Ak antigen 
expression on the (at most) 10% uncharacterised cells present in these 
cultures. 1000 u/ml IFN-/) also inhibited the ability of 10 u/ml IFN- 7 to 
augment H-2Ak antigen expression on at least 5% of the cells present in the 
astrocyte cultures. Since the cultures are (at least) 90% GFAP+ astrocyte 
in composition, it is not possible to determine whether IFN-/) inhibited the 
kability of IFN- 7  to augment H-2A antigen expression on astrocytes or on 
the uncharacterised cells present in the cultures. The ability of IFNs-a/) 
and /) to inhibit the induction by IFN- 7  of class II MHC antigen expression 
has been reported previously in other cell systems. Thus, it has been
demonstrated that natural IFN-a, natural IFN-0 and recombinant IFN-fi 
inhibit the ability of recombinant IFN-y to augment class II MHC antigen 
expression on macrophages (Ling ££ Al. > 1985; Inaba £_£ al. , 1986; Fertsch 
et al. . 1987; Kltaura at al. , 1988) and hence the ability of IFN-y treated 
macrophages to stimulate an allogeneic mixed lymphocyte reaction (Inaba a£ 
al., 1986) . Experiments in which monoclonal antibodies to IFN-a and IFN-/9 
were found to neutralise the ability of natural IFN-a and IFN-0 to inhibit 
the induction by IFN-y of class II MHC antigen expression also demonstrated 
that the effects observed were not due to contaminants in the natural IFN 
samples. Similarly, Lapierre and coworkers demonstrated that recombinant 
IFN-a and recombinant IFN-/) inhibit the ability of recombinant IFN-y to 
augment class II MHC HLA-DR antigen expression on human endothelial cells 
(Lapierre al., 1988) and Dr A Morris (University of Warwick) 
demonstrated that natural IFN-a/) and recombinant IFN-/) inhibit the ability 
of IFN-y to augment H-2A** and H-2A^ antigen expression on G26-24 cells and 
C3H10T4 fibroblast cells, respectively (unpublished observations). The 
mechanisms by which IFN-a and ITV-fi inhibit the ability of IFN-y to augment 
class II MHC antigen expression on macrophages has been subject to a number 
of studies. Thus, it has been shown that IFN-a and IFN-/) down-regulate the 
level of IFN-y induced, class II MHC antigen mRNA synthesis in macrophages, 
in a dose-dependant manner (Fertsch al- , 1987; Kitaura a£ al- , 1988).
The down-regulation by IFN-/) of the level of IFN-y induced class II MHC 
antigen mRNA synthesis was also found to be sensitive to cycloheximide, an 
inhibitor of protein synthesis. Since the induction by IFN-y of class II 
mRNA synthesis was insensitive to cycloheximide, these results suggest that 
the negative effect of IFN-/9 was mediated by some de novo synthesised 
protein(s) which interfered with class II MHC antigen mRNA induction by 
IFN-y (Kitaura *1-, 1988). Whether natural ITV-afi and recombinant IFN-/) 
inhibit the ability of recombinant IFN-y to augment class II MHC antigen
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expression on Che cells present In Che astrocyte cultures by a similar 
mechanism, remains to be determined.
The potential importance of the effect of IFNs on class I and class II MHC 
antigen expression lies in the fact that T-cells can only recognise viral 
antigen which is presented in association with antigen of the MHC (Klein ££ 
al.. 1981). Since brain cells usually express essentially undetectable 
amounts of MHC antigen, the augmentation by IFN of class I and class II MHC 
antigen expression may increase the cytotoxic T-cell and helper T-cell 
recognition of virus infected cells, and hence play a role in the 
elimination of virus from the brain. This possibility is investigated 
further in chapters 5 and 6 . Since cytotoxic T-cells and helper T-cells 
release IFN- 7  on recognition of viral antigen (Morris ££ al., 1982; 
Cunningham at al., 1985) and IFN- 7  induces class II MHC antigen expression, 
the existence of a possible feedback loop to amplify T-cell responses is 
apparent. That IFN-a/9 can at least to some extent inhibit the induction by 
IFN- 7  of class II MHC antigen expression suggests a mechanism by which the 
feedback loop may also be controlled. A problem however is that (in terms 
of antiviral activity units) a large amount of IFN-a/9 over IFN- 7  is needed 
in order to have a significant effect, and in many situations this may not 
be the case. For example, during an avirulent SFV infection of mice IFN-a/3 
is produced within the brain relatively early in Infection and reaches 
maximal levels around day 5 post-infection, after which time the level 
declines (see chapter 7). In contrast, the ability of T-cells to produce 
IFN- 7  develops relatively late in infection and reaches maximal levels at 
day 7 post-infection (Blackman and Morris, 1984). Thus, when T-cell 
production of IFN- 7  reaches maximal levels there may only be low levels of 
IFN-<*0 present, and probably below the concentration required to inhibit 
the ability of IFN- 7  to induce class II MHC antigen expression.
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Chapter 5
Effect of IFN on the susceptibility of brain cells to SFV-.specif 1c 
cytotoxic T-lymphocyte lvsls
As discussed in detail in chapter 1, the importance of MHC antigen 
expression in the immune recognition of target cells by antigen-specific 
cytotoxic T-lymphocytes is now well recognised. With few exceptions, CTL 
only recognise foreign antigen on the surface of a target cell when 
presented in association with class I MHC antigen. Furthermore, the 
activity of CTL is restricted to those targets that express the same class 
I MHC antigen gene products as the effector CTL. Since CTL recognise both 
foreign antigen and class I MHC antigen on the surface of a target cell, it 
follows that any factor which modulates the expression of either of these 
antigens may also modulate the susceptibility of the target cell to CTL 
lysis.
In chapter U, data were presented which showed that IFN pretreatment of 
astrocytes, G26-24 oligodendroglioma cells and C1300 neuroblastoma cells, 
prior to Infection with SFV, markedly reduced the expression of SFV antigen 
on the surface of the infected cells. In contrast, IFN-treatment was found 
to markedly Increase the expression of class I MHC antigen on the surface 
of the cells. In this chapter the effect of IFN pretreatment of 
astrocytes, G26-24 cells and C1300 cells, prior to infection with SFV, on 
the susceptibility to SFV-specific CTL lysis is investigated.
Effect of IFN treatment on susceptibility of astrocytes 
cytotoxic T-lymphocyte lysis
SFV-speclflc
The effect of natural IFN-a0 and recombinant IFN- 7 treatment on the 
susceptibility of SFV-infected astrocytes to lysis by SFV-specific 
cytotoxic T-lymphocytes (CTL) and anti-SFV serum in the presence of 
complement was investigated as described in methods section M. Astrocytes 
were treated with 1000 u/ml IFN-a/3 or 100 u/ml IFN- 7  since these 
concentrations were previously found to strongly augment class I MHC 
antigen expression, completely inhibit SFV-RNA synthesis and markedly 
reduce SFV antigen expression on astrocytes (see chapter 4) .
Figure 5.la shows the effect of IFN-a0 treatment on the susceptibility of 
SFV-infected astrocytes to SFV-specific CTL lysis. It can be seen that 
both non-IFN treated SFV-infected astrocytes and IFN-a/9 treated SFV- 
infected astrocytes were clearly susceptible to lysis by SFV-specific CTL, 
and that quantitatively similar levels of lysis were observed for each. 
Uninfected astrocytes (either non-IFN treated or IFN-a/9 treated) and SFV- 
infected allogeneic EL4 cells (H-2^) were not killed, hence the killing by 
the SFV-speclflc CTL was both specific and MHC restricted. Yac-1 cells 
(which are highly susceptible to lysis by natural killer cells: Chervenak 
and Uolcott, 1988) were not killed, showing that there was no significant 
natural killer cell activity in the effector population. The 
susceptibility of the astrocytes to lysis by anti-SFV serum in the presence 
of complement was also investigated in order roughly to assess the level of 
SFV antigen displayed on the cells. As shown in figure 5.lb, non-IFN 
treated SFV-infected astrocytes were highly susceptible to lysis by the
FIturb 5.1
Effect: of IFN-aß on eueceptlbllltv of SFV-Infected »itroevt«« to
Ivals by SFV-gp«clflc cytotoxic I-lYUBhasYEca and antl-SFV «ru a  
in the prenne« o f  f l — at
(A) SFV-specific cytotoxic T-lymphocytes
(B) anti-SFV serun in tho presence of compleaent
(1). (A— A) Astrocytes (H-2k> ♦ IFN-a/9 + SFV
(ID. (A A) Astrocytes <H-2k) ♦ SFV
( H D . (O— O) Astrocytes <H-2k) + IFN-a0
(It ). (•— •) Astrocytes <H-2k> untreated
(0 — 0 ) ELA cells <H-2b> ♦ SFV
(♦— ♦) Yac- 1 cells (H-2*> untreated
A, lysis by snti-SFV serum in the presence of complement 
C, lysis by complement alone 1
(1) Cells were treated with 1000 u/ml IFN-a/9 or medium alone for 48 hours 
prior to infection with SFV. The susceptibility of the cells to 
lysis by SFV-specific cytotoxic T-lymphocytes and anti-SFV serum in 
the presence of complement were then determined, as described in 
methods section H.
(ii) SFV-specific cytotoxic T-lymphocytes were derived from C3H/He <H-2 )^ 
mice as described in methods section J, and were used in a 5 hour 
chromium release assay.
antí-SFV serum in che presence of complement. Indicating chat Che cells 
were expressing SFV antigen on the cell surface. In contrast, IFN-a/J 
created SFV-infected astrocytes were not susceptible to lysis by the anti- 
SFV serum in the presence of complement, indicating that IFN-O0 treatment 
had markedly reduced SFV antigen expression on the cells (as was shown by 
indirect immunofluorescence staining, see chapter 4 figure 4.7). Thus, 
IFN-O0 treated SFV-infected astrocytes were killed by the SFV-specific CTL 
to Che same level as non-IFN created SFV-Infected astrocytes, despite a 
marked reduction of SFV antigen expression on the cells. Similar 
observations were also made in parallel experiments by Mr M J Blackman 
(currently at the National Institute for Medical Research, London). Mr M J 
Blackman also demonstrated that SFV infection Itself did not Increase the 
non-specific susceptibility of astrocytes to lysis by the SFV-specific CTL, 
since SFV-infected astrocytes derived from allogeneic DBA/2 mice (H-2d) 
were not killed by the CTL (data not shown).
Figures 5.2a and 5.2b show the effect of IFN- 7 treatment on the 
susceptibility of SFV-infected and BPLSFV-treated astrocytes to lysis by 
SFV-specific CTL and anti-SFV serum in the presence of complement. Again, 
it can be seen that non-IFN treated SFV-Infected astrocytes were highly 
susceptible to lysis by both SFV-specific CTL and anti-SFV serum in the 
presence of complement. IFN- 7 treated SFV-Infected astrocytes were found 
to be markedly more susceptible to SFV-specific CTL lysis than non-IFN 
treated SFV-infected astrocytes, despite a marked reduction of SFV antigen 
expression on the cells as assessed by the reduced susceptibility to lysis 
by anti-SFV serum in the presence of complement (and by indirect 
immunofluorescence staining, see chapter 4, figure 4.8). Non-IFN treated 
BPLSFV-treated astrocytes were also clearly susceptible to SFV-specific CTL 
lysis, although at a lower level than non-IFN treated SFV-infected
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(1). ( * - ^ > Astrocytes (*-2k) ♦ SFV
(11). ( ^ - ^ ) Astrocytes <H-2k) + IFH- 7  + SFV
(111). (•— •> Astrocytes (H-2k) BPLSFV
(lv). ( O - O ) Astrocytes (H-2k) + IFN- 7  + BPLSFV
(▼). ( ■ - * > Astrocytes <H-2k) untreated
o*>. ( 0 - 0 Astrocytes <H-2k) + IFN- 7
(vll). <♦— ♦> ELA cells (*-2b) + SFV
(O— O) Yac-1 cells <H-2*> untreated
A, lysis by anti-SFV serum In Che presence of complement 
C, lysis by complement alone
(!) Cells were treated with 100 u/ml IFN- 7  or medium alone for 48 hours
prior to infection with SFV or treatment with an equivalent amount of 
a ¿3 - prop i o lac tone inactivated preparation of SFV (BPLSFV) . The 
susceptibiity of the cells to lysis by SFV*speci£ic cytotoxic T- 
lymphocytes and anti-SFV serum in the presence of complement were 
then determined, as described in methods section M.
(ii) SFV-specific cytotoxic T-lymphocytes were derived from C3H/He (H-2^) 
mice as described in methods section J, and were used in a 5 hour 
chromium release assay.
astrocytes. IFN-7 treated BPLSFV-treated astrocytes were markedly more 
susceptible to SFV-specific CTL lysis than non-IFN treated BPLSFV-treated 
astrocytes. The susceptibility of non-IFN treated BPLSFV-treated 
astrocytes and IFN- 7 treated BPLSFV-treated astrocytes to lysis by anti-SFV 
serum in the presence of complement corresponded to the background level 
observed for uninfected astrocytes (either non-IFN treated or IFN- 7  
treated) indicating that the cells were not displaying any detectable SFV 
antigen on the cell-surface (indirect immunofluorescence staining showed 
that only 4% of non-IFN treated BPLSFV-treated astrocytes displayed SFV 
antigen, see chapter 4, figure 4.8). Thus, non-IFN treated BPLSFV-treated 
astrocytes and IFN- 7 treated BPLSFV-treated astrocytes were susceptible to 
SFV-specific CTL lysis despite displaying essentially no detectable SFV 
antigen on the cell surface. Uninfected astrocytes (either non-IFN treated 
or IFN- 7 treated) and SFV-infected allogeneic EL4 cells (H-2**) were not 
killed by the SFV-specific CTL, hence the killing was both specific and 
MHC-restricted. Similarly, Yac-1 cells were not killed, showing that there 
was no detectable natural killer cell activity in the effector population.
Effect of SFV-Infection and BPLSFV-treatment on class I and class II MHC
antiwn espxsaslau fry astrvsYSes
It is now well established that a number of viruses modulate host cell MHC 
antigen expression, and by a mechanism which is not mediated via IFN. For 
example, JHM coronavirus has been shown to induce class II MHC antigen 
expression, and measles virus has been shown to induce both class I and 
class II MHC antigen expression,on cultured astrocytes derived from newborn 
Lewis rats (Massa et al-, 1986, 1987a). Virus-modulation of host cell MHC 
antigen expression has also been shown to influence the ability of the host 
cell to participate in T-cell mediated immune reactions. Thus, adenovirus-
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12 has been shown to abolish class I MHC antigen expression on fibroblasts 
(Schrler ££ al. . 1983) and reduce the susceptibility of the cells to both 
alloreactlve CTL lysis (Andersson ££ ¿1-, 1987) and virus-(Influenza)- 
specific CTL lysis (Yewdell *1., 1988a). Moloney murine leukemia virus 
has been shown to Increase class I MHC antigen expression on fibroblasts, 
and Increase the susceptibility of the cells to alloreactlve CTL lysis 
(Flyer ££ al. , 1985). It was thereby possible that Infection with SFV or 
treatment with BPLSFV modulated the expression of MHC antigen on astrocytes 
during the cytotoxicity assays described In the previous section, and hence 
modulated the susceptibility of the cells to SFV-specific CTL lysis. To 
Investigate this possibility astrocytes (either non-IFN treated, IFN-a/J 
treated or IFN- 7  treated) were infected with SFV or treated with BPLSFV, 
and the effect on class I and class II MHC antigen expression assessed by 
Indirect immunofluorescence staining with quantitation by flow cytometry.
The data In table 5.1 show the effect of SFV-Infection and BPLSFV-treatment 
on class I MHC H- 2Dkick antigen expression by astrocytes (at 10 hours post­
treatment) . It can be seen that SFV-infection had no effect on H- 2DkKk 
antigen expression by astrocytes (either non-IFN treated, IFN-o^ treated or 
IFN- 7 treated) since the mean fluorescence for SFV-infected cells and 
uninfected cells were essentially identical. BPLSFV treatment of non-IFN 
treated astrocytes also had no effect on H- 2DkKk antigen expression. In 
contrast, BPLSFV-treatment of IFN-a/3 treated and IFN- 7  treated astrocytes 
very slightly reduced H- 2oS;k antigen expression, with a decrease in mean 
fluorescence from 104 for non-BPLSFV treated IFN-a/3 treated astrocytes to 
89 for BPLSFV-treated IFN-a/3 treated astrocytes, and from 92 for non-BPLSFV 
treated IFN- 7 treated astrocytes to 72 for BPLSFV-treated IFN- 7  treated 
astrocytes. The decrease In fluorescence was H- 2DkKk specific since the 
mean fluorescence of BPLSFV-treated IFN-a0 treated (or IFN- 7 treated)
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lifal« 5.1
Effect ?f BFLSfv. treatment and SFv Infection on slaai I MHC 11-20^ antigen 
expression fry astrocytes *(I)
Uninfected SFV BPLSFV
Non-IFN treated n * 38 33
IFN-o/J 104 102 89
IFN-7 92 97 72
(a) refer co the mean fluorescence of the cells, scalned with anti-H- 20V .
(I) Astrocytes were treated with either medium alone, 1000 u/ml IFN-a/3 or 
100 u/ml IFN- 7  for 48 hours, prior to Infection with SFV or treatment 
with BPLSFV. At 10 hours post-Infection H- 2DkXk antigens were 
stained by Indirect immunofluorescence, as described In methods 
section H.
(II) 10,000 cells analysed in each case using the FACS440 flow cytometer 
at the University of Birmingham, operated by Hiss A Milner.
astrocytes stained with an Irrelevant antibody (anti-H-2Kd) was identical 
to that for non-BPLSFV treated IFN-a/) treated or IFN- 7  treated) astrocytes 
stained with the same antibody (data not shown).
The data in table 5.2 show the effect of SFV infection and BPLSFV treatment 
on class II MHC H-2Ak antigen expression by astrocytes. It can be seen
kthat SFV-infection and BPLSFV-treatment had no effect on H-2A antigen 
expression by non-IFN treated and IFN-a/) treated astrocytes, since the mean 
fluorescence of uninfected cells was essentially identical to the mean 
fluorescence for SFV-infected and BPLSFV-treated cells. SFV-infection and
kBPLSFV treatment of IFN- 7  treated astrocytes very slightly reduced H-2A 
antigen expression, with a decrease in mean fluorescence from 97 for 
uninfected IFN- 7 treated astrocytes to 86 for SFV-infected IFN- 7 treated 
astrocytes and to 78 for BPLSFV-treated IFN- 7 treated astrocytes. The 
decrease in fluorescence was H-2Ak specific since the mean fluorescence for 
SFV-infected and BPLSFV-treated IFN- 7  treated astrocytes stained with an 
irrelevant antibody (anti-H-2Kd) were identical to that for uninfected IFN- 
7 treated astrocytes stained with the same antibody (data not shown). 
Astrocytes were also treated with BPLSFV for a longer period of time in
korder to determine whether a greater effect on H-2A antigen expression 
would be observed. The data in figure 5.3 show the effect of 4 day BPLSFV 
ktreatment on class II MHC H-2A antigen expression by non-IFN treated 
astrocytes. It can be seen that 4-day BPLSFV treatment of non-IFN treated
kastrocytes very slightly increased H-2A antigen expression on astrocytes, 
since the fluorescence of BPLSFV-treated non-IFN treated astrocytes was 
slightly higher than for non-BPLSFV treated non-IFN treated astrocytes. 
However, this increase in fluorescence was not specific for staining H-2Ak 
antigen, since the fluorescence of BPLSFV-treated astrocytes stained with 
an irrelevant antibody (anti-H-2Kd) was also slightly higher than for non-
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lahlt ¿.2
Ettast ai BrL5ry traatnant end m  lniasttvi 
Uninfected SFV
u  tin* iwft__a n m a n
BPLSFV
Non-IFN treated 24* 22 21
IFN-a/3 17 IS 18
IFN- 7 97 86 78
(a) refer to the mean fluorescence of the cells, stained with antl-H-2A*C.
(1) Astrocytes were treated with either medium alone, 1000 u/ml IFN-q/9 or 
100 u/ml IFN- 7 for 48 hours, prior to infection with SFV or treatment
I,with BPLSFV. At 10 hours post-infection H-2A antigen was stained by 
indirect immunofluorescence, as described in methods section H.
10 000 cells analysed in each case using the FACS440 flow cytometer 
at the University of Birmingham, operated by Miss A Milner.
(it)
ritute s. a
Effect of A-dav treatment of astrocytes with BPLSFV on class II MHC H-2Ak 
antigen expression
solid line 
spaced dots 
close dots 
dashed line
Non-IFN treated, non-BPLSFV treated 
IFN- 7 treated, non-BPLSFV treated 
Non-IFN treated, BPLSFV treated 
IFN- 7 treated, BPLSFV treated
FL1; Fluorescence intensity channel
(1) Astrocytes were treated for four days with S mis medium either (i)
alone, (ii) supplemented with 100 u/ml IFN-7 , (ill) supplemented with 
a 1:5 dilution of BPLSFV (see methods section B), (iv) supplemented 
with a 1:5 dilution of BPLSFV and 100 u/ml IFN-y.
(il) H-2A antigen was stained by indirect immunofluorescence and
quantitated by flow cytometry as described in methods section H.
(ill) 10 000 cells analysed in each case.
BPLSFV created astrocytes stained with the same antibody (data not shown). 
Four day BPLSFV-treatment of IFN-y created astrocytes also had no effect on 
H-2A^ antigen expression, since the fluorescence of BPLSFV-treated IFN-7  
treated astrocytes was identical to that for non-BPLSFV treated IFN-7  
treated astrocytes.
E ffect 9f IFF treatment ?n gu acm lbU lty  v f  ,626-24 ce lls  tv SFY-gpcciflc 
cYtetexlc T-lYWPhgcyts lysis
The effect of recombinant IFN-y treatment on the susceptibility of SFV- 
infected G26-24 oligodendroglioma cells to lysis by SFV-speclflc CTL and 
antl-SFV serum in the presence of complement were Investigated. G26-24 
cells were treated with 500 u/ml IFN- 7 since this concentration was 
previously found strongly to augment class I MHC antigen expression, 
completely Inhibit SFV-RNA synthesis and markedly reduce SFV antigen 
expression on G26-24 cells (see chapter 4).
In a preliminary series of experiments (carried out in exactly the same 
manner as for the astrocyte SFV-speclflc CTL assays) the ratio of maximum 
release to spontaneous release of ^chromium for SFV-infected G26-24 cells 
was found to be less than 2:1. Ratios this low make calculations of the 
percent specific release of ^chromium value unreliable (typically ratios 
between 5:1 and 10:1 were obtained for data presented in this thesis). The 
spontaneous release of ^chromium from SFV-infected G26-24 cells and 
susceptibility to lysis by anti-SFV serum in the presence of complement was 
therefore monitered at various times post-infection, in order to determine 
whether there was a time period during which SFV-infected G26-24 cells 
display SFV-antigen on the cell surface (hence may be susceptible to SFV- 
specific CTL lysis) and spontaneously release only low levels of
^chromium. This time period could Chen be used for Che co-culCure of SFV- 
lnfecced G26-24 cells with SFV-speclflc CTL during subsequenc cycocoxlclCy 
assays and more reliable data would be obCalned. As shorn In figure 5.4, 
SFV-infecced G26-24 cells became clearly suscepclble Co lysis by anCi-SFV 
serum In Che presence of complemenc ac 44 hours pose*infecClon, and Che 
sponcaneous release of ^chromium did not rise above 20% (which gives a 
maximum release Co sponcaneous release value of 5:1) uncll 64 hours posc- 
InfecCion (lc Is also InCeresclng Co noce that Che high sponcaneous release 
of ^ C r  from SFV-Infected cells also parallels Che developmenc of a rapid 
cycopachlc efface, see chapeer 3). A furcher SFV-speclflc CTL assay wlch 
G26-24 cells was chereby carried ouc and harvesCed aC 64 hours posc- 
infecCion (astrocyce SFV-speclflc CTL assays were Cyplcally harvesCed 
beeween 9 and 10 hours pose-InfecClon).
Figures 5.5a and 5.5b show Che efface of IFN-y treatment on Che 
suscepclblllcy of SFV-lnfecced and BPLSFV-creaCed G26-24 cells Co lysis by 
SFV-speclflc CTL and anCl-SFV serum In Che presence of complemenc. 1C can 
be seen ChaC non-IFN ereaCed SFV-Infected G26-24 cells were clearly 
susceptible to lysis by both SFV-speclflc CTL and anti-SFV serum In the 
presence of complemenc. IFN-y created SFV-Infected G26-24 cells were very 
markedly more susceptible to SFV-speclfic CTL lysis chan non-IFN created 
SFV-infected G26-24 cells, despite a marked reduction of SFV anCigen 
expression on Che cells as assessed by Che reduced suscepcibillty Co lysis 
by ancl-SFV serum in Che presence of complemenc (and by Indirect 
immunofluorescence sCaining, see chapter 4 figure 4.9). Non-IFN treated 
BPLSFV-treated G26-24 cells were not specifically suscepcible Co SFV- 
specific CTL lysis, since Che level of lysis corresponded to ChaC for 
uninfecced G26-24 cells (either non-IFN treated or IFN-y treated). In 
contrast, IFN-y created BPLSFV-treated G26-24 cells were very markedly
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F U u ri 3.6
Spontaneous release of 51chromium froa SFV-Infected G26-24 cell« and lvila
bv anti-SFV serum in the presence of complement
(A—  A) Lysis by snti-SFV serum in the presence of complement 
(■— ■) Spontaneous release of ^ C r
(i) G26-24 cells were labelled with overnight, Infected with SFV,
and the susceptibility to lysis by anti-SFV serum in the presence of 
complement and the spontaneous release of 5*Cr measured at various 
times post-Infection, as described in methods section M.
Fleure 5.5
Ef t t m - Si  i n i - I  on  » m c t p t lb l l l t v  o f  S fV - ln f .c t .d  . n j  BPLSFV 
C g « l» d  G26-24 c a l l «  to lv i l>  by SFV I O T I f i c  c v co to g lc  
T-lY llplm cvt«! . n d  a n ti -SFV . . n .  i n th . n r . . . n e .  o f  m i l . -
(A) SFV-specific cytotoxic T-lymphocytes
(B) anti-SFV serum in presence of complement
(t). (0 -0 ) G26-24 cells <H-2b> + SFV
(11). <•— •> G26-24 cells (H-Jk> ♦ IFN- 7  ♦ SFV
(111). (0 -0 ) G26-24 cells (H-2b) ♦ BPLSFV
(tor). (■- ■ > G26-24 cells (H-2b) ♦ IFN- 7 ♦ BPLSFV
(v). (A~ A ) G26-24 cells (H-2b) untreated
(Vl). < * - * > G26-24 cells (H-2b ) ♦ IFN- 7
(Vll). (0 — 0 ) ELA cells <H-2b> ♦ SFV
(vili), (♦— ♦> 
( » - 0 )
RDM4 cells 
Yac-i cells
(H*2b)
(H-2*)
+ SFV 
untreated
A, lysis by anti-SFV serum in ths presence of complement 
C, lysis by complement alone (i)
(i) Cells were treated with 500 u/ml IFN-y or medium alone for 48 hours 
prior to infection with SFV or treatment with an equivalent amount of 
a /9' prop io lac tone inactivated preparation of SFV (BPLSFV) . The 
susceptibility of the cells to lysis by SFV-specific cytotoxic T- 
lymphocytes and anti-SFV serum in the presence of complement were 
then determined, as described in methods section M.
(ii) SFV-specific cytotoxic T-lymphocytes were derived from C57 BL/6 (H- 
2b) mice as described in methods section J, and were used in a 34 
hour chromium release assay.
susceptible to SFV-speclfic CTL lysis, despite displeying no detectable SFV 
antigen on the cell surface as determined by the non-susceptibility to 
lysis by anti-SFV serum in the presence of complement (indirect 
immunofluorescence staining demonstrated that only 3% of IFN- 7 treated 
BPLSFV-treated G26-24 cells displayed SFV antigen on the cell surface, see 
chapter 4 figure 4.9). Uninfected G26-24 cells (either non-IFN treated or 
IFN- 7 treated) and SFV-infected allogeneic RDM4 cells (H-2k) were found to 
be slightly susceptible to lysis by SFV-speciflc CTL. Untreated Yac-1 
cells showed a similar level of susceptibility to lysis, suggesting that 
natural killer cells were also present in the effector population. All 
killing above this background level of natural killer cell cytotoxicity 
appears to be both specific and MHC restricted, since SFV-Infected EL4 
cells (H-2b) were killed whereas allogeneic SFV-infected allogeneic RDH4 
cells (H-2^) and uninfected G26-24 cells (either non-IFTi treated or IFH-7  
treated) were not.
Effect of IFN-treatment on susceptibility of C1300 cells to SFV-«peciflc
cytotoxic T-lymphocyte lysis
It is now well established that for virus-specific CTL lysis to occur, the 
virus infected target cell and virus specific CTL must share identical 
class I MHC H-2D or H-2K region products (the phenomenon of MHC 
restriction: Zinkernagel and Doherty, 1974, 1979). C1300 neuroblastoma
cells were derived from the recombinant A/J mouse (H-2a) which encodes the 
class I MHC region alleles H-2Dd and H-2Kk (hereafter referred to as d'V*. 
or with the different haplotype designations for different cell-types and 
strains of mice as appropriate) . It was thereby reasoned that by using 
SFV-speclfic CTL generated in H-2d (d'Sc*1) and H-2k (DkKk) mice, it should 
be possible independently to study the SFV-specific CTL responses to H-2Dd
and H-2K region produces on SFV-infected C1300 cells.
The effect of recombinant IFN-7 treatment on the susceptibility of SFV- 
infected C1300 cells to lysis by SFV-specific CTL (generated in H-2d and H- 
2k mice) and anti-SFV serum in the presence of complement were 
investigated. C1300 cells were treated with 1000 u/ml IFN - 7  since this 
concentration was previously found strongly to augment class I MHC antigen 
expression on C1300 cells, and inhibit both SFV-RNA synthesis and SFV 
antigen display on at least the majority of SFV-Infected C1300 cells (see 
chapter 4). Figures 5.6a and 5.6b show the effect of IFN- 7  treatment on 
the susceptibility of SFV-infected and BPLSFV-treated C1300 cells to lysis 
by both SFV-specific CTL (derived from C3H/He mice, H-2k) and anti-SFV 
serum in the presence of complement. It can be seen that neither SFV- 
infected nor BPLSFV-treated C1300 cells (either non-IFN treated or IFN-7  
treated) were significantly killed by the SFV-specific (H-2k) CTL. In 
contrast, SFV-Infected C1300 cells (both non-IFN treated and IFN- 7 treated) 
were clearly susceptible to lysis by anti-SFV serum in the presence of 
complement, indicating that at least some cells were displaying SFV antigen
on the cell-surface. Hence, non-IFN treated and IFN- 7 treated SFV-infected
vC1300 cells were not susceptible to SFV-specific (H-2 ) CTL lysis despite
vdisplaying SFV antigen (and class I MHC H-2K antigen, see chapter 4 
figures 4.28 and 4.29) on the cell surface. SFV-infected L929 cells (H-2k) 
were highly susceptible to SFV-specific (H-2k) CTL lysis, showing that a 
potent preparation of SFV-specific (H-2k) CTL was used. SFV-infected 
allogeneic P815 cells (H-2d), SFV-infected allogeneic EL4 cells (H-2*>) and 
untreated Yac-1 cells were not killed by the SFV-speclflc CTL, hence 
killing was MHC restricted and there was no detectable natural killer cell 
activity in the effector population. C1300 cells (H-2*, d V )  and the SFV- 
speclflc CTL (H-2k , DkKk) share an Identical class I MHC H-2K region. That 
SFV-infected C1300 cells were not susceptible to lysis by SFV-specific
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Fleure 5.6
SSfec; Pf IFP-7 gn imctpclbllltv of SFV-Infected end 
¡rurv i m u d  CUPO eil. t° lv.l. bv CM/«. m.;ki srv-.b.bifir 
¡Vtctgille l u t n a n  IM T.dl-srv „nm ln eh. pr...ne« „f 
spmplcggnt
<A) SFV-*p*ciflc cytotoxic T-lyaphocytes
(1). Cl300 cells (H-2DdKk) ♦ IFN- 7  ♦ SFV
(11). < ■ - ■ > C1300 cells (H-2DdKk) + SFV
(111). (O— O) C1300 cells (H-2DdKk) ♦ IFN- 7  ♦ BPLSFV
(Iv). (0 — 0 ) C1300 cells (H-2DdKk) + BPLSFV
(V). C1300 cells (H-2DdKk) ♦ IFN- 7
(Vi). C1300 cells (H-2DdKk) untreated
(Vil). (♦— ♦> EL4 cells (H-2DbKb) ♦ SFV
(Vili). (A— A) P815 cells (H-2DdKd) ♦ SFV
(i*). (•— •) L929 cells (H-2DkKk) * SFV
(O— O) Yac-1 cells untreated
A, lysis by anci-SFV serum in presene# of complement 
C, lysis by complement alone 1
(1) Cells were treated with 1000 u/ml IFN- 7  or medium alone for 48 hours, 
prior to Infection with SFV or treatment with an equivalent amount of 
BPLSFV. The susceptibility of the cells to lysis by SFV-specific 
cytotoxic T-lymphocytes and anti-SFV serum in the presence of 
complement were then determined, as described in methods section M. 
(li) SFV-cytotoxic T-lymphocytes were derived from C3H/He mice (H-2k ;
dV >  as described in methods section J, and were used in a 5 hour
chromium rei» ‘y-
H-2k) CTL implies that the SFV-specific CTL are unable to recognise SFV 
lrantigen in association with H-2K antigen on C1300 cells. C1300 cells are 
not inherently resistant to CTL lysis since they have previously been shown 
to be highly susceptible to alloreactive CTL lysis (see chapter 4 figure
4.29).
The effect of IFN- 7  treatment on the susceptibility of SFV-infected C1300 
cells to lysis by both SFV-specific (H-2d) CTL (derived from Balb/c mice) 
and anti-SFV serum in the presence of complement were also investigated. 
However, in a series of experiments no detectable SFV-specific (H-2d , dV )  
CTL activity was observed when SFV-Infected C1300 cells (H2*. D**^) and 
SFV-infected syngeneic P815 cells (H-2d , D*Scd ) were used as targets. SFV- 
infected C1300 cells and SFV-infected P81S cells were highly susceptible to 
lysis by anti-SFV serum in the presence of complement, indicating that the 
cells were displaying SFV antigen on the cell-surface (data not shown). 
Identical experiments were also set up using DBA/2 mice (H-2d) as the 
source of SFV-specific CTL, and again no CTL activity was observed (data 
not shown). Similarly, an experiment was set up using B10.A(5R) mice as 
the source of SFV-specific CTL. C1300 cells (H-2a , DdKk) and B10.A(5R) 
mice (H-2^, d'Hc*3) share an identical class I H-2Dd antigen region. Yet 
again, no SFV-specific (H-2*-^ ) CTL activity was observed when SFV-infected 
C1300 cells, SFV-infected P815 cells (H-2d , dV )  and SFV-infected G26-24 
cells (H-2'>, D^ K**) were used as targets. All target cells displayed SFV 
antigen on the cell-surface as determined by the susceptibility to lysis by 
antl-SFV serum in the presence of complement (data not shown). Finally, an 
experiment was set up using A/J mice as the source of SFV-specific CTL. 
C1300 cells (H-2a , D^^) were derived from the A/J mouse, hence share 
identical class I MHC H-2Dd and H-2Kk regions. Figures 5.7a and 5.7b show 
the effect of IFN- 7 treatment on the susceptibility of SFV-infected C1300 
cells to lysis by both SFV-specific (H-2a) CTL and anti-SFV serum in the 
presence of complement. It can be seen that non-IFN treated SFV-infected
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E ffect o f  I flh a  on lu ic m lb l l l t Y  at 5rY-lnfBct*d C130Q c a l l*  t c  
lYala by A/J. ill-2*) SFY-iptciflc CYtataalc T - lv r o h o c y f  and 
antl-SfY acrua In the preiencfi a f conplcatnt
(A) SFV-specific cytotoxic T-lyaphocytas
(B) anti-SFV ■•na In tha praaanca of coaplaaant
(1). (O— O) C1300 cells (H-!dV ) + SFV
(11). (•— •) C1300 cells (H-2DdKk) + IFTÏ-7 ♦ SFV
(111). (O - *A) C1300 cells (H-2DdKk) untreated
(!▼). (*>-▲) C1300 cells (H-2DdKk) + IFH-7
(v). (■-a) P813 cells (H-2D<Sc‘1) ♦ SFV
Orl). (♦— ♦> L929 cells (H-2KkDk) + SFV
(vll). (0— 0) EL4 cells <H-2KbDb) + SFV
(0-0) Yac-1 cells untreated
A, lysis by anti-SFV serum in presence of complement 
C, lysis by complement slone
(i) Cells were trested with 1000 u/ml IFN-y or medium alone for 48 hours, 
prior to infection with SFV. The susceptibility of the cells to 
lysis by SFV-specific cytotoxic T-lymphocytes and anti-SFV serum in 
the presence of complement were then determined, as described in 
methods section M.
(ii) SFV-cytotoxic T-lymphocytes were derived from A/J (H-2a; o V )  as 
described in methods section J, and were used in a 5 hr chromium
»y-
C1300 cells were clearly susceptible to lysis by both SFV-specific (H-2*) 
CTL and anti-SFV serum in the presence of complement. IFN-y treated SFV- 
infected C1300 cells were markedly more susceptible to SFV-specific (H-2*) 
CTL lysis than non-IFN treated SFV-Infected C1300 cells, despite a very 
slight reduction of SFV antigen expression on the cells as assessed by the 
slightly reduced susceptibility to lysis by anti-SFV serum in the presence 
of complement (and a marked reduction of SFV antigen expression on 32* of 
cells as assessed by indirect immunfluorescence staining, see chapter 4 
figure 4.10). SFV-infected P815 cells (H-2d , d 'Hc*1) were clearly 
susceptible to SFV-specific (H-2*. d'Sc^ ) CTL lysis. In contrast, SFV- 
infected allogeneic EL4 cells (H-2b , DbKb). SFV-infected L929 cells (H-2k , 
dV )  and uninfected C1300 cells (either non-IFN treated or IFN- 7  treated) 
were not susceptible to SFV-specific (H-2*, D*Hck) CTL lysis. Hence killing 
by the SFV-specific CTL was both specific and MHC restricted. Yac-1 cells 
were not killed showing that there was no detectable natural killer cell 
activity in the effector population.
Discussion
The discussion has been split up Into two aectlona due to the breadth of 
data presented in this chapter, (a) the effect of IFN treatment on the 
susceptibility of SFV-infected brain cells to SFV-specific CTL lysis, (b) 
genetic mapping of the SFV-specific CTL response.
(a) Effect of IFN treatment on the susceptibility of SFV-Infected brain 
cells to SFV-speclfic CTL lvsis
The data presented In this chapter show that non-IFN treated SFV-Infected 
astrocytes displayed SFV antigen on the cell surface, as determined by the 
susceptibility to lysis by anti-SFV serum in the presence of complement 
(and as shown by indirect immunofluorescence staining, see chapter 4 figure 
4.8), and were clearly susceptible to lysis by SFV-specific CTL. The fact 
that the lysis by SFV-specific CTL was found to be MHC restricted, and that 
at least some non-IFN treated astrocytes display class I MHC antigen on the 
cell surface (see chapter 4 figure 4.13) suggests that the non-IFN treated 
SFV-infected astrocytes were killed by class I MHC restricted SFV-specific 
CTL. Astrocytes treated with natural IFN-a0, prior to infection with SFV, 
showed a quantitatively similar level of susceptibility to SFV-specific CTL 
lysis as non-IFN treated SFV-infected astrocytes, despite a marked 
reduction of SFV antigen expression on the cells, as assessed by the 
reduced susceptibility to lysis by anti-SFV serum in the presence of 
complement (and by Indirect immunofluorescence staining, see chapter 4 
figure 4.7). Similarly, astrocytes treated with recombinant IFN-y, prior 
to infection with SFV, were found to be markedly more susceptible to SFV- 
specific CTL lysis than non-IFN treated SFV-infected astrocytes, again 
despite a marked reduction of SFV antigen expression on the cells, as
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assessed by Che reduced susceptibility to lysis by anti-SFV serum In the 
presence of complement (and by Indirect Immunofluorescence staining, see 
chapter 4 figure 4.8). Since virus-specific CTL recognise viral antigen in 
association with class I MHC antigen on the surface of an infected target 
cell, and both 1FN-O0 and IFN- 7  markedly increase class I MHC antigen 
expression on astrocytes (as assessed by indirect immunofluorescence 
staining and the Increased susceptibility of IFN-treated astrocytes to 
alloreactive CTL lysis, see chapter 4 figures 4.11 to 4.15) the simplest 
explanation for these data is that although IFN-a£ and IFN- 7  treatment 
markedly reduced SFV antigen expression on infected astrocytes, in the 
context of increased class I MHC antigen expression, IFN-treated SFV- 
infected astrocytes remained susceptible to lysis by SFV-speciflc CTL. 
Bearing in mind IFN-a0 and IFN- 7 treatment inhibited SFV-replication in 
astrocytes (see chapter 4 figures 4.1 and 4.2) and essentially abolished 
SFV antigen display on infected cells, the question arises as to the source 
of SFV antigen which was recognised by the SFV-specific CTL. Experiments 
in which astrocytes treated with an equivalent amount of a /9-propiolactone 
inactivated preparation of SFV (BPLSFV) were found to be susceptible to 
lysis by SFV-speciflc CTL, again despite expressing essentially no SFV 
antigen detectable by indirect immunofluorescence staining or lysis by 
anti-SFV serum in the presence of complement, suggest that the input SFV 
antigen with which the cells were challenged may be recognised by the SFV- 
specific CTL. Astrocytes treated with IFN-7 , prior to treatment with 
BPLSFV, were also found to be markedly more susceptible to SFV-specific CTL 
lysis than non-IFN treated BPLSFV-treated astrocytes, and again this 
increase in susceptibility correlated with an increase in class I MHC 
antigen expression on the cells. That treatment with inactivated virus can 
sensitise cells for lysis by virus-specific CTL has also been reported 
previously in other systems. Thus, Schrader and Edelman (1977)
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demonstrated that P815 mastocytoma cells treated with ultra-violet 
Inactivated sendal virus were susceptible to lysis by sendai-virus specific 
CTL, and Yewdell and co-workers showed that L929 fibroblast cells treated 
with ultra-violet Inactivated Influenza virus (strain PR8 , which was also 
heated at 55°C to Inactivate viral neuraminidase activity and hence 
prevented the elution of virus from cellular sialic acid receptors) were 
lysed by influenza-virus specific CTL (Yewdell £_£ fl_l- . 1988b; Hosaka £_£ 
a l .. 1988). Since it Is currently believed that virus-specific CTL 
recognise viral antigen peptide fragments which have bound to class I MHC 
antigen on the surface of a target cell (Townsend ££&!-, 1986; Bjorkman ££ 
a l .. 1987a, 1987b; Bastin si al. . 1987) the observation In the present 
study that astrocytes treated with BPLSFV were susceptible to SFV-specific 
CTL lysis does at least suggest that the astrocytes were able to process 
SFV antigen into a form which could be recognised by the SFV-specific CTL. 
The ability of astrocytes to process antigen has not yet been formally 
demonstrated although Takiguchi and Frelinger (1986) showed that IFN-y 
treated astrocytes presented keyhole limpet hemocyanln (KLH) to the class 
II MHC restricted KLH-speclfic T-cell hybridoma SKK-45.10, which only 
recognises processed KLH antigen. That IFN-y treated SFV-Infected 
astrocytes and BPLSFV-treated astrocytes (both non-IFN treated and IFN-y 
treated) were clearly susceptible to SFV-speciflc CTL lysis despite 
expressing essentially no detectable SFV antigen on the cell- surface, as 
assessed by the susceptibility to lysis by anti-SFV serum In the presence 
of complement and by indirect immunofluorescence staining, may be a 
reflection of the fact that T-cells and antibody recognise different forms 
of antigen. Thus, T-cells recognise linear viral peptide fragments between 
eight and twelve amino-acids long, whereas antibodies usually recognise 
sterically exposed non-linear viral epitopes involving approximately 
fifteen amino-acid contacts (Rothbard, 1987). Hence, if astrocytes do
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indeed process SFV antigen into short peptide fragments, these will be 
recognised by SFV-speclflc T-cells but not by SFV-speciflc antibody. An 
alternative explanation is that T-cells are more sensitive than antibody in 
detecting viral antigen on the surface of cells.
It should be noted that a number of studies have recently reported the 
isolation of class II MHC restricted antigen-specific CTL clones (Morrison 
et al. . 1986, 1988; Jones ££ al. . 1987). Class II MHC restricted CTL 
however constitute only a minor proportion of the total CTL population, the 
majority being class I MHC restricted (BraaVcman £_£ al. . 1987). Since the 
SFV-speciflc T-cells used in the present studies were a mixed population, 
it is possible that some IFN- 7 treated SFV-Infected astrocytes and IFN-7  
treated BPLSFV-treated astrocytes (which express class II MHC antigen on 
the cell surface, see chapter 4 figure 4.16) were killed by class II MHC 
restricted SFV-specific CTL. It does at least seem unlikely that non-IFN 
treated and IFN-a/9 treated SFV-Infected astrocytes were killed by class II 
MHC restricted SFV-speclflc CTL, since these cells do not express any 
detectable class II MHC antigen on the cell-surface (see chapter 4 figure 
4.17). Recently, Sun and Vekerle (1986) have shown that IFN- 7 treated 
astrocytes treated with myelin basic protein (MBP) were susceptible to 
lysis by a class II MHC restricted MBP-specific T-cell line. A future 
experimental approach which could be used to determine whether any IFN- 7  
treated SFV-infected astrocytes were killed by class II MHC restricted SFV- 
speclflc CTL, would be to add anti-class II MHC antigen antibodies to co­
cultures of astrocytes with SFV-speciflc CTL, during the cytotoxicity 
assay. A comparison of the levels of SFV-speciflc CTL lysis observed in 
the presence and absence of the anti-class II MHC antigen antibodies could 
then be made, and any reduction in the level of lysis assigned to class II 
MHC restricted SFV-specific cytotoxicity.
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Since Che astrocyte cultures were at least 90% GFAP+ astrocyte In 
composition, and at least 86% of SFV-infected cells displayed SFV antigen 
on the cell-surface (see chapter 3), the observation that upto 87% SFV- 
specific CTL lysis occurred does at least indicate that astrocytes were 
indeed killed by the SFV-specific CTL. Whether the uncharacterised cells 
present (e.g. oligodendrocytes, neurones and microglial cells) were also 
killed by the SFV-speclflc CTL remains to be determined.
The effect of SFV-Infection and BPLSFV-treatment on class I and class II 
MHC antigen expression by astrocytes were also Investigated, since it was 
possible that infection with SFV or treatment with BPLSFV modulated the 
expression of MHC antigen on astrocytes during the cytotoxicity assays, and 
hence modulated the susceptibility of the cells to SFV-speciflc CTL lysis. 
The data presented show that SFV-infection of astrocytes (either non-IFN 
treated, IFN-a0 treated or IFN--y treated) and BPLSFV-treatment of non-IFN 
treated astrocytes had no effect on class I MHC H- 2DkKk antigen expression. 
In contrast, BPLSFV-treatment of IFN-a0 treated and IFN-y treated 
astrocytes very slightly reduced class I MHC H- 2DkKk antigen expression (on 
12% and 8% of cells, respectively) indicating that BPLSFV-treatment may 
have also slightly reduced the susceptibility of these cells to class I MHC 
restricted SFV-speclfic CTL lysis. SFV-infection and BPLSFV-treatment had 
no effect on class II MHC H-2A antigen expression by non-IFN treated and
kIFN-a/? treated astrocytes, but in contrast very slightly reduced H-2A 
antigen expression on some IFN- 7 treated astrocytes (on 5% and 10% of cells 
for SFV-infection and BPLSFV-treatment [at 10 hours post-treatmentJ, 
respectively) again indicating that SFV-infection and BPLSFV-treatment may 
have also slightly reduced the susceptibility of these cells to class II 
MHC restricted SFV-specific CTL lysis. Since BPLSFV-treatment was found to
reduce class II MHC H-2A antigen expression on 10% of IFN- 7  treated 
astrocytes when stained at 10 hours post-infection, IFN-7 treated 
astrocytes were also treated with BPLSFV for 4 days in order to determine 
whether a greater effect on H-2A^ antigen expression would be observed.
The data presented show that 4-day BPLSFV-treatment of IFN- 7  treated 
astrocytes had no effect on H-2A antigen expression. Taken together these 
observations do at least indicate that the slight reduction of H-2Ak 
antigen expression observed at 10 hours post-treatment may have only been
due to a short-term disturbance of the cell- membrane which was brought 
aabout byAtreatment of the IFN- 7  treated astrocytes with BPLSFV.
The data presented in this chapter also show that SFV-infected G26-24 
oligodendroglioma cells and SFV-infected C1300 neuroblastoma cells 
displayed SFV antigen on the cell-surface, as determined by the 
susceptibility to lysis by anti-SFV serum in the presence of complement 
(and as shown by indirect immunofluorescence staining, see chapter 4 
figures 4.9 and 4.10), and were susceptible to lysis by SFV-speciflc CTL 
(derived from C57BL/6 [H-2b ] mice and A/J [H-2a ] mice for G26-24 cells and 
C1300 cells, respectively). As was found with astrocytes, IFN- 7 treatment 
of G26-24 cells and C1300 cells, prior to infection with SFV, markedly 
increased the susceptibility of the cells to SFV-speclfic CTL lysis despite 
a reduction of SFV antigen display on the cells, as assessed by the reduced 
susceptibility to lysis by anti-SFV serum in the presence of complement 
(which was only very slight for C1300 cells) and by indirect 
immunofluorescence staining (see chapter 4 figures 4.9 and 4.10). The 
increase in susceptibility to SFV-specific CTL lysis correlated with an 
increase in class I MHC antigen expression (and class II MHC antigen 
expression for G26-24 cells) on the cells, as assessed by indirect 
immunofluorescence staining and the increased susceptibility of IFN-treated
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cells to alloreacclve CTL lysis (see chapter 4 figures 4.18 Co 4.29) again
indicating that although IFN-y treatment reduced SFV antigen display on (at
least some) infected cells, in the context of Increased MHC antigen
expression IFN-y treated SFV-infected G26-24 cells and IFN-y treated SFV-
infected C1300 cells remained susceptible to lysis by SFV-speclflc
CTL.BPLSFV-treated non-IFN treated C26-24 cells were not killed by SFV- 
BPLSFV-treated
specific CTL. In contrast, IFN-y treated^G26-24 cells were highly 
susceptible to SFV-specific CTL lysis, indicating that the input SFV 
antigen with which the cells were challenged may be recognised by SFV- 
specific CTL, but only when MHC antigen expression on G26-24 cells is 
Increased by treatment with IFN-y. Since at least some non-IFN treated 
G26-24 cells and non-IFN treated astrocytes display class 1 MHC antigen on 
the cell-surface (see chapter 4) the observations that BPLSFV-treated non- 
IFN treated astrocytes were highly susceptible to lysis by SFV-specific CTL 
and that BPLSFV-treated non-IFN treated G26-24 cells were not susceptible 
to lysis by SFV-specific CTL, do at least suggest that the astrocytes may 
have been more efficient at processing the input SFV antigen for 
recognition by SFV-specific CTL. Whether the observations that SFV- 
lnfected G26-24 oligodendroglioma cells and SFV-lnfected neuroblastoma 
cells were susceptible to lysis by SFV-specific CTL reflect the situation 
with normal oligodendrocytes and neurone , remains to be determined.
Blackman and Morris (1985) have also shown that RDM4 lymphoblastold cells 
and C3H10Th fibroblast cells treated with natural IFN-afi or natural IFN-y, 
prior to infection with SFV, remained susceptible to lysis by SFV-speclflc 
CTL despite a reduction in SFV antigen display on the cells (as assessed by 
the reduced susceptibility to lysis by anti-SFV serum in the presence of 
complement). Furthermore, natural IFN-a0 and natural IFN-y treatment were 
found to increase class I MHC antigen expression on both RDM4 and C3H10Th
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calls, as assessed by the Increased susceptibility to alloreactive CTL 
lysis. This effect does not appear to be restricted to the SFV system 
since similar observations have also been reported in other virus-systerns. 
Thus, Yewdell and co-workers demonstrated that treatment of adenovirus-12 
transformed (Ad-12) cells with IFN-y (not specified whether natural or 
recombinant), prior to infection with Influenza virus, resulted in a 
decreased expression of Influenza virus genes yet the cells were markedly 
more susceptible to lysis by influenza-specific CTL. The Increase in 
susceptibility to lysis by influenza-specific CTL also correlated with an 
Increase in class I MHC antigen expression on the cells (Yewdell &£ &1., 
1988a; Eager *1., 1985). Similarly, King and co-workers demonstrated 
that treatment of Balb/c mouse embryo fibroblasts with a supernatant 
harvested from concanavalin-A stimulated splenocyte cultures (which 
contained IFN-y), prior to infection with murine cytomegalovirus (MCMV), 
Increased the susceptibility of the cells to lysis by MCMV-speclflc CTL. 
Again, the increased susceptibility to lysis by MCMV-specific CTL was found 
to correlate with an increase in class I MHC antigen expression on the 
cells, although the effects of IFN-y treatment on MCMV replication and 
antigen display were not investigated in this study (King ££ Al-, 1985). A 
number of studies have also shown that where cells are infected with virus, 
prior to IFN treatment, viral antigen display on the cells may not always 
be reduced by IFN treatment, and again in such situations it was found that 
the susceptibility of IFN-treated targets to lysis by virus-specific CTL 
was increased. For example, Bukowski and Welsh (1985) demonstrated that 
natural IFN-a/9 and natural IFN-y treatment of low passage murine embryonic 
fibroblasts, infected with lymphocytic choriomeningitis virus (LCMV), had 
no effect on the level of LCMV antigen expressed on the surface of the 
cells, but increased the susceptibility of the cells to LCMV-speclfic CTL 
lysis. Once again, the increase in susceptibility to lysis was found to
correlate with an increase in class I MHC antigen expression on the cells. 
Subsequent studies by these workers (Bukowski and Welsh, 1986) also 
demonstrated that natural IFN-0 treatment of LCMV-infected fibroblasts 
derived from either the brain, heart, liver or skin, rendered the cells 
more susceptible to lysis by LCMV-specific CTL, and that the increase in 
susceptibility correlated with an increase in class I MHC antigen 
expression on the cells. Similarly, Blackman and Morris (1985) and Flyer 
et al. (1985) showed that natural IFN-a/} and natural IFN- 7 treatment of 
fibroblasts, chronically infected with the retroviruses murine sarcoma 
virus/murine leukemia virus (MSV/MLV) (Kirsten or Moloney strains), 
increased both class I MHC antigen expression on the cells and the 
susceptibility of the cells to lysis by virus-specific CTL.
The general conclusion from each of the experimental systems so far 
discussed is that whenever the level of class I MHC antigen expression on a 
virus-infected cell is Increased by treatment with IFN, there results an 
increased susceptibility of the cell to lysis by virus-specific CTL. 
However, it is important to note that some cells may constitutively express 
very high levels of class I MHC antigen and in such cases IFN treatment may 
not increase the level of class I MHC antigen expression nor the 
susceptibility of the cells to CTL lysis. For example, Bukowski and Welsh 
(1985) demonstrated that natural IFN-/} treatment of the continuous cell 
line MC57G, which expressed high levels of class I MHC antigen, and which 
had been previously Infected by either LCMV or vaccinia virus, did not 
increase the level of class I MHC antigen expressed by the cells and did 
not increase the already high susceptibility of these cells to lysis by 
virus-specific CTL. It is also Important to note that in cases where IFN 
treatment was found to increase the susceptibility of virus-Infected cells 
to lysis by virus-specific CTL, the Increase in susceptibility may not have
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been due solely Co Che IFN-Induced Increase in class I MHC antigen 
expression, since ocher cell-surface nolecules nay have played a role in 
the interaction between the virus-specific CTL and target cell. For 
example, it is now clear that cell-adhesion molecules enhance the 
efficiency of specific receptor-dependant lymphocyte-target cell 
interactions (Springer g£ gl. , 1987). To date, two receptor-ligand pairs 
Involved in these interactions have been defined. Thus, the CD2 receptor 
Interacts with the ligand lymphocyte function associated antigen-3 (LFA-3), 
whilst the LFA-1 receptor interacts with the ligand intercellular adhesion 
molecule-1 (ICAM-1). The CD2 and LFA-1 receptors are expressed on the 
surface of T-cells (and with the exception of some macrophages on all other 
leukocytes for the case of LFA-1, and on thymocytes and large granular 
lymphocytes for the case of C02) whereas LFA-3 and ICAM-1 are widely 
distributed on the surface of a variety of cell-types (Dustin g£ gl. , 1986; 
Springer g£ gl. , 1987). A number of studies have recently shown that IFN-y 
treatment increases ICAM-1 expression on a variety of cell-types (reviewed 
by Dustin g£ gl. , 1988) indicating that the IFN-y treated cells may also 
have an increased ability to Interact with T-cells (which express the LFA-1 
receptor) . Of particular relevance to the data presented in this chapter 
are the unpublished observations of Frohman (research laboratory location 
not stated) who has demonstrated that IFN-y treatment of astrocytes 
increased ICAM-1 expression (reported by Dustin g£ gl-. 1988). It does 
thereby seem a strong possibility that the increased susceptibility of IFN- 
y treated SFV-infected astrocytes to lysis by SFV-specific CTL, may have 
been a reflection of both increased class I (and class II) MHC antigen 
expression and increased ICAM-1 expression on the cells. Whether IFN-a/9 
treatment also increases ICAM-1 (or LFA-3) expression on astrocytes remains 
to be determined. Similarly, whether IFN-a/J or IFN-y treatment Increase 
ICAM-1 (or LFA-3) expression on G26-24 cells and C1300 cells, remains to be
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determined.
(b) Genetic mapping of the SFV-soeclflc CTL response
C1300 neuroblastoma cells were derived from the recombinant A/J mouse which 
encodes the class I MHC region alleles H-2Dd and H-2K*6. By using SFV- 
specific CTL derived from inbred strains of mice which shared an Identical 
H-2Dd or H-2K^ region, it was possible lndependantly to study the SFV- 
specific CTL responses to H-2Dd and H-2K^ region products on SFV-Infected 
C1300 cells. The data presented show that SFV*Infected C1300 cells (D^K^) 
were not susceptible to lysis by SFV-speclfic CTL derived from C3H/He mice 
( D V )  despite sharing an identical H-2K^ region. In contrast, SFV- 
infected syngeneic L929 cells (D^K^) and SFV-Infected syngeneic astrocytes 
(dS c*) were clearly susceptible to lysis by SFV-specific (dV )  CTL. The 
C1300 cell H-2K*1 region product (H-2K^ antigen) was functional since it was 
previously shown to act as e target for recognition by alloreactlve CTL 
(see chapter 4 figure 4.29). Taken together these data indicate that the 
SFV-specific <dV )  CTL were unable to recognise SFV antigen in association
Ifwith H-2K antigen, and suggest that the SFV-specific CTL response was 
associated with the H-2D region products of the H-2^ haplotype. Similar 
observations have also been reported previously by Mullbacher and Blanden 
(1978) who demonstrated that SFV-specific CTL derived from CBA mice (dS c^ ) 
only lysed SFV-infected macrophage targets which shared an identical H-2D^ 
region, and did not lyse targets which shared an identical H-2K^ region.
The data presented in this chapter also show that SFV-infected L929 cells 
(D^K^) were not susceptible to lysis by SFV-speclfic (D^K^) CTL (derived 
from A/J mice) despite sharing an identical H-2K^ region. Again, this
observation suggests that the SFV-speclflc CTL were unable to recognise SFV
I-antigen in association with H-2K antigen. In contrast, SFV-lnfected C1300
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cells (DdKk) were clearly susceptible to lysis by syngeneic SFV-specific 
( O V )  CTL. Since SFV-specific CTL do not recognise SFV antigen in 
association with H-2Kk antigen, the SFV-speclflc (DdRk) CTL must have 
recognised SFV antigen on C1300 cells in association with H-2Dd region 
products. The H-2D region contains the genes which encode both the H-2D 
and H-2L antigens (Biddison e_£ ¿1-, 1978; Hale , 1987). It is
thereby possible that the SFV-specific (D^K*1) CTL nay have recognised SFV 
antigen on C1300 cells in association with H-2D antigen and/or H-2L 
antigen. To date, H-2L restricted virus-specific CTL responses have only 
been demonstrated in a small number of virus systems (an example being the 
influenza virus system: Biddison ££ al. , 1978). A future experimental 
approach which could be used to determine whether the SFV-speclflc < o V )  
CTL recognised SFV antigen on C1300 cells in association with H-2D antigen 
or H-2L antigen, would be to add anti-H-2D serum or anti-H-2L serum to the 
co-cultures of SFV-infected C1300 cells with SFV-specific (d’Sc'1) CTL during 
subsequent cytotoxicity assays and monitor the effect on the level of lysis 
observed. Any reduction in the level of SFV-specific CTL lysis observed in 
the presence of anti-H-2D serum or anti-H-2L serum could then be assigned 
to H-2D antigen and H-2L antigen restricted SFV-specific CTL activity, 
respectively. As mentioned previously, a number of studies have recently 
demonstrated class II MHC restricted antigen-specific CTL activity. The 
possibility that the SFV-specific CTL responses actually mapped to the 
class II MHC region cannot be excluded. This does however at least seem 
unlikely since class II MHC restricted CTL only constitute a minor 
proportion of the total CTL population and C1300 cells (both non-IFN 
treated and IFN-y treated) do not display any detectable class II MHC 
antigen on the cell surface (see chapter 4 figure 4.30). The data 
presented in this chapter also show that SFV-lnfected G26-24 
oligodendroglioma cells (D^K^) were susceptible to lysis by syngeneic SFV-
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specific (DbKb) CTL (derived from C57 BL/6 mice) . 1c Is not possible from 
the date obtained to deduce whether the SFV-speclflc (DbKb)CTL recognised 
SFV antigen In association with H-2D or H-2K region products on C26-24 
cells. That the SFV-speclflc CTL response was associated with the H-2D
Itregion products of the H-2 haplotype does not mean that the SFV-speclflc 
CTL response is also associated with the H-2D region of the H-2b haplotype, 
since responses also vary with haplotype. For example, Kesson and co­
workers have demonstrated that the West Nile virus (WNV) specific CTL
Itresponse was associated with the K region of the H-2 haplotype and both 
the K and D regions of the H-2d haplotype (Kesson jlL Al- . 1988). The 
observation In the present study that a clear SFV-speclflc CTL activity was 
generated in CS7 BL/6 mice (H-2b) clearly contrasts with the results of 
Mullbacher and Blanden (1978) who were unable to detect any SFV-speclflc 
CTL activity In this system. The reason for this discrepancy In results Is 
not clear since both studies used a population of SFV-speclflc CTL which 
were prepared by an essentially Identical protocol. In the present study, 
no detectable SFV-specific CTL activity was generated In either the Balb/c 
(H-2d) or DBA/2 (H-2d) mouse system. These observations are consistent 
with the results of Mullbacher and Blanden (1978) who also failed to 
demonstrate any clear SFV-specific CTL activity In the Balb/c mouse system. 
Since Balb/c mice (H-2d, dV )  and A/J mice (H-2*. o V )  both encode an 
Identical class I MHC H-2Dd region, the question arises as to why a H- 2<f>. 
restricted SFV-speciflc CTL response was demonstrated In the A/J srause 
system but not in the Balb/c mouse system. A possible explanation may be 
that the generation of H-2Dd-restrlcted SFV-speclflc CTL was controlled by 
class II MHC I-region genes, and the A/J mouse encodes 'responder' 1^ 
region genes whereas the Balb/c mouse encodes 'non-responder’ Id region 
genes. It Is also interesting to note that a SFV-speciflc CTL response was 
demonstrated In the C3H/He mouse system, which encodes 1^ region genes.
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Th« observation that a SFV-specific CTL response was generated in the C57 
BL/6 (DbIbKb) mouse system also suggests that the C57 BL/6 mouse encodes 
responder Ib region genes. The B10.A(5R) mouse (H-215, KbIbkDd) has a 
recombinant I-region composed of genes derived from both H-2b and H-2k 
mice, and encodes H-2Db region genes. The observation in the present study 
that no detectable H-2Dd-restricted SFV-specific CTL response was generated 
in the BIO.A(SR) mouse system, indicates that the recombinant Ibk region 
(which was derived from two responder I- regions) was a non-responder 
region.
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Chapter 6
Effect of IFN on the ability of brain cells to present SFV antigen to 
SFV-speclflc T-cells as assessed by proliferation and the release of IFKii
Introduction
It is now well established that an essential step in the induction of an 
inuaune response to a protein antigen is the activation of T-helper cells.
As discussed in detail in chapter 1, this activation cannot be induced by 
free antigen but only by antigen presented by an accessory cell which 
displays class II MHC antigen on the cell surface. Since the expression of 
class II MHC antigen is essential for antigen presentation (and hence the 
development of helper and cytotoxic T-cells, as well as antibody formation) 
it follows that any modulation of class II MHC antigen expression may 
significantly influence the immune response.
In chapter 4, data were presented which show that IFN-y treatment induced 
class II MHC antigen expression on astrocytes. In this chapter the effect 
of IFN-y treatment on the ability of astrocytes to present SFV antigen to 
SFV-specific T-cells is investigated, via T-cell proliferation assay.
Since virus-specific CTL and T-helper cells release IFN-y only on 
appropriate recognition of viral antigen (Morris £_£ &1. , 1982; Cunningham 
et al. . 1985) the release of IFN-y by virus-specific T-cells can be used as 
a marker for T-cell recognition of antigen. The effect of IFN-a/9 and IFN-y 
on the ability of astrocytes and G26-24 cells to stimulate SFV-specific T- 
cell release of IFN-y is thereby also investigated.
1 6 4
Effect of IFN on the ability of utrocYMi to present SFV antigen to 
SFV-epeciflc T-cella
The effect of natural IFN-a£ and recombinant IFN- 7 treatment on the ability 
of BPLSFV-treated astrocytes to present SFV antigen to SFV-specific T-cells 
was assessed via proliferation assay as described in methods section N. 
Aatrocytes (untreated, IFN-a/9 treated and IFN- 7  treated) were first treated 
with a 0-propiolactone inactivated preparation of SFV (BPLSFV) and then 
with mitomycin C (to prevent their subsequent proliferation) after which 
the cells were co-eultured with SFV-specific T-cells and the Incorporation 
of [^H]thymidine monitored over 24 hour periods upto day 7 post-co-culture. 
Indomethacin (a potent inhibitor of prostaglandin synthesis: Fontana U  
al., 1986) was also added to the co-cultures to a final concentration of 10 
jjg/al, since astrocytes have previously been shown to produce prostaglandin 
E (Fontana al., 1982) which is known to supress T-cell mediated Immune 
responses (Male al.. 1987) . In a series of experiments it was found 
that BPLSFV-treated astrocytes (either non-IFN treated, IFN-afl treated or 
IFN - 7  treated) did not stimulate SFV-specific T-cell proliferation since 
the amounts of [^H]thymidine Incorporated into co-cultures of BPLSFV- 
treated astrocytes with SFV-specific T-cells and into co-cultures of non- 
BPLSFV treated astrocytes with SFV-specific T-cells were essentially 
identical (data not shown). However, no conclusions regarding the ability 
of astrocytes to present SFV antigen to SFV-specific T-cells can be made 
from these studies since BPLSFV-treated syngeneic C3H/He splenocytes (used 
as an experimental positive control) also did not stimulate any detectable 
SFV-specific T-cell proliferation (data not shown). Antigen-specific T- 
cell proliferation requires the presence of lnterleukin-2 (IL-2, T-cell
165
growth factor: Balkwill, 1987). A further series of experiments were 
thereby set-up in which either recombinant IL- 2  (at a final concentration 
of 10 u/ml) or a concanavalin-A stimulated rat splenocyte supernatant 
('conditioned medium' which contains IL-2, used at a 1:10 dilution) were 
added to the co-cultures of BPLSFV-treated astrocytes with SFV-speciflc T- 
cells, in an attempt to assist any T-cell proliferation. However, again no 
SFV-specific T-cell proliferation was observed (data not shorn). The 
failure to detect T-cell proliferation does not appear to be due to 
technical problems since IFN- 7 treated astrocytes were previously found to 
stimulate the proliferation of an alloreactlve T-cell line (see chapter 4, 
table 4 .1).
Effect at X B U  an the ability at BfLSFY-treated m c a a t u  and
BPLSFV-treated G26-24 cells to stimulate SFV-speclflc T-cell release of 
IFN--V
The effect of natural IFN-a£ and recombinant IFN- 7 treatment on the ability 
of BPLSFV-treated astrocytes to stimulate SFV-speclflc T-cell release of 
IFN- 7  was investigated as described in methods section N.
The data in table 6.1 show the titres of IFN activity detected in 
supernatants harvested from co-cultures of astrocytes with SFV-specific T- 
cells, and from cultures of astrocytes alone. It can be seen that 
astrocytes alone released small amounts of IFN when treated with BPLSFV 
(between 3 and 32 ± 6 u/ml, see data in column headed 'supernatants from 
cultures of astrocytes alone’). The IFN type appears to be IFN-a0 since 
activity was neutralised by anti-IFN-a£ serum but not by a monoclonal 
antibody to IFN-7 . Anti-IFN-a/3 serum did not neutralise any IFN- 7 activity 
in a control experiment (data not shown). Non-BPLSFV-treated astrocytes
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Tabla 6.1
Effact of IFN-ad and IFN-7 treatment on ability of BPLSFV-treat«d
u t n g t M  ta itlaulMtB SfV-ipftclIls i -c a ll  xaliaia ai IB L a
Suparnatants from co-cultura Supernatant» froa cultura» 
of astrocytas with SFV T-call» of astrocyta» alone
Aatrocyta
treatment Alone + Anti 
IFN-o/9
• + Anti 
IFN-7
Alone + Anti- 
IFN-afl
+ Anti- 
IFN-7
IFN7 + BPLSFV 82+6 20±9 32±6 <3 32±7
BPLSFV alone 20±1 10±1 <3 3 <3 3
IFNod + BPLSFV 72+14 57±11 <3 10±7 <3 3
IFNy alone <3 *N.D. N.D. <3 N.D. N.D.
ITWafi alone <3 N.D. N.D. <3 N.D. N.D.
Untreated <3 N.D. N.D. <3 N.D. N.D.
+ ; titres refer to mean of six replicate titrations ± S.D. units/ml IFN
activity.
*; N.D. not dona. (I)
(I) Experimental protocol as described In methods section N.
(II) Calls treated with 1000 u/al IFN-O0, 100 u/ml IFN- 7  or medium alone.
(III) Supernatants were harvested from cultures of astrocytes, treated as 
Indicated, In the presence and absence of SFV-speclflc T-cells 
(derived from C3H/He mica). IFN activity was assessed and
characterised as described In methods section P.
did not reíaos« any detectable IFN. Supernatants harvested froa co­
cui tures of non-BPLSFV treated astrocytes (either non-IFN treated, IFN-o£ 
treated or IFN-y treated) with SFV-specific T-cells also contained no 
datactable IFN activity. In contrast, supernatants harvested frosi co­
cultures of non-IFN treated BPLSFV-treated astrocytes with SFV-specific T- 
cells contained small amounts of IFN (20 t 1 u/al). The IFN type appears 
to be IFN-y since activity was significantly neutralised by the monoclonal 
antibody to IFN-y (from 20 1 1 u/ml to < 3 u/ml, Students t-tsst 
p <0.001). The anti-IFN-y monoclonal antibody did not neutralise any IFN- 
afi activity in a control experiment (data not shown). That antl-IFN-a£ 
serum also apparently significantly neutralised some activity (from 20 ♦ 1 
u/ml to 10 u/ml. Students t-test p <0.001) suggests that soull amounts of 
IFN-al were also present, and at a level which corresponds to the 
background production of IFN-a^ due to BPLSFV-treatment of the astrocytes 
(3 u/ml). The observation that the antl-IFN-y monoclonal antibody 
specifically neutralised all IFN activity present in this supernatant, yet 
antl-IFN-a£ serum also specifically neutralised some activity, probably 
reflects the fact that the IFN activities were titrated in a biological 
assay which Inherently Involve a background level of error. Supernatants 
harvested from co-cultures of IFN-a£ treated BPLSFV-treated astrocytes with 
SFV-specific T-cells were found to contain significantly (Students t-test p 
<0.001) higher tltres of IFN activity (72 ± 14 u/ml) than the supernatants 
harvested from co-cultures of non-IFN treated BPLSFV-treated astrocytes 
with SFV-specific T-cells (20 ± 1 u/ml). The predominant IFN type present 
appears to be IFN-y since activity was neutralised by the monoclonal 
antibody to IFN-y (from 72 ± 14 u/ml to < 3 u/ml). Antl-IFN-a£ serum also 
significantly neutralised some activity (from 72 ± 14 u/ml to 37 + 11 u/ml, 
Students t-test p < 0.1) indicating that small amounts of IFN-a/9 were also 
present, and at a level which corresponds to the background production of
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IFN-ad due Co BPLSFV treatment of Che aetrocycea (10 ± 7 u/al).
Supernecence herveeced from co-culture* of IFN-y craacad BPLSFV-treated 
aacrocytaa with SFV-»pacific T-cell* wara alao found Co con Cain 
algnlflcancly (Student* t-teat p < 0.001) higher tltrae of IFN activity 
(131 ± 14 u/al) Chan cha aupernacanca harvaaCad fro« co-culCurea of non-IFN 
craacad BPLSFV-craacad aacrocycaa with SFV-»pacific T-calla (20 ± 1 u/al). 
The predoalnant IFN type preaenc again appaara Co ba IFN-y alnca no»t 
activity waa naucrallaad by cha Monoclonal antibody Co IFN-y (froa 131 ± 14 
u/al to 20 ± 9 u/al). Antl-IFN-af) alao algnlflcancly naucrallaad soae 
activity (froa 131 ± 14 u/al to 82 1 6 u/al, Student* c-caac p < 0.001) 
again Indicating chat ana11 amounta of IFN-ad ware praaanc, and aC a laval 
which corraaponda Co Cha background laval of IFN-ad production due to 
BPLSFV-treatment of cha aatrocytea (32 ± 6 u/al). The clcrea of IFN 
activity dacaccad In aupernatanca harvaaCad froa co-culCuraa containing 
IFN-ad created BPLSFV-Created aatrocytea (72 ± 14 u/al) and IFN-y craacad 
BPLSFV-craaced aaCrocytea (131 ± 14 u/al) wara alao found to ba 
algnlflcancly different (Studenta C-CaaC p < 0.001). The ralaaaa of IFN-y 
waa alao found Co ba MHC restricted, alnca VEHI 3b cella (H-2d) treated In 
Cha aaaa manner did noc atlaulace cha SFV-apaclflc T-call ralaaaa of IFN-y 
(daCa not ahown).
The preparation of BPLSFV uaad In Chaaa aCudlea waa prepared froa a aCock 
of SFV grown In BHK cella (aaa aathoda section A). Since Chla preparation 
nuac alao contain BHK call procelna, 1C waa poaalbla Chat cha T-calla wara 
noc releaalng IFN-y In raaponaa Co SFV antigen buc In reaponae Co BHK call 
anClgan. To lnveaClgate Chla poaalblllcy astrocyte* (uncreated, IFN-ad 
created and IFN-y craacad) wara created wlch a BHK call lysate (prepared In 
Cha aaaa Banner aa for Cha production of an SFV atock, wlch Cha exception 
Chat SFV Infection waa oalctad and calla wara reaovad ualng glaas beada)
and Che ability Co stimulate SFV-speclfic T-cell release of IFN-7  assessed. 
The results obtained clearly showed that BHK-cell-lysate treated astrocytes 
did not stimulate the SFV-speclflc T-cell release of IFN-7  (data not 
shown) . Hence, the release of IFN-7  described In the above experiment must 
have been In response to SFV antigen.
Since astrocytes were found to release l¥V-afi when treated with BPLSFV, a 
comparison was also made of the amount of IFN-a£ released by astrocytes 
when treated with BPLSFV and Infected with SFV. As shown In figure 6.1, 
SFV-Infected astrocytes clearly released higher titres of IFN-afi than 
BPLSFV-treated astrocytes. Untreated astrocytes did not release any 
detectable IFN-O0.
The effect of the supernatants harvested from co-cultures of astrocytes 
with SFV-speclflc T-cells, and from cultures of astrocytes alone, on class
k k11 MHC H-2A antigen expression by astrocytes was also Investigated. H-2A
antigen expression was assessed by Indirect Immunofluorescence staining
with quantification by flow cytometry. As shown In table 6.2, all
supernatants harvested from cultures of astrocytes alone had no effect on
1cH-2A antigen expression by astrocytes, since the fluorescence of cells 
treated with these supernatants was essentially Identical to background 
fluorescence. Supernatants harvested from co-cultures of non-BPLSFV- 
treated astrocytes (either non-IFN treated, IFN-a/9 treated or IFN-7  
treated) with SFV-speclflc T-cells also had no effect on H-2A^ antigen 
expression by astrocytes. In contrast, supernatants harvested from co­
cultures of non-IFN treated BPLSFV-treated astrocytes with SFV-speclflc T- 
cells markedly Increased H-2A** antigen expression on astrocytes, with a 
shift in mean fluorescence from 13 for untreated astrocytes to 40 for 
supernatant-treated astrocytes, and an increase in the percentage of cells
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Production <st im-atì bv SPY-lnlactad and flfLSFY-troBtBd j jt r o c v t«  culturoi
Figura 6.1
( 0 —0 )  Untraatad 
(A A) BPLSFV - traatad
(# #) SFV-lnfactad 1
(1) Aatrocytes vara mock-InfacCad, traacad with BPLSFV or lnfactad with 
SFV as daacrlbad In mathoda aacclon H. At 1 hour post-infaction 
nonolayera «ara waahad thraa timaa with froah medium and 2 ala fraah 
medium replaced. Medium aupamatanta varo than harvested at varioua 
timaa poat-Infaction and dlalyaad twice agalnat pH2 glyclna buffar 
ovarnlght followad by a final dlalysls agalnat PBS. IFN waa than 
aaaaysd aa daacrlbad In aathoda aectlon P.
Table 6.2
Effect of supernatants harvested from co-culturei of astroevtca and 
srv-epecif ic T-ceiie on d a » »  ii h -2a__anti ten w r e n  ion by ftltrgCYtta
Fluorescence Intensity Distribution (I)
Astrocyte Treatment Supernatants from co-cultures Supernatant from
of astrocytes with SFV-T-cells astrocytes alone
MN* %+ MN «
IFN7 ♦ BPLSFV 48 30 10 3
BPLSFV alone 40 26 14 7
IFNa0 ♦ BPLSFV S3 33 14 6
IFN7 alone 17 9 19 10
IFNa£ alone 18 10 14 6
Untreated 18 9 19 10
Background fluorescence (non-supernatant treated stained for H-2A^ antigen)
; MN - 13, % - 5.
KN; mean fluorescence
+% ; percentage of cells above 5% background fluorescence marker (non-
supernatant treated, stained with an irrelevant antibody).
(I) Supernatants were harvested from wells containing astrocytes treated 
as Indicated, and cultured in the presence or absence of SFV-specific 
T-cells as described in methods section N. Supernatants were then 
diluted 1:4 prior to addition to astrocyte cultures for 48 hours. 
Class II (H-2A^) antigen was then stained by indirect
imnunofluorescence as described in methods section H.
(II) 10000 cells analysed in each case using the FACS440 at the University 
of Birmingham, operated by Miss A Milner.
collected «bove the background fluorescence aerker from 5% for untreated 
astrocytes to 26% for supernatant-treated astrocytes. Supernatants 
harvested froa co-cultures of IFN-a£ treated BPLSFV-treated astrocytes with 
SFV-specific T-cells Increased H-2A^ antigen expression on astrocytes to an 
even higher level, with a shift In Bean fluorescence froa 13 for untreated 
astrocytes to S3 for supernatant-treated astrocytes, and an Increase In the 
percentage of cells collected above the background fluorescence Barker froa 
S% for untreated astrocytes to 33% for supernatant treated astrocytes.
Slallarly, supertants harvested froa co-cultures of IFN-y treated BPLSFV-
lrtreated astrocytes with SFV-speclflc T-cells Increased H-2A antigen 
expression on astrocytes to a high level, with a shift In aean fluorescence 
froa 13 for untreated astrocytes to 48 for supernatant-treated astrocytes, 
and an Increase In the percentage of cells collected above the background 
fluorescence Barker froa 5% for untreated astrocytes to 30% for 
supernatant-treated astrocytes.
The effect of antl-IFN-y monoclonal antibody on the ability of supernatant 
harvested froa co-cultures of IFN-y treated BPLSFV-treated astrocytes with 
SFV-speclflc T-cells to Increase H-2Ak antigen expression on astrocytes was 
also Investigated. As shown In figure 6.2, the supernatant alone aarkedly 
Increased H-2Ak antigen expression on astrocytes, with an Increase In the 
percentage of cells collected above the 3% background fluorescence Barker 
froa 7% for untreated astrocytes to 62% for supernatant treated astrocytes. 
The aonoclonal antibody to IFN-y completely Inhibited the ability of the 
co-culture supernatant to Increase H-2A^ antigen expression on astrocytes, 
with a decrease In the percentage of cells collected above the 5% 
background fluorescence aarker from 62% for astrocytes treated with 
supernatant alone to 7% for astrocytes treated with supernatant and anti- 
IFN-y antibody. These observations suggest that IFN-y was the factor
Effect gf anti-IFN-T antibody on ability of «uotmitant harvested from 
CQ-culturea of IFW-7  treated RPLSFV-treated «»crocvcti with SFV-T-cells to
Figura 6.2
l iLt tlUi II H-2A— antiten expression on ntrocvt«i
KlX
■olid line : co-culture supernatant alone 
spaced dota : co-culture supernantant +■ antl-IFN-y antibody 
close dots : untreated
FLI : Fluorescence intensity distribution
(i) Supernatants were harvested froe co-cultures of IFN-7  treated BPLSFV- 
treated astrocytes and SFV-T-cells as described in methods section N. 
Supernatants were then diluted 1:4 prior to addition to astrocyte 
cultures for 48 hours in the presence or absence of a 1:100 dilution 
of R4-6A2 anti-1FN-7  antibody ascites fluid. Class II (H-2Ak) 
antigen was then stained by Indirect immunofluorescence as described 
in methods section H.
(11) 5000 cells analysed in each case.
wpresene In Che co-culture supernatant which increased H-2A antigen 
expression on Che astrocytes.
The effect of Che supernatants on class I MHC H-2K antigen expression by 
astrocytes was also investigated. As shown in table 6.3, all supernatants
harvested froa cultures of astrocytes alone (with the exception of IFN-7
vtreated BPLSFV-Crea ted astrocytes) had essentially no effect on H-2K 
antigen expression by astrocytes, since the fluorescence of cells treated 
with these supernatants were essentially identical to background
fluorescence. Supernatant harvested from cultures of IFN- 7  treated BPLSFV-
wtreated astrocytes alone slightly Increased H-2K antigen expression on 
astrocytes, with an increase in mean fluorescence froa 27 for untreated 
astrocytes to 44 for supernatant treated astrocytes, and an Increase in the 
percentage of cells collected above the S% background fluorescence marker 
froa 18% for untreated astrocytes to 32% for supernatant-treated
|rastrocytes. The ability of this supernatant to increase H-2K antigen 
expression on astrocytes is probably due to the presence of saall amounts 
of IFN-a£, produced by the astrocytes when treated with BPLSFV (see table
6.1). Supernatants harvested froa co-cultures of non-BPLSFV-treated 
astrocytes (either non-IFN treated, IFN-a£ treated or IFN-7  treated) with 
SFV-speclfic T-cells also slightly Increased H-2K^ antigen expression on 
astrocytes, with an Increase in mean fluorescence from 27 for untreated 
astrocytes to around 44 for supernatant-treated astrocytes, and an Increase 
in the percentage of cells collected above the 5% background fluorescence 
marker froa 18% for untreated astrocytes to around 31% for supernatant- 
treated astrocytes. The ability of these supernatants to Increase H-2K*1 
antigen expression on astrocytes existed despite the absence of detectable 
IFN (see table 6.1). The aost likely explanation for these data is that 
the SFV-speclfic T-cells released very saall amounts of IFN- 7  which was
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Tabla 6.3
EffgsE s l eupcrnatanta hflryggtsd frga co-culturgg gf .-MtrgcYtcg with 
SFV-speclflc T-cells on class I H-2Kk antigen expression bv astrocytes
Fluorescence Intensity distribution
Astrocyte treatment Supernatants from co-cultures 
of astrocytes with SFV-T-cells
Supernatant from 
astrocytes alone
MN* .♦ MN «
IFN-7 + BPLSFV 77 48 44 32
BPLSFV alone 84 54 32 22
IFN-o/9 + BPLSFV 91 58 26 14
IFN-y alone 47 34 28 17
IFS-afi alone 44 31 33 23
Untreated 46 31 29 19
Background fluorescence (non-supernatant treated stained for H-2K* 
antigen); MN - 27, « - 18.
MN; Mean fluorescence
+%; percentage of cells above 5* background fluorescence marker (non­
supernatant treated, stained with an irrelevant antibody). (I)
(I) Figure legend as for Table 6.2, except cells were stained for H-2K^ 
antigen by indirect immunofluorescence.
(II) 10 000 cells analysed In each case, using the FACS440 at the 
University of Birmingham operated by Miss A Milner.
able Co Increase H-2Kk antigen expression on astrocytes, yet was beyond the 
detection limit of the IFN assay (3 u/ml). That these supernatants did not
Italso Increase class II H-2A antigen expression on astrocytes (see table
6.2) may be a reflection of the fact that higher concentrations of IFN-7  
(in terms of antiviral activity units) are needed to Increase class II MHC 
antigen expression on astrocytes than are needed to Increase class I MHC 
antigen expression. Thus, the data presented in chapter 4 (figures 4.14 
and 4.16) show that the lowest concentration of IFN-y which brought about a 
detectable Increase in class II MHC H-2A*6 antigen expression on astrocytes 
was 1 u/ml, whereas a detectable Increase in class I MHC H-2K^ antigen 
expression was observed at the lower concentration of 0.01 u/ml. In the
present study, supernatants harvested from co-cultures of non-IFN treated
wBPLSFV-treated astrocytes with SFV-speclfic T-cells Increased H-2K antigen 
expression on astrocytes to an even higher level, with an increase in mean 
fluorescence from 27 for untreated astrocytes to 84 for supernatant-treated 
astrocytes, and an Increase in the percentage of cells collected above the 
5% background fluoresence marker from 18% for untreated astrocytes to 54% 
for supernatant- treated astrocytes. The increased ability of this 
supernatant to increase H-2K^ antigen expression on astrocytes (as compared 
to supernatants harvested from co-cultures of non-BPLSFV treated astrocytes 
with SFV-specific T-cells) is probably due to the presence of IFN-7  
released by SFV-specific T-cells when stimulated by SFV antigen on the 
BPLSFV-treated astrocytes. Supernatants harvested from co-cultures of IFN- 
afi treated BPLSFV-treated astrocytes with SFV-specific T-cells, and from 
co-cultures of IFN-7  treated BPLSFV-treated astrocytes with SFV-specific T- 
cells also Increased H-2K^ antigen expression on astrocytes to a high 
level, with an increase in mean fluoresence from 27 for untreated 
astrocytes to 91 for IFN-a/9 treated BPLSFV-treated co-culture supernatant- 
treated astrocytes and to 77 for IFN-7  treated BPLSFV-treated co-culture
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supernatant treated astrocytes, and an Increase in the percentage of cells 
collected above the 5% background fluorescence marker from 18% for 
untreated astrocytes to 58% for IFN-a£ treated BPLSFV-treated co-culture 
supernatant treated astrocytes and to 48% for IFN-y treated BPLSFV-treated 
co-culture supernatants.
The effect of natural IFN-a/9 and recombinant IFN-y treatment on the ability 
of BPLSFV-treated G26-24 cells to stimulate SFV-speclflc T-cell release of 
IFN-y was also investigated. The data in table 6.4 show the tltres of IFN 
activity detected in supernatants harvested from co-cultures of G26-24 
cells with SFV-speclflc T-cells, and from cultures of G26-24 cells alone.
It can be seen that G26-24 cells alone did not release any detectable IFN 
when treated with BPLSFV. Supernatants harvested from co-cultures of non- 
BPLSFV treated G26-24 cells (either non-IFN treated, IFN-a£ treated or IFN- 
7 treated) with SFV-speclfic T-cells, and from co-cultures of non-IFN 
treated BPLSFV-treated and IFN-a£ treated BPLSFV-treated G26-24 cells with 
SFV-speciflc T-cells also contained no detectable IFN activity. In 
contrast, supernatants harvested from co-cultures of IFN-y treated BPLSFV- 
treated G26-24 cells with SFV-speclfic T-cells contained high levels of IFN 
activity (142 ± 16 u/ml) . The IFN type appears to be IFN-y since activity 
was neutralised by the monoclonal antibody to IFN-y (from 142 ± 16 u/ml to 
< 3 u/ml). The release of IFN-y was also found to be MHC restricted, since 
VEHI 3b cells (H-2d) treated in the same manner did not stimulate the SFV- 
speciflc T-cell release of IFN-y (data not shown).
The effect of the supernatants harvested from co-cultures of G26-24 cells 
with SFV-specific T-cells, and from cultures of G26-24 cells alone, on 
class II MHC H-2A^ antigen expression by G26-24 cells was also 
investigated. H-2Ab antigen expression was assessed by indirect
Tabla 6.4
Ellect PI IfH'ito and ifH'7 » B ia tn t  oo a a iu ty  gt artfrY-traati
>m cultures 
alone
C26-24 cell 
treatment
Supernatants from co*culture of 
G26-24 cells with SFV-T-cells
Supernatants fr< 
of C26-24 cells
Alone ♦ Anti 
i p n-7
Alone ♦  Anti 
IW-7
IFN- 7  ♦ BPLSFV 142 ± U* <3 <3 N.D.
BPLSFV alone <3 Ü.D.* <3 N.D.
IFN-ol + BPLSFV <3 N.D. <3 N.D.
IFN-y alone <3 N.D. <3 N.D.
IFN-al alone <3 N.D. <3 N.D.
Untreated <3 N.D. <3 N.D.
*i titras rafar to a a m  of duplicata titrations ± S.D. unlta/al IFN 
activity 
*; N.D. not done (I)
(I) Experimental protocol as described In methods section N.
(II) Calls treated with 1000 u/ml IFN-afi, 500 u/ml IFN-y or medium alone.
(III) Supernatants were harvested from cultures of C26-24 cells, treated as 
Indicated, In the presence and absence of SFV-speclflc T-cells 
(derived from CS7 BL/6 mice). IFN activity was assessed and 
characterised as described In methods section P.
immunofluorescence staining with quantification by flow cytometry. As 
shown In table 6.5, all supernantants harvested from cultures of G26-24 
cells alone had no effect on H- 2A*3 antigen expression by G26-24 cells, 
since the fluorescence of cells treated with these supernatants was 
essentially Identical to background fluorescence. Similarly, all 
supernatants harvested from co-cultures of C26-24 cells with SFV-speciflc 
T-cells (with the exception of supernatant harvested from co-cultures of 
IFN-y treated BPLSFV-treated G26-24 cells with SFV-speclflc T-cells) had no 
effect on H-2A** antigen expression by G26-24 cells. Supernatants harvested 
from co-cultures of IFN-7  treated BPLSFV-treated G26-24 cells with SFV- 
speclflc T-cells markedly increased H-2Ab antigen expression on G26-24 
cells, with an increase in mean fluorescence from 6 for untreated G26-24 
cells to 51 for supernatant-treated G26-24 cells and an increase In the 
percentage of cells collected above the 5% background fluorescence marker 
from 5% for untreated G26-24 cells to 63% for supernatant-treated G26-24 
cells.
The effect of anti -IFN-7  monoclonal antibody on the ability of supernatant 
harvested from co-cultures of IFN-y treated BPLSFV-treated G26-24 cells 
with SFV-speciflc T-cells to Increase H-2Ab antigen expression on G26-24 
cells was also investigated. As shown In figure 6.3 (and as discussed 
above) the supernatant alone markedly increased H-2Ab antigen expression on 
G26-24 cells. The anti-IFN-7  monoclonal antibody completely inhibited the 
ability of the co-culture supernatant to Increase H-2Ab antigen expression 
on C26-24 cells, with a decrease in mean fluorescence from 51 for G26-24 
cells treated with supernatant alone to 5 for G26-24 cells treated with 
supernatant and antl-IFN-y antibody. These observations suggest that IFN-y 
was the factor present In the co-culture supernatant which increased H-2Ab 
antigen expression on the G26-24 cells.
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Tabi* 6.5
>arnatantg naryggtJtSi. tr?a çg-cuituraa gl sang « u n
Fluorescence Intensity distribution
G26-24 Supernatant from co-cultures Supernatant from cultures
treatment of G26-24 cells with SFV-T-cells of G26-24 cells alone
«
IFN-7 + BPLSFV 51 63 7 4
BPLSFV alone 7 3 8 5
IFN-O0+BPLSFV 7 4 8 3
IFW-7  alone 7 2 7 2
IFN-a£ alone 6 3 7 5
Untreated 6 3 5 4
Background fluorescence (non-supernatant treated, stained for H-2A**);
MN - 6 , « - 5.
MN; Mean fluorescence
+%; Percentage of cells above 5% background fluorescence Barker (non­
supernatant treated, stained with an Irrelevant antibody).
(1) Supernatants were harvested from wells containing G26-24 cells
treated as Indicated, and cultured In the presence or absence of SFV- 
speclflc T-cells as described In methods section N. Supernatants 
were then diluted 1:20 prior to addition to G26-24 cells for 48 
hours. Class II (H-2A1 1*) antigen was then stained by Indirect 
lanunofluorescence as described In methods section H.
(11) 5000 cells analysed In each case.
Egftct ai in t l- ira -T  aatlbgdv aa ab llltY  oí luptmatant h irv a iu d  ¿iaa 
cg-cultm aa g f IFH-7 sraatgd BfLSFY-traaf d C26-24 c a li»  vrlth ■SIY.-T-cbII* 
tg aucwnt c la n  II (H-2Ab ) antlwn axaraailgn gn <?26-2¿» calla
Figura 6.3
■ olid lina : co-cultura aupamatant alona 
opacad dota : co-cultura aupamatant anti-IFN--y antibody 
cloaa dota : Untraatad
FLI, Fluoraacanca Intanalty hlstograa
(I) Suparnatanta vara harvaatad froa co-culturaa of IFN-7  traatad BPLSFV- 
craatad C26-24 calla and SFV-T-calla aa daacrlbad ln aathoda sactlon 
N. Suparnatanta vara than dllutad 1:20 prior to addltlon to C26-24 
calla ln tha praaanca or abaanca of a 1:100 dllutlon of R4-6A2 antl- 
IFN-7  antibody aacltaa fluid. Claaa II (H*2Ab) antlgan vaa atalnad 
by lndlract lmaunofluoreacanca aa daacrlbad ln aathoda aactlon H.
(I I ) 5000 calla vara analyaed ln aach caaa.
Th« effect of the supernetants on das« I MHC H-2Db antigen expression by 
G26-24 cells was also investigated. As shown in table 6 .6 , all 
supernatants harvested from cultures of G26-24 cells alone had no effect on 
H-2Db antigen expression, since the fluorescence of cells treated with 
these supernatants was essentially identical to background fluorescence. 
Supernatants harvested fron co-cultures of non-BPLSFV treated G26-24 cells 
(either non-IFN treated, IFN-al treated or IFN-7  treated) with SFV-specific 
T-cells slightly Increased H-2Db antigen expression on G26-24 cells, with 
an Increase in mean fluorescence froa 48 for untreated G26-24 cells to 
around 122 for supernatant-treated G26-24 cells, and an Increase in the 
percentage of cells collected above the St background fluorescence aarker 
fron 5% for untreated C26-24 cells to around 16% for supernatant-treated 
G26-24 cells. The ability of these supernatants to increase H-2Db antigen 
expression on G26-24 cells existed despite the absence of any detectable 
IFN activity (see table 6.4). The aoat likely explanation for this data is 
that the SFV-specific T-cells non-specifically released very saall amount* 
of IFN-7  which was able to Increase H-2Db antigen expression on G26-24 
cells, yet was beyond the detection Unit of the IFN assay (3 u/al). That 
these supernatants did not also increase H-2Ab antigen expression on G26-24 
cells (see table 6.5) may be a reflection of the fact that higher 
concentrations of IFN-7  (in terms of antiviral activity units) are needed 
to increase class II MHC antigen expression on G26-24 cells than are needed 
to increase class I MHC antigen expression. Thus, the data presented in 
chapter 4 (figures 4.19 and 4.23) show that the lowest concentration of 
IFN- 7  which brought about a detectable increase in class II MHC H-2Ab 
antigen expression on G26-24 cells was 0.5 u/ml, whereas a detectable 
Increase in class I MHC H-Db antigen expression was observed at the lower 
concentration of 0.05 u/ml. In the present study, supernatants harvested 
from co-cultures of non-IFN treated BPLSFV-treated G26-24 cells with SFV-
Tabla 6.6
E ffect g l aupernatanta harycatcd frga sg-culturaa <?f G26-24 ce lia  y lth  
SFV-epeclflc T -cella  an elea» I MHC (H-2DÌL antUan expreeefen fry 026-24 
calla *1
G26-24
treatment of
Fluorescence Intensity distribution 
Supernatant from co-cultures Supernatant from 
G26-24 cells with SFV-T-cells G26-24 cells
cultures
alone
*MN .♦ MN »
IFN-7  + BPLSFV 323 73 51 4
BPLSFV alone 140 24 61 4
IFN-ofi + BPLSFV 136 23 55 3
IFN-7  alone 126 16 59 3
IFN-q/9 alone 109 14 46 2
Untreated 122 16 57 3
Background fluorescence (non-supernatant treated, stained for H-2Dd 
antigen); MN - 48, « - 5.
MN; Mean fluorescence
+%; Percentage of cells above 5% background fluorescence marker 
(as above).
(1) Figure legend as for table 6.5, except cells were stained for H-2d '5 
antigen by Indirect Immunofluorescence.
(11) 5000 cells analysed In each case.
•pacific T- cells and from co-cultures of IFV-afi treated BPLSFV-treated G26- 
24 cells with SFV-speclflc T-cella, increased H-2Db antigen expression on 
C26-24 cells to a slightly higher level than for supernatants harvested 
from co-cultures of non-BPLSFV treated G26-24 cells (either non-IFN 
treated, IFN-a£ treated or IFN-y treated) with SFV-speclfic T-cells (see 
table 6 .6). The slightly Increased ability of theae supernatants to 
Increase H-2Db antigen expression on G26-24 cells may be due to the 
presence of a very small amount of IFN-7  released by SFV-speciflc T-cells 
when stlsnilated by SFV antigen on the BPLSFV-treated G26-24 cells. 
Supernatants harvested from co-cultures of IFN-7  treated BPLSFV-treated 
G26-24 cells with SFV-speclflc T-cells Increased H-2Db antigen expression 
to an even higher level, with an Increase in mean fluorescence from 48 for 
untreated G26-24 cells to 323 for supernatant treated G26-24 cells, and an 
increase in the percentage of cells collected above the 5% background 
fluorescence marker from 5* for untreated G26-24 cells to 73% for 
supernatant-treated G26-24 cells. The ability of this supernatant to 
Increase H-2Db antigen expression to such an high level is probably due to 
the presence of the large amount of IFN-7  released by the SFV-specific T- 
cells when stimulated with IFN-y treated BPLSFV-treated G26-24 cells (see 
table 6.4).
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Discussion
In this chapter tha effect of natural IFV-afi and recombinant IFN-y 
treatment on the ability of BPLSFV-treated astrocytes to present SFV 
antigen to SFV-speclfic T-cells was investigated. The data obtained show 
that non-IFN treated BPLSFV-treated astrocytes stimulated SFV-speclflc T- 
cells to release IFN-y and that IFN-a/9 pretreatment of astrocytes prior to 
BPLSFV treatment Increased the ability of the cells to stimulate SFV- 
speclfic T-cell release of IFN-y. Since at least some non-IFN treated 
astrocytes display class I MHC antigen on the cell surface (see chapter 4 
figure 4.14) and non-IFN treated BPLSFV-treated astrocytes were found to be 
susceptible to SFV-speclfic CTL lysis (see chapter 5 figure 5.2) it does at 
least seem possible that the IFN-y may have been released by class I MHC 
restricted SFV-speclflc CTL on recognition of SFV antigen on the 
astrocytes. That IFN-a0 pretreatment Increased the ability of BPLSFV- 
treated astrocytes to stimulate SFV-speclflc T-cell release of IFN-7  may be 
a reflection of the fact that IFS-afi treatment Increased class I MHC 
antigen expression on the astrocytes (see chapter 4 figures 4.11 and 4.13) 
hence the ability to be recognised by SFV-speclflc CTL. The ability of 
virus-specific CTL to release IFN-7  on recognition of a virus-infected cell 
has been reported previously in the influenza virus system (Morris ££ Al-. 
1982; Taylor a1-. 1985). The possibility that SFV-specific T-helper 
cells may have released IFN-y on recognition of SFV antigen on the non-IFN 
treated BPLSFV-treated and IFN-a£ treated BPLSFV-treated astrocytes cannot 
be excluded. However, this does at least seem unlikely since T-helper 
cells only recognise viral antigen in association with class II MHC antigen 
(Klein *1. , 1981) and neither non-IFN treated nor IFN-a0 treated 
astrocytes display any detectable class II MHC antigen on the cell surface 
(see chapter 4 figure 4.17). The data presented in this chapter also show
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IFN-y precreatnenc of BPLSFV-treated astrocytes Increased tha ability of 
the astrocytes to stimulate SFV-specific T-call release of IFN-y, and to an 
even higher level than observed for IFN-a0 treated BPLSFV-treated 
astrocytes. That IFN-y pretreataent increased tha ability of BPLSFV- 
treated astrocytes to stimulate SFV-specific T-call release of IFN-y may 
again be a reflection of tha fact that IFN-y treatment Increased class I 
MHC antigen expression on the astrocytes (see chapter 4 figures 4.12 and 
4.14) hence the ability to be recognised by SFV-specific CTL, which release 
IFN-y (IFN-y treatment was also found to Increase tha susceptibility of 
BPLSFV-treated astrocytes to SFV-specific CTL lysis, sae chapter 5 figure
5.2). There are several explanations which aay account for the observation 
that the SFV-specific T-cells released higher tltres of IFN-y when 
stimulated with IFN-y treated BPLSFV-treated astrocytes than when 
stimulated with IFN-a£ treated BPLSFV-treated astrocytes. The first is 
that the IFN-y treated astrocytes displayed a higher level of class I MHC 
antigen on the cell surface than IFN-a^-treated astrocytes (see chapter 4 
table 4.2) hence were more effectively recognised by the SFV-specific CTL. 
Alternatively, the induction by IFN-y (but not IFN-a£) of class II MHC 
antigen expression on astrocytes (see chapter 4 figure 4.17) may have 
Increased the ability of the cells to be recognised by class II MHC 
restricted SFV-specific T-helper cells, which also released IFN-y. Since 
class II restricted CTL have now been demonstrated in a number of 
experimental systems (Sun and Vekerle, 1986; Morrison i£ Al-• 1988) it is 
also possible that the induction by IFN-y (but not IFN-O0) of class II MHC 
antigen expression on astrocytes may have Increased the ability of the 
cells to be recognised by class II restricted SFV-specific CTL, which 
released IFN-y. A possible experimental approach which could be used in 
order to determine which MHC antigens on astrocytes were Involved in the 
stimulation of IFN-y release from SFV-specific T-cells, would be to add
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anclbodies against class I or class II MHC antlgan to tha co-cultures of 
astrocytes with SFV-specific T-cells and assess the effect on the aatount of 
IFN-7  released. Similarly, since class I MHC restricted CTL express Lyt-2 
antigen on the cell surface and both class II MHC restricted CTL and T- 
helper cells express L3T4 antigen on the cell surface (Male g£ al. , 1987) 
antibodies against Lyt-2 and L3T4 could be used in the presence of 
complement to deplete each of these cell types from the SFV-specific T-cell 
preparation prior to the addition to the co-culture with astrocytes. A 
comparison could then be made of the amount of IFN-7  released by the Lyt-2 
depleted, L3T4 depleted and non-depleted SFV-specific T-cell preparations, 
when stimulated with astrocytes, in order to determine the phenotype(s) of 
the SFV-specific T-cells with release IFN-7 . An alternative approach would 
also be to study the release of IFN- 7  from class I and class II MHC 
restricted SFV-specific T-cell clones. It is important to note that the 
astrocyte cultures used for the experiments presented in this chapter also 
contained (at most) 10% uncharacterlaed cells. Hence, it is not possible 
to definitely state that the SFV-specific T-cell release of IFH-7  was In 
response to SFV-antlgen on astrocytes, but may have been In response to SFV 
antigen on the uncharacterised cells also present. It Is however 
interesting to note that Fontana and co-workers demonstrated that cultured 
rat astrocytes (derived from Lewis rets and which contained less than 1% 
uncharacterised cells) presented myelin basic protein (MBP) to a MBP- 
speciflc T-helper cell line, as assessed by proliferation assay, and 
observed the antigen-specific and MHC-restricted aggregation of T-cells 
around calls which were positively identified as astrocytes by antl-CFAP 
indirect immunofluorescence staining (Fontana gfc g l.  , 1984; Flare i£  g l .  , 
1985). The results of these studies also demonstrated that cultured 
astrocytes did not express any detectable class II MHC antigen on the cell 
surface (as assessed by Indirect Immunofluorescence staining) and were only
able to present MBP to the MBP-speclflc T-helper cells when Induced to 
express class II MHC antigen by either treatment with recombinant IFN-y or 
by a period of co-culture with the MBP-speciflc T-cells (which were thought 
to have released IFN-y). Thus a correlation existed between the expression 
of class II MHC antigen on astrocytes and the ability to present MBP to a 
MBP-specific T-helper cell line. The Importance of class II MHC antigen 
expression on the astrocytes was also demonstrated by the addition of anti­
class II MHC antigen monoclonal antibodies which were found to Inhibit the 
ability of astrocytas to present MBP to MBP- specific T-helper cells (Fierz 
et al. . 1985). Subsequent studies by Fontana and co-workers also 
demonstrated that whilst cultured non-IFN treated murine astrocytes 
(derived from C57BL/6 mice and which expressed class I MHC H-2K** antigen on 
the cell surface) presented N- iodoacetyl-N-(5-aulfonic-l-naphthyl) - 
ethylenedlamine (AED) hapten to a class I MHC H-2K** restricted AED-specific 
CTL clone, as assessed by proliferation assay, only IFN-y treated 
astrocytes (hence which expressed class II MHC antigen on the cell surface) 
presented beef Insulin to a class II MHC restricted beef-insulin-specific 
T-cell hybridoma, as assessed by the release of interleukin-2 (Fontana ££ 
al. . 1986). Similarly, Taklguchi and Frelinger (1986) demonstrated that 
cultured snirine astrocytes (derived from BIO.A mice) were only able to 
present key-hole limpet hemocyanin (KLH) and egg white lysozyme to 
appropriate class II MHC-restricted T-cell hybridomas when induced to 
express class II MHC antigen by treatment with recombinant IFN-y. The 
Importance of class II MHC antigen expression on astrocytes was again 
demonstrated by the addition of anti-class II MHC antigen monoclonal 
antibodies which (unlike anti-class I MHC antigen monoclonal antibodies) 
inhibited the ability of the astrocytes to present KLH to the class II MHC 
restricted KLH-speciflc T-cell hybridoma.
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Since it la currently believed that cytotoxic T-cells and helper T-cells 
recognise processed foreign antigen fragments which have bound to class I 
and class II MHC antigen (Bjorkman ££ al. . 1987a, 1987b; Babbitt ££ Al-• 
1986; Germain, 1986) the observation in the present study that astrocytes 
treated with a /?-propiolactone inactivated preparation of SFV stimulated 
SFV-speclfic T-cell release of IFN-y does at least suggest that the 
astrocytes were able to process SFV antigen into a form which could be 
recognised by the SFV-specific T-cells. The ability of astrocytes to 
process antigen has not yet been formally demonstrated although Takiguchl 
and Frellnger (1986) found that IFN-y treated astrocytes presented KLH 
antigen to the SKK-45.10 KLH-specific T-cell hybrldoma, which only 
recognises processed KLH antigen.
The data presented in this chapter also show that the IFN-y released by 
SFV-speclfic T-cells, when stimulated with BPLSFV-treated astrocytes. 
Increased both class I and class II MHC antigen expression on astrocytes. 
These observations suggest positive feedback mechanism «»hereby the immune 
response may escalate in a virus-Infected brain. Thus, on recognition of 
viral antigen on an astrocyte («rhich is expressing class I or class II MHC 
antigen on the cell surface) virus-specific CTL and T-helper cells release 
IFN-y «rhich then further increases class I and class II MHC antigen 
expression on astrocytes and hence enhances the presentation of viral 
antigen to T-cells. IFN-y released by virus-specific T-cells on 
recognition of viral antigen would also inhibit viral replication and 
thereby contain the spread of virus within the brain.
In a series of experiments it was found that neither BPLSFV-treated 
astrocytes (either non-IFN treated, IFN-a/J treated or IFN-y treated) nor 
BPLSFV-treated syngeneic C3H/He mouse splenocytes (used as an experimental
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positive control) stimulated any detectable SFV-specific T-call 
proliferation, as assessed by the incorporation of [^H]thymidine. In 
contrast, BPLSFV-treated astrocytes (either non-IFN treated, IFN-a^ treated 
or IFN- 7  treated) were regularly found to stimulate SFV-specific T-cell 
release of IFN-7 , indicating that the SFV-specific T-cells were able to 
recognise SFV antigen on the astrocytes. That no SFV-specific T-cell 
proliferation could be detected does not appear to have been due to a 
deficiency in T-cell interleukin-2 production (IL-2, T-cell growth factor) 
since the addition of recombinant IL-2 had no effect. Astrocytes have also 
been previously shown to release lnterleukin-1 (IL-1, T-cell activation 
factor: Fontana fit Al-. 1982). That BPLSFV-treated syngeneic C3H/He mouse 
splenocytes also did not stismlate SFV-specific T-cell proliferation, 
suggests that the SFV-specific T-cell effector population used was unable 
to undergo proliferation. A possible explanation may be that the frequency 
of responder SFV-specific T-cells in the effector population used was too 
low to enable the detection of proliferation in the assay system used. A 
possible future experimental approach would be to produce an SFV-specific 
T-cell line which is highly enriched with SFV-specific T-cells. This could 
be achieved by the successive restimulation of the SFV-specific T-cell 
effector population with SFV antigen in vitro (for example, according to 
the method of Ben-Nun fit fil- (1981)).
The data presented in this chapter also show that the astrocyte cultures 
released IFN-a£ when treated with BPLSFV or Infected with SFV. The ability 
of astrocytes to release IFN-afl has also been reported previously by 
Tedeschi and co-workers who treated astrocytes with the interferon inducer 
polyriboinosinic-polyribocytidylic acid (Tedeschi fit fil. , 1986). In the 
present study, IFN-a^ released from BPLSFV-treated astrocytes was also 
found to slightly increase class I MHC antigen expression on astrocytes.
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This observation suggests that IFN-a0 released fros SFV-Infected astrocytes 
within an SFV-infected brain may Increase class I MHC antigen expression on 
astrocytes, and hence enhance the presentation of SFV antigen to SFV- 
specific CTL. The ability of inactivated virus to Induce IFN-O0 production 
has also been reported previously In other systems (Meager and Burke,
1972).
The effect of IFN-<*0 and IFN-y treatment on the ability of BPLSFV-treated 
G26-24 oligodendroglioma cells to present SFV antigen to SFV-speclflc T- 
cells was also Investigated. The data obtained show that neither non-IFN 
treated BPLSFV-treated G26-24 cells nor IFH-afi treated BPLSFV-treated G26- 
24 cells stimulated SFV-specific T-cells to release IFN-y. Since at least 
some non-IFN treated C26-24 cells display class I MHC antigen on the cell- 
surface (see chapter 4 figures 4.18 and 4.19) these observations suggest 
that in this system the class I MHC restricted SFV-specific CTL did not 
release IFN-y. In contrast, IFN-y treated BPLSFV-treated G26-24 cells 
clearly stimulated SFV-specific T-cells to release IFN-7 . Since only IFN-y 
treated G26-24 cells display class II MHC antigen on the cell surface (see 
chapter 4 figure 4.24) these data very obviously suggest that in this 
system the release of IFN-y from SFV-specific T-cells was class II MHC 
restricted. Thus, either class II MHC restricted SFV-specific T-helper 
cells or class II MHC restricted SFV-specific CTL may have released IFN-y 
on recognition of SFV antigen on G26-24 cells. The data presented in this 
chapter also show that the IFN-y released by SFV-specific T-cells, when 
stimulated with IFN-y treated BPLSFV-treated astrocytes, increased both 
class I and class II MHC antigen expression on G26-24 cells. The 
observation that IFN-y treated BPLSFV-treated G26-24 oligodendroglioma 
cells appear to participate in class II MHC restricted T-cell responses 
does not reflect the situation with normal murine oligodendrocytes. Thus,
I 83
IFN-7 treatment does not Induce class II MHC antigen expression on normal 
murine oligodendrocytes either In vitro (Suzumura al-. 1986) or in vivo 
(Wong at Al- . 1984) and IFN--y created oligodendrocytes (derived from 
newborn BIO.A mice) do not present either KLH or egg white lysozyme to 
appropriate class II MHC restricted T-cell hybrldomas (Taklguchl and 
Frelinger, 1986).
In summary, IFN treatment Increased the ability of BPLSFV-treated 
astrocytes and BPLSFV-treated G26-24 cells to present SFV antigen to SFV- 
speciflc T-cella, as assessed by the release of IFN-y. The increase in 
ability to present SFV antigen to SFV-specific T-cells was also found to 
correlate with an Increase in the level of class I or class II MHC antigen 
expression on the astrocytes and C26-24 cells. It is however Important to 
note that the increased ability of BPLSFV-treated astrocytes and BPLSFV- 
treated G26-24 cells to present SFV antigen to SFV-speciflc T-cells may not 
have been due solely to the IFN-induced increase in MHC antigen expression, 
since other membrane molecules may have played a role in the interaction 
between the antigen presenting cells and SFV-speciflc T-cells (for example, 
LFA-1, I CAM -1, LFA-3, CD2 - for discussion see chapter 5) whose roles were 
not Investigated in the present studies.
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Chapter 7
Presence o f  IFN w lch ln  the bra ins o f  SFV-Infected C3H/He n ic e ,  e f f e c t  on
brain sell MAC antUen expression and preliminary studies using R4-6A2
m onoclonal antibody to  determine the ro le  o f  endogenously produced IFN-7
In trod u ction
In the previous chapters, data were presented which show that IFN-ct£ and 
IFN-7  modulate both MHC antigen expression on brain cells and the ability 
of SFV-infected brain cells to participate in T-cell mediated immune 
reactions. It is however important to note that all of these studies were 
performed in vitro, hence may not have any relevance to the situation in 
vivo during SFV-Infection of mice. In this chapter the studies are 
extended to the in vivo system. As mentioned In chapter 1, a number of 
studies have shown that infection of mice with SFV results in the 
appearance of IFH-afi in the serum and brain (Bradish and Allner, 1972; 
Bradlsh *£ «1. . 1975a; Oaten *1.. 1976; Fleming, 1977). That IFN-afi has 
a protective role was shown by experiments in which Intravenous 
administration of anti-IFN-a/9 serum Immediately following infection with 
low doses of SFV was found to result in an earlier and increased mortality 
(Fauconnler, 1970, 1971). To date, no studies have monitored levels of 
IFN-y present in SFV-infected mice, or have used anti-IFN-7  antibody to 
determine the role of endogenously produced IFN-7 . In this chapter the 
effect of avirulent A7(74) SFV Infection of C3H/He mice on both the amount 
of IFN-O0 and IFN-7  present within the brain and the level of MHC antigen 
expressed by cells within the brain is investigated. Furthermore, to 
determine the role of endogenously produced IFN-7 , R4-6A2 rat-anti-murine 
IFN-7  monoclonal antibody (Spitalny and Havell, 1984) is administered to
105
C3H/He mice, prior to infoctlon with the avirulent A7(74) strain of SFV, 
and the effect on the clinical course of SFV disease monitored.
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Presence of IFN within the brains of SFV-infected C3M/He alee and effect an 
brain cell MHC antigen expression
Adult C3H/He alee were intranasally infected with the avirulent A7(74) 
strain of SFV, and at various tines post-infection, brain extracts prepared 
fron duplicate nice. Brain extracts were then treated with ¿-proplolactone 
(BPL) to inactivate live virus prior to IFN assay in the presence and 
absence of nonoclonal antibody to IFN-y. BPL treatment does not affect the 
activity of IFN-afi or IFN-y (Barrett ftfc al., 1984). The data in table 7.1 
show the titres of IFN present in SFV-infected C3H/He nouse brain. It can 
be seen that IFN was present in large amounts at day 3 post-infection and 
reached a maximal level around day 5 post-infection after which time the 
amount present declined. Brains harvested from mice at day 10 post- 
infection (or later) did not contain any detectable IFN. Titration of 
brain extracts in the presence of anti-IFN-7  monoclonal antibody had no 
significant effect on the amount of IFN detected (p < 0.05, see methods 
section P). The activity of an IFN-7  preparation was neutralised by the 
anti-IFN-7  monoclonal antibody in a control experiment. In a separate 
experiment, brain extracts dialysed agalnt pH2 glycine-HC1 buffer were 
found to contain high levels of IFN activity (data not shown). These data 
suggest that IFN-a/J was present in the brain extracts. Since a 0.5 log1Q 
units difference in IFN titre was required for statistical significance 
(see methods section P) it follows that one could have expected the anti- 
IFN-7  antibody to significantly reduce the titre of IFN detected only if 
IFN-7  was present in at least 0.5 log^Q units excess over IFN-O0. Hence, 
the possibility cannot be excluded that at least some IFN-7  may have been 
present.
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Table 7.1
line courae gf tltre« of IFN present in srv-infected adult C3H/H« .ou«« 
brain
Day post* infection Total IFN activity IFN activity In praaenca
brain harvast of «ntl-IFN-y
0 a'*’ <1.60* <1.60
B <1.60 <1.60
3 A 2.23 2.65
B 2.95 3.00
5 A 2.95 2.85
* 3.40 3.30
7 A 1.60 1.60
B 2 .0 0 2.25
10 A <1.60 <1.60
B <1.60 <1.60
14 A <1.60 <1.60
B <1.60 <1.60
IFN-o/3 sample 3.60 3.80
IFN-7 sanple 2.40 <1.60
, A and B refer to brains from duplicate nice harvested on day 
indicated.
. refer to log1Q IFN units for each brain.
(i) 5 to 6 week-old C3H/He alee were intranasally Infected with 6.4 x 105 
pfu (ILD^q ) A7(74) SFV as described in methods section C. At various 
times post-infection brains were harvested from duplicate mice and an 
extract prepared as described in methods section E. Brain extracts 
(and control samples of IFN-a0 and IFN-7 ) were then treated with /?- 
propiolactone to inactivate live virus (Barrett ££ *1., 1984) prior 
to IFN assay in the presence and absence of R4-6A2 monoclonal 
antibody to IFN-7 .
(ii) Differences in titre greater than 0.5 log1Q units are statistically 
significant (see methods section P).
To determine whether SFV-infection of adult C3H/He mice had any effect on 
the level of MHC antigen expressed by cells within the brain, sections were 
prepared froa brains harvested at day 0,3,5,7,10 and 14 post-infection and 
class I (H-2Kk) and class II (H-2Ak) MHC antigens stained by the indirect 
immunoperoxidase technique. Indirect iaaunoperoxidase staining was 
perforaed using a kit (K660) obtained froa Dako Ltd (High Wycoabe, UK) and 
sections were cut froa snap-frozen tissue as described in the instruction 
sheet supplied. However, in a series of experiaents, no specific staining 
of class I or class II MHC antigen was observed, since sections stained 
with anti-H-2Kk or anti-H-2Ak antibody always showed a similar pattern of 
staining as sections stained with an Irrelevant antibody (either anti-H-2Dd 
or anti-H-2Kd) (sections not shown). The non-specific staining was not due 
to the presence of Fc receptors since these were blocked with a normal 
swine serua. Similarly, non-specific staining was not due to the presence 
of endogenous peroxidase activity since this was suppressed by submerging 
the sections in aethanollc hydrogen peroxide. Brains harvested froa SFV- 
lnfected adult C3H/He alee were also mechanically disaggregated and 
subjected to trypsinisation (see methods section F) to produce a single- 
cell suspension of brain cells, since MHC antigens may then be stained by 
indirect laaunofluorescence and quantified by flow cytometry. However, it 
was not found possible to prepare a single-cell suspension froa adult 
C3H/He brains using this protocol.
To determine whether IFN present within the brains of SFV-infected adult 
C3H/He alee had the ability to Increase MHC antigen expression on brain 
cells, extracts prepared froa the brains of SFV-infected mice were added to 
cultures of astrocytes and the effect on class I (H-2Kk) and class II (H- 
2A^) MHC antigen expression investigated, via indirect immunofluorescence
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T«bl. 7.2
ItlKt Of brain H t f c t .  fro. A7<7<.) SFV-Inf.rr.H .dult C3H/H. .,c. on 
t U «» I HHC H-2Kk intlnn tumiliin b» cultur.rt ..tract..
Fluorescence intensity distribution data
Day post-infection Treated with Treated with
brain harvest brain 'A' brain 'B'
0 7* (4%)* 7 (5%)
3 28 (46%) 35 (41%)
5 41 (78%) 69 (85%)
7 28 (47%) 81 (87%)
10 29 (47%) 19 (30%)
14 9 (12%) 12 (19%)
untreated 7 (3%)
treated with IFN-a£ 182 (94%)
treated with IFN-y 425 (94%)
+; data outside brackets refer to mean fluorescence 
*
; data inside brackets refer to percentage of cells collected above a 
5% background fluorescence marker for untreated astrocytes stained 
with anti-H-2Kk.
(I) Adule C3H/H* mice were infected with A7(74) end e breln extract 
prepared (from duplicate mice, brain 'A' and 'B') as described for 
Table 7.1. Brain extracts were added to astrocyte cultures at a 1:6 
dilution. 1000 u/el IFN-a/3 and 100 u/el IFN-y were added to control 
cultures (both IFN-a0 and IFN-y were also treated with 0- 
propiolactone). After 48 hours H-2K*1 antigen on astrocytes was 
•tained by Indirect Immunofluorescence and quantitated by flow 
cytometry.
(I I ) 10 000 cells were analysed in each case.
staining with quantification by flow cytoaetry. The data In table 7.2 show 
the effect of brain extracts on class I MHC H-2Kk antigen expression by 
cultured astrocytes. It can be seen that brain extracts prepared froai alee 
at day 0 post-Infection (l.e. Immediately after Infection) had no effect on 
H-2Kk antigen expression by astrocytes, since the fluorescence of untreated 
cells and cells treated with day 0 brain extracta were Identical. In 
contrast, brain extracts prepared froa alee at day 3, 5 and 7 post- 
Infectlon markedly Increased H-2Kk antigen expression on astrocytes, and to 
a level which correlated with the amount of IFN present In the brain 
extracts (see table 7.1). Similarly, brain extracts prepared from alee at 
day 10 and 14 post-Infection also Increased H-2Kk antigen expression on 
astrocytes. The ability of day 10 and 14 post-Infection brain extracts to 
Increase H-2Kk antigen expression on astrocytes existed despite the absence 
of detectable IFN (see table 7.1). The Increased fluorescence of brain 
extract treated astrocytes was specific for staining H-2Kk antigen since 
the fluorescence of brain extract treated astrocytes stained with an 
Irrelevant antibody was Identical to that of untreated astrocytes stained 
with the same antibody (data not shown). The effect of the brain extracts 
on class II MHC H-2Ak antigen expression on astrocytes was also 
investigated. The data obtained clearly showed that brain extracts 
prepared at day 0,3,5,7,10 and 14 post-Infection had no effect on H-2Ak 
antigen expression by astrocytes, since the fluorescence of untreated cells 
and cells treated with brain extract were Identical (data not shown) .
Newborn (0 to 15 hours old) C3H/He mice were lntraperltoneally infected 
with the avirulent A7(74) strain of SFV and the production of IFN within 
the brain investigated. The reason for using newborn alee was that a 
single-cell suspension can be prepared froa the brains of newborn alee 
(unlike adult alee) hence It was possible to study MHC antigen expression
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T«bla 7.3
H ,M-Cgur»fi Pf titres of IFN-ol and SFV pr«««nt In SFV-Infected newborn 
C3H/He mouse brain
TIm  Post-infection SFV* IFN-a0+ *1
0 hr <10* <3
24 hr 2 .8 x 107 31 ± 10
42 hr *.l » 10* 880 ± 220
; refers to mean p.f.u./brain 
♦ ,; refers to mean ± S.D. IFN-afi activity per brain
(1) Newborn C3H/He nice were infected lntraperitoneally with 8 x 103
p.f.u. A7(74) SFV in 50 pi CHEM medium. At 0, 24 and 42 hours post- 
infection brains were harvested frosi 5 replicate nice as described in 
aethods section E. SFV present in the subsequent brain suspension 
was then assayed by plaque assay. Brain suspension was dialysed 
twice against pH 2 glycine-HCl overnight and once against CM EM mediua 
prior to IFN assay.
on colls within an SFV-infected brain via indirect iaiunofluorescence 
staining with quantitation by flow cytometry. The data in table 7.3 show 
the tltres of IFN-O0 and SFV present in the brains of SFV-infected newborn 
C3H/He nice. It can be seen that the amount of IFN-o/J within the brains 
Increased throughout the course of infection and correlated with the tltre 
of virus present. No IFN-a/9 or SFV were detected in the brains of newborn 
mice treated intraperitoneally with medium alone (data not shown) . In a 
separate experiment all SFV-Infected newborn mice died at around 48 hours 
post-infection (data not shown). Figures 7.1a and b show the effect of 
SFV-infection on class I (H-2Kk) and class II (H-2Ak) MHC antigen 
expression by cells within the brains of newborn C3H/He mice. As shown in 
figure 7.1a, cells harvested from the brains of uninfected mice displayed 
no detectable H-2K*1 antigen since the fluorescence of anti-H-2K^ stained 
cells was identical to that of the same calls stained with an Irrelevant 
antibody (anti-H-2Dd). In contrast, at least some cells harvested from the 
brains of SFV-infected mice displayed H-2Kk antigen since the fluorescence 
of a small proportion of anti-H-2Kk stained cells was clearly higher than 
for the same cells stained with an Irrelevant antibody. Statistical 
analysis of the fluorescence data showed that 6% of cells harvested from 
the brains of SFV-infected mice displayed H-2K antigen on the cell- 
surface. As shown in figure 7.1b, cells harvested from the brains of 
uninfected mice also displayed no detectable H-2A*t antigen since the 
fluorescence of anti-H-2A*C stained cells was identical to that of the same 
cells stained with an Irrelevant antibody. A very small proportion of
cells harvested from the brains of SFV-infected mice appeared to display
k klow levels of H-2A antigen since the fluorescence of some anti-H-2A
stained cells was slightly higher than for the same cells stained with an
irrelevant antibody. Statistical analysis of the fluorescence data showed
that 2% of cells harvested from the brains of SFV-infected mice displayed
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r i t u r g  7 . 1
Effect of A7(74) SFV Infection of newborn alee on cl»«« I and class IIHHC a n tU sn  cxprcuiop by celia  y ith la  the b n ia
FLI: Fluorescence intensity channel
(A) solid line 
spaced dots 
close dots 
dashed line
uninfected, stained with an irrelevant antibody 
Vuninfected, stained with anti-H-2K
infected, stained with anti-H-2K^
infected, stained with an irrelevant antibody
(B) solid line 
spaced dots 
close dots 
dashed line
uninfected, stained with an irrelevant antibody
iruninfected, stained with anti-H-2A
Infected, stained with anti-H-2Ak
infected, stained with an irrelevant antibody
(i) Newborn C3H/H« mice were infected Intreperltoneally with A7(74) SFV 
or treated with medium alone, aa described in methods section C. At 
42 hours post - infection brains were removed and a single cell- 
suspension prepared as described in methods section F. Brain cells 
were then stained with antl-H-2Kk, anti-H-2Ak or anti-H-2Dd 
(Irrelevant antibody) by indirect lasnmofluorescence and analysed by 
flow cytometry.
(11) Debris was excluded from analysis using a forward scatter threshold 
as shown by Wong g£ *1. (1984). 5 000 cells were analysed in each
case.
H-2Ak antigen on the cell-surface. In a separate experiment, the cell-size 
and granularity profile (determined by constructing data analysis dot-plots 
of forward scatter against side scatter) for cells harvested from the 
brains of newborn mice was found to be similar to the profile for blood
cells alone (data not shown). Hence, it is not possible from the data
k kobtained to determine whether the cells which expressed H-2K and H-2A 
antigen were Indeed brain cells (neurones, astrocytes, etc) or cells 
derived from blood.
Brain extracts were also prepared from SFV-infected newborn C3H/He mice, 
added to cultures of astrocytes, and the effect on class I (H-2Kk) and 
class II (H-2A*C) MHC antigen expression investigated via indirect 
immunofluorescence staining with quantification by flow cytometry. As 
shown in figure 7.2a, brain extract prepared from uninfected mice very 
slightly increased H-2Kk antigen expression on a small proportion of 
astrocytes, since the fluorescence of astrocytes treated with brain extract 
was slightly higher than for untreated astrocytes. Brain extracts prepared 
from mice at 24 hours post-Infection clearly increased H-2Kk antigen 
expression on a greater proportion of astrocytes, and brain extract 
prepared at 42 hours post-Infection strongly increased H-2Kk antigen, 
expression on essentially all astrocytes present. Statistical analysis of 
the fluorescence data showed that brain extracts prepared from uninfected 
mice increased H-2Kk antigen expression on 3% of astrocytes, and that brain 
extracts prepared from mice at 24 and 42 hours post-infection increased H- 
2Kk antigen expression on 8% and 78% of astrocytes, respectively. The 
Increased fluorescence of brain extract treated astrocytes was specific for 
staining H-2Kk antigen since the fluorescence of brain extract treated 
astrocytes stained with an irrelevant antibody (anti-H-2D1*) was identical 
to that of untreated astrocytes stained with the same antibody (data not
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Effect of brain extracts from A7(74) SFV-Infected newborn alee gn fiiiU I 
and class II MHC antigen expression bv cultured astrocvtee
FLI: Fluorescence intensity channel
(A) stained »1th .ntl-H-2Kk 
dashed line : untreated
solid line : treated with brain extract from uninfected mice
spaced dots : treated with brain extract from 24 hour-infected mice
close dots : treated with brain extract from 42 hour-infected mice
(t) «Lalmd Kith
close dots : untreated
solid line : treated with brain extract from 24 hour-infected mice 
spaced dots : treated with brain extract from 42 hour-infected mice 
dashed line : treated with 100 u/ml IFN-y (experimental positive
control)
(I) Newborn C3H/H« nice were Infected lntraperltoneely with A7(74) SFV as 
described in methods section C. At 24 end 42 hours post-infection 
brains were harvested and an extract prepared as described in methods 
section E. Brain extracts (and a control sample of IFN-7 ) were then 
treated with ¿-propiolactone to inactivate live virus (Barrett £_£
&1-. 1984) prior to addition to astrocyte cultures at a 1:6 dilution, 
k kH-2K and H-2A antigens were stained by indirect immunofluorescence 
after 48 hours.
(I I ) 10 000 cells analysed in each case.
shown). As shown in figure 7.2b, brsin extracts prepared from uninfected 
nice, and fron nice at 24 and 42 hours post-infection, had no effect on H- 
2Ak antigen expression by astrocytes since the fluorescence of brain 
extract treated astrocytes and untreated astrocytes were identical.
The effect of brain extracts fron SFV-infected newborn and adult C3H/He 
nice on the susceptibility of astrocytes to lysis by alloreactlve CTL was 
also investigated. As shown in figure 7.3, treatswnt with brain extracts 
prepared fron both SFV-infected newborn and adult nice increased the 
susceptibility of astrocytes to lysis by alloreactive CTL, indicating that 
the brain extracts increased the ability of astrocytes to participate in 
class I MHC restricted T-cell nediated immune reactions. This increased 
ability nay be due to an increased level of functional class I MHC antigen 
and/or adhesion nolecule display on the cells. The killing by alloreactive 
CTL was H-2b specific since L929 cells (H-2^) were lysed whereas WEHI 3b 
calls (H-2d) and G26-24 cells (H-2b) were not.
Preliminary studies using the R4-6A2 rat-antl-murine IFH--r monoclonal
antibgdy-tg tetcrmine the role o f IFP-t produced emto&enougly during
S FY -In iftctlo o  gj q h /h s  nice
C3H/He nice (5 to 6 week-old) were treated intraperltoneally with R4-6A2 
rat-anti-murine IFN-y nonoclonal antibody (on day 0 and 5) and at various 
tines post-treatment serum harvested from duplicate nice. The tltre of 
antibody present in serun was then assessed by IFN-7  neutralisation assay 
as described in methods section P. As shown in table 7.4, serum harvested 
fron nice between day 1 and 14 post-treatment contained high tltres of IFN- 
7 neutralising activity, indicating that high titres of R4-6A2 antibody 
were present. Differences in neutralisation tltre of 10®'^ (or greater)
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Tabi« 7■
Feralscance of R4-6A2 anti-IFN--r monoclonal antibody In the u n a  of
adult C3H/Hc mica
Neutralisation titra of harvestad serun+
Day of serum 
harvest*
mouse 'A* mouse 'B*
Prior to treatment <102 <102
day 1 10* >io4
2 >104 >io4
4 103 * >io4
6 >10* >io4
8 10* 10*
10 >104 >104
14 103 ‘ 103 5
+ ; Neutralisation titre of serum refers to the dilution of serum which
neutralised 50% of the antiviral activity of a IFN-7  standard
preparation (titra 1000 u/ml).
; Refers to day after first treatment with R4-6A2 antibody.
(1) 200 i*l of R4-6A2 anti-IFN-7 monoclonal antibody ascites fluid 
(neutralising titre 105'^ ) was administered intraperitoneally to 5 to 
6 week-old C3H/He mice on day 0 as described in methods section D. 
Serum was then harvested from duplicate mice at various times post- 
treatment, as described in methods section E. A further 200 pi of 
R4-6A2 ascites fluid was also administered intraperitoneally on day 5 
post-treatment.
(ii) The neutralisation titre of serum was assessed as described in 
methods section P.
F lP tff 7.2
1 3 10 30
E'T ratio
KlX 1
Astrocytes <H-2k) untreated
(A— A) Astrocytes <H-2k> +■ extract from newborn mouse brain
<■-■> Astrocytes <M-2k) + extract from adult mouse brain
(0— 0) L929 cells (H*2k) untreated
(A— &) G26-24 cells <H-2b) untreated
(O— O) WEHI-3b cells (H-24) untreated
(1) Brain extracts were prepared at 42 hours post-infection from newborn 
C3H/He mice, and on day S post-infection from adult mice, as 
described in methods section E. Brain extracts were then dialysed 
twice against pH2 buffer and once against DMEM medium, prior to 
addition to astrocyte cultures at a 1:6 dilution, for 48 hours prior 
to alloreactive CTL assay.
(ii) Susceptibility to alloreactive CTL lysis was measured in a 4h hour
chromium release assay using Balb/c-anti-C3H/He (H-2<*-anti-H-2'C) CTL,
as described in methods section M.
are statistically significant (p <0.05, see methods section P). However, 
since the neutralisation tltrea were often found to be beyond the upper 
detection limit of the assay used (10*) it is not possible to statistically 
compare many of the neutralisation titres for serum harvested. It can 
however be seen that the neutralisation titre of serum did not drop 
significantly (p <0.05) below 10^ until day 14 post-treatment, at which 
time neutralisation titres of 10^ 4 and 10^'^ were observed. Serum 
harvested from mice prior to treatment with R4-6A2 antibody did not contain 
any detectable IFN-y neutralising activity. In a preliminary experiment, 
brain extracts prepared from mice treated with R4-6A2 antibody were found 
to contain very low titres of IFN-y neutralising activity (data not shown).
The effect of R4-6A2 rat-anti-murine IFN-y monoclonal antibody on the 
clinical course of SFV disease in mice was also investigated. In 
particular, C3H/He mice (5 to 6 week-old) were intraperitoneally treated 
with R4-6A2 antibody (on day 0 and 5) and intranasally Infected with 1LD5Q 
of the avlrulent A7(74) strain of SFV (on day 0). Control mice were not 
treated with R4-6A2 antibody and were Infected with SFV alone. The time 
course of development of clinical symptoms of SFV disease and time of death 
were then studied. As shown in table 7.5, intraperitoneal treatment with 
R4-6A2 antibody had no effect on the percentage of mice surviving Infection 
with SFV. Thus, two non-R4-6A2 antibody treated SFV-infected mice and 
three R4-6A2 antibody treated SFV-infected mice survived Infection. No 
difference in the time of development of clinical symptoms of SFV disease 
(i.e. hunched posture, rear leg paralysis and full paralysis) or time of 
death was observed for non-R4-6A2 antibody treated SFV-infected mice and 
R4-6A2 antibody treated SFV-infected mice (data not shown). Uninfected 
control mice (both untreated and treated with R4-6A2 antibody) remained 
healthy throughout the experiment. In a preliminary experiment, no
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T«bl« 7.5
Effect of anti-IFN-t antibody gn 
with A7<741 SFV
Treatment
antibody/virus Number of mice surviving infection
untreated/uninfected 8/8
untreated/infected with SFV 2/8
R4-6A2/infected with SFV 3/8
R4-6A2/uninfected 8/8
(i) 200 pi of R4-6A2 anti-IFN-y monoclonal antibody aacitea fluid
(nautraliaing titre 10 ,^ see methoda section I) was administered 
intraperitoneally to 6 -week-old C3H/He mice as described in methods 
section D. Mice were then infected with 6.4 x 10^ pfu (ILD^q ) A7(74) 
SFV, as described in methods section C. On day 5 post-infection a 
further 200 pi of R4-6A2 ascites fluid was administered 
intraperitoneally. Clinical symptoms were scored each day until day 
13 post-infection.
difference was observed in the titres of IFN-a/J detected in brain extracts 
prepared from non-R4-6A2 antibody treated SFV-infected nice and R4-6A2 
antibody treated SFV-infected mice (data not shown).
To determine whether R4-6A2 monoclonal antibody had the ability to 
neutralise the activity of IFN-y In vivo it was first necessary to set up a 
model system in which an effect of IFN-y In  vivo could be monitered. The 
ability of R4-6A2 antibody to block this effect of IFN-y in  vivo could then 
be investigated in subsequent experiments. Previous studies by Talmadge £_£ 
al. (1985) had demonstrated that intravenous administration of recombinant 
murine IFN-y (a non-glycosylated bacterial product was used) Increased the 
level of natural killer (NK) cell activity in the spleens of C3H/HeN mice. 
The ability of IFN-y to Increase NK cell activity In vivo thereby provided 
a simple model system. However, since Talmadge and co-workers used a non- 
glycosylated form of IFN-y it was necessary to establish whether the 
'natural' glycosylated fora of recombinant IFN-y also Increased NK cell 
activity in vivo (since the ala of these studies is to determine whether 
R4-6A2 antibody neutralises the effect of the ’natural' from of IFN-y in  
vivo). C3H/He mice were thereby intraperitoneally treated with various 
doses of glycosylated recombinant IFN-y in PBS (IFN-y produced by Chinese 
hamster ovary cells, see materials section E), or PBS alone, and the NK 
cell activity of splenic lymphocytes examined in a chromium release assay 
with Yac-1 cells as targets, as described in methods section M. As shown 
in table 7.6, splenic lymphocytes harvested from C3H/He mice treated with 
PBS alone showed moderate levels of NK cell activity at all effector to
2target ratios studied. Treatment of C3H/He mice with 2.5 x 10 u IFN-y was 
found to very slightly reduce the NK cell activity of splenic lymphocytes. 
In contrast, treatment with 2.5 x 103 u IFN-y somewhat Increased the NK 
cell activity of splenic lymphocytes and 2.5 x 10* u IFN-y very markedly
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labi* Z.6
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Effect of IFN-nr on the natural kllltr cell activity at C3H/H« «QUI* gpltoic
Treatment
Effector : Target ratio 
60:1 30:1 15:1
PBS
2.5 x IO2 U IFN -7
2.5 X IO3 O IFH-7
2.5 x IO4 U IFM-7
29 ± 6 
22 ± 3 
39 ± 5
37 ± 3
23 ± 4 
13 ± 1 
31 ± 2 
42 ± 6
16 ± 3 
« ± 2 
22 ± 2 
44 ± 4
(i) The appropriate concentration of IFN-7  in 200 pi PBS, or 200 pi PBS 
alone, was administered intraperitoneally to duplicate 9 week-old 
C3H/He mice, as described in methods section D. After 19 hours the 
spleens were removed and the lymphocytes harvested over lymphoprep as 
described in methods section L. The non-specific cytotoxic activity 
of the lymphocytes was then tested in a 4.5 hr chromium release assay 
with Yac-1 as target cells, as described in methods section M.
(ii) Data are presented as mean specific percentage lysis ± standard 
deviation for duplicate mice.
Increased the NK cell activity of splenic lymphocytes. The effect of R4- 
6A2 antibody on the ability of IFN-7  to Increase the NK cell activity of 
C3H/He mouse splenic lymphocytes was then Investigated. In particular, 
C3H/He alee were treated lntraperltoneally with either R4-6A2 antibody or 
PBS alone, and 24 hours later treated intraperltoneally with IFN-7 . The NK 
cell activity of splenic lymphocytes was then assessed as before. As shorn 
In table 7.7, Intraperltoneal treatment with R4-6A2 antibody had no effect 
on the ability of IFN- 7  to Increase the NK cell activity of splenic 
lymphocytes, since the NK cell activity of splenic lymphocytes from R4-6A2 
antibody treated IFN- 7  treated mice and non-R4-6A2 antibody treated IFN-7  
treated mice were Identical. Control experiments in vltrg showed that a 
44-fold excess of R4-6A2 antibody was administered over the amount required 
to neutralise the antiviral activity of the IFN-7  administered (data not 
shown).
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Figure 1J.
E ffe ct  o f  anti-lFW -T antibody on a b i l i t y  o f  IFN-7 £a_lncrease the natura l 
k i l l e r  c e l l  a c t iv i t y  o f  C3H/He mouse sp le n ic  ly p h o c v t s i
Treatment Effector : Target ratio
day 'O' ♦ day '1' 60:1 10:1 15:1
PBS + PBS 
R4-6A2 + IFN-7 
PBS + IFN-7
37 ± 2 
S3 ± 2 
31 ± 3 1
32 ± 0 
40 ± 2 
42 ± 3
19 ± 1 
27 ± 1 
26 ± 2
(1) 200 m 1 of R4-6A2 antibody ascites fluid (neutralising tltre 105'5,
see methods section I) or 200 fil PBS were intraperitoneally 
administered to duplicate 9-week-old C3H/He mice. 24 hours later 
7 x 103 U IFN-7  In 200 p1 PBS, or PBS alone, were intraperltoneally 
administered. After a further 19 hours spleens were removed and non­
specific cytotoxic activity of lymphocytes tested in a 4 hour 
chromium release assay, with Yac-1 as target cells, as described in 
methods section M.
(ii) Data are presented as mean ± S.D. percentage lysis for duplicate
mice.
The discussion has been spliC up into two sections, (a) Presence of IFN 
within the brains of SFV-infected C3H/He nice and effect on brain cell MHC 
antigen expression, (b) Preliminary studies using R4-6A2 anti-IFN-7  
monoclonal antibody to determine the role of IFN-y produced endogenously 
during SFV-infection of C3H/He mice.
(a) Presence of IFN within the brains of SFV-injected C3H/He alee and 
effect gp brain call MHC antigen gxvrggslpn
In this chapter the effect of avirulent A7(74) SFV infection of newborn and 
adult C3H/He mice on both the amount of IFN present within the brain and 
the level of MHC antigen expressed by cells within the brain is 
investigated. The data presented show that uninfected newborn and adult 
mice did not possess any detectable IFN activity within the brain. In 
contrast, SFV-infected newborn and adult mice clearly possessed IFN 
activity within the brain. The amount of IFN present within the brains of 
newborn mice, infected intraperltoneally with SFV, was found to increase 
throughout the course of infection (all mice died at day 2 post-infection) 
and correlated with an increase in the titre of virus present. The amount 
of IFN present within the brains of adult mice, infected intranasally with 
SFV, increased until around day 5 post-infection when maximal levels were 
reached, and thereafter declined to an undetectable level by day 10 post­
infection. The IFN type present within the brains appeared to be 
IFN-a/? since activity was stable at pH2 and was not significantly 
neutralised by monoclonal antibody to IFN-y. The possibility cannot be 
excluded that small amounts of IFN-y were indeed present and at a level too 
low to enable detection in the assay system used. Similarly, it
Discussion
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Is possible chac IFN-7  present within ths brains of SFV-lnfactad nice nay 
have been bound tightly to receptors for IFN-7  on brain tissue and was not 
thereby detected in the brain extracts subjected to IFN assay. The fact 
that the increase in amount of IFN-a0 present within the brains of newborn 
nice correlated with an Increase in the of virus present suggests that the 
brain cells released IFN-O0 when Infected with SFV. Numerous studies by 
undergraduates at the Department of Biological Science, University of 
Warwick, have also demonstrated a correlation between the increase in 
amount of IFV-afi and increase in tltre of virus present within the brains 
of adult Balb/c mice infected intranasally with either the virulent L10 
strain or avirulent A7<74) strain of SFV. However, these observations 
differ from those reported previously by Oaten a£ al■ (1976) and Fleming 
(1977) who did not find any correlation between the increase in amount of 
IFN-a¿3 and Increase in titre of virus present within the brains of adult 
Swiss AjC mice infected intracerebrally with the avirulent A7(74) strain of 
SFV and adult Porton mice Infected intraperitoneally with either the 
virulent L10 strain or avirulent A7(74) strain of SFV. The difference in 
results obtained may be a relection of the fact that different strains of 
mice and routes of Inoculation with virus were used.
The effect of avirulent A7(74) SFV-infection on the level of class I (H- 
2Kk) and class II (H-2Ak) MHC antigen expressed by cells within the brains 
of newborn C3H/He mice was also Investigated. The data presented show that 
none of the cells harvested from the brains of uninfected mice displayed 
any detectable H-2Kk or H-2Ak antigen on the cell- surface. These 
observations are consistent with a previous report by Wong al. (1984) 
which demonstrated that less than 1% of cells harvested from the brains of 
uninfected newborn CBA mice displayed detectable class I or class II MHC 
antigen on the cell surface. In the present study, 6% of cells harvested
from the brains of SFV-InfscCsd mice wers found to display H-2K antigen on 
the cell surface, and 2% displayed H-2A^ antigen. Hence, Infection with 
SFV led to an Increase In the number of cells which expressed class I and 
class II MHC antigen within the brains of newborn C3H/He mice. It Is not 
possible from the data obtained to determine whether the cells which 
expressed H-2K^ and H-2A*1 antigen were Indeed brain cells or cells derived 
from blood. A future experimental approach which could be used to Identify 
the cells would be to use a fluorescence activated cell sorter to sort the 
cells which express H-2Kk and H-2A* antigen and then use a range of 
antibodies to stain markers specific for the possible cell types present 
(for further details see chapter 4 discussion). It does at least seem
Itpossible that some brain cells may have expressed H-2K antigen since IFN- 
afi was found to be present within the brains of SFV-Infected newborn mice 
and IFN-a£ Increases class I MHC antigen expression on brain cells (see 
chapter 4). Experiments In which brain extracts prepared from SFV-Infected 
newborn mice were found to Increase class I MHC antigen expression on 
astrocytes In vitro also Indicate that IFN-a/) present within the brains had 
the ability to Increase class I MHC antigen expression on brain cells. The 
fact that brain extracts prepared from SFV-infected newborn mice had no 
effect on class II MHC antigen expression by astrocytes in vitro also 
suggests that no IFN-y was present within the brains. It Is however 
Important to note that IFN-a/) Inhibits the ability of IFN-y to Induce class 
II MHC antigen expression on astrocytes (see chapter 4). Hence, large 
amounts of IFN-a0 present In the brain extracts may have inhibited the 
ability of any low levels of IFN-y also present to increase class II MHC 
antigen expression on the astrocytes. The observation that no class II MHC 
inducing activity was present in the brain extracts also suggests that the 
2% of cells which expressed H-2Ak antigen within the brains of SFV-lnfected 
newborn mice may have Infiltrated Into the brain from blood. A future
V
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experimental approach to determine whether IFN-a0 or IFN-7  increased class 
I or class II MHC antigen expression on cells within the brains of SFV- 
infected newborn mice would be to intracerebrally administer anti-IFN-a0 
and anti-IFN-7  antibody, prior to infection, and monitor the effect on the 
number of cells which express class I and class II MHC antigen within the 
brain.
Technical problems prevented a study of the effect of avirulent A7(74) SFV 
infection on the level of class I (H-2K*C) and class II (H-2Ak) MHC antigen 
expressed by cells within the brains of adult C3H/He mice. However, Id  
vitro experiments demonstrated the ability of brain extracts prepared from 
SFV-infected adult mice to Increase H-2K antigen expression on astrocytes, 
indicating that class I MHC antigen expression may also be Increased on 
cells within the brains of SFV-infected adult mice. Brain extracts 
prepared from mice at day 3, 5 and 7 post-Infection increased H-2K* antigen 
expression on astrocytes to a level which correlated with the amount of 
IFK-afi present. In contrast, brain extracts prepared from mice at day 10 
and 14 post-infection Increased H-2K*C antigen expression on astrocytes 
despite the absence of detectable IFN-a0. Since IFN-a/? only increases H- 
2Kk antigen expression on astrocytes at concentrations which may be 
detected by IFN assay (i.e. above 10 u/ml, see chapter 4 figure 4.13) these 
data suggest that IFN-O0 may not have been the only factor present in the 
brain extracts which was able to increase class I MHC antigen expression on 
the astrocytes. It is possible that IFN-7  may have been present in the 
brain extracts since IFN-7  increases H-2K antigen expression on astrocytes 
at concentrations which cannot be detected by IFN assay (i.e. at 0.01 to 1 
u/ml, see chapter 4 figure 4.14). Very recently it has been shown that 
classical tumour necrosis factor (TNF-o) also Increases class I (but not 
class II) MHC antigen expression on astrocytes derived from C57 BL/6 and
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Balb/c mice (Lavi &£ ¿1., 1988). This observaCion suggests the possibility 
that TNF-a may also have been present in the brain extracts prepared from 
both newborn and adult mice. A possible experimental approach to determine 
whether IFN-7  or TNF-a were Indeed present in the brain extracts would be 
to add anti-IFN- 7  or anti-TNF-a to the brain extracts, prior to addition to 
the astrocytes, and investigate the effect on the Increase in class I MHC 
antigen expression. The observation that astrocytes treated with brain 
extracts prepared from the brains of SFV-infected newborn and adult mice 
were found to be more susceptible to alloreactive CTL lysis indicates that 
the factors present within the brains of Infected mice wore able to 
Increase the ability of brain cells to participate in class I MHC 
restricted T-cell immune reactions. If a similar effect occurred In vivo 
during SFV-Infection of mice the susceptibility of infected brain cells to 
lysis by virus-specific CTL would be increased thereby facilitating the 
clearance of virus from the brain.
The data presented also show that brain extracts prepared from SFV-infected 
adult mice had no effect on class II MHC antigen expression on astrocytes 
in vitro, indicating that class II MHC antigen expression may not be 
increased on cells within the brains of SFV-infected adult mice. However, 
the fact that brain extracts prepared from SFV-infected newborn mice also 
had no effect on class II MHC antigen expression on astrocytes 1b  vitro and 
that 2% of cells within the brains of SFV-infected newborn mice were found 
to display class II MHC antigen does at least indicate that some cells 
which express class II MHC antigen may also be present within the brains of 
SFV-infected adult mice. Cells which express class II MHC antigen within 
the brains of SFV-infected mice may present viral antigen to T-helper cells 
and thereby play a role in the amplification of the immune response within 
the brain. IFN-a0 present within the brains of SFV-infected mice would
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inhibit the replication of SFV in brain cells (see chapter 4 figures 4.1,
4.3 and 4.5) and possibly contain the spread of virus within the brain 
until an imnune response developed.
(b) Preliminary studies using R4-6A2 antl-IFN-y monoclonal antibody to 
determine the role of IFN-ir produced endogenously during...SFV-Infection af 
C3H/Hc alee
It was reasoned that if IFN-y produced endogenously in an SFV-Infected 
mouse functions in the generation or expression of an immune response, then 
the administration of an anti-IFN-y monoclonal antibody, to block IFN-y 
mediated function(s), would result in an exacerbation of disease. Adult 
C3H/He mice were therefore treated with R4-6A2 rat-anti-murine IFN-y 
monoclonal antibody, prior to infection with 1LD5q of the avlrulent A7(74) 
strain of SFV, and the effect on the clinical course of SFV disease 
studied. The data presented show that intraperitoneal treatment with R4- 
6A2 antibody had no clear effect on either the clinical course of SFV 
disease or the number of mice surviving Infection. Since the tiers of R4- 
6A2 antibody present in the serum of treated mice was found to remain at a 
high level throughout the time-course over which the clinical course of SFV 
disease was monitered, these observations suggest that either endogenously 
produced IFN-y did not have any role in controlling infection by SFV, or 
the R4-6A2 antibody did not neutralise the activity of IFN-y in vivo. The 
ability of R4-6A2 antibody to block the induction by exogenous recombinant 
IFN-y of natural killer (NK) cell activity in mouse splenic lymphocytes was 
thereby Investigated in order to determine whether R4-6A2 antibody had the 
ability to neutralise the activity of IFN-y in vivo. The data presented 
show that intraperitoneal treatment with R4-6A2 antibody did not block the 
ability of intraperitoneally administered recombinant IFN-y to increase the
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NK cell activity of mouse splenic lymphocytes. despite the feet that mice 
were treated with a 44-fold excess of antibody over the amount required in 
vitro to neutralise the antiviral activity of the IFN- 7  administered.
Recent studies by Mr R Darley (University of Warwick) have shown that co- 
administration of IFN-7  with a 60 fold-excess of R4-6A2 antibody slightly 
reduced the ability of IFN- 7  to increase the NK cell activity of splenic 
lymphocytes (unpublished observations). These observations suggest that 
the R4-6A2 antibody is able to neutralise the ability of IFN-7  to increase 
the NK cell activity of splenic lymphocytes in vivo, but only when present 
in large excess (in terms of the amount required to neutralise antiviral 
activity in vitro). Whether the R4-6A2 antibody neutralises the antiviral 
activity of IFN-7  in vivo, and whether similar amounts of antibody are 
required as in vitro. remains to be determined.
Schreiber £_£ . (1985) generated 4 monoclonal hybridomas (HI, H2, H21,
H22) that produced anti-murine IFN-7  monoclonal antibody. They found that 
two of the antibodies (HI and H2) had a specificity for an epitope on the 
amino terminus of IFN-7  and two (H21 and H22) had a specificity for an 
epitope on the carboxyl terminus. All of the antibodies inhibited the 
antiviral activity of IFN-7  but only the antibodies directed against the 
carboxyl terminal epitope of IFN-7  inhibited the macrophage activating 
activity (for tumour cytotoxicity) of IFN-7 . These studies suggest that 
there are at least two functional domains on murine IFN-7 . While both of 
the domains appear to be involved in the antiviral activity of IFN-7 , it 
appears that only one of the domains plays a role in the macrophage 
activating activity of IFN-7 . Studies by Langford si al. (1983) have also 
shown that polyclonal antibodies directed to a synthetic peptide 
corresponding to 20 amino-acids of the amino terminus of murine IFN-7  
abrogated the antiviral activity of IFN-7 . Similarly, Gray and
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Rlnderknecht observed that IFN-7  lacking 18 amino-acids of the carboxyl 
terminus displayed less than 1% of the antiviral activity of complete IFN-7  
(reported by Schrelber *1., 1985). Taken together, these studies also 
Indicate that both amino and carboxyl termini are Important for the 
expression of IFN-7  antiviral activity.
Since IFN-7 contains distinct functional domains responsible for different 
activities, it is possible that in the present study the 44-fold excess of 
R4-6A2 monoclonal antibody (in terms of the amount required to neutralise 
antiviral activity In vitro) did not neutralise the ability of IFN-7  to 
Increase the NK cell activity of splenic lymphocytes in vivo because the 
epitope recognised by the R4-6A2 antibody was on a different domain on IFN- 
7 to that which is responsible for mediating the NK cell activity of IFN-7 . 
The epitope on IFN-7  recognised by the R4-6A2 monoclonal antibody remains 
to be determined. Previous studies by Vogel fit gl- (1986) have 
demonstrated that IFN-7  induces an antiviral state, Fc receptor expression 
and class II MHC antigen expression on macrophages in vitro over the same 
dose-response curve. However, 10 to 50 times more R4-6A2 monoclonal 
antibody was required to inhibit the induction by IFN-7  of Fc receptor 
expression and an antiviral state that was required to inhibit induction of 
class II MHC antigen expression. These observations suggest that the R4- 
6A2 monoclonal antibody recognises an epitope on a domain of IFN-7  
responsible for mediating class II MHC antigen Inducing activity and which 
may be distinct from the two domains which mediate antiviral activity.
Taken, together the results of these studies emphasize the point that 
extreme caution must be exercised in interpreting findings in which a given 
anti-IFN-7 monoclonal antibody is either found to be ineffective or only 
partially effective in abolishing an effect believed to be mediated by
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IFN-7 . The aaounc of antibody present and whether the epitope on the IFN-7  
molecule recognised by the antibody has a role in the expression of an IFN- 
7 mediated activity must be given consideration prior to reaching a 
conclusion as to whether IFN-7 mediates an activity, based on the degree of 
neutralisation achieved with the monoclonal antibody. It is possible that 
in the present study treatment of mice with R4-6A2 monoclonal antibody, 
prior to infection with SFV, had no clear effect on either the clinical 
course of SFV disease or number of mice surviving infection because the R4- 
6A2 monoclonal antibody (under the conditions used) did not neutralise the 
activities of IFN-7  which are responsible for controlling infection by SFV. 
A comprehensive study of the ability of R4-6A2 monoclonal antibody to 
neutralise the various activities of exogenous IFN-7  in vivo would define 
the activities of IFN-7 which are neutralised by the R4-6A2 monoclonal 
antibody. The antibody could then be used in studies on the role of IFN-7  
produced endogenously during SFV-infection of mice with the knowledge of 
which activities of IFN-7  nay be neutralised. The use of a range of anti- 
IFN-7  monoclonal antibodies to different functional domains of IFN-7  (hence 
which neutralise different activities of IFN-7) would also provide 
information about the roles of the different activities of IFN-7  during 
infection of mice with SFV. A polyclonal antiserum to recombinant IFN-7  
(recombinant IFN-7  to exclude the possibility of contamination with other 
lymphokines which may be present in natural IFN-7  preparations) could be 
used to study the 'overall' role of IFN-7  produced endogenously during 
infection of mice with SFV. To determine the role of IFN-7  produced 
endogenously during SFV-infection of mice a number of parameters may be 
studied including; time course of development of clinical symptoms of SFV 
disease and death: number of mice surviving infection: number of mice 
surviving infection which are immune to further infection by lethal doses 
of SFV: titre of IFN-a0 and SFV present in the brain, serum and spleen:
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titre of anti-SFV neutralising and cytolytic antibody (both IgM and IgG) in 
serum and brain: development of SFV-specific cytotoxic T-cella: ability of 
T-cells to release IFN-7  in response to SFV antigen presented by accessory 
cells: level of class I and class II MHC antigen expression on both brain 
cells and cells present in blood.
Since the blood brain barrier normally prevents the entry of antibody into 
the brain (Uekerle $£ ai., 1986b) it is possible that intraperitoneally and 
intravenously administered anti-IFN-7  antibody may not enter the brain. 
Hence, even if anti-IFN-7 antibody had the ability to neutralise all 
activities of IFN-7  in vivo it may not reach sites of IFN-7  production 
within an SFV infected mouse brain. In the present study, brain extracts 
prepared from uninfected mice treated intraperitoneally with R4-6A2 
monoclonal antibody were found to contain very low titres of IFN-7  
neutralising activity. However, these low titres of IFN-7  neutralising 
activity may be accounted for by the presence of R4-6A2 antibody in serum 
within the capillaries of the brain rather than by R4-6A2 antibody actually 
crossing the blood brain barrier and entering the brain. Since the blood 
brain barrier also normally prevents the entry of T-cells into the brain 
(Uekerle al. , 1986b), and IFN-7  is produced exclusively by activated T- 
cells, the question arises as to whether IFN-7  would ever be produced 
within a brain which has an intact blood brain barrier. This does seem 
likely since activated T-cells (but not resting T-cells) have been shown to 
attach to endothelial cells and subsequently penetrate the barrier 
(possibly via the release of endoglycosidase, Naparstek e£ Al-. 1983,
1984). It is possible that during acute SFV-encephalitis the blood brain 
barrier may break down thereby allowing anti-IFN-7  to enter the brain. 
Future experiments in which anti-IFN-7  is intracerebrally administered to 
mice, prior to infection with SFV, may provide an insight into the role of 
IFN-7  (if it is present) within the brain.
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Chapter 8
Final discussion
The aims of this thesis were to investigate the ways in which IFN treatment 
may modulate the ability of SFV-infected brain cells to participate in T- 
cell mediated immune reactions, and to study the role of IFN-7  produced 
endogenously during SFV-infection of mice via administration of a 
neutralising monoclonal antibody to IFN-y. In this final chapter, the 
major points of the thesis will be interrelated, and the possible 
significance during SFV-infection of mice discussed. The possible 
significance of these studies to the understanding of the roles of IFNs in 
human disease will also be discussed.
As mentioned in chapter 1, SFV exists in essentially two forms, avirulent 
and virulent (wild type). In adult mice, the avirulent form produces a 
self-limiting demyelinating disease which is usually subcllnlcal, whereas 
the virulent form causes a rapid lethal encephalitis. The role of T- 
lymphocytes in recovery from avirulent SFV-infection has been studied using 
nude (nu/nu; T-cell deficient) mice, and by analysing the activity of T- 
lymphocytes from infected mice (Atkins ££ fil., 1985). Jagelman ££ •
(1978) showed that the brains of nude mice, Infected with avirulent SFV, 
did not have focal demyelinating lesions, whereas lesions were present in 
infected phenotypically normal (nu/+) control mice. Furthermore, clearance 
of virus from the brains of avirulent SFV-infected nude mice was both 
delayed and incomplete (Jagelman £_£ &1. , 1978). Bradish £_£ ¿1 ■ (1979) and 
Fazakerley £_£ al. (1983) confirmed that clearance of virus from the brains 
of avirulent SFV-infected nude mice was incomplete, and showed that T-cell 
dependant IgG neutralising antibody synthesis and efficient clearance of
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virus could be rescored by the crensfer of spleen cells from immune 
competent phenotypically normal (nu/+) control mice. Fleming (1977) also 
showed that the appearance of T-cell dependant (IgG) neutralising antibody 
within the brains of avirulent SFV-infected Porton mice correlated with a 
decline in the titre of virus in the brain, and suggested that the antibody 
may be involved in the clearance of virus from the brain. Reconstitution 
of avirulent SFV-Infected nude mice with purified T-cells from SFV 
sensitized mice, or with spleen cells from SFV sensitized and unsensitized 
mice, also resulted in the formation of demyellnating lesions in the brain 
(Fazakerley al-, 1983, 1987). In contrast, no demyelinating lesions 
were found in the brains of avirulent SFV-Infected nude mice reconstituted 
with SFV-sensitized spleen cells depleted of T-cells (Fazakerley at &1- • 
1987). Taken together, the results of these studies clearly Indicate a 
role for T-cells in both the clearance of virus and formation of 
demyelinating lesions. It is however important to note that T-cells may 
not be the only component of the immune system involved in the formation of 
demyelinating lesions. Thus, Berger (1980) carried out reconstitution 
experiments following immune suppression of avirulent SFV-infected CBA mice 
with cyclophosphamide and showed that SFV-sensitized spleen cells depleted 
of T-cells could reconstitute lesions, as could spleen cell populations 
depleted of B-cells. When both T and B cells were depleted, no lesions 
developed, and lesions were most severe when both T and B cells were 
present.
Since the blood brain barrier normally prevents the entry of T-cells into 
the brain, and brain cells do not usually express MHC antigens (which are 
required for T-cell recognition of antigen), the question arises as to how 
T-cells may be involved in the clearance of virus and formation of 
demyelinating lesions within an avirulent SFV-infected mouse brain. Based
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upon the observations made in this thesis, and previous studies by other 
workers, it is possible to present a hypothetical model for the mechanism 
whereby T-cells participate in the immune response during SFV-infection of
mice.
Intraperitoneal infection of adult mice with the avirulent strain of SFV 
results in viraemia which is accompanied by an increase in the titre of 
virus present in the spleen, and is followed by an increase in the titre of 
virus present in the brain (Bradish and Allner, 1972). IFN-a/J present in 
the serum and brain early in infection may play a role in controlling viral 
replication to some extent, as shorn by experiments in which administration 
of antl-IFN-a£ serum to SFV-Infected mice was found to result in increased 
virus tltres in the brain and increased mortality (Fauconnier, 1970, 1971). 
SFV present in the spleen may be processed by macrophages (and possibly 
also by dendritic cells in lymph nodes) and presented to SFV-speciflc T- 
helper cells leading to the initiation of the SFV-specific T-cell response. 
The clearance of viraemia is associated with an Increase in T-cell 
independent (IgM) anti-SFV neutralising antibody in serum at around day 4 
post-Infection (Fleming, 1977; Bradish £_£ al-. 1979), and may also be 
mediated to some extent by natural killer cells (possibly activated by IFN- 
afi in serum: Macfarlen a£ al-. 1977; DJeu a£ al-. 1979). The increase in 
T-cell Independent (IgM) anti-SFV neutralising antibody in serum is not 
associated with a reduction in the titre of virus in the brain, possibly 
due to the inability of IgM to cross the blood brain barrier (Fleming,
1977; Bradish at Al-. 1979). SFV-specific CTL activity in the spleen 
reaches a detectable level at around day 5 post-Infection, and is maximal 
around day 7 post-infection (Blackman and Morris, 1984). The ability of 
spleen cells to release IFN- 7  in response to SFV antigen also develops in 
parallel to SFV-specific CTL activity (Blackman and Morris, 1984). It is
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possible chat SFV-specific CTL «ay also play a rola in the final clearance 
of SFV-infected cells from sites outside the brain. Futheraore, IFN-a0 
present in serum early in infection may Increase class I MHC antigen 
expression on cells at a number of sites outside the brain and hence 
Increase the recognition of SFV-Infected cells by SFV-specific CTL. T-cell 
dependant (IgG) anti-SFV antibody is secreted from about day 5 post- 
inf action, and is the predominant form of antibody present in serum at day 
7 post-Infection (Fleming, 1977). The appearance of T-cell dependant (IgG) 
antibody in the brain at around day 5 post-infection correlates with a 
rapid decline in the tltre of virus (Fleming, 1977). The appearance of IgG 
antibody in the brain may not however reflect a general breakdown of the 
blood brain barrier since the subclasses detected were IgG2a and 
which are reported to permeate membranes with great facility (Fleming,
1977). Interleukin-1 (IL-1: T-cell activation factor) and IFH-y released 
into serum during the T-cell activation process would Increase 
intercellular adhesion molecule-1 (ICAM-1) expression on endothelial cells 
(Dustin fit ai- , 1986) and thereby facilitate the binding of SFV-specific T- 
cells bearing lymphocyte function associated antigen-1 (LFA-1, the receptor 
for ICAM-1: Springer fit fil-, 1987). McCarron fit ai- (1985) showed that 
treatment of brain endothelial cells with concanavalin-A conditioned medium 
(which contains IFN-y) resulted in the induction of class II MHC antigen 
expression and ability to present guinea pig basic protein to sensitized 
lymph node cell cultures depleted of macrophages-monocytes. IFN-y present 
in the serum of an SFV-infected mouse may thereby also induce class II MHC 
antigen expression on brain endothelial cells and enable the cells to 
present SFV antigen to SFV-specific T-helper cells leading to the further 
amplification of the T-cell response. Activated SFV-specific T-cells bound 
to brain endothelial cells may then penetrate the blood brain barrier via 
the release of endoglycosidases (Naparstek fi£ fil., 1983, 1984). Having
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arrived in the brain, SFV-«pecific CTL would be able to recognise SFV 
antigen on astrocytes, oligodendrocytes and neurons since IFN-a£ produced 
in the brain early in infection would have induced class 1 MHC antigen 
expression on the cells. SFV-specific CTL may thereby lyse SFV-infected 
brain cells and hence play a role in the clearance of virus from the brain. 
Furthermore, IFN-y released by SFV-specific CTL on recognition of SFV 
antigen on brain cells may Induce class II MHC antigen expression on 
astrocytes and enable the cells to present SFV antigen to SFV-specific T- 
helper cells within the brain. Frei fe£ fll- (1987) showed that recombinant 
IFN-y treatment of murine microglial cells resulted in the Induction of 
class II MHC antigen expression and ability to present ovalbumin to 
ovalbumin-specific T-helper cells. IFN-y released by SFV-speclflc CTL on 
recognition of SFV antigen on brain cells may thereby also Induce class II 
MHC antigen expression on microglial cells and enable the cells to present 
SFV antigen to SFV-specific T-helper cells. Both astrocytes and microglial 
cells have been shown to release IL-1 (Fontana fe£ &1. , 1982; Glulian fe£ 
al. . 1986). The significance of intracerebral IL-1 synthesis may be 
fundamental to further T-cell activation within the brain since IL-1 
enhances T-cell production of Interleukln-2 (IL-2, T-cell growth factor) 
and the expression of IL-2 receptors on T-cells (Fontana a£ al-. 1987). It 
is possible that IFN-y released by SFV-specific CTL on recognition of SFV 
antigen on brain cells may not actually Increase class II MHC antigen 
expression on astrocytes and microglial cells until the amount of IFN-a£ 
within the brain declines at around day 7 post-Infection, since IFN-a0 was 
shown to inhibit the ability of IFN-y to induce class II MHC antigen 
expression on brain cells. Astrocytes have also been shown to release 
interleukin-3 (IL-3, multiple colony stimulating factor, mast cell growth 
factor, P (persistant)-cell stimulating factor: Frei fetal., 1985), 
prostaglandin E (PGE: Fontana fe£ fel-, 1982), and tumour necrosis factor
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(TNF, whether a or 0 not specified: Robbins &1-. 1987). Microglial
cells also release TNF-a (Frei al-. 1987). PGE and IL-3 have been shown 
to Inhibit the ability of IFN-y to Induce class II MHC antigen expression 
on macrophages and mast cells, respectively (Snyder a£ Al-. 1982; Wong at 
al-, 1984b). Whether PGE and IL-3 Inhibit the ability of IFN-y to induce 
class II MHC antigen expression on astrocytes and microglial cells remains 
to be determined. However, if this was Indeed the case, IL-3 and PGE 
released by astrocytes during the Inflammatory processes within the brain 
may also represent an important negative feedback mechanism during the T- 
cell activation process. IFN-y released by SFV-specific CTL and helper T- 
cells on recognition of SFV antigen on brain cells, and TNF released by 
astrocytes and microglial cells, would also increase class I MHC antigen 
expression on astrocytes (Lavl ££ ai., 1988), as well as on
oligodendrocytes, microglial cells and neurons for the case for IFN-y (Wong 
et al. . 1984), hence increase the susceptibility of the cells to SFV- 
specific CTL lysis. IFN-y would Increase class I MHC antigen expression in 
the presence of IFN-o/3, at least on astrocytes, since IFN-a0 and IFN-y were 
shown to have an additive effect with regard to the augmentation of class I 
MHC antigen expression. Interleukin-1 has been shown to stimulate the 
proliferation of astrocytes (but not oligodendrocytes) (Glullan and 
Lachman, 1985). Similarly, IL-3 induces the growth of microglial cells 
(Frei ££ al-, 1986). IL-1 and IL-3 present in an SFV-infected brain may 
thus stimulate the proliferation of astrocytes and microglial cells, and 
thereby essentially replace those cells lysed by the virus or by SFV- 
specific CTL. This would also ensure the maintenance of a high number of 
cells which may be induced to express class II MHC antigen, hence which may 
present SFV antigen to SFV-specific T-helper cells within the brain. As 
mentioned above, the appearance of IgG antibody in the brains of SFV- 
infected mice at around day 5 post-infection correlates with a rapid
decline In Che eicre of virus. Since uncreated microglial cells have been 
shown to express Fc receptors and to possess a phagocytic activity (Frei at 
al.. 1987) it does at least seem a strong possibility that microglial cells 
may play a role in the clearance of virus from the brain. The activities 
of T-cell dependent anti-SFV IgG neutralising antibody, IFNs-o^ and -7 , IL- 
1, -2 and -3, TNF. astrocytes, microglial cells, SFV-speclflc CTL and T- 
helper cells may thereby account for the clearance of virus from the brains 
of avirulent SFV-infected mice, at around day 10 post-infection (Jagelman 
11 al.. 1978).
A possible experimental approach to determine whether SFV-specific CTL 
actually play a role in the clearance of virus from the brains of SFV- 
infected mice would be to administer antl-Lyt 2 antibody to mice prior to 
Infection with SFV. Since class I MHC restricted CTL express the Lyt 2 
antigen (Hale g£ gl., 1987) this procedure would ensure the depletion of 
class I MHC restricted SFV-speciflc CTL generated in response to SFV- 
infection and allow comparison of the titres of virus in the brain with and 
without the presence of class I MHC restricted SFV-speciflc CTL.
Similarly, the role of SFV-specific T-helper cells in the production of T- 
cell dependent IgG antibody and the generation of SFV-speclfic CTL could be 
studied via the administration of anti-L3T4 antibody to mice, prior to 
Infection with SFV, since this procedure would ensure the depletion of SFV- 
specific T-helper cells which express the L3T4 antigen (and also class II 
MHC restricted SFV-specific CTL which express L3T4 antigen: Male g£ al - , 
1987). The experimental protocol used may be based on that by Ranges g£ 
al. (1987) who used anti-L3T4 monoclonal antibody to study the role of 
L3T4+ cells in humoral and cell-mediated responses to tentanus toxoid. The 
role of IFN-a/?, IFN-7 , TNF and IL-3 in the Induction or inhibition of class 
I and class II MHC antigens on cells within the brains of SFV-infected mice
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may be studied by Intracerebral administration of neutralising antibody to 
each of these cytokines, prior to infection with SFV, and subsequent 
analysis of brain cell MHC antigen expression. The fact that Intracerebral 
administration will damage the blood brain barrier must however be 
considered when interpreting the results of such a study.
Jagelman g_£ al.. (1978) reported that demyellnation first began at the time 
just after virus had been cleared from the brain. Demyellnation may be an 
indirect result of the release of myelin antigens brought about by lysis of 
oligodendrocytes, the myelin producing cell in the brain (Atkins At ¿1., 
1985). Thus, lysis of oligodendrocytes due to the direct cytopathic effect 
of SFV (Atkins and Sheahan, 1982; Atkins, 1983), the activity of SFV- 
specific CTL, or the presence of TNF (Robbins At al. . 1987), may result in 
the release of myelin antigens which are normally sequestered from the 
Immune system. Astrocytes, endothelial cells, and possibly microglial 
colls, expressing class II MHC antigens may then present myelin antigen to 
myelin-specific T-helper cells (Fontana At al. . 1984; Fierz At &1- , 1985), 
and T-cells thus sensitized could mount a demyelinatlng autoimmune attack 
on the brain (Zamvll At Al-• 1985). Since only activated T-cells appear to 
cross the blood brain barrier (Naparstek et al.. 1983, 1984; Uekerle At 
al.. 1986), non-actlvated myelin specific T-helper cells may only enter the 
brain and hence recognise myelin presented by astrocytes and microglial 
colls after a breakdown of the blood brain barrier due to SFV infection. 
Evidence that astrocytes may indeed be involved in the formation of 
demyelinating lesions has been obtained by light and electron microscopic 
studies of sections prepared from the brains of SFV-Infected mice. Thus, 
Kelly At al. (1982) reported that astrocyte processes were expanded in most 
demyelinatlng areas, and Pathak At al. (1983) reported that astrocytes 
could be easily seen in lesion areas, particularly surrounding demyelinated
? ! ^
axons. Furthermore, the development of demyelinating lésions was shown to 
be accompanied by an infiltration of lymphocytes possessing characteristic 
projections which extended deep into the cytoplasm of adjacent astrocytes 
(Kelly a 1>. 1982; Pathak at ¿1-, 1983). Macrophages were also found to 
be present in the lesion areas and again projections of lymphoblastic cells 
were seen projecting into the cytoplasm of these cells without any obvious 
damage being caused (Pathak at Al- • 1983). Degenerated myelin was also 
observed in both astrocytes and macrophages (Pathak ai Ai-. 1983). The 
origin of the macrophages observed was not clear although Pathak ai Al-
(1983) suggested that at least the majority of macrophages may have 
infiltrated into the brain from blood, whilst some may be derived from 
activated microglial cells. It is tempting to speculate that the 
astrocytes, macrophages, and at least some activated microglial cells may 
have been presenting myelin to myelin-specific T-cells around these 
demyellnating lesions. It would be interesting to determine in future 
experiments whether the astrocytes and macrophages which interacted with 
lymphocytes around the demyelinating lesions actually expressed class I and 
class II MHC antigens. Similarly, it would be of Interest to determine the 
actual identity of the lymphocytes which interacted with the astrocytes and 
macrophages. This may be achieved by the indirect immunochemical staining 
of brain sections with antibody to Lyt 2, L3T4, class I MHC antigen or 
class II MHC antigen and visualisation by light microscopy. Furthermore, 
the Importance of class II MHC antigen expression in the development of 
demyelinating lesions could be investigated by studying the effect of 
intracerebral administration of anti-class II MHC antigen antibody. It 
would also be interesting to determine whether intracerebral administration 
of anti-IFN-y antibody prevents the induction of class II MHC antigen 
expression on brain cells and the development of demyelinating lesions.
Another experimental model of demyellnation in mice and rata, experimental 
allergic encephalomyelitis (EAE), does not involve virus infection, but is 
induced by the injection of myelin together with adjuvants (Craggs and 
Webster, 1985). The formation of lesions in EAE has also been shown to be 
mediated by an autoimmune T-cell reaction directed against myelin basic 
protein (MBP) (for review see Wekerle a£ fl_L- , 1986b). Furthermore, it has 
been shown that class II MHC antigen expression is dramatically Increased 
around lesions of EAE in rat brains (Craggs and Webster, 1985; Vass &£ al-.
1986). Craggs and Webster (1985) and Vass al. (1986) both identified
macrophages which expressed class II MHC antigen around lesions. Craggs 
and Webster (1985) also suggested that some class II MHC antigen positive 
astrocytes may have been present, while Vass ai- (1986) reported that 
activated microglial cells expressed class II MHC antigen and astrocytes 
did not. In both studies, the cells expressing class II MHC antigen were 
proposed to have a role in antigen presentation which led to the 
development of EAE lesions.
The results of these studies may assist in the understanding of the 
pathogenesis of the most common demyelinating disease of man, multiple 
sclerosis, which has been proposed to have a viral aetiology (McKhann,
1982). Traugott &£ al. (1983) showed that the progression of demyelinating 
lesions in multiple sclerosis was associated with the presence of large 
numbers of T-helper and cytotoxic T-cells around the lesion margin, and 
that class II MHC antigen positive macrophages were present within lesions. 
Subsequent studies also demonstrated both class I and class II MHC antigens 
on astrocytes and endothelial cells, as well as class II MHC antigen on 
macrophages (Traugott and Ralne, 1985; Traugott, 1987). While class I and 
class II MHC antigen positive astrocytes were mainly found at the edge of 
active lesions, endothelial cells expressing class I and class II MHC
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antigen were found to be randomly distributed throughout the brain 
(Traugott and Ralne, 1985; Traugott, 1987). These observations suggest 
that class II MHC antigen positive astrocytes and macrophages may present 
myelin to T-helper cells during lesion development. Class II MHC antigen 
positive endothelial cells may also present myelin to T-helper cells in 
blood and thereby amplify the autoimmune T-cell response. Myelin-specific 
class I restricted CTL may lyse class I MHC antigen positive astrocytes 
(and oligodendrocytes) which have bound fragments of myelin, and hence play 
a role in the formation of lesions. The factor(s) involved in the 
Initiation of a T-cell autoimmune response and the induction of class I and 
class II MHC antigen expression on brain cells in multiple sclerosis are 
not yet known. The results of these studies do however at least suggest a 
possible mechanism. Thus, some virus infection of the brain (possibly 
subclinical) may result in the release of IFN-a£ which Increases class I 
MHC antigen expression on brain cells. Activated infiltrating virus- 
specific CTL may then lyse virus-Infected brain cells, and release IFN- 7 on 
recognition of viral antigen. IFN- 7 thus released would increase class I 
and class II MHC antigen expression on astrocytes, microglial cells and 
infiltrating macrophages. Oligodendrocyte lysis due to either the 
cytopathic effect of the virus, the presence of TNF, or the activity of 
virus specific CTL may result in the release of myelin which may then be 
presented to infiltrating myelin specific T-helper cells by class II MHC 
antigen positive astrocytes, microglial cells or macrophages leading to the 
Initiation of the myelin-specific autoimmune T-cell response.
Panitch ££ ai. (1987) recently reported that intravenous administration of 
recombinant IFN-y resulted in an increase in the number of circulating 
monocytes which expressed class II MHC antigen, and led to an exacerbation 
of multiple sclerosis. It is possible that the exacerbation of disease may
2!6
have been due Co an increase in Che number of class II MHC anCigen poslClve 
macrophages which infilcraCed inCo Che brain and subsequencly played a role 
in lesion development In concrasc, lncracerebral adminiscracion of 
nacural IFN-/3 has been shown Co reduce exacerbaClons of mulclple sclerosis 
(Jacobs al. . 1981; Jacobs al. . 1986), possibly due Co Che abllicy of 
IFN-/9 Co InhibiC Che inducción by IFN-y of class II MHC anCigen expression 
on brain cells. IC may be CherapeuCically important Co decermine whether 
intracerebral administration of anti-IFN-y or ancl-class II MHC anCigen 
antibody reduce exacerbaCions of mulclple sclerosis.
The results of chese studies also suggest a possible mechanism whereby IFNs 
may play a role in Che immune response Co viral infección of Che human 
brain. Thus, IFN-O0 produced by brain cells in response to virus infección 
may help to contain the spread of virus until Che cellular and humoral 
immune responses develop. Furthermore, IFN-a£ would also increase class I 
MHC antigen expression on brain cells, and chereby Increase recognición of 
brain cells by infiltrating virus-specific CTL. Virus-specific CTL may 
Chen lyse virus-infected brain cells, and also release IFN-y on recognition 
of viral antigen. IFN-y thus released would increase class II MHC antigen 
expression on ascrocytes, microglial cells and infiltrating macrophages, 
and thereby enable Chese cells to present viral antigen to T-helper cells 
wichin the brain. Evidence chat IFN may indeed be present in Che brains of 
humans with viral encephalitis was obtained by Luby ££ al■ (1969) who 
showed Chat IFN was present within the brains of patients who were dying 
from St Louis encephalitis virus (the class of IFN detected was not 
specified and the assay procedure used would have enabled the detection of 
both IFN-<*0 and IFN-y).
Further experiments on the interactions between brain cells and components
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of the Immune system nay provide a clearer understanding of the roles of 
the immune system In both resistance to viral disease and the pathogenesis 
of autoimmune disease. It may then be possible to develop strategies of 
immunomodulation for therapeutic purposes.
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Infection of Cultured Murine Brain Cells by Semliki Forest Virus: Effects 
of Interferon-«/? on Viral Replication, Viral Antigen Display, M^jor 
Histocompatibility Complex Antigen Display and Lysis by Cytotoxic T 
Lymphocytes
By A  M O R R IS .*  P. T .  T O M K I N S .  D .  J .  M A U D S L E Y  AN D  M . B L A C K M A N f
D epartm ent o f  Biological Sciences. U n iversity  o f  W arw ick, C oventry C V 4  7A L .  U .K .
{A ccep ted  10  S ep tem ber 1986 )
Primary brain cell cultures prepared from newborn mice were infected with Sem liki 
Forest virus (SFV ). The effects of interferon (IF N u /J) treatment on S F V  replication,
S F V  and major histocompatibility complex (M H C ) class I antigen expression, and 
susceptibility to lysis by SFV-specific cytotoxic T  lymphocytes (C T L )  were determined.
The IF N -s /I  treatment prevented replication of S F V  as determined by incorporation of 
(3H]uridine into S F V  R N A  and very markedly reduced the expression of S F V  antigens 
on the cell surface as determined by lysis with antibody and complement or indirect 
immunofluorescence. However. IF N -* /J increased expression of M H C  class I antigens, 
measured by indirect immunofluorescence and as assessed indirectly by susceptibility 
to killing by alloreactive T  cell lines. S F V  infection had no effect on M H C  class I 
expression in either IFN-«/)-treated or -untreated cells. The infected IFN-a/?-untreated 
brain cells were susceptible to killing  by the C T L  at effector/target ratios in  the range 3 
to 30. The killing  was M H C  antigen-restricted, and uninfected cells were not killed. A 
target cell (Y A C )  highly susceptible to natural killer cell cytotoxicity was not killed by 
the C T L .  IF N -« /j treatment prior to S F V  infection resulted in an augmentation of lysis 
by the C T L .  indicating that even where S F V  antigen expression is reduced, in the 
context of enhanced M H C  class I expression brain cells remain susceptible to C T L  
killing.
IN TR O D U C T IO N
Infection of mice with virulent strains of Sem liki Forest virus (S F V ) which replicates to very 
high litres in the central nervous system (C N S ) results in a severe encephalitis and death of the 
mice (Atkins e ta ! . ,  1985). The mechanism of the encephalitis is unclear; it may be due either to 
direct cvtopathic effects of the virus replication in brain cells (Gates e l a t ., 1985) o r to immune- 
mediated damage to infected cells. Evidence from reconstitution of SFV-infected nude mice 
with normal spleen cells (Fazakerley e t a!.. 1983) and adoptive transfer of SFV-sensitized spleen 
cells (Berger. 1980) suggests a contribution of cell-mediated immunity to the pathological 
process.
There are several ways in which cell-mediated immunity might result in encephalitis. One of 
the most obvious is that SFV-specific cytotoxic T-lymphocytes (C T L )  infiltrating into the 
infected brain could lyse infected brain cells. However, for C T L  lysis to occur, the target cell 
must bear not only 'foreign' (in this case viral) antigen but also self major histocompatibility 
complex (M H C ) class I antigens (Zinkem agel &  Doherty. 1974, 1979). B rain cells normally 
express very little M H C  class I antigens (Vitetta &  Capra, 1978) and hence should be relatively 
insusceptible to C T L  lysis. However, during S F V  infection large amounts of interferon (IFN -a/I)
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may be present in  the brain (A. G . M orris St N. J. D im m ock. unpublished observations); IF N - 
afi is known to stimulate M H C  antigen expression in a range of cell types, including brain cells 
(Wonger a!., 1983). Therefore an obvious possibility is that IF N -o $  produced during infection of 
mice by S F V  stimulates M H C  antigen expression in infected brain cells, thus making them more 
susceptible to lysis by C T L .  We have previously shown that IFN -a/J treated SFV-infected 
fibroblasts or lymphoblastoid cells (which normally express M H C  antigens) remain susceptible 
to C T L  despite complete inhibition of S F V  replication in these cells (Blackman St Morris, 1983). 
We have now extended these observations to primary brain cell cultures derived from newborn 
mice in order to study whether this occurs in S F V ’s major target cells. We find that IFN -a/f 
treatment of these cells induces raised expression of M H C  class 1 antigen; S F V  replication is 
then blocked and the display of S F V  antigens markedly reduced; however. C T L  lysis is 
augmented.
RDM4 (H-2*) and Y A C  (a natural killer cell target) were cultured in RPMI 1640 medium (Gibco) supplemented 
with 10% foetal calf serum (Gibco).
Bicester, 1‘ a . ) which arc H-2* and H-2* respectively. Brains were removed from the mice, meninges separated by
at 37 *C) to reduce viscosity due to released DN  A  The resulting cell suspension was pelleted at low speed, washed
(Calbiochcm; from Cambridge Bioscicncc. U  K .) or anti-glial fibrillary acidic protein (G FAP) (Dako. High
GFAP* astrocytes. This method of preparation of brain cells is essentially that of Bruce r i a I (I9W)
previously described (Blackman & Morris, 1985). Brain cell cultures were treated with 1000 (reference research)
for 2 days prior to cytotoxicity assays. Control cultures were left untreated. The cultures were treated with “ Cr 
( “ CrjiSOJj from Amcrsham) at 20pCi/ml overnight and the next morning mock infected or infected with SFV 
(m.o.i. 30. 300 or 1000 in different experiments). Cells were harvested by treatment with E D TA  |04)2% ut 
phosphate-buffered saline (PBS)) for 15 min at 37 *C. counted and distributed into the wells of 96-well microtilrc 
plates at 2 * 10* ceUs/well. SFV-spccific effector C T L  were harvested and washed and added to the target ceUs in 
wells at about 4 h post-infection to give effector :target (E :T )  ratios ranging from 3:1 to 30:1. 5'Cr release was 
determined after a further S h and specific release was calculated by the formula %  lysis -  100 * ((release in 
presence of effectors -  spontaneous release)/(total release -  spontaneous release)), where total release was that in 
the presence of 0-5 M-hydrochloric acid.
In some experiments cytotoxicity against the lympboblastoid cell targets EL4. RDM4 (infected or uninfected) 
or YAC (uninfected) was determined (depending on the numbers of effector cells available) to monitor 
cytotoxicity observed against the brain cell targets
AUorcactivc C T L  killing was determined in essentially the same way but omitting the SFV infection
expression on the surface of infected cells was determined in parallel to the cytotoxicity assays SFV antigens were 
measured either by 5,Cr  release in the presence of SFV-specific antibodies and complement (Pel-Freez, from 
North-East Biomedical. Uxbridge, U.K.). or by indirect immunofluorescence, quantified by flow cytometry.
lymphoblastoid cells but some reactivity with uninfected fibroblasts, (ii) Monoclonal anti-H-2K‘  from hydridoma 
clone 11.4.1 (A T C C , TIB95). (iii) Monoclonal anli-H-2D* from clone 15-5-55 (A TC C . HB24) generously
METHODS
Viruses and ce lls. The avirulcnt strain of SFV (A774; Bradish e ia l. 1971) was used for immunization of mice and 
the virulent LI0 strain for in vitro infection of target cells. Slocks of these viruses were prepared and titrated as 
previously described (Blackman A Morris. 1984),
L929 and C 3 H I0 T) (Reznikoffrt. m l., 1973) fibroblasts were cultured in the Glasgow modification of Eagle's 
MEM (G M E M ; Gibco) supplemented with 10% newborn calf serum (Gibco). Lymphoblastoid cells F.L4 (H-2*).
brain cell cultures prepared from I - or 2-day-old C3H He or DBA (obtained from Oiac,
Wycombe, U .K .) showed few if any fibroblasts present and that at least the majority of the cells -
Cytotoxic T  ce lls and cytotoxicity assays SFV-specific and alloreactive (ann-H-2*) C TL were prepared
units/ml of mouse IFN-O0 (Lee Biomolecular, sp. act. 4 x I O’ units/ml. from Stratech Scientific. London. U.K.)
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fibroblasts (JU and cultured brain cells (■ ). Incorporation is expressed as a percentage of that by
uninfected cells. 10 %  or less that of infected cells) subtracted, 
provided as purified antibody by E Culbert (ICI. Macclesfield. U K ). <av) FITC-conjugated sheep anti-rabbit Ig
IFN-ifl Maturity o f  astrocytes. To determine the relative sensitivity to IFN-«/) of SFV replication in C3H 
astrocytes these were distributed in 96-well microtitre plates at 4 * 10* cells per well. Two C3H fibroblast lines 
(L9I9 and C3HI0TJ) both of which are highly sensitive to IFN-«/) were distributed in parallel Next day the 
cultures were treated with a laboratory standard IFN-a/l preparation. 0-1 to 1000 units/ml in tenfold steps. The 
next day the cells were challenged with SFV (m.o.i. about 300) and labelled from 3 to 5 h post-infection with 
[»HJuridine (Amersham) in the presence of actinomycin D (Sigma). Under these conditions (’Hfcmdine is 
incorporated almost exclusively into SFV progeny RNA since cellular DNA-dependent RNA synthesis is 
inhibited TCA-insduble radioactivity was measured and plotted against IFN-«/) concentration (Atkins n  a!..
Fig. 1 shows the incorporation of [5H)uridine into IFN -«/) treated, SFV-infected brain cells, 
L929 cells and C 3 H I0 T $  cells. The data show that all three cell types had about equal sensitivity 
to IF N -i/?. with about 5 0 %  inhibition of virus R N A  replication at I unit/ml IF N -a /)  and no 
RN A replication above background levels at 1000 units/ml. Hence 1000 units/ml was used for 
subsequent experiments.
Effect o f  IF N -x fi  trea tm en t on  S F V  an tigen  expression in brain cells m easured b y  indirect
Infection of brain cells with S F V  resulted in a marked increase in reactivity with the an ti-S F V  
serum (Fig. 2 a  and b)  with a shift in the mean fluorescence intensity channel (M N ) from 30 to 
160 and a rise from 4 to 2 6 %  in the numbers of cells showing in the maximum fluorescence 
intensity channel ( C H ; maximum intensity is channel 255). Pretreatment o f the cells with IF N - 
7fi however, very markedly reduced S F V  antigen display (Fig. 2c) but did not abolish it; a small 
number of cells were still intensely stained ( 4 %  showing in maximum intensity channel) and the 
mean intensity was clearly elevated over levels seen in the uninfected cells.
(Wellcome Diagnostics. Beckenham. U K ), (v) FITG-conjugated goat ami-mouse Ig (Nordic Immunological 
Laboratories. Maidenhead. U K.) These antibodies were all titrated and used at saturating concentrations. Flow
RESULTS
Relative sensitiv ity  o f  C 3 H  brain cells to  IFN-a.fi
immunofluorescence
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Fluorescence intensity
Fig. 2. SFV antigen expression by infected brain cell». SFV antigens were quantified by flow cytometry 
Panels (a). (A) and (r) show the fluorescence intensity distribution for untreated, uninfected cells; 
untreated, infected cells, and IFN-a/l treated. SFV-infected cells respectively. In each case 
approximately 10* cells were processed. M N . mean fluorescence of cells. CV. coefficient ofSanation. 
CH , fluorescence channel with largest number of cells in it (i.e peak fluorescence); HI. number of cells 
in CH and as a percentage of total cells processed. Fluorescence intensity units are arbitrary, and the 
scale is linear from channel 0 to 255.
E ffec t o f  IF N -a fi treatm ent an d  S F V  in fection  on expression o f  M H C  class I  antigens m easured  
b y  indirect fluorescence a n d  susceptib ility  to a lloreactive C T L  killing  
Analysis by flow cytometry showed that the untreated, uninfected brain cells displayed 
undetectable levels of H -2 K k since the fluorescence intensity of a n ti-H -2K k-stained cells was not 
significantly elevated above that of the same cells stained by an irrelevant antibody of the same 
class (data not shown). However, as others have found, H -2 K k levels were markedly increased 
by IF N -a /l treatment of these cells (F ig . 3a  and b)  with a shift in  the mean fluorescence intensity 
channel from 42 to 85. S F V  infection itself d id not induce H -2 K k expression in the cultured brain 
cells (Fig. 3c) nor did S F V  infection have any effect on the elevated levels of H -2 K k expression 
in IF N -a /l treated cells (data not shown). Levels of H -2 D k were sim ilarly determined in  brain 
cells treated with IF N -a /l. As with H -2 K k, untreated brain cells showed no detectable H T 2 I>  
expression since again background fluorescence was essentially the same as for brain cells 
stained with an irrelevant antibody. However, brain cells treated with IF N -a /l showed strong 
expression of H -2 D k, with mean fluorescence rising from channel 54 to channel 89 (Fig . 4). 
Hence expression of both major M H C  class I antigens is increased in these brain cells by I F N -a /l 
treatment.
A n  indirect measure of H -2  expression by cells is their susceptibility to killing by alloreactivc 
C T L ,  since these recognize only M H C  class I determinants. Accordingly the effect of IF N -a /l
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Fig 3 H-2K antigen expression by IFN-a/Mreated brain cell* MHC class I antigen (H-2K*) was 
quantified by flow cytometry. Panels (o), (b) and (c) show the fluorescence intensity distribution for 
untreated. IFN-a/l-treated and SFV-infected cells respectively. In each case approximately 10* cells 
were processed. Abbreviations as for Fig. 2.
Fig. 4. H-2D expression by IFN-o/l-treated brain cells. M H C class I antigen (H-2D*) was quantified by 
flow cytometry Panels (a) and (h)show the fluorescence intensity distribution for untreated and lFN-«/l 
cells respectively. In each case more than 14000 cells were processed. Abbreviations as for Fig. 2; S, 
number of cells sampled and as a proportion of the total.
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Fig 5. Effect of IFN-a/lon lysis of infected brain cell», (a) Ly»i» by C TL  of infected C3H (A )  or DBA 
(• ) brain cell*, untreated ( - )  or IFN-a^-treated ( - - - ) .  and uninfected non-IFN-treated Y A C  cell* 
(■ ). (6and r) Killing of C3H and DBA brain cells respectively by anli-SFV antibody and complement. 
without ( - )  and with ( + ) IFN-oJ
Table I . L ysis o f  b ra in  cells b y  a lloreaclite  C T L
Cytotoxicity* <*; specific ” Cr release)
Allorcactivc C T L  line 
I (2nd passage)
1 (3rd pasaage)
2 (3rd passage)
3 (3rd passage)
Without IFN
* Brain cells were treated with IFN-o/land subjected to lysis by allorcactive C TL  as described i 
are quoted for an E :T  ratio of 10:1.
Methods Data
treatment on susceptibility of brain cells to alloreacti ve C T L  was determined. The data in Table 
1 show that in four experiments using three independent alloreactive lines, IF N -a /1  treatment of 
target cells increased killing, implying an increase in H -2  expression.
E ffect o f  IF N -a fi  trea tm en t on  cyto lysis o f  S F V -in fe c te d  cultured brain  ce lls  b y  SF V -specific  
C T L  or S F V -sp ec ific  a n tib o d y  a n d  com plem ent
In  a series of experiments carried out with SFV-specific C T L  prepared as above it was 
regularly found that infected syngeneic brain cells were killed efficiently irrespective of whether 
they were IFN-a/J-treated. In most of these experiments uninfected targets were not killed and 
nor were allogeneic targets (infected or uninfected), hence the killing by these effectors was 
specific and H-2-restricted as we have previously found with lymphoblastoid targets (Blackman 
i t  Morris. 1985). O ccasionally the killing was unrestricted, and uninfected cells were also killed; 
in such experiments Y A C  cells were also killed, implying the presence of natural killer (N K ) 
cells, and results o f these experiments were disregarded. K illin g  of infected lymphoblastoid 
targets R D M 4  and E L 4  was parallel to k illin g  of brain cell targets and quantitatively similar 
levels of lysis were obtained. In  the experiment shown in  Fig. 5 killing  of infected C 3 H  brain 
cells with or without IF N -a / l  by C T L  and antibody to S F V  plus complement is  shown. The 1FN - 
a p  treatment resulted in somewhat increased C T L  k illin g  at all E : T  ratios but abolished 
antibody and complement killing. T h is  augmentation of C T L  killing by IF N -a /f  treatment of 
infected targets occurred in  eight out of ten experiments; in the other two the killing was 
undiminished. T h e  experiment shown in  F ig . 5 also demonstrated that the C T L  k illing was 
M HC-restricted since infected D B A  targets (whether or not IFN-a/J-treatcd) were not lysed 
whereas these were lysed by a n ti-SF V  antibody and complement. Y A C  cells were not lysed, 
showing that there was no significant N K  cell activity in the effector population. Therefore, 
brain cells treated w ith  IF N -a /1 and infected with S F V  were killed by S FV -sp ecific  C T L  as well
as or better than non-IFN-a/J-treated brain cells, despite a marked diminution of S F V  
replication and antigen expression.
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DISCUSSION
The importance of M H C  antigen expression in  immune recognition by T  cells of their Urget 
cells is now well recognized. Cells that express no M H C  class I antigens are not lysed by C T L  
(Zinkem agel & Doherty. 1979). Equally, ‘foreign' antigens to which the T  cell is sensitized must 
be present for recognition to occur: hence the T  cell recognizes the foreign and self M H C  antigen 
together. Since IFN -«/? regulates the expression of both viral antigens and M H C  antigens, in 
opposite directions, the effects on C T L  lysis of IF N -o /l  treatment of target cells infected with a 
virus are likely to be complex. In previous experiments with fibroblasts and lymphoblastoid cells 
we have found that IF N -s /?  treatment usually reduces but does not abolish C T L  lysis of S F V - 
infected cells: others have found in different systems that IFN -a/J treatment can augment lysis 
(Bukowski &  Walsh. 1985; Flyer e ta ! . , 1985). W e have extended these experiments to brain cells 
because these cells normally express very low levels of M H C  and so the effects of IF N -a /l 
treatment on C T L  lysis may be more clear-cut. The study of T  cell responses to brain cells is in 
itself of interest because of the possible role of T  cell-mediated immunity in virus encephalitis 
and encephalopathies such as multiple sclerosis and subacute sclerosing panencephalitis.
We have found that cultured murine brain cells (predominantly G F A P *  astrocytes) infected 
with S F V  are susceptible to lysis by C T L .  T h e  fact that this lysis is M HC-restricted very 
obviously implies that there is sufficient M H C  expression for T  cell recognition to occur, 
although this could not be detected by indirect immunofluorescence. It was possible that 
infection with S F V  induced M H C  expression during the cytotoxicity assay thus allowing C T L  
recognition. Considering the short length of time involved this does seem unlikely; however, 
retroviruses, at least, can induce M H C  antigens (F lye r e t a!., 1985) and so can coronavirus 
(Massa e t  a t . 1986) so this also was a formal possib ility  in the case of S F V  infection. The flow 
cytometric data show that H -2 K ‘  was not induced by S F V  infection, but that does not exclude 
the possibility that some other restriction element m ay be involved. However, the simplest 
explanation for the data is that M H C  antigens are present in amounts sufficient for C T L  
recognition but insufficient for detection by antibody. The experiments in  which we have found 
alloreactive C T L  to lyse brain cells tend to confirm  the presence of M H C  antigens.
The I F N -i/ )  treatment o f the brain cells reduced S F V  replication and S F V  antigen expression 
to a very low level but did not completely abolish S F V  antigen expression. H -2  expression on the 
other hand was increased as was shown by increased staining with monoclonal antibodies 
reactive with H-2K* and H-2D * and by increased susceptibility to lysis by alloreactive C T L .  The 
net result was that although lysis by antibody and complement was essentially abolished, C T L  
lysis was somewhat augmented. Th is  could well p lay an important role in T  cell-mediated 
mechanisms of SFV-induced encephalitis in  mice.
Since our primary brain cell cultures are mixed, although predominantly G F A P *  astrocytes, 
we cannot at present determine in which cell type S F V  replication m ainly occurs nor which type 
is the major target for C T L .  However, since up to 8 0 %  o f cells displayed S F V  antigens and up to 
80*. lysis by C T L  occurred, then at least some o f the astrocytes must express virus antigens and 
are killed. Whether other cells (e g. oligodendrocytes), making up a m inor proportion of the 
cultures, are also killed remains to be determined.
These results have a number of significant im plications for resistance to virus infections, 
especially for infections of the C N S  Provided I F N  is present to increase M H C  expression, C T L  
(or other T  cell) responses occur even though virus replication is limited and virus components 
may be present at very low levels. Once such a response is triggered, it could be self- 
perpetuating: in response to virus-infected target cells T  cells produce I F N -y (  Morris era/. 1982; 
Blackman &  Morris. 1984) which is particularly effective at augmenting M H C  expression and 
so despite its effect in lim iting virus replication the T  cell response could continue. Prelim inary 
results employing recombinant murine IF N -y  prepared in this laboratory from genetically 
engineered Chinese hamster ovary cells indicate that IF N -y  also augments C T L  lysis of IF N -  
treated. SFV-infected brain cells, in a way very s im ila r  to that described above for natural IF N -
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ofi. The production of IF N -y  by T  cell* responding to virus-infected brain cells could precipitate 
autoimmune responses to normal C N S  components. T h u s, it  has been shown that IF N -y  
augmenting H 2 -la  expression by astrocytes enables these cells to present myelin basic protein 
(M BP) to T  cells (F ie rze la l . ,  19*5), T  cells thus sensitized to M B P  could mount an autoimmune 
attack on the C N S  (Zam vil e l  a l.. 1985). Hence, a C N S  v irus infection could trigger in  this way 
diseases such as multiple sclerosis. In such a case one might expect IF N  treatment of multiple 
sclerosis to exacerbate the disease; however, at least IF N -a / i  does not (Jacobs e l  a !., 1982) 
Our results overall emphasize the importance of histocompatibility antigens in immune 
recognition of virus-infected cells and also suggest an im portant role for lF N -a ^ s  and virus 
infections in  autoimmune diseases of the C N S .
Wc wish lo ilunk Anne M cr (University of Birmingham) for running ihe FACS 440 and providing excellent 
iccr Research Campaign and Science and Engineering Research Council for
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Role o f  interferon-gam m a in T-cell responses to  Semliki F o rest 
virus-infected murine torain cells
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S U M M A R Y
Primary brain cell cultures prepared from newborn C3H  mice were infected with Semliki Forest virus 
(SFV) or treated with a /l-propiolactone-inactivated preparation of S F V  (BPL-SFV). The effects of 
recombinant interferon-gamma (IFN-y) treatment on S F V  replication. S F V  antigen display, major 
histocompatibility complex (M HC) class I and class II  antigen expression, susceptibility to lysis by 
SFV-specific cytotoxic T  lymphocytes (C T L ) and the ability to stimulate SFV-specific T  lymphocytes 
to release IF N -y  were determined. The IFN -y  treatment prevented replication of S F V , as determined 
by incorporation of (’ HJuridine into S F V -R N A . and reduced expression o fS F V  antigens on the cell 
surface, as determined by lysis with antibody and complement or indirect immunofluorescence. B P L - 
SFV-treatcd brain cells expressed no S F V  antigen delectable by lysis with antibody and complement 
or indirect immunofluorescence. IFN -y  increased expression of M H C  class I and class II antigens, 
measured by indirect immunofluorescence, susceptibility to killing by allorcactive T-cell lines and 
ability to stimulate an allogeneic mixed lymphocyte reaction (M LR). Brain cells infected with S F V  or 
treated with B P L -S F V  were susceptible to killing by the C T L . The killing was M H C  restricted and 
neither uninfected nor untreated cells were killed. IFN -y  treatment prior to S F V  infection or B P L - 
S F V  treatment resulted in an augmentation of lysis by the C T L . indicating that even where S F V  
antigen expression is reduced or present at very low levels, in the context of enhanced M H C  class I 
expression cells remain susceptible to C T L  killing. Brain cells treated with B PL -S FV  stimulated S F V -  
spccific T  cells to release IFN -y. Pretreatment of brain cells with IF N -a /l or IFN -y  prior to B P L -S F V  
treatment markedly increased the ability of the cells to stimulate the SFV-specific T  cells to release 
IFN -y. Release of IFN -y  was M H C  restricted and brain cells untreated with B P L -S F V  did not 
stimulate IF N -y  release. IFN -y  released by T  cells stimulated with BPL-SFV-trcatcd brain cells 
increased class II  M H C  expression by brain cells as assessed by indirect immunofluorescence.
IN T R O D U C T IO N
There have now been repeated demonstrations that cells of the 
brain express unusually low levels of antigen encoded by the 
major histocompatibility complex (M HC) (Vitctta A  Capra. 
1978; Wong c l at.. 1984; Momburg e l a!.. 1986). This is 
surprising since class I (H 2 D . K . L) and class II (IA . IE) M H C 
antigens play a central role in the immune recognition of foreign 
antigen by T  cells. Thus, with few exceptions, cytotoxic T  
lymphocytes (CT L) only recognize foreign antigen in associ­
ation with class I antigen, whereas T-hclpcr (Th) lymphocytes 
recognize foreign antigen in association with class II  antigen 
(Klein e l al.. 1981). Several reports have demonstrated that 
whilst both IFN -x/l and IF N -y  augment class I M H C  antigen 
expression by brain cells, only IF N -y  augments class II M H C 
antigen expression, and then only upon a specific population of 
brain cells (Wong e t a l.. 1984; Tcdcschi. Barrett A  Keane. 1986;
Correspondence: Mr P. T . Tomkins. Dept, of Biological Sciences. 
University of Warwick. Coventry CV4 7AL. U.K.
Morris e t a l.. 1987). IF N  modulation o f M H C  antigen ex­
pression may thereby render these cells competent to initiate and 
participate in T-cell mediated immune reactions within the
Our interests relate to the ways in which IF N s can influence 
T-cell responses to brain cells infected with the neurotropic 
Semliki Forest virus (SFV) via modulation of M H C antigen 
display. Our previous work has demonstrated that IFN -a0 
treatment of primary brain cells, prior to infection with SFV. 
results in an augmentation of class I M H C  antigen display and 
in susceptibility to lysis by SFV-spccific C T L .  despite a marked 
diminution of S F V  replication and antigen display (Morris et 
al.. 1987). We have now extended these observations and found 
that IFN -y  augments C T L  lysis of IFN-y-trcatcd SFV-infccted 
brain cells in a similar manner. C T L  and T h  lymphocytes have 
been shown to produce IF N -y  upon appropriate recognition of 
a virus-infected cell (Morris. Lin A  Askonas. 1982: Cunn­
ingham e t al.. 1985). Therefore, we have studied whether or not 
our SFV-specific T  cells produce IF N -y  when stimulated by 
brain cells treated with a /7-propiolactonc-inaclivalcd prep-
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■ ration of S F V  (BPL-SFV). It was found that BPL-SFV-lrealed 
brain cell* stimulated SFV-spedfic T  cells to release IFN -y and 
that pretrcatment of brain cells with cither IF N -a /l or IFN -y 
prior to treatment with BPL -SFV  markedly increased the 
amount of IF N -y  released.
M A T E R IA L S  A N D  M E T H O D S
Celli
L929 cells were cultured in the Glasgow modification of Eagles 
MEM  (G M E M ; Gibco, Paisley. Renfrewshire) supplemented 
with 10 %  newborn calf serum (Gibco), 2 m a glutamine, 
penicillin (60 pg/m l)  and streptomycin (100 >ig/ml). Lymphob- 
lastoid cells E L 4  (H2*), RDM 4 (H2‘ ). Y A C - I  (H2*) (a natural 
killer cell target) and mastocytoma P815 (H 2°) were cultured in 
RPMI-1640 medium (Gibco) supplemented with 10 %  fetal calf 
serum (Gibco). heat-inactivated prior to use for 30 min at 56°. 
with glutamine, penicillin and streptomycin as before. Primary 
brain cell cultures were prepared from l-2-day-o ld  C3H-Hc 
mice (H24) from breeding pairs supplied by Banlin and 
Kingman (Aldbrough, Hull) as previously described (Morris el 
at.. 1987). Indirect immunofluorescence of permeabilized cells 
using anli-fibronecun (Calbiocbem, Cambridge Bioscience, 
Cambridge) or anti-glial-fibrillary acidic protein (GFAP) 
(Dako, High Wycombe. Bucks) showed there were few if any 
fibronectin-containing fibroblasts present and that at least the 
majority of cells present were G F A P * astrocytes.
BALB/c (H2°) mice (OUc, Bicester. Oaon) were primed i.p. with 
I x 10* C3H -H c spleenocytes. Ten days later single-cell suspen­
sions were prepared from the spleens of these pruned B ALB /c 
mice and also C3H -H e mice. The C 3 H -H c cells (stimulators) 
were treated with mitomycin C  (Sigma) at 25 p g jm i  in PBS for 45 
min at 37°. followed by four washes in medium, to prevent their 
proliferation. The C3H /H c spleen cells were then mixed with the 
primed BALB/c cells in RPM I medium (supplemented as before 
and including 10* * m /f-mercaplocthanol) with 25 x HP of each 
cell type in 25 ml. For cytotoxicity and proliferation assays, cells 
were harvested at 5 and 10 days, respectively, and spun over 
lymphoprep (Nyegaard. Torshov, Norway) prior to use. in 
order to remove cell debris.
C yto tox ic ity  assays an d  production o f  IF N  b y  effector T  cells 
Two days prior to cytotoxicity assays, brain-cell cultures were 
treated with 100 U/ml (laboratory units) murine IFN -y. Control 
cultures were left untreated. Cultures were treated with 
" C r P 'C f i (S O ,k  Amersham, Aylesbury. Bucks] at 20 >iCi/ml 
overnight and the next morning mock infected or infected with 
S F V  or B PL -S FV  [muliiplidly of infection (M OI) 1000). At 2 hr 
post-infection, cells were harvested by treatment with E D T A  
(0-02% in PBS) for 15 min at 37°. then distributed into wells of 
96-well round-bottomed nucrotiire plates at I x 10* cclU/weU. 
SFV-specific effectors were then added to urge! wells at 4 hr 
post-infection, to give effector:target ratios ( E :T )  of 3 :1  to 
30:1. “C r release was determined 5 hr later and specific release 
calculated using the formula:
Finises
The a virulent strain of S F V  A774 (Bradish. Allncr A  Maber, 
1971) was used for the immunization of mice and the virulent 
L I0  strain for in vitro  infection of target cells. Stocks of these 
viruses were prepared as described previously (Blackman A 
Morris, 1984). For experiments with inactivated virus, the slock 
L I0  virus was treated with /l-propiolactone (BPL). Virus was 
dialysed overnight against 50 mu T n s -H C l (Sigma. Poole. 
Dorset). pH 7 25 then incubated with a  I %  B P L  (Sigma, grade 
II) for 5 hr at 4°, followed by overnight dialysis against the same 
Tris buffer to remove residual B PL and its breakdown products, 
prior to final dialysis back into G M E M . Th is  procedure reduced 
the infectivity of S F V  from 10* plaque-forming units (PFU)/ml 
to less than 10 PFU/m l and rendered the virus unable to 
undergo replication, as assessed by incorporation of (’HJuridinc 
into viral R N A  in infected cells.
Interferons
Murine IF N -« /l. specific activity 4 x 10’ U /m l. was purchased 
from Lee Biomolecular, San Diego, C A . M urine IFN -y was 
prepared from Chinese hamster ovary cells (G . D. Searle, High 
Wycombe. Bucks) transfected with the mammalian expression 
vector pKSVi* containing a cD N A  copy of the M u-IFN-y 
m RN A. Details of the procedures used are published elsewhere 
(Morris A  Ward. 1987). The supernatant harvested from the 
transfected cells contained about 1000 U/m l M u-IFN -y. which 
was partially purified by affinity chromatography on cibicron 
blue Sepharose (Sigma) to a specific activity o f  about 10’ U/mg 
protein.
Preparation o f  SFV-specific an d  alloreactive effector T  cells 
SFV-specific lymphocytes were prepared as described pre­
viously (Blackman A  Morris, 1985). For allorcactivc effectors
%  lysis-
(rdeaae in presence effectors — spontaneous release)
* (total release—spontaneous release)
where total release is in the presence of 0-5 m hydrochloric acid. 
Cytotoxicity against lymphoblastoid cells was determined in
prepared in this way to be antigen specific and M H C  restricted 
(Morris e ta ! ., 1987; Blackman A  Morris. 1984.1985) Allorcac- 
livc killing was determined in essentially the same way as for 
SFV-specific C T L  assays but omitting S F V  infection.
In order to monitor the production o fIF N  by S F V  effector T  
cells stimulated by brain cells, the assay was carried out in the 
same way except that target cells were not labelled with “C r; the 
E :T  ratio was 10 :1. cells were only treated with B P L -S F V  (since 
live virus would interfere with the subsequent IF N  assay), and 
some brain cells were treated with 1000 U/ml murine IF N -o £ 
(related to N IH  mouse IF N  standard G002-904-5II). The 
supernatant medium was collected after 6 hr. centrifuged at 
10,000 g  for 2 min and the IF N  assayed as outlined below.
Alloproliferaiion assays
For alloproliferaiion experiments the assay was set up in 
essentially the same way as for cytotoxicity assays, except that 
brain cells were treated with mitomycin C  (25 pgjm i in PBS) to 
prevent their proliferation prior to the addition of the allo­
rcactivc responders. After 30 hr co-culture ('HJthymidinc 
(Amersham) was added to each well to a final concentration of 
3 pCi/ml. After a further 24 hr cells were harvested and amounts 
of (’H)thymklinc incorporated measured.
IF N  assays a nd  IFN -y sensitivity o f  brain cells
IF N  was assayed by the I N A S » method (Atkins e l a!.. 1974)
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using S F V  challenge of L*» cells. IFN  activity was characterized 
by neutralization assay using a polyclonal rabbit antisera to 
IF N  induced by Newcastle Disease virus in L*» cells (IFN 
a + fi) . and by the monoclonal antibody anti-M u-IFN -y (R4- 
6A2. E  H a veil. Trudeau Institute, New York). The relative 
sensitivity of brain cells to IFN -y was determined as previously 
described (Morris e l a t., 19*7).
Quantification o f  surface S F V  and M H C  antigen  
S F V  antigens were measured in parallel to the cytotoxicity 
assays either by “C r release in the presence of SFV-specihc 
antibodies and complement (Pel-freez, North-East Biomedical. 
Uxbridge, Middlesex) or by indirect immunofluorescence, 
quantified by flow cytometry. M H C  class I and II antigen 
expression were also measured by indirect immunofluorescence 
Antibodies used were (i) a hyperimmune rabbit antiserum 
against S F V  prepared by inoculation of purified S F V  (Black­
man *  Morris, 1985); (ii) monoclonal antibody anU-H2-K‘ 
from hybridoma clone 1 1-4-1 (A T C C , TIB95); (iii) monoclonal 
anti-H2-D* from clone 15-5-55 (A T C C . HB24) provided as 
purified antibody by E. Culbert ( IC I, Macclesfield); (iv) mono­
clonal anti-H 2-IA‘  from clone 10-3-6 (A T C C , TIB92); (v) 
monoclonal anli-H2-K< from clone 3I-3 -4 S  (Uniscience. Lon­
don); (vi) FITC-conjugaled sheep anti-rabbit Ig (Wellcome 
Diagnostics. Beckenham. Kent); (vii) FITC-conjugaled goat 
anti-mouse Ig (Nordic Immunological Laboratories, Maiden­
head, Berks). A ll antibodies were uiraied and used in saturating 
concentrations. After staining, cells were fixed in 3 %  parafor­
maldehyde in PBS and stored in the dark at 4° prior to flow 
cytometry analysis using the Becton-Dickinson FACS440 at 
Birmingham University. Fluorescence data were collected in list 
mode using linear amplification and analysed subsequently. 
Histograms of cell number against fluorescence intensity were 
printed. The number of fluorescing cells were determined by 
setting a marker on the histograms at the fluorescence intensity 
channel for control sample, stained with an irrelevant antibody, 
at a point where only 5 %  of the cells processed were of higher 
fluorescence. For each sample thereafter all cells of higher 
fluorescence than the marker were deemed above background 
fluorescence.
Figure I. SFV antigen display by infected brain cells Panels show ihc 
fluorescence intensity distribution for (a) untreated, uninfected cells, (b) 
BPL-SFV-Ircated cells, (c) SFV-infocted ceils, and (d) IFN-y-lrealed. 
SF'V-infected cells In each case 9721 cells were processed Abbrevia­
tions S. number of cells above marker and as percentage of total cells 
processed, MN. mean fluorescence of cells. CV. coefficient of variation. 
CH. fluorescence channel with largest number of cells in it (l e. peak 
fluorescence); HI. number cells in CH and as percentage of cells 
processed fluorescence intensity uniU are arbitrary, and the scale is 
Unear from channel 0 to 255
equivalent amount of B P L -S F V  resulted in essentially no 
increase in reactivity with anti-SFV scrum (Fig. la and b). IFN -y 
pretreatment of brain cells prior to infection with Uve SFV  
reduced S F V  antigen expression to a level only slightly above 
background fluorescence (Fig. la , c  and d).
RESULTS
Relative sensitivity of C3H brain cells to IFN-y and effect of 
IFN-y treatment on SFV antigen expreanion measured by indirect
In order to assess the relative sensitivity of C 3 H  brain cells lo 
IFN -y, the incorporation of (’H)uridine inlo IFN-y-treated 
SFV-infected brain cells and L .»  cells was determined. It was 
found that both cell types had approximately equal sensitivity lo 
IFN -y, with SO"/, inhibition of virus R N A  synthesis at I U/ml 
IF N -y  and no R N A  synthesis above background levels at 
100 U/ml (data not shown). One-hundred units per millilitre 
IF N -y  were therefore used in subsequent experiments.
Infection of brain cells with live S F V  markedly increased 
reactivity with the anti-SFV serum (Fig. la  and c). with a shift in 
mean fluorescence from 6 to 1 10. peak channel from 3 to 255, 
and an increase in the percentage of cells above channel 9 from 
9 %  to 95*/.. In contrast, treatment of the brain cells with an
Effect of IFN-y treatment on expression of clam I aad class II 
MHC antigens by C3H brain cells, as measured by indirect
Analysis by flow cytometry showed that untreated brain cells 
express undetectable levels of H2K* since the fluorescence 
intensity distribution of anti-H 2Kk-slaincd cells was not signifi­
cantly higher than that of the same cells stained with an 
irrelevant antibody an li-H 2K‘  (Fig. 2a and b). However, as 
others have demonstrated (Wong e ta i .,  1984), IFN -y treatment 
markedly increases H2IC‘  expression by the cells (Fig. 2b and c). 
with a shift in mean fluorescence from 11 to 162, peak channel 
from 3 to 255, and the percentage of cells above the marker 
increasing from 8 %  to 9 3 % . Levels of H 2-D 1 expression were 
determined in the same manner. At least some untreated brain 
cells displayed low levels of H2-D* since the fluorescence 
intensity of cells stained with anti-H2-D* was slightly higher 
than for the same cells stained with the irrelevant antibody (Fig. 
3a and b), with a shift in mean fluorescence from 26 to 41. and 
the percentage of cells above background fluorescence marker
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Klgw* 2. H2-K expression by IFN-y-lrealed brain cell» M HC ch u  I 
antipen (H2-Kk) was quantified by Bow cytometry Panel (a) shows the 
background fluorescence intensity distribution Panels (b) and (c) show 
the fluorescence intensity distribution for untreated and IFN-y-treated 
brain cells, respectively, stained with anti-H2Kk. In each case 97211 cells 
were processed Abbreviations as for Fig. I.
Figure 3. H2-D expression by IFN-y-lrcalcd brain cells M H C class I 
antigen (H2-D4) was quantified by flow cytometry. Panel (a) shows the 
background fluorescence intensity distribution Panels (b) and (c) show 
the fluorescence intensity distribution for untreated and IFN-y-lrealed 
brain cells, respectively, stained with anli-H2-D*. In each case 972» cells 
were processed. Abbreviations as for Fig. I.
rising from 5 %  to 1 2 % .  IFN -y  treatment of brain cells 
considerably increased H2-D* expression (Fig. 3b and c). with a 
shill in peak channel from 10 to 255, and a rise in the mean 
fluorescence from 41 to 1 17. IF N -y  treatment did not increase 
binding of the irrelevant antibody (data not shown). IF N -y  
treatment therefore increases expression of both major M H C  
class I antigen. Concentrations of IFN -y  as low as 0-1 U/ml were 
found to result in a distinct enhancement of H 2 I>  and H 2 K k 
expression, although enhancement was actually maximum at 10 
U/ml (dau not shown). S F V  or B PL -S FV  infection itself did not
augment class I antigen on the cultured cells, nor have any effect 
upon the elevated levels of expression on IFN-y-treated cells 
(dau not shown).
Analysis by flow cytometry also showed that the untreated 
brain cells displayed undetecublc levels of H 2-IA k since the 
fluorescence intensity of anti-H 2-IAk-sUined cells was essen­
tially identical to the same cells stained with an irrelevant 
antibody (dau not shown). Treatment with IFN-a/J had no 
effect upon class II M H C  antigen expression since the fluores­
cence intensity distribution of IFN-a/f-treated cells was essen­
tially identical to that of untreated cells (Fig. 4a and b). 
However, treatment of brain cells with IFN -y  greatly increased 
the fluorescence intensity distribution with a rise in peak channel 
from I to 255 and a mean shift from 17 to 97 (Fig 4b and c). 
showing that IF N -y  treatment increases expression of M HC 
class II antigen by these cultured brain cells. Concentrations of 
IFN -y  at I U/ml gave distinct enhancement of H 2IA k expression 
and enhancement was maximal at 10 U/m l (data not shown).
Effect of IFN-a/f aad IFN -y treatment of brain cells upon class I 
and class II MHC expression, ax assessed by alloreacti.e 
lymphocytes
A n  indirect measure of class I M H C  expression by cells is their 
susceptibility to lysis by alloreactive C T L .  since these recognize 
only M H C  class I determinants. Consequently the effect of 
IFN -y  treatment upon the susceptibility of the brain cells to 
alloreactive C T L  lysis was determined. Figure 5 shows that 
untreated brain cells were slightly more susceptible to allorcac- 
tive C T L  than control cells of the wrong haploiypc (P8I5). 
indicating that at least some brain cells express sufficient M H C 
class I antigen for recognition. IF N -y  treatment of the brain cells 
increased susceptibility, implying increased M H C  class I ex­
pression. As reported previously (Morris e l a l., 1987) IFN -x/l 
treatment also increased killing, also implying increased M HC
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Hear* 5. Effect of IFN -r on lysis of brain cell« by altoreactive (H2‘ -anti- 
H2*) CTL. Untreated (a —a ). IFN-y-treated (•— •). IFN-a/!-trealed 
(■ - ■ ) .  untreated P « l} (H2*) cells (0 — 0 )  and RDM4 (H2») cell* 
(A —A).
TaMe I. Ability of brain celli to tumulate an allogeneic MLR
Stimulator brain cell 10:1 J : l  Alone
Untreated *920 ±1295 7925 ±1211 4095 ±1675
IFN i/l treated M IS ± IJM  *9S9±I9J3 2912 ±1)73
IFN -r treated 29971 ±2074 26992 ±2*5* 2674 ± 300
Rciulli were the mean of quadruplicale cult urei and are etprcaacd at 
mean cp.m.±SD of |»H)thymidine incorporation. Retpondert were 
(H2* anti-H2‘ ) alloline
clast I expression. A ll killing was H -2  specific since RDM 4 cells 
( « 2 “) were lysed whereat P8I5 cellt (H2<) were not
A measure of functional M H C  class II expression can be 
obtained by assaying the ability of cells to stimulate an 
allogeneic M LR. Hence the ability of these brain cell cultures to 
stimulate an M L R  has been investigated. Treatment of brain 
cells with IFN -«0  did not increase the ability to stimulate an 
allogeneic M LR . since levels of [’HJthymidinc incorporated by 
responders stimulated by untreated and I FN-s/J-treated cells 
«vere identical (Table I). In contrast, cells treated with IFN -y 
clearly stimulated an allogeneic M L R  with levels of[’H)lhymi- 
dinc incorporated by the responders rising from 8920 to 29971 
c.p.m. (Table I ). This increase in functional class II  M H C  upon 
treatment with IF N -y  but not IFN -a/J parallels the increases in 
H-2-IA* expression determined by flow cytometry analysis.
F.lfect of IFN -y treatment on lysis of S F V -infected brain cells by 
S F V -specific C T L  or S F V -specific antibody and complement
Figure 6a illustrates that SFV-infected or BPL-SFV-trcatcd 
brain cells are susceptible to SFV-specific C T L  lysis. Untreated 
SFV-infccted brain cells were found to be more susceptible to 
C T L  lysis than untreated. BPL-SFV-treated cells, and in a series 
of experiments it was found that IF N -y  treatment of SFV- 
infccted or BPL-SFV-treated brain cells increased C T L  killing. 
Uninfected syngeneic and infected allogeneic targets were not 
killed nor were Y A C -I  cells, hence all killing was specific. H-2 
restricted and not mediated by natural killer cells. As shown in
Figure 6. Effect of IFN -y o nly«« of infected brain cells (a) Lysis by C T L  
of: SFV-infected brain cells, untreated ( a -  - a ) or IFN-y Heated 
(A -A ); HIM SI V infested brain cells, untreated (O - -• ) or IFN-y 
treated (•— •); uninfected brain cells, untreated (■ - -■ )  or IFN-y 
treated (• -■ ) ;  SFV- or BPL-SFV-infected EL4 cells ( 0 -0 ) ;  and 
uninfected, untreated Y A C -I cells (O— O). (b) Killing of brain cells by 
anti-SFV and complement: (i) SFV infected; (ii) IFN-y treated. SFV 
infected, (hi) BPL-SFV treated, (iv) untreated, uninfected
Fig. 6b. treatment of brain cells with IF N -y  prior to infection 
with S F V  reduced lysis by SFV-specific antibody and comple­
ment to essentially background levels. BPL-SFV-treated brain 
cells were not susceptible to antibody and complement lysis. 
Therefore brain cells treated with IFN -y and infected with SFV  
are more susceptible to lysis by SFV-specific C T L  than 
untreated. SFV-infected cells and this occurs despite a marked 
reduction in S F V  antigen display. Also, BPL-SFV-treated brain 
cells are susceptible to lysis by SFV-specific C T L ,  despite no 
SFV  antigen display detectable by antibody.
The effect of IFN-a/? and IFN-y treatment of BPL-SFV-treated 
brain cells npon the ability to stimulate lymphocytes from SFV- 
immunc mice to produce IFN-y
The data in Table 2 show that these brain 'D U  produce small 
amounts of IF N  upon treatment with B PL -SFV . The IF N  type 
produced appears to be IFN -afl since activity was neutralized by 
specific antibodies to IF N -i/ I  but not IFN -y. Control brain cells, 
untreated with B P L -S F V . did not produce any detectable IF N . 
The ability of these brain cells to stimulate IF N  production by 
SFV-specific lymphocytes was also assessed. As shown in Table 
2. supernatants harvested from co-cultures of IFN-untreated. 
BPL-SFV-treated brain cells with specific lymphocytes con­
tained small amounts of IFN -y. since some activity was 
neutralized by the monoclonal antibody to IF N -y  (which did 
not neutralize any IFN -a/J activity in control experiments; data 
not shown). Small amounts of IFN -a/) activity were also 
detected in these supernatants at levels which correspond to the 
background production of IFN -a/l due to B P L -S F V  treatment 
of the brain cells. Supernatants harvested from co-cultures 
containing IFN-a/J-trcalcd. BPL-SFV-treated brain cells were 
found to contain significantly (Student's Meat, P  <  0 001) higher 
litres of IFN  activity than those supernatants from co-cullures 
containing IFN-untrealed. BPL-SFV-treated brain cells. Like­
wise. supernatants from co-cultures of IFN-y-trealcd. BPL- 
SFV-treated brain cells possessed even higher levels of IF N  
activity, which could be neutralized to background levels using 
antibodies to IF N -y . The litres of IFN  detected in supernatants
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TaMc 2. lFN-e/andlFN-y pretrealment of BPL-SFV-lrcaled beau celi» increases the ability to stimulate SFV- 
lymphocytcs to releaie IFN-y
Brain cell
Supernatants from co-culture of 
brain cells with SFV lymphocytes
Supernatants from cultures 
of brain cells only
Alooc 4-Aau-IFN-M + Anli-IFN-y Alow ♦ Anti-IFN-e* ♦ Anti-IFN-y
IFN-y + BPL-SFV 131± 14* 82± 6 20±9 32±6 <3 32±7
BPL-SFV alone 20± 1 I0± 1 <3 3 <3 3
IF N -« l  + BPL-SFV 72 ±14 S7± 11 <3 I0±7 <3 3
IFN-y alone <3 ND N D <3 ND N D
IFN-a/l alone <3 ND N D <3 ND N D
Untreated <3 ND N D <3 ND N D
Supernatant» were harvested from cultures of brain odi», treated as indica led, in the presence and absence of SFV- 
specihc lymphocytes. IFN activity was assessed and characterized as desenbed in materials and methods 
• Ture» refer to mean of aia replicale titrations ± SD U/ml IFN  activity 
N D. not done.
harvested from co-cultures of SFV-specific lymphocytes with 
either IFN-a/l-treated or IFN-y-trcaled brain cells (also treated 
with B PL-SFV) were significantly different (Student’s /-test; 
/*<0-001). The production of IFN -y  was also M H C  restricted 
since W EHI3b cells (H2*) treated in a similar manner did not 
stimulate the lymphocytes to produce IFN -y  (data not shown).
The effect of each of these supernatants upon M H C  class II 
(H2-IAM expression on brain cell cultures was investigated. 
Table 3 shows that all supernatants harvested from wells
TaMe 3. Effect of IFN  produced by the co-culture of bruin cells and 
SFV-spccilie-lymphocytes upon class II M H C (H 2-IAk) expression by 
brain cell cultures
since the fluorescence intensity of cells treated with these 
supernatants was essentially identical to background fluores­
cence. Supernatants harvested from co-cultures of SFV-spccific 
lymphocytes and brain cells untreated with B P L -S F V  (irrespec­
tive of any treatment with IFN -a/l or IFN -y) also had no effect 
upon M H C class II expression. However, treatment of brain 
cells with supernatants harvested from co-cultures containing 
BPL-SFV-trcaied, I FN-untreated brain cells significantly 
increased H 2-I A k expression, with a shift in mean fluorescence 
from 13 to 40 and in percentage of cells above background 
marker from 5 to 26. Those supernatants harvested from co- 
cultures containing BPL-SFV-trcaied, IFN-lrcated brain cells 
elevated the fluorescence intensity to even higher levels, with a 
rise in the mean from 13 to S3 and the percentage of cells above 
background marker from S to 33. Hence BPL-SFV-treated 
brain cells stimulate SFV-spccific lymphocytes to produce 
IFN -y, which augments M H C  class II expression by brain cell 
cultures. Preliminary studies have indicated that the super­
natants can also augment class I M H C  expression by brain cells.
D IS C U S S IO N
We have shown previously that IFN -a/f treatment of lympho- 
blastoid or primary brain cells prior to infection with S F V  
results in an augmentation of class I M H C  antigen display and 
of lysis by SFV-specific C T L ,  despite a marked diminution of 
S F V  replication and antigen display (Morris e l a l., 1987; 
Blackman &  Morris, I98S). We have now extended these studies 
in order to determine whether or not IFN -y  augments C T L  lysis 
of IFN-y-treated, SFV-infected brain cells in a similar'manner.
% t  MN %
IFN-y +  BPL-SFV 48
BPL-SFV alone 40
I FN -al+BPL-SFV S3
IFN-y alone 17
IFN-a£ alone It
Untreated It
10
14
19
14
19
Supernatants were harvested from wells containing brain cells 
treated as indicated, and cultured in the presence or absence of SFV- 
spcdbc-lymphucylcs. Supernatants were then diluted 1:4 poor to 
addition to brain cell cultures for 48 hr al 37". Cells were then harvested 
and stained by indirect immunofluorescence for class II (H2-IA‘ ) MHC 
antigen expression, quantified by flow cytometry.
Background fluorescence: MN -  13. %  -5 .
t  Percentage of cells above 5% background fluorescence marker.
Our data show that brain cells (predominantly G F A P  • 
astrocytes) infected with S F V  arc susceptible to SFV-spcctlic 
C T L  lysis. Since killing was M H C  restricted, this implies that 
there was sufficient class I M H C  antigen present for T-cell 
recognition to occur, although this could not be detected by 
indirect immunofluorescence. Experiments in which allorcac- 
ti ve C T L  were found to lyse brain cells also imply the presence of 
at least low levels of class I M H C antigen. IF N -y  treatment of 
brain cells reduced S F V  replication in the cells to a level 
undetectable via the incorporation of *(H]uridinc into S FV - 
R N A . Likewise IF N -y  reduced S F V  antigen expression to a
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level undetectable by indirect immunofluorescence of by lysis 
using antibodies to S F V  in the presence of complement In 
contrast. IF N -y  greatly increased expression of class I M H C 
antigen, as assessed by an increased susceptibility of IF N -y- 
trealed brain cells to lysis by alloreactive C T L . Indirect 
e studies demonstrated that IFN -y  greatly 
oth major class I M H C  antigen. H2D* 
and H2K* IF N -y  treatment of the brain cells prior to S F V  
infection resulted in an augmentation of lysis by the S F V - 
specific C T L .  indicating that even where S F V  antigen ex­
pression is greatly reduced, in the context of enhanced M H C 
class I expression, brain cells remain susceptible to C T L  lysis. 
This may play an important role in T-cell mediated mechanisms 
of SFV-induced encephalitis in mice. Bearing in mind IFN -y 
treatment of brain cells essentially abolished S F V  replication 
and antigen display, yet cells remained susceptible to S F V - 
spccifk C T L  lysis, the question arises as to the source of viral 
antigen recognized by the C T L .  Experiments in which brain cells 
treated with B P L -S F V  were found to be susceptible to lysis by 
SFV-specific C T L .  despite expressing no S F V  antigen detect­
able by indirect immunofluorescence or antibody and comple­
ment lysis, suggest that the input viral antigen with which cells 
are challenged may be recognized by C T L .
IFN -y treatment of the brain cells increased expression of 
class II  (IA*) M H C  antigen from otherwise undetectable levels.
found to represent a functional increase in expression which 
could be recognized by Th cells, since IFN-y-treated brain cells 
were found to stimulate an allogeneic M LR . Treatment of the 
brain cells with IFN -o /l had no effect upon class II expression as 
assessed by indirect immunofluorescence or ability to stimulate 
an allogeneic M LR .
Our data also show that brain cells treated with B PL -S FV  
stimulate SFV-specific T  cells to release IF N -y  and that 
pretreatment of brain cells with IFN -ajt prior to B PL -SFV  
treatment increases the ability of the cells to stimulate S F V - 
spccific T  cells to release IFN -y. Similarly, brain cells pretreated 
with IFN -y  were found to stimulate SFV-specific T  cells to 
release even higher litres of IFN -y. A possible explanation for 
the data is that IFN-aJIand IF N -y  augment class I M H C  antigen 
expression and hence the ability of C T L . which release IF N -y. to 
recognize BPL-SFV-treated brain cells. Furthermore, IFN -y 
pretrested BPL-SFV-lrented brain cells may stimulate S F V - 
speofic T  cells to release higher litres of IF N -y  than IF N -afi-  
pretreated BPL-SFV-treated brain cells because IF N -y. unlike 
IFN-a/f. augments class I I  M H C  expression on brain cells and 
thereby increases their ability to be recognized by Th cells, which 
also release IF N -y. We have also found that IF N -y  released by 
SFV-specific T  cells stimulated with BPL-SFV-treated brain 
cells augments class II  M H C  (I A*) antigen expression on brain 
cells, as assessed by indirect immunofluorescence. Our brain cell 
cultures also produced IF N -a /l when treated with B PL -SFV . 
The ability of inactivated virus to induce IF N  production has 
been reported previously in other systems (Meager A  Burke, 
1972).
Overall, our results have a number of significant implica­
tions for resistance to virus infections, especially for infections 
of the CN S . Provided IF N -y  is present to increase M H C  
expression. C T L  responses still occur, even though virus 
replication is limited and virus components may be present at 
very low levels. The production of IF N -y  by T  cells responding
responses to normal C N S  components. Thus it has been shown 
that IF N -y  augmentation of class 11 M H C  antigen expression by 
astrocytes enables these cells to present myelin basic protein 
(M BP) to T  cells (Fontana. Fierz A  Wekerle. I9S4; Fierz e t a t., 
1985); T  cells thus sensitized to M BP could then mount an 
autoimmune attack on the C N S  (Zamvil e l a t., 198$). A  recent 
study in which IF N -y  treatment of multiple sclerosis patients 
resulted in an exacerbation of disease (Panitch e l  at., 1987) 
emphasises the necessity for further studies in this direction.
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